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In 2017, an estimated 219 million people became infected with a Plasmodium 
parasite, resulting in malaria. Of the 435,000 deaths, 61% were in children aged 5 
years and under. With increasing incidences of resistance to standard anti-malarial 
therapies, and the unprecedented failure of rapid diagnostic tests in Sub-Saharan 
Africa, there is an onus on the scientific community to identify new mechanisms 
by which parasites of the Plasmodium genus can be detected and targeted for 
eradication.  
 
In the present study, the epigenetic mechanisms by which the rodent malaria 
parasite, Plasmodium berghei, regulates its transmission were examined. In 
malaria parasites, transmission from a mosquito vector to a mammalian host is 
mediated by a stage of sexual development known as gametocytogenesis. Using 
reverse genetics approaches, in combination with fluorescence-assisted cell 
sorting, a previously undetermined role for histone acetyltransferase 1 (HAT1) in 
Plasmodium intraerythrocytic growth and gametocytogenesis was determined. In 
a similar manner, histone deacetylase 1 (HDA1), a protein previously shown to be 
transcribed alongside proteins AP2-G and LSD2 prior to schizont egress, was 
determined to be essential to optimal asexual growth of P. berghei.   
 
In addition to these functional studies, acid extraction of histones and tandem 
mass spectrometry were used to determine the array of histone post-translational 
modifications that define the mature asexual schizont from sexual-stage 
gametocytes. To examine some of these sex-specific histone modifications 
further, a novel chromatin-immunoprecipitation/high-throughput sequencing 
technique, called ‘ChIPmentation’, was used to identify the genomic targets of 
four epigenetic modifications in mature asexual parasites, with a view to future 
comparison of these histone marks to those found at gametocyte stage. This study 
also represents the first time that H3K122 acetylation has been examined at any 
stage in any Plasmodium species. 
 
The insights gleaned from this study add to our current knowledge of the 
landscape of epigenetic modifications and their regulatory enzymes at asexual and 
sexual stages of Plasmodium parasite development.    
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Malaria is a term used to describe the intermittent, recurring fever caused by 
infection with protozoan parasites of the Plasmodium genus. In 2017 alone, an 
estimated 219 million people worldwide were infected with a Plasmodium 
parasite, resulting in illness. Of these infected individuals, approximately 435,000 
died, 61% of these being in children under 5 years of age. By the end of 2017, 90 
countries and territories had ongoing malaria transmission, down from 108 
countries in 2000. The majority of malaria cases (80%), were concentrated in 17 
countries of the WHO African Region and India, with 53% of all deaths occurring in 
the 7 countries of Nigeria, Democratic Republic of the Congo, Burkina Faso, India, 
United Republic of Tanzania, Niger, and Sierra Leone. (World Malaria Report 2018, 




Figure 1.1: Countries and territories with indigenous cases of malaria in 2000 and 2017. 
According to the WHO World Malaria Report 2018, malaria was considered endemic to 90 countries 
worldwide (shown in orange and yellow), compared to 108 countries in the year 2000 (shown in 
orange, yellow, blue, and green). Countries with zero indigenous cases of malaria over a period of 
at least the past three consecutive years are eligible to request a status of "malaria-free’ from the 
WHO. In this figure, countries shown in green have been awarded ‘malaria-free’ status since the 
year 2000. Countries shown in blue in this image are either awaiting certification from the WHO, 
or have not requested certification despite zero indigenous cases having been recorded in the past 
three consecutive years. Source: Image reproduced from the World Malaria Report 2018 (WHO, 
2018). 
 




Plasmodium is a genus of parasitic protozoans (single-celled microscopic 
organisms of the Protista kingdom) in the phylum, Apicomplexa. Protists are an 
informal group of diverse eukaryotic organisms, i.e. those members of the 
Eukaryota taxon that are not animals, plants or fungi. Outside of animals, plants 
and fungi, are five ‘protist’ super-groups: Amoebozoa, Opisthokonta, Excavata, 
Archaeplastida, and ‘SAR’ (Stramenopiles (heterokonts), Alveolates, and 
Rhizaria). Plasmodium falls under the SAR super-group, within the Apicomplexa 
phylum (Adl et al., 2012).  
 
This large phylum of obligate intracellular parasites is distinguished from other 
Alveolata by the presence of a unique organelle, called an apicoplast; and an 
apical complex structure, consisting of the anterior structures of the parasite cell: 
the rhoptries, micronemes, conoid, subpellicular tubules, and polar ring (Levine, 
1988). The apicoplast is a small organelle, a vestigial plastid, that is derived 
evolutionarily from a chloroplast; a remnant to past endosymbiosis between the 
ancestral Apicomplexan (debated as being of red algal origin) and a photosynthetic 
organism, the identity of which has yet to be discovered (Fast et al., 2001; Funes 
et al., 2002.; Janouskovec et al., 2010). The most probable purpose of the apical 
complex in Plasmodium species and other Apicomplexa is to facilitate the invasion 
of host cells, most probably by actin-based gliding motility; rhoptries and 
micronemes are specialised secretory organelles that secrete proteins involved in 
adhesion during invasion and formation of the parasitophorous vacuole; the conoid 
is a cone-shaped spiral of filaments thought to play a role in mechanical invasion 
in some Apicomplexans (not present in Plasmodium or Theileria); the apical polar 
ring is a structural ‘microtubule-organising centre’ (MTOC) to which subpellicular 
tubules are laterally attached, giving motile Apicomplexan ‘zoites’ their 
elongated and polarised shape (Russell & Burns, 1984; Morrissette & Sibley, 2002). 
(Figure 1.2).  
 




Figure 1.2: The apicoplast and apical complex structure of the Apicomplexa, using the 
Toxoplasma gondii tachyzoite and Plasmodium falciparum merozoite as examples. This 
comparison of two ‘zoites’ of the Apicomplexa phylum clearly shows placement of the apical 
complex structure elements (the micronemes, rhoptries, subpellicular tubules, and apical polar 
ring), in addition to the apicoplast in the motile Toxoplasma tachyzoite and Plasmodium 
falciparum merozoite. Note the absence of a ‘conoid’ in the Plasmodium merozoite. Source: 
(Baum et al., 2006). 
 
The phylum, Apicomplexa, consists of approximately 5,000 species, with 60,000 
more yet to be named. Within this phylum are many genera of obligate 
endoparasites of medical importance, among others: Babesia, Toxoplasma, 
Cryptosporidium, Eimeria, and Plasmodium. With comparative analyses of small 
subunit rRNA genes, it has been concluded that the Plasmodium lineage of 
Apicomplexa diverged from its nearest relative parasites several hundred million 
years ago, perhaps even before the Cambrian Period (543 to 485.4 million years 
ago) during which it is hypothesised that vertebrates (chordates) emerged from 
their ancestral invertebrate lineage (Escalante & Ayala, 1995; Knoll et al., 2004; 
Morrison & Ellis, 1997).  
 
Plasmodium is a member of the order Haemosporida (also known as 
Haemosporidia), a diverse group of parasites with heteroxenous life cycles, 
alternating between a vertebrate host and a Dipteran insect host that acts as a 
vector for parasite transmission (Martinsen et al., 2008). Plasmodium share many 
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traits with other haemosporidians: they are obligate vertebrate endoparasites 
with a complex life cycle that involves a blood-feeding Dipteran host. All 
haemosporidians use host erythrocyte haemoglobin as a major nutrient source, 
though members of this group often store haemoglobin degradation products in a 
different manner; a morphological characteristic often used to separate and 
define species. Haemosporidians can also be differentiated by variations in their 
complex life cycles, and by their host and insect vector specificities (Goldberg et 
al., 1990; Blanquart & Gascuel, 2011). The Plasmodium genus contains 
approximately 200 species, infecting a range of vertebrate hosts, including bats, 
rodents, lizards, birds, non-human primates, and humans (Hayakawa, et al., 2008; 
Duval et al., 2010; Schaer et al., 2013). The Plasmodium genus itself is split into 
a number of subgenera, with groups based on similarities in both morphology and 
host preference (Figure 1.3).  
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Figure 1.3: Phylogenetic tree of Plasmodium species. This image shows a Bayesian phylogenetic 
tree of Plasmodium spp. based on complete mitochondrial genomes taken as part of routine 
chimpanzee (Pan troglodytes) health examinations at the Jane Goodall Institute (JGI) 
Tchimpounga Chimpanzee Rehabilitation Center in the Republic of Congo (RC), in combination 
with other Plasmodium species’ sequences available from GenBank. Values above branches are 
posterior probabilities together with bootstrap values (in bold text) as a percentage obtained for 
a phylogenetic tree using Maximum Likelihood (ML) methods. Human Plasmodium spp. are shown 
in red text (orange indicates both human- and primate- infective) and chimpanzee data is indicated 
in green text. Green branches indicate African ape Plasmodium species; blue branches correspond 
to other mammal Plasmodium species; and black branches indicate non-mammalian Plasmodium 
species. Source: (Pacheco et al., 2013).      
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Of these Plasmodium subgenera, it is only one member of the Laverania subgenus, 
Plasmodium falciparum, and 4 members of the Plasmodium subgenus: 
Plasmodium vivax, Plasmodium ovale, Plasmodium malariae, and Plasmodium 
knowlesi that are responsible for malarial illness in humans. In recent times 
however, further research has determined that in fact P. ovale consists of two 
distinct but sympatric subspecies, P. ovale curtisi and P. ovale wallikeri, both of 
which occur throughout Africa and Asia-Pacific (Hay et al., 2004; Mueller, 
Zimmerman, & Reeder, 2007; Sutherland et al., 2010). In addition, it has been 
postulated that six further species of non-human primate malaria are 
transmissible to humans via insect bite: Plasmodium cynomolgi, Plasmodium 
brasilianum, Plasmodium eylesi, Plasmodium inui, Plasmodium simium, and 
Plasmodium schwetzi. In 2014, the first case of naturally acquired human infection 
with P. cynomolgi was confirmed in Malaysia, highlighting the importance of PCR 
diagnosis in determining malaria parasite species in humans, as opposed to 
diagnosis based purely on blood film microscopy, as morphology between 
Plasmodium species can be ambiguous (Ta et al., 2014)
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1.3 The Plasmodium life-cycle  
 
1.3.1 Sporozoite infection and pre-erythrocytic development  
 
Plasmodium parasites are obligate endoparasites that alternate between a 
vertebrate host and a Dipteran insect vector (Cox, 2010). The duration of time 
spent at each developmental stage of the Plasmodium life-cycle differs between 
species, though a Plasmodium mammalian infection always begins at the same 
point: infection into the vertebrate skin with Plasmodium sporozoites from the 
insect vector salivary glands, following by migration of sporozoites through the 
bloodstream, to the liver sinusoids (Kappe et al., 2004; Medica & Sinnis, 2005). 
When the Plasmodium sporozoite reaches the liver, it traverses a number of 
hepatocytes, often permanently wounding or killing Kupffer cells within the liver 
parenchyma, before selecting a single hepatocyte within which a parasitophorous 
vacuole is formed to establish sporozoite residence (Mota et al., 2001; Tavares et 
al., 2013). Selection of a single host hepatocyte within which to begin schizogony 
is a choice that is still not understood. One hypothesis is that invasion begins with 
sporozoite interaction with the hepatocyte-of-choice via the surface 
circumsporozoite protein, which is cleaved upon contact with highly sulphated 
proteoglycans at the hepatocyte surface (Coppi et al., 2011). However, the 
mechanisms by which this cleavage initiates formation of a parasitophorous 
vacuole remains to be seen (Kaushansky and Kappe, 2015).  
 
Once hepatocyte invasion by the Plasmodium sporozoite has occurred, this 
parasite develops into an exo-erythrocytic form (EEF), also known as the liver 
stage (LS), within an intrahepatic parasitophorous vacuole. This EEF, or LS, of the 
malaria parasite expresses a unique set of virulence proteins that it shares with 
the sporozoite; a set of proteins necessary for hepatocyte invasion that are the 
subject of vaccine development research (Jaijyan, Singh and Singh, 2015). In P. 
falciparum, a single intrahepatic sporozoite grows into a liver-stage trophozoite 
(1 nucleus (1n) to 2 nuclei (2n)) before undergoing 13 to 14 rounds of DNA 
synthesis, mitosis, and nuclear division, to produce a schizont containing 
approximately 10,000 to 30,000 merozoites (Singh et al., 2007; Gerald, Mahajan 
and Kumar, 2011). At 2-16 days post-invasion of the hepatocyte (depending on 
Plasmodium species), the parasitophorous vacuolar membrane (PVM) is breached, 
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with the release of thousands of free merozoites, and merozoites that are encased 
in membrane-bound vesicles devoid of cell nuclei, a parasite-filled vesicle known 
as a merosome (Sturm et al., 2006). Little is known about how the PVM is ruptured 
at the liver stage, though it has been demonstrated that a Plasmodium 
phospholipase (labelled PbPL and encoded by gene PBANKA_1128100 in P. berghei) 
plays a role in PVM disruption (Burda et al., 2015) (Figure 1.4). 
 
Figure 1.4: Cartoon showing Plasmodium sporozoite infection, invasion, and development to 
a merozoite or merosome, based on current knowledge of these life-cycle stages. (1) depicts 
invasion of a host hepatocyte by a Plasmodium sporozoite (in this case, P. berghei). As the 
sporozoite moves, it excretes a potent P. berghei inhibitor of cysteine proteases (PbICP) that is 
thought to play a role in hepatocyte invasion, as well as sporozoite egress from mosquito salivary 
glands, and liberation of the exo-erythrocytic merozoites from the liver. In (2) and (3), schizogony 
occurs. The question mark in (2) indicates the possibility of PbICP in the host cell cytoplasm. At 
present, it is postulated that the majority of PbICP is confined to the parasite cytosol and 
parasitophorous vacuole. In (4), schizogony is completed and a merosome emerges from the 
infected host cell, with free merozoites (presumably released upon PVM rupture) still inside the 
schizont. The host cell nucleus is depicted as black at this point to indicate the possible activity 
of PbICP in inhibition of host cell cysteine proteases, to allow for a well-timed host cell death 
without disruption to merozoite and merosome formation. Source: (Rennenberg et al., 2010). 
 
1.3.2 Host erythrocyte invasion and tropism 
 
In the absence of hypnozoite formation, merosomes are released and traverse 
through the liver sinusoids, protecting merozoites from phagocytosis before they 
reach the host bloodstream. Each merozoite is then free to invade a host 
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erythrocyte. This process marks the beginning of the recurrent malaria parasite 
infection (Prudêncio et al., 2006). The process of red blood cell recognition, 
attachment, and invasion of host erythrocytes is postulated to take mere seconds, 
as the merozoite surface antigens are particular susceptible to immune attack 
(Cowman & Crabb, 2006). Plasmodium species also differ in age preference of 
erythrocytes to which they attach and invade. A merozoite of P. falciparum is 
capable of invading erythrocytes at all stages of maturation, while P. vivax and P. 
ovale species show a marked preference for the invasion of young erythrocytes 
(reticulocytes), and P. malariae for mature erythrocytes (Kerlin et al., 2013).  
 
Primary Plasmodium merozoite attachment is thought to be mediated by 
glycosylphosphatidyl inositol (GPI)-anchored merozoite surface proteins (MSPs) 
located on the ‘fuzzy’ fibrillar merozoite surface coat. Numerous GPI-anchored 
MSPs have so far been characterised in P. falciparum: MSP1, MSP2, MSP4, MSP5, 
MSP10, and 6-cysteine domain family proteins, Pf92, Pf38, and Pf12 (Sanders et 
al., 2005). These proteins, in combination with other GPI-anchored proteins such 
as rhoptry-associated membrane antigen (RAMA) and GPI-anchored micronemal 
antigen (GAMA), anchor the merozoite to the erythrocyte surface and initiate tight 
junction formation (Beeson et al., 2016; Arumugam et al., 2011; Topolska et al., 
2004; Lamarque et al., 2011). From here, the attached merozoite traverses the 
erythrocyte membrane via a conserved actin-myosin motor complex (Baum et al., 
2006).  
 
Once merozoite invasion has occurred, the infected erythrocyte undergoes brief 
echinocytosis (red blood cell deformation characterised by ‘thorny’ membrane 
protrusions), before normal shape is resumed and the parasite, now referred to 
as a ‘ring’ stage, has been completely internalised (Gilson & Crabb, 2009). Within 
the erythrocyte, this ring stage parasite is encased within a parasitophorous 
vacuolar membrane and modifies host cell permeability to provide adequate 
nutrition for growth and development to a trophozoite (Maier et al., 2009). The 
trophozoite stage of the Plasmodium life-cycle is characterised by rapid growth 
and the appearance of non-toxic haemozoin, sometimes referred to as ‘malaria 
pigment’. Haemozoin is an inorganic and insoluble crystal containing haem (or 
‘heme’) that is released from the parasite digestive vacuole upon haemoglobin 
degradation (Bakar et al., 2010). The highly permeabilised erythrocyte membrane 
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is prevented from haemolysis during the growth of the trophozoite by the decline 
in intracellular haemoglobin, reducing colloid osmotic pressure, and therefore 
reducing swelling of the host red blood cell (Lew et al., 2003).   
 
The final intraerythrocytic stage of the Plasmodium parasite is the schizont stage, 
during which the intracellular parasite generates up to 32 daughter merozoites. It 
is at this final stage that the infected red blood cell will rupture to release free 
merozoites into the host blood stream. These merozoites in turn will reinvade 
more host erythrocytes, continuing the asexual cycle of the malaria parasite 
(Grüring et al., 2011). The pathogenicity of Plasmodium parasites is often a result 
of the sequestration of trophozoites and schizonts to the endothelia of small blood 
vessels, causing obstruction of host tissue perfusion. The cycles of host red blood 
cell rupture may also manifest clinically in a Plasmodium-infected human as 
anaemia (Miller et al., 2002; Dondorp et al., 2000). Severe anaemia and the 
blockage of microvasculature by infected red blood cells in malaria patients can 
hinder tissue perfusion and oxygen delivery, leading to metabolic acidosis and 
respiratory distress (Sasi et al., 2007; Olliaro, 2008). Frontline antimalarial drugs 
primarily target the asexual cycle of Plasmodium parasites to alleviate clinical 
symptoms of infection. However, despite this, cerebral malaria and metabolic 
acidosis carry a mortality rate of 15-20%, with survivors often suffering long-term 
neurological sequelae (Miller et al., 2013).   
 
1.3.3 Plasmodium sexual development: Gametocytogenesis 
 
From invasion of the sporozoite, through Plasmodium development in the host 
liver, to intraerythrocytic parasite growth; all of these stages of the malaria 
parasite life-cycle undergo asexual replication. Though these stages are 
responsible for morbidity and mortality in the Plasmodium host, it is only with 
sexual development of the parasite, a process known as gametocytogenesis, that 
transmission from a vertebrate host to a mosquito vector can occur, therefore 
ensuring the spread of the malaria parasite from one host to another (Baker, 
2010). Gametocytogenesis is the process by which a male or female sexual-stage 
Plasmodium parasite (a gametocyte) is produced. This process takes 
approximately 10-12 days in P. falciparum and is a process marked by molecular 
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mechanisms that are distinct from parasites of the asexually replicating stages 
(Josling, Williamson and Llinás, 2018) (Figure 1.5).  
 
Figure 1.5: Commitment and maturation of the gametocytes of P. falciparum. The images 
above depict the life-cycle of a P. falciparum parasite about to undergo asexual replication to 
produce exclusively asexually-committed parasites (a), and the separate life-cycle progression of 
a parasite that has become committed to producing only sexually-committed merozoites (b). At 
present, it is unknown whether commitment to gametocytogenesis is pre-determined at the 
parasite ‘ring’ stage, or whether environmental factors during ring-to-trophozoite development 
are responsible for gametocyte conversion in the second reproductive cycle. In (a), an abundance 
of lysophosphatidylcholine (LysoPC) and the repression of ap2-g result in downstream commitment 
to asexual development. In parasites without ap2-g expression (AP2-G-), alterations in the 
activities of both heterochromatin protein 1 (HP1) and histone deacetylase 2 (Hda2) ensure that 
the trophozoite develops into a schizont in which all resulting merozoites will invade new host 
erythrocytes to continue the asexual proliferation of Plasmodium parasites. In (b), in the absence 
of LysoPC (possibly in parasitised cells sequestered in the host bone marrow), the ring or early 
trophozoite becomes committed to gametocytogenesis. This process is also marked by alterations 
in the expression of transcription factors (TFs) such as AP2-G3 and, in P. falciparum and a number 
of other human malaria parasite spp., by the removal of HP1 from genomic loci by gametocyte 
development protein 1 (GDV1). This parasite then undergoes what has been termed above as 
‘sexual schizogony’, with all merozoites of this particular schizont producing either male or female 
gametocytes exclusively. In gametocytes, AP2-G is expressed (AP2-G+ cells) and the maturation of 
the gametocyte occurs (taking 10-12 days in P. falciparum). Source: (Josling, Williamson and 
Llinás, 2018).  
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1.3.3.1 Species-specific gametocyte morphologies 
       
Different species of the Plasmodium genus differ in their gametocyte 
morphologies. In P. falciparum, gametocytogenesis is divided into five stages 
(stages I-V) that can be distinguished by their morphology (Carter & Miller, 1979) 
(Figure 1.5). At stage I, 24 h to 30 h post-invasion, the P. falciparum gametocyte 
is indistinguishable from a mononucleated asexual trophozoite. As stage II of 
gametocyte development begins (Day 2), the parasite cell can be seen to elongate 
and form subpellicular microtubules, with an accumulation of F-actin at opposite 
ends of the parasite periphery, elongating the cell into a half-moon, or D-shaped 
cell (Hliscs et al., 2015; Tibú Rcio et al., 2015). 
 
From approximately Day 4 to Day 8 of gametocyte development in P. falciparum, 
the parasite passes through gametocyte stages III-IV. Stage III gametocytes can be 
distinguished by rounded ends and further elongation of the cell, with more 
noticeable subpellicular tubule development. At stage IV, the P. falciparum 
gametocyte has pointed ends and is slightly curved, with the host erythrocyte 
reduced to a thin layer around the edge of the parasitophorous vacuole. This 
crescent or sickle-shaped form of the P. falciparum parasite is the form from 
which the species was named (the Latin word ‘falx’ meaning ‘sickle’, and noun 
‘parere’ meaning ‘to give birth’) (Josling & Llinas, 2015; Dixon et al., 2012).  
 
From stages III-IV in P. falciparum, discrimination between male and female 
gametocytes is not possible by microscopy. However, from late stage IV onwards, 
it has been shown that discerning gametocyte sex is possible prior to induction of 
male gametocyte exflagellation and female gamete emergence by light 
microscopy and the use of antibodies recognising protein Pfg377 (primary marker) 
and D-tubulin II (secondary marker). Using the well-characterised female-specific 
Pfg377 protein (encoded by gene PFL2405c) and male-specific D-tubulin II (gene 
PFD1050w), male/female sex ratios could be derived, with Pfg377 recognising 
female gametocytes and D-tubulin II showing decreased abundance in female 
gametocytes relative to males (Schwank et al., 2010; Severini et al., 1999; 
Rawlings et al., 1992). 
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At Days 10-14 of gametocyte development, mature stage V male and female P. 
falciparum gametocytes are permissible to uptake from host peripheral blood to 
the mosquito vector, though the optimum day at which infectivity is at its peak 
may be specific to P. falciparum strains (Lensen et al., 1999). Stage V P. 
falciparum gametocytes are readily identifiable as male or female. Stage V female 
gametocytes are more elongated and curved, whereas mature male gametocytes 
tend to be straight, shorter and thicker than female gametocytes (Josling & Llinas, 
2015) (Figure 1.6). 
 
 
Figure 1.6: Stages I-V of gametocyte development in P. falciparum. Row (a) shows P. falciparum 
(3D7 strain) gametocytes at stages I-V of development, corresponding to the cartoon depictions in 
row (b). Photographs also enable observation of the different morphologies between female and 
male gametocytes at stage V. Row (b) depicts stages I-V of P. falciparum gametocytogenesis. Stage 
I is indistinguishable from trophozoites of the same age. However, stage II gametocytes become 
distinguishable from asexual parasites as a result of their elongation, becoming D-shaped and 
forming subpellicular tubules. Stage III gametocytes are further elongated, with visible 
subpellicular tubules. At stage III, the gametocyte body becomes visibly larger than the remaining 
host cell cytosol. At stage IV, gametocytes have lost their rounded ends; showing pointed ends and 
elongation to the point that only a sliver of host cell cytoplasm can be discerned. At stage IV, an 
abundance of osmiophilic bodies and extensive rough endoplasmic reticulum become visible in 
female gametocytes (not shown; only a few osmiophilic bodies are shown in this diagram). At stage 
V, P. falciparum male and female gametocytes have their characteristic crescent shape. Male and 
female gametocytes can be differentiated morphologically, with males being straighter and 
thicker. Not shown is the fact that at stage V, female and male gametocytes of P. falciparum can 
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be differentiated by Giemsa stain, with females staining blue, and males staining pinker in colour 
(Josling & Llinas, 2015). Source: (Josling & Llinas, 2015). 
 
Outside of P. falciparum, much less is understood about gametocyte development 
in human-infective Plasmodium species that are not part of the Laverania 
subgenus. In Plasmodium vivax, considered to be the most widely distributed 
malaria parasite throughout temperate and tropical climates, difficulties in 
maintaining continuous cultures have severely hampered the ability of researchers 
to document changes in parasite biology throughout gametocytogenesis (Gething 
et al., 2012; Roobsoong et al., 2015). P. vivax parasites preferentially invade 
young red blood cells; reticulocytes expressing high levels of Cluster of 
Differentiation protein 71 (CD71) that are most abundant in host bone marrow 
(Martín-Jaular et al., 2013). So far, it has been observed that P. vivax gametocytes 
do not exhibit distinct gametocyte morphological stages such as P. falciparum 
stages I-V. Both sexes of gametocytes are large and round (sometimes oval) and 
fill the entirety of the stippled host red blood cell. At a molecular level, little can 
be determined until advances in P. vivax in vitro culture has been established, 
possibly by usage of genetically modified erythrocytes that express P. vivax 
reticulocyte binding proteins on their cell surface (Bousema & Drakeley, 2011; 
Udomsangpetch et al., 2008).  
 
Even less is known about malaria parasite species, P. knowlesi, P. malariae and 
P. ovale (either subspecies). P. knowlesi has the shortest intraerythrocytic life-
cycle of all five human-infective Plasmodium species, at 24 h. For P. falciparum, 
P. vivax, and P. ovale, this cycle lasts approximately 48 h; while in P. malariae, 
the cycle takes approximately 72 h (Garnham, 1966). In blood samples from human 
infections, P. knowlesi and P. malariae gametocytes appear similar in morphology 
to those of P. vivax: round, filling the host erythrocyte, and with both sexes 
indistinguishable from one another (Singh & Daneshvar, 2013). For P. ovale curtisi 
and P. ovale wallikeri; gametocytes from a human P. ovale infection (subspecies 
unknown) showed round or oval morphologies, with immature gametocytes 
showing more pointed ends. All P. ovale gametocytes filled the host erythrocyte 
cell, with the host cell again stippled with darkened dots (most likely haemozoin 
crystals) (Garnham, 1966; Ribaut et al., 2008). Again, sex determination at a 
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molecular level between P. ovale gametocyte males and females is not yet 
possible. (Figure 1.7).     
 
Figure 1.7: Comparison of gametocyte stage morphology between human-infective 
Plasmodium species. (a) shows a Giemsa stain of a P. falciparum male gametocyte (MG) next to 
P. falciparum female gametocytes (FGs) (adapted from (Schwank et al., 2010)). (b) and (c) show 
Giemsa stains of male and female P. vivax gametocytes respectively (both adapted from (Bousema 
& Drakeley, 2011)). (d) depicts a Giemsa stain of a P. malariae gametocyte (sex undetermined) 
(adapted from the Center for Disease Control (CDC) DPDx Laboratory Guidelines (CDC, 2017)). (e) 
shows a Giemsa stain of a P. ovale (subspecies unknown) gametocyte of undetermined sex (adapted 
from (Ribaut et al., 2008)). (f) shows a Giemsa stain of a P. knowlesi gametocyte of undetermined 
sex (adapted from (Lee, Cox-Singh & Singh, 2009)). 
 
1.3.3.2 Molecular mechanisms of sexual development in Plasmodium 
 
The exact moment at which a ring-stage or early trophozoite-stage Plasmodium 
parasite commits to sexual development in any species of Plasmodium, is still 
unknown and the subject of much research (Josling and Llinas, 2015; Josling, 
Williamson and Llinás, 2018). However, in 2014, it was demonstrated that the 
production of gametocytes in Plasmodium (in these studies, P. berghei and P. 
falciparum were used), is dependent upon the expression of a conserved member 
of the Apetala 2 (AP2) family of apicomplexan DNA-binding proteins, AP2-
gametocyte (AP2-G). In P. berghei, mutations in the ap2-g gene 
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(PBANKA_1437500) generated parasite lines unable to produce male or female 
gametocytes, with repair of these mutations reversing this gametocyte non-
producer phenotype (Rovira-Graells et al., 2012; Kafsack et al., 2014; Sinha et 
al., 2014).  
 
In a recent study, the role of gametocyte development 1 (GDV1) protein in P. 
falciparum as an antagonist of heterochromatin protein 1 (HP1)-mediated 
silencing of pfap2-g has been demonstrated (Filarsky et al., 2018). Though 
undoubtedly an upstream regulator of sexual commitment in P. falciparum in this 
manner, the rodent malaria parasite clade (encompassing P. berghei, P. chaboudi, 
P. yoelii and P. vinckei) does not possess a GDV1 gene, therefore suggesting a 
divergence in the regulation of sexual development in these Plasmodium species.    
  
Despite these milestones in our understanding of Plasmodium sexual 
development, there is still much that we don’t understand. In a natural P. 
falciparum infection, the gametocyte to asexual stage parasite ratio is less than 
1:10, and has been documented as low as 1:156 (Eichner et al., 2001; Talman et 
al., 2004; Sinden, 1983). In P. falciparum, it has been demonstrated that sexual 
development choice for merozoites of a single schizont are mutually exclusive, 
with one pre-committed schizont generating either sexual or asexual stage 
parasites, and not the other (Bruce et al., 1990).  
 
Individual pre-committed P. falciparum schizonts are also mutually exclusive in 
their generation of male or female gametocyte populations. Each schizont that is 
pre-conditioned to commit to gametocytogenesis will produce progeny of the 
same sex (Silvestrini, Alano, & Williams, 2000). Of all pre-committed schizonts, 
67-71% will produce female progeny, with this female-biased sex ratio remaining 
even under field conditions (Smith et al., 2000; Robert et al., 2003; Gbotosho et 
al., 2011). At present, it is still unknown at which stage a Plasmodium parasite 
commits to sexual development, the complete array of environmental conditions 
underlying this choice, or how these conditions dictate male/female sex 
determination.  
 
Despite the many still-unanswered questions regarding commitment to, and 
initiation of, Plasmodium gametocytogenesis, implementation of a novel flow-
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cytometry-based assay for the examination of early gametocyte development in 
P. falciparum (Brancucci et al., 2015) led to the identification of one 
environmental factor responsible for regulating sexual development upstream of 
ap2-g transcription. The exogenous, host-derived lipid, lysophosphatidylcholine 
(‘LysoPC’), was identified as a serum factor responsible for the reversible 
repression of gametocyte commitment in P. falciparum (Brancucci et al., 2017). 
Exposing P. falciparum parasites to ‘parasite-conditioned’ medium, as opposed to 
freshly-prepared culture medium, had previously been shown to increase 
gametocyte numbers by approximately 5.9-fold to 7.6-fold (Williams, 1999), with 
further experiments demonstrating that exposing P. falciparum parasites to 
medium that was free of human serum (mimicking restricted host factor 
availability in vivo) also resulted in the induction of sexual commitment in vitro. 
Ultimately, LysoPC was determined an environmental repressor of 
gametocytogenesis, inhibiting sexual development at a 50% inhibitory 
concentration of 1.73 PM in vitro in both Pf2004 (derived from NF54) and HB3 
strains of P. falciparum (Brancucci et al., 2017).     
 
1.3.4 Plasmodium development within the mosquito  
 
At the end of the Plasmodium gametocyte maturation process, male gametocytes 
(microgametocytes) and female gametocytes (macrogametocytes) are amenable 
to uptake by female mosquitoes during a blood meal (Paul et al., 2002). A female-
biased sex ratio, with the generation of one microgametocyte to every five 
macrogametocytes results in an approximate 1:1 ratio of male to female gametes 
in the mosquito midgut. This is because each microgametocyte produces 8 
microgametes upon exflagellation within the mosquito midgut, with the female 
macrogametocyte differentiating to a single macrogamete (Reece et al., 2008). 
Within seconds of entering the mosquito midgut, gametogenesis is induced by a 
drop in temperature to 5qC lower than that of the host vertebrate blood, and by 
a change in pH from 7.4 in the vertebrate to 8-8.2 in the Dipteran vector (Sinden 
et al., 1996; Nijhout & Carter, 1978). A secondary requirement for gametogenesis 
has also been documented. At a lowered temperature, but in the absence of an 
increased pH, gametogenesis (of both sexes) can be stimulated by the addition of 
xanthurenic acid (XA) derived from crude insect homogenates. Previous studies in 
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gametocyte-to-gamete activation using insect secreted factors and homogenates 
have referred to this factor as mosquito exflagellation factor (MEF), and later, 
gametocyte activating factor (GAF). The activating factor involved has now been 
identified definitively as XA. (Nijhout, 1979; Billker et al., 1998; Billker et al., 
1997).  
 
Upon induction of gametogenesis, exflagellation of the male microgametocyte 
results in 8 motile flagellar microgametes that detach from the residual activated 
male gametocyte. Microgamete exflagellation and macrogamete emergence are 
both dependent upon XA, though so far, no ligand for XA has been identified on 
the Plasmodium gametocyte surface. In mammals, it has been suggested that XA 
acts through a G-protein coupled receptor (GPCR), coupled with a GPCR-induced 
cationic channel modulatory mechanism (Taleb et al., 2012). So far, what we do 
know of microgamete exflagellation is that XA triggers an increase in intracellular 
calcium ion (Ca2+) concentration that is in part mediated by calcium-dependent 
protein kinase 4 (CDPK4) (Billker et al., 2004). Evidence for the role of second 
messengers phospholipase A (PLA), phospholipase C (PLC), and cyclic GMP has also 
been revealed; with inhibitors of PLA and PLC disrupting microgamete 
exflagellation, and agents that increase cGMP levels enhancing exflagellation 
(Ogwan’g et al., 1993; Martin et al., 1994; Kawamoto et al., 1990). In fact, cGMP-
dependent protein kinase, Protein Kinase G (PKG), has been shown as essential to 
the activation of microgamete exflagellation (McRobert et al., 2008). In summary, 
Plasmodium microgamete exflagellation is in all probability, subject to both 
calcium-dependent and calcium-independent effector pathways, though the 
timing of activation of these pathways in relation to one other is so far not 
understood (Kuehn & Pradel, 2010).  
 
Female gamete formation appears much less arduous when compared to 
microgamete exflagellation, though it is equally as important to malaria 
transmission. Macrogametes egress from the host erythrocyte upon uptake into 
the mosquito midgut, first by Ca2+-independent rupture of the parasitophorous 
vacuolar membrane (PVM) at multiple sites, and followed by rupture of the 
erythrocyte membrane at a single point. This form of egress is shared between 
male and female gametocytes (Sologub et al., 2011). During both male and female 
gametocyte egress, electron-dense secretory vesicles known as osmiophilic bodies 
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are observed to accumulate at rupture sites, often disintegrating simultaneously 
with the PVM. However, osmiophilic bodies are consistently observed in much 
greater number in female gametocytes and are associated with gametocyte-
specific proteins Pfg377, PfMDV1/PfPEG3, and gamete egress and sporozoite 
traversal (GEST) protein (De Koning-Ward et al., 2007; Talman et al., 2011; 
Olivieri et al., 2015; Lal et al., 2009; Ponzi et al., 2009). Upon rounding and 
emergence of the female macrogamete, translation of transcripts occurs which, 
until now, been translationally repressed by a messenger ribonucleoprotein 
(mRNP) silencing complex that includes both the DDX6 class RNA helicase, DOZI 
(development of zygote inhibited) and the Sm-like factor, CITH (homolog of 
worm CAR-I and fly Trailer Hitch) (Mair et al., 2006; Mair et al., 2010). This 
undoing of translational repression in Plasmodium macrogametes has been shown 
to be initiated by calcium-dependent protein kinase 1 (CDPK1) (Sebastian et al., 
2012).  
 
Once fertile male and female gametocytes have emerged from the host 
erythrocyte into the mosquito midgut lumen, the motile microgamete must attach 
to the surface of a macrogamete to initiate zygote production. A number of 
proteins have been implicated in this attachment process, including gamete-
associated Limulus coagulation factor C, Coch-5b2 and Lgl1 (LCCL)- domain-
containing proteins (termed PfCCp proteins in P. falciparum), and proteins 
containing a six cysteine (6-Cys) structural domain, such as microgamete-
associated protein P48/45 and P230, and macrogamete-associated P47 (Pradel et 
al., 2004; Delrieu et al., 2002; van Dijk et al., 2001; van Dijk et al., 2010; van 
Schaijk et al., 2006). The Armadillo repeat domain-containing protein, PF16, has 
also been shown as essential for correct functioning of microgamete flagellar 
morphology via its role in axoneme assembly. In Plasmodium parasites, the 
axoneme is made up of central C1 and C2 microtubules, surrounded by nine 
doublet microtubules and is fundamental to motility of the male gamete (Straschil 
et al., 2010).  
 
Zygote formation in Plasmodium occurs upon fusion of the male and female 
gamete plasma membranes and uptake of the male nucleus and axoneme into the 
cytoplasm of the macrogamete. Gamete fusion is mediated in part by male-
specific generative cell specific 1 (GCS1) protein (also referred to as plant sterility 
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protein HAP2), which nuclear fusion ensuing thereafter by meiosis (Janse et al., 
1986; Liu et al., 2008; Hirai et al., 2008). Two NIMA (Never in mitosis/Aspergillus)-
related protein kinases (Neks), Nek-2 and Nek-4 are vital for Plasmodium gamete 
nuclear fusion and the parasite tetraploidy that precedes ookinete conversion 
(Guttery et al., 2012; Reininger et al., 2005; Reininger et al., 2009). 
 
1.3.5 The final stretch: From ookinete to sporozoite 
 
Soon after nuclear fusion, the zygote in the mosquito midgut lumen matures into 
a motile ookinete, the development of which is directed by a plethora of ookinete-
specific proteins necessary for midgut invasion, such as membrane-attack 
ookinete protein (MAOP) and chitinase (Vinetz et al., 2000; Vlachou et al., 2006; 
Kadota et al., 2004). Expression of many genes responsible for ookinete 
development are, as in gametocyte formation, regulated by an AP2 DNA-binding 
factor; in this case named AP2-ookinete (AP2-O) (Yuda et al., 2009). Once 
matured, motile ookinetes exit the mosquito midgut lumen, only to traverse it 
once more to facilitate oocyst formation. Mechanisms for ookinete midgut 
epithelium and peritrophic membrane traversal are controversial and require 
further elucidation (Baton & Ranford-Cartwright, 2005; Bennink, Kiesow, & 
Pradel, 2016). 
 
The Plasmodium oocyst develops beneath the basal lamina of the midgut 
epithelium. Beneath the basal lamina of the mosquito midgut, a motile ookinete 
transforms into an immobile (or ‘sessile’) spherical oocyst via a proposed 
intermediate stage known as a ‘took’ stage, with oocyst development requiring 
only a minimal environmental stimulus, namely lowering of pH to 7.0 (Carter et 
al., 2007). The production of the Plasmodium oocyst is the longest stage of the 
parasite’s life-cycle, taking 10-15 days, depending on species. During this time, 
the oocyst grows from approximately 5 Pm to 50-60 Pm in size and undergoes 
multiple rounds of nuclear division to produce up to 8,000 haploid nuclei (Canning 
& Sinden, 1973). This period of nuclear division and sporozoite formation is called 
sporogony, with the oocyst cytoplasm subdivided by cleft formation into separate 
sporoblasts, though without loss of outer oocyst membrane integrity (Terzakis et 
al., 1967; Nacer et al., 2008).  
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Oocyst-derived sporozoites bud from sporoblast bodies once development has 
been completed. 1x103 to 1x104 sporozoites are released from each oocyst, which 
travel through the midgut to the salivary glands. This process of sporozoite 
invasion into the mosquito salivary glands is inefficient, with only 25% of 
sporozoites making it to the salivary glands; the rest remaining, and subsequently 
degrading, within the mosquito haemocoel (Baton & Ranford-Cartwright, 2005; 
Beier, 1998). Only a relatively small number of sporozoites will eventually be 
inoculated upon a mosquito blood meal of a host vertebrate, typically fewer than 
100, which rapidly lose infectivity after leaving the mosquito (Pumpuni & Beier, 
1995; Frischknecht et al., 2004). Once inoculated into a vertebrate host, the 
Plasmodium cycle begins anew (Figure 1.8). 
 
Figure 1.8: Malaria parasite development within the mosquito vector; from uptake of 
gametocytes to a new host infection. Transmission of malaria is facilitated by the uptake of 
mature Plasmodium gametocytes from the vertebrate host to a mosquito vector and activation of 
gametogenesis by environmental factors within the insect midgut. Zygote formation occurs upon 
nuclear fusion of a male microgamete with a female macrogamete, followed by development of 
the motile ookinete in the midgut lumen. Mature, motile ookinetes are capable of invading, and 
then traversing, the mosquito midgut epithelium whereupon an immobile oocyst can develop 
beneath the midgut basal lamina. The elongated ookinete becomes a spherical oocyst via a 
proposed intermediate ‘took’ stage. At oocyst stage, multiple rounds of nuclear division occur, 
producing thousands of haploid sporozoites. One oocyst subdivides into multiple sporoblasts, 
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followed by release of the sporozoites to the mosquito salivary glands. These sporozoites can then 
be passed to a vertebrate host when the female mosquito takes a blood meal, initiating a new 
host infection. Source: (Flannery et al., 2013). 
 
1.4 Regulation of gene expression in Plasmodium 
 
1.4.1 Regulation of transcription initiation 
 
To account for stage-specific transcriptomes and proteomes throughout the 
Plasmodium life-cycle (Bozdech et al., 2003, 2008; Hall et al., 2005; Young et al., 
2005; Foth et al., 2011), a number of studies have been carried out to identify 
the underlying molecular mechanisms responsible for controlling gene expression 
and the translation of messenger RNA (mRNA) transcripts. Throughout the life-
cycle of Plasmodium spp., as in other eukaryotes, mRNA transcription begins when 
RNA polymerase II is recruited to a gene promoter to synthesise pre-mRNA (also 
called ‘nascent’ RNA) that corresponds to the 5’-untranslated region (5’UTR), 
coding sequence (or ‘exon’), introns (if present), and 3’-untranslated region 
(3’UTR) of the gene in question (Lenhard, Sandelin and Carninci, 2012; Vembar, 
Droll and Scherf, 2016). Even at this very early point in the transcription process, 
regulation of gene expression can be very complex. In protozoan parasites such as 
Plasmodium, as in metazoa, promoters of genes can consist of both ‘core’ and 
‘proximal’ promoters which can be located 20 to 3000 base pairs upstream of the 
transcription start site (TSS) (Rodríguez et al., 2010). In metazoa, the ‘core’ 
promoter is described as the promoter in the immediate vicinity, or overlapping, 
the TSS, and presumed to dock the pre-initiation complex (PIC).  
 
Metazoan core promoters display a number of mechanisms for tight control of 
gene expression. Core promoters can be defined as ‘TATA-box’-dependent 
promoters, with ‘TATA-box’ referring to a sequence of DNA containing TATAWAWR 
that is located about 30 base pairs upstream of the TSS. ‘TATA-box’-binding 
proteins (TBPs) attach to this DNA sequence within a promoter, beginning the 
process of PIC assembly (Sainsbury, Bernecky and Cramer, 2015). TATA-dependent 
promoters are often tissue-specific in metazoa. However, core promoters may also 
be dispersed, with high CG content, or alternatively, placed within a region of 
DNA sequence with large amounts of cytosine nucleotides directly followed by 
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guanine nucleotides, areas known as CpG islands (where CpG stands for 5’-C-
phosphate-G-3’) (Lenhard, Sandelin and Carninci, 2012). A comprehensive review 




Figure 1.9: A summary of eukaryotic promoter elements and regulatory signals. (a) shows a 
cartoon depiction of a gene with the its upstream core promoter and proximal promoter regions 
outlined. Above the DNA sequence, molecular mechanisms for control of the gene’s expression are 
illustrated. At the very top left is shown a length of chromatin that is then split up to reveal the 
separate nucleosomes. The nucleosomes in turn are comprised of eight core histones surrounded 
by a length of DNA (~147 base pairs of DNA). Chromatin can be found as either tightly-packed 
heterochromatin or loosely packed euchromatin, with its conformation heavily effecting whether 
the encased DNA (including promoter regions) are accessible to the transcriptional machinery of 
the cell. Long-range regulatory elements such as insulators or enhancers (both DNA sequences of 
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varied length) can also effect downstream gene expression and pre-initiation complex (PIC)-
promoter binding. At the promoter site itself, the region around the transcription start site (TSS) 
is divided into a larger ‘proximal’ promoter upstream of the TSS, and the smaller ‘core’ promoter 
that surrounds and overlaps the TSS. To recruit RNA polymerase II, sequence-specific regulatory 
proteins (known as transcription factors) bind to transcription factor binding sites (TFBSs) that are 
located proximal to the TSS. TFBSs can occur in clusters to form cis-regulatory modules (CRMs). In 
(b) sequence patterns are shown that have been identified in eukaryotic ‘core’ promoters. Around 
the TSS, TATA-box and initiator (Inr) sequences are often found and over-represented. The 
locations of sequence patterns are shown relative to the TSS, with all sequence logos depicted 
other than the Inr sequence which varies considerably between eukaryotes. Most promoters 
contain only one or a few of these sequence patterns, and many appear to be species-specific. 
BRE: B recognition element; DCE: downstream core element; DRE: DNA recognition element; MTE: 
motif ten element. Source: (Lenhard, Sandelin and Carninci, 2012).  
 
In Plasmodium spp., the transcription of protein-coding genes is thought to be 
generally monocistronic, though a bicistronic mRNA for the maebl gene and an 
adjacent putative mitochondrial ATP synthase has been identified in P. falciparum 
(Balu, Blair and Adams, 2009; Rodríguez et al., 2010). Transcription of 
Plasmodium genes is carried out by RNA polymerase II, with homologues to all 12 
subunit proteins identified in the genome, though only one third of the expected 
transcription-associated proteins (TAPs) were identified (Coulson, Hall and 
Ouzounis, 2004). The P. falciparum TATA-box binding protein (TBP) homologue 
also shows low sequence identity (42%) when compared at the primary sequence 
level to the archetypal yeast TBP, though it retains most residues known to be 
responsible for DNA-binding (McAndrew et al., 1993). 
 
With regard to the transcription initiation sites and TSSs within Plasmodium spp., 
the vast majority of P. falciparum genes have been shown to contain multiple 
transcription initiation sites, with initiation occurring primarily at adenine 
nucleotides (Watanabe et al., 2002). An in-depth analysis of the dynamics of 
transcription initiation during the P. falciparum IDC further demonstrated that 
81% of TSSs were positioned less than 1000 bp upstream of the start codon, and 
that distribution of TSSs were similar in genes displaying both tandem or 
bidirectional configuration (Adjalley et al., 2016). Moreover, this study identified 
transcription initiation during the P. falciparum IDC at non-conventional sites, 
such as coding regions of single exon genes. In fact, 49% of all TSSs were located 
downstream of a start codon. In addition, evidence for stage-specific selection of 
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TSSs within a single gene, producing transcript isoforms, suggests that gene 
expression in Plasmodium is indeed subject to regulation at a transcriptional level 
(Adjalley et al., 2016). 
 
1.4.2 Regulation of gene expression by post-transcriptional mechanisms  
 
In addition to the control of gene expression at the point of transcription 
initiation, nascent Plasmodium mRNA, once transcribed, is subject to a range of 
regulatory mechanisms. In P. falciparum, it has been shown that exoribonuclease-
mediated degradation of nascent mRNA is involved in the silencing of upsA-type 
var genes that have been implicated in severe malaria (Zhang et al., 2014). The 
chromatin-associated exoribonuclease, termed PfRNaseII, controls the silencing 
of upsA-type var genes by marking the gene TSS and intronic promoter sites to 
produce short-lived cryptic mRNAs (both upstream and intronic promoter-derived 
antisense long non-coding RNAs (lncRNAs) being the main type in upsA-type var 
gene regulation) (Zhang et al., 2014).  
 
Furthermore, both RNA ligation-based and non-polyA-selected strand-specific 
RNA-sequencing studies revealed the presence of stage-specific independently-
transcribed antisense transcripts, lncRNAs, and circular RNAs (circRNAs) during 
the IDC of P. falciparum, supporting the theory that non-coding regulatory 
elements play a role in the regulation of gene expression in Plasmodium spp. 
(Siegel et al., 2014; Broadbent et al., 2015). An examination of the transcriptional 
dynamics associated with early gametocyte formation in P. falciparum, using a 
novel nascent mRNA biosynthetic labelling approach, also identified gametocyte-
specific transcription and mRNA stabilisation at a point earlier than, and 
independent of, the transcriptional regulator, Apetala 2-gametocyte (AP2-G) 
(Painter, Carrasquilla and Llinás, 2017). This study demonstrated enrichment of a 
cis-regulatory motif, AGACA, at the 5’UTR (within 1 kilobase (kb) upstream of the 
start codon) of 371 of 808 gametocyte-associated genes, and enrichment of a 
UGUR motif at the 3’UTR of the same gametocyte-associated genes, the latter of 
which resembles the RNA sequence motif that is recognised by the P. falciparum 
Puf2 RNA-binding protein (Miao et al., 2013). The identification of sequence 
motifs with the potential for interaction with DNA/RNA-binding proteins in genes 
associated with early gametocyte development hints at a role for post-
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transcriptional regulatory mechanisms in commitment to gametocytogenesis in 
Plasmodium (Painter, Carrasquilla and Llinás, 2017).   
 
Upon completion of nascent mRNA (or pre-mRNA) synthesis, these mRNA 
molecules are then subject to RNA-processing mechanisms such as alternative 
splicing (to remove introns or to produce truncated mRNA transcripts) (Sorber, 
Dimon and Derisi, 2011), addition of the 7-methyl guanosine (m7GpppN) cap 
structure to the 5’ mRNA end (Calero et al., 2002; Vembar, Droll and Scherf, 
2016), and addition of a polyA-tail to the 3’ mRNA end (Vembar, Droll and Scherf, 
2016). This mRNA molecule is then suitable for export to the cytoplasm of the 
parasite cell where it can undergo an array of fates: i) translation by the 80S 
ribosome and tRNAs charged with amino acids; ii) degradation by exo- or endo- 
ribonucleases; or iii) sequestration by specific ribonucleoprotein (RNP) complexes 
to inhibit translation and/or decay, i.e. translational repression. The full array of 
post-transcriptional modifications available to Plasmodium spp. parasites is shown 
in figure 1.10.  
 
Figure 1.10: Cartoon summary of post-transcriptional modifications to which Plasmodium spp. 
mRNA is exposed. Starting from the top of the cartoon, the gene of interest (GOI) is depicted as 
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being transcribed into a pre-mRNA transcript, with the possibility of cryptic RNA generation (such 
as long non-coding RNAs) in an exoribonuclease-mediated fashion. In this image, green arrows/bars 
are used to depict the start codon (AUG) in the GOI or mRNA transcript, with red bars being used 
to indicate the stop codon of the same GOI or mRNA transcript. In addition to the generation of 
cis cryptic RNAs, the possible transcription of regulatory antisense RNA transcripts is also shown 
relative to the GOI. Below the GOI, the mechanisms that are responsible for pre-mRNA processing 
are listed (splicing, 5’ m7GpppN capping, and 3’ polyA-tailing). The mature mRNA molecule is then 
shown to be subject to nuclear export and/or binding by a nuclear ribonucleoprotein (RNP) 
complex. Beyond this, exported mature mRNA can then be forwarded to the ribosome for 
translation, bound to cytoplasmic RNPs (for translational repression), or degraded by exo- or endo- 
ribonucleases. mRNP: mRNA-RNP granule. Source: (Vembar, Droll and Scherf, 2016).        
 
1.4.3 Regulation of translation initiation, elongation, and termination 
 
As mentioned in section 1.4.2, mature mRNA molecules are not simply free to 
immediately begin translation. In addition to regulatory mechanisms at the point 
of transcription initiation and pre-mRNA processing, translation of mature mRNA 
transcripts is tightly controlled and stage-specific in nature. Plasmodium protein 
translation occurs in the parasite nucleus, mitochondrion, and apicoplast with the 
core translational machinery in Plasmodium spp. being highly conserved (Jackson 
et al., 2011). The conserved Plasmodium spp. core translational machinery 
consists of a repertoire of ribosome components, translation factors, tRNA 
molecules, and aminoacyl-tRNA synthetases with certain features of translation 
being specific to parasite stage transitions. 
 
In contrast to the ribosomal DNA (rDNA) clusters of other eukaryotes, Plasmodium 
spp. genomes contain 4-8 single-copy rDNA subunits on different chromosomes 
that are expressed in a stage-specific manner. These rDNAs are split into A-type 
(liver and intraerythrocytic asexual-stage), O-type (ookinete-specific), and S-type 
(sporozoite specific) rDNAs and are functionally divergent from the archetypal 
yeast rDNAs (McCutchan et al., 1995; Vembar, Droll and Scherf, 2016). In addition, 
the P. falciparum 18S ribosomal RNA (rRNA) differs from other eukaryotes in that 
it contains large peripheral rRNA expansion elements that may be targeted by 
translational regulatory mechanisms (Wong et al., 2014).  
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Strikingly, the P. falciparum intraerythrocytic parasite stages were shown to lack 
a RACK1 (receptor for activated C kinase 1) protein from a conserved binding site 
near the mature mRNA exit channel (Sengupta et al., 2004; Wong et al., 2014). In 
other eukaryotes, RACK1 is a 40S ribosome subunit-associated protein that is 
postulated as acting as a link between cell-signalling and translational machinery, 
with its absence suggesting a marked difference in Plasmodium translational 
regulation (Gallo and Manfrini, 2015; Vembar, Droll and Scherf, 2016). RACK1 was 
initially described as an anchoring protein for Protein Kinase C (PKC), a homologue 
of which is not present in the Plasmodium genome (Madeira et al., 2003). Despite 
this, RACK1 expression is essential for P. falciparum intraerythrocytic 
proliferation, with the PfRACK1 protein localised diffusely throughout the parasite 
cell cytoplasm (Blomqvist et al., 2017). These findings may suggest that 
Plasmodium RACK1 is required for protein translation by interaction with the 40S 
ribosome subunit at stages outside of the intraerythrocytic cycle, stages that have 
yet to be examined. PfRACK1 may also function as a key mediator of processes 
outside of translation, with an as-yet-undiscovered protein taking over the RACK1 
role in Plasmodium. Of course, this mechanism of RACK1-40S ribosome interaction 
at the mature mRNA exit tunnel may be absent entirely from Plasmodium spp., 
with the parasite regulating translation by alternative means.     
 
In eukaryotes, translation of a mature mRNA molecule to a polypeptide is divided 
into three stages: initiation, elongation, and termination. In P. falciparum, the 
conserved functions of eukaryotic translation initiation factor 4E (eIF4E), 
eukaryotic translation initiation factor 4F (eIF4F), and polyA-binding protein 
(PABP) have all been demonstrated in vitro (Shaw et al., 2007; Tuteja and 
Pradhan, 2009). At initiation, a conserved method of translational repression of 
global mRNA levels has been demonstrated in Plasmodium, i.e. phosphorylation 
of the D-subunit of eukaryotic initiation factor 2 (eIF2D). Though repressing global 
protein synthesis, phosphorylation of eIF2D also acts to enhance gene-specific 
translation of a subset of mRNAs. In Plasmodium, as in Toxoplasma, elevated 
levels of phosphorylated eIF2D have been observed in latent parasite life stages, 
suggesting a role for this mechanism of translational repression in Apicomplexa 
dormancy (Zhang et al., 2013). In addition, the three P. falciparum eIF2D 
serine/threonine kinases; eIF2D kinase 1 (PfIK1), eIF2D kinase 2 (PfIK2), and 
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eIF2D-kinase related protein 4 (PfPK4), have been shown to be differentially 
expressed throughout the life cycle (Mohrle et al., 1997; Fennell et al., 2009; 
Zhang et al., 2010; Solyakov et al., 2011). As such, regulation of these enzymes 
in a stage-specific manner is indicative of regulatory mechanisms at the level of 
translation initiation.  
 
In P. falciparum blood stages, structural subunits of the translation elongation 
complex have also been identified (elongation factor (EF) subunits 1D, E, J, and 
G), though they have yet to be functionally characterised (Takebe et al., 2007; 
Vembar, Droll and Scherf, 2016). The P. falciparum translation elongation factor 
2 (PfEF2) has also been identified as the target of a novel antimalarial compound 
(DDD107498), but again, this protein has not been functionally characterised 
either in vitro or in vivo (Baragaña et al., 2015). With regards to termination of 
translation by eukaryotic peptide chain release factors (eRFs), homologues to 
these factors have been annotated in Plasmodium spp., however, as with 
elongation factors, functional characterisation of these proteins has yet to be 
carried out (Vembar, Droll and Scherf, 2016).      
 
1.4.4 Translational repression  
 
Although technically coming under the umbrella term of ‘post-transcriptional’ 
modifications, translational repression of mature mRNAs has been extensively 
characterised in Plasmodium spp., and occurs at a point after regulation of pre-
mRNA by ribonucleases or cryptic RNAs, but before mRNA processing and 
translation in the ribosome. In Plasmodium spp., translational repression of mRNA 
transcripts has been shown to be carried out by a number of proteins, including, 
dihydrofolate reductase-thymidylate synthase (DHFR-TS) (inhibits translation of 
its cognate mRNA) (Zhang and Rathod, 2002); P. falciparum protein Alba1 (a 
homologue to archaeal Acetylation lowers binding affinity protein 1) (Chêne et 
al., 2012; Vembar et al., 2015); messenger ribonucleoprotein (mRNP) complexes 
containing the DDX6 DEAD-box RNA helicase, DOZI (Development of Zygote 
Inhibited) and the Sm-like factor, CITH (a homologue of the Caenorhabditis 
elegans factor, CAR-I and fly Trailer Hitch) (Mair et al., 2006; Mair et al., 2010); 
and P. falciparum RNA-binding proteins, PfPuf1 and PfPuf2 (Puf standing for 
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Pumilio and fem-3 binding factor homologue) (Müller, Matuschewski and Silvie, 
2011; Shrestha et al., 2016).    
 
Unlike the bidirectional protein, PfDHFR-TS, which binds its own cognate mRNA, 
therefore acting as a translational repressor of itself (Zhang and Rathod, 2002), 
the PfAlba1 RNA-binding protein has been shown to bind 1193 RNA transcripts in 
replicative trophozoites, followed by carefully timed release of previously 
PfAlba1-bound mRNAs encoding erythrocyte invasion components in later schizont 
stages (Vembar et al., 2015). With these results, the authors propose that PfAlba1 
acts as a post-transcriptional regulator of mRNAs during the P. falciparum IDC, 
with a particularly important role in regulating erythrocyte invasion as the end of 
the asexual parasite stage nears.  
 
The DOZI and CITH proteins (characterised in P. berghei) act at different parasite 
stages, exhibiting crucial roles as translational regulators of gametocytogenesis, 
sexual differentiation, and post-fertilisation development in the mosquito vector 
(Mair et al., 2006; Mair et al., 2010). Further studies into the roles of PbDOZI and 
PbCITH established that, without the presence of these repressors, mRNA 
transcripts of the mature female gametocyte are destabilised, abolishing 
Plasmodium transmission and zygote development (Guerreiro et al., 2014).  
 
In P. falciparum, integrated transcriptomic and proteomic analyses of male and 
female gametocytes identified a putative set of translationally repressed P. 
falciparum transcripts in female gametocytes, with 260 novel repressed 
transcripts. This study also highlighted the fact that some of these newly-
identified, translationally-repressed transcripts in female gametocytes encoded 
for genes whose corresponding proteins have only ever been reported in oocyst- 
or sporozoite- stage parasites. Therefore, these mRNA transcripts may not only be 
repressed until after fertilisation in the mosquito, but may be translationally 
repressed in a more long-term manner (Lasonder et al., 2016). Despite these 
findings, it remains to be determined whether these P. falciparum female 
gametocyte transcripts are subject to translational repression by DOZI, CITH, or 
an as-yet-unidentified mechanism of translational repression. In fact, to date, the 
functions of the DOZI-CITH complex in the human malaria parasite P. falciparum 
remain to be characterised (Shrestha et al., 2016).  
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In the case of P. falciparum Puf proteins, the RNA-binding protein, PfPuf1 has also 
been determined to regulate sexual development in the parasite. PfPuf1 has been 
shown to be expressed in all gametocyte stages, with higher levels reported in 
female gametocytes in particular (Shrestha et al., 2016). At present, PfPuf1 is 
postulated to promote either translational repression by blocking transcription 
factor binding itself, by recruiting further repressor complexes, or by recruiting 
factors involved in mRNA degradation. In eukaryotes, two common mechanisms of 
repression by Puf proteins have been identified: inhibition of mRNA 5’-capping to 
block translation initiation, or interaction with mRNA 3’UTR cis regulatory 
elements to recruit the CCR4-POP2-NOT deadenylase complex which mediates 
polyA-tail removal (Miller and Olivas, 2011). In P. falciparum, it is quite possible 
that PfPuf1 may act in concert with the DOZI-CITH complex to repress mRNA 
translation and regulate sexual development, although only with further 
experiments can this relationship be examined (Shrestha et al., 2016).  
 
In addition to Plasmodium Puf1, the Puf2 RNA-binding protein has also been 
examined in detail in both P. berghei and P. falciparum. In P. falciparum, Puf2 
gene disruption resulted in an increase of gametocyte conversion and 
differentiation to male gametocytes, with an increase in PfPuf2 repressing male 
gametocyte maturation and exflagellation (Miao et al., 2010). Further studies 
revealed that PfPuf2 is in fact an instigator of translational repression of a number 
of gametocyte mRNA transcripts, including mRNA of the ookinete surface proteins 
P25 and P28 (Miao et al., 2013). Unlike PfPuf1, the mechanism by which PfPuf2 
mediates translational repression in P. falciparum has been determined. In a study 
by Miao et al. (2013), PfPuf2 was shown to bind to Puf-binding elements (PBEs) in 
the 3’UTR of the P. falciparum P28 mRNA transcript (pfs28) and the 5’UTR of the 
P. falciparum P25 mRNA transcript (pfs25). This study represented the first time 
that the mechanism of PfPuf2-mediated translational repression was determined 
in the human malaria parasite, and shows its regulatory role in P. falciparum 
gametocytogenesis.  
 
In P. berghei, PbPuf2 was also shown to be a key regulator in the transition of 
sporozoites from the mosquito salivary glands to EEF parasite liver stages in the 
mammalian host (Gomes-Santos et al., 2011; Müller, Matuschewski and Silvie, 
2011). During sporozoite-to-EEF transition, PfPuf2 regulates the translation of the 
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key sporozoite protein, UIS4 (Upregulated in Infectious Sporozoites protein 4) by 
binding to its mRNA transcript, directly repressing translation (Silva et al., 2016). 
Perturbation of Puf2 expression in an additional rodent malaria model, P. yoelii 
(strain P. yoelii 17 XNL (non-lethal)) confirmed the role of this translational 
repressor in the correct timing of sporozoite-to-EEF transformation, with 
premature PyPuf2 overexpression resulting in deregulation of sporozoite 
maturation and infectivity (Lindner et al., 2013).  
 
The role of a third Puf protein, Puf3, has only recently been investigated in both 
P. falciparum and P. yoelii, though the function of this RNA-binding protein 
appears to be unrelated to gametocytogenesis (Liang et al., 2018). In P. 
falciparum, Puf3 activity appeared localised to the nucleolus during the IDC. With 
subsequent analysis of P. yoelii Puf3 during mosquito and liver stages, a movement 
from the nucleolar compartment to cytosolic puncta were observed in oocysts, 
oocyst sporozoites, and early liver-stage sporozoites. Protein co-
immunoprecipitation studies and RNA-immunoprecipitation with high-throughput 
sequencing (RIP-seq) further demonstrated an association of PfPuf3 with 
ribosomal proteins and enrichment at rRNA internal-transcribed spacer 2 (ITS2) 
sequences. Taken together, these findings suggest that Puf3 is involved in 
ribosomal biogenesis at parasite transmission stages within the mosquito and early 
intra-hepatocytic development (Liang et al., 2018).     
 
The roles of DHFR-TS, Alba1, CITH, DOZI, and the Puf proteins mark only the 
beginning of investigations into mechanisms of translational repression in 
Plasmodium parasites. Experiments have only just begun to reveal the possible 
roles of the transcriptional regulators, SAP1 (sporozoite asparagine-rich protein 
1), CELF 1 (CUG-BP, Elav-like family proteins 1), and PABP 1 and 2 (Poly(A)-binding 
proteins 1 and 2) in the translational repression of Plasmodium spp. RNA (Aly et 
al., 2011; Wongsombat et al., 2014; Minns et al., 2018). In a comprehensive study 
using hidden Markov model (HMM) searches, nearly 1000 possible RNA-binding 
proteins were identified in P. falciparum (Bunnik et al., 2016). Among these were 
a number of mRNA-binding proteins associated with polysomes throughout the P. 
falciparum IDC, some of which have been identified as translational repressors 
(Alba1 and PABP1 for example), and more with the potential for roles in 
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translational repression such as Alba3, CAF1, and CAF40 (Bunnik et al., 2013, 




Figure 1.11: An overview of the regulation of translation in Plasmodium spp. This image is a 
cartoon representation of our current knowledge of translational regulation in Plasmodium spp. 
The upper panel of this image shows the stages of mRNA translation from the 5’untranslated region 
(5’UTR), through the coding sequence (CDS), to the 3’untranslated region (3’UTR), with the stages 
of initiation, elongation, and termination highlighted. Upon entering the cell cytoplasm, mature 
mRNA can be subject to translation initiation by eukaryotic initiation factors (eIFs), a number of 
which are shown in the above image (eIF4A, eIF4G and eIF2D). Initiation factors can be inhibited 
in their action by binding proteins, such as the eIF4E binding proteins shown. The factor eIF4E 
binds the 5’m7GpppN cap of the mRNA molecule and forms part if the heterotrimeric translation 
initiation complex with the helicase eIF4A, and scaffold protein eIF4G. Eukaryotic translation 
usually begins with the assemblage of the 80S ribosome and a methionine-loaded transfer RNA 
(tRNAmet) at the mRNA start codon (AUG). The eIF2 protein is involved in this process but can be 
inhibited in its actions by phosphorylation of the eIF2D subunit. In Plasmodium eIF2D kinases (as 
shown above) can repress translation by phosphorylation of the eIF2D subunit. The polypeptide 
chain is then elongated by eukaryotic elongation factors (eEFs) and the final polypeptide released 
from the ribosome by eukaryotic translation release factors (eRFs). A core element of successful 
translation is the interaction of the eIF4F complex (made up of eIF4A, eIF4E and eIF4G) with a 
poly(A)-binding protein (PABP) at the 3’ polyA-tail of the mRNA. This interaction forms the mRNA-
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ribonucleoprotein (mRNP) structure that prevents the mRNA being translated from degradation by 
outside factors. The three panels beneath the main mRNA translation image depict methods by 
which Plasmodium spp. translation can be inhibited; again from the 5’UTR to the 3’UTR. A number 
of Plasmodium translation repressors are depicted in the centre image (ALBA, CITH, DOZI, PUF, 
CELF, and PABP). uORF: upstream open reading frame; PBE: Puf-binding element; DCP: decapping 
protein; XRN1: exoribonuclease 1; RRP6: exosome complex exonuclease RRP6; DIS3: exosome 
complex exonuclease RRP44; CCR4: carbon catabolite repressor 4; NOT: Negative on TATA; CAF1: 
CCR4-associated factor 1. Source: (Vembar, Droll and Scherf, 2016).           
 
1.5 Transcription factors in Plasmodium: the AP2 protein family 
 
Outside of the mechanisms of transcriptional, post-transcriptional, and 
translational control of gene expression as outlined in section 1.4, and regulation 
by epigenetic mechanisms (detailed in section 1.6), Plasmodium spp., as well as 
other members of the Apicomplexa genus, show an unexpected paucity of 
transcription factor families with homology to those found in other eukaryotes 
(Balaji et al., 2005). Unlike other mechanisms of gene regulation that have been 
previously mentioned, transcription factors are proteins that bind to regulatory 
elements of a gene (such as a specific sequence motif) and regulate the baseline 
expression of that gene. Transcription factors can act as either activators or 
repressors and are composed of at least a family-designating DNA-binding domain 
(DBD) and a transcription regulatory domain that mediates activation or repression 
of the gene (Staby et al., 2017). Transcription factor regulatory domains can also 
bind to co-activators of transcriptional machinery, or take part in remodelling or 
modification of adjacent chromatin (Näär, Lemon and Tjian, 2001). 
 
In Plasmodium spp., the few identified transcription factors are: P. falciparum 
Myb1 and Myb2 (“Myb” from “myeloblastosis”) (Gissot et al., 2005; Bischoff and 
Vaquero, 2010); high-mobility-group box (HMGB) factors 1-4 (Kumar et al., 2008; 
Tuteja, Ansari and Chauhan, 2011); the Apicomplexan Apetela2/ethylene 
response factor (AP2/ERF) family of DNA-binding proteins (Balaji et al., 2005); 
and the novel P. falciparum Prx regulatory element binding protein, PfPREBP 
(Komaki-Yasuda et al., 2013). At present, it is the AP2 family of transcription 
factors that are subject to the most intensive investigations, with studies in P. 
berghei revealing roles for 11 out of 26 P. berghei AP2 family genes in 
transmission. An additional 14 genes in P. berghei were demonstrated as being 
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necessary for asexual parasite stage development, with one final gene of the 26 
being incompatible with the knockout screen used and possibly requiring further 
elucidation (Modrzynska et al., 2017). In P. falciparum, the AP2 transcription 
factor family consists of 27 members; the Apicomplexan parasite Toxoplasma 
gondii possesses 67 AP2 DNA-binding proteins; and Cryptosporidium parvum 
contains only 23 AP2 domains across 18 proteins (Oberstaller et al., 2014; Hong, 
Radke and White, 2017; Modrzynska et al., 2017). Despite the seemingly 
unconserved nature of the AP2 family of transcription factors in the Apicomplexa 
genus, in Plasmodium spp., these factors have been shown to be fundamental to 
developmental stage transitions in the parasite (Modrzynska et al., 2017).  
 
One of the first Plasmodium AP2 transcription factors to be functionally 
characterised was AP2-sp (AP2 in sporozoites), a major transcriptional regulator 
of gene expression in sporozoites (Yuda et al., 2010). In P. berghei, disruption of 
the pbap2-sp gene resulted in parasite development up until the point of 
sporozoite formation within the mosquito oocyst. In pbap2-sp-disrupted parasites, 
oocysts were shown to have undergone nuclear division, but with no invagination 
of the oocyst plasma membrane, therefore hindering sporoblast development. 
This study also demonstrated that the AP2-sp DNA-binding domain recognised a 
specific sequence motif beginning with TGCATG, located in the proximal promoter 
region of all sporozoite-specific genes (Yuda et al., 2010).  
 
In P. falciparum, the AP2-sp orthologue (PF3D7_1466400) was shown to play 
another biological role (Martins et al., 2017). In this human-infective parasite, 
Martins et al. demonstrated that the orthologous P. falciparum transcription 
factor, which was called ‘AP2-exp’ throughout this study, was in fact responsible 
for regulating a subset of clonally variant genes involved in virulence. Upon 
disruption of pfap2-exp in red blood stage parasites, 190 genes were upregulated 
and 47 genes downregulated, most belonging to groups of subtelomeric gene 
families that showed mutually-exclusive expression, including surface proteins of 
the rif and stevor gene families. Of considerable importance was the fact that 
this study demonstrated a role for the non-DNA-binding domain of AP2-exp in the 
expression of clonally-variant gene families (Martins et al., 2017). However, it 
remains to be seen whether AP2-exp retains its function in sporozoite 
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development in P. falciparum, or whether PbAP2-sp also acts as a regulator of 
clonally-variant gene families in blood stages of the rodent malaria model.  
 
In a similar manner, a P. berghei AP2 gene necessary for the motility of sporozoites 
within oocysts, and subsequent infectivity of the parasite into the host liver 
(pbap2-sp3) (Modrzynska et al., 2017) contained an orthologue in P. falciparum 
(PF3D7_0622900) that was subjected to investigation for a very different reason. 
This P. falciparum orthologue, denoted as PfAP2Tel (for P. falciparum AP2-
telomeric) was pulled down as a member of a telomere-binding protein complex 
during the intraerythrocytic parasite life cycle (Sierra-Miranda et al., 2017). As a 
result, PfAP2Tel was again implicated as having a role in the regulation of clonally-
variant subtelomeric gene families such as var, rif and stevor gene families during 
blood stages, with a possible function in sporogony of P. falciparum that has yet 
to be examined.  
 
In yet another study of P. falciparum chromosome end biology, the AP2 domain-
containing protein, PfSIP2 (P. falciparum SPE2-interacting protein) was also shown 
to interact with SPE2 motifs (two imperfect 6 bp repeats separated by 4 bp) at 
heterochromatic domains upstream of subtelomeric var genes (Flueck et al., 
2010). In the later P. berghei AP2 protein knockout screen, a pbsip2 knockout was 
lethal to the parasite (Modrzynska et al., 2017), suggesting that this transcription 
factor is indispensable for asexual growth. In future studies, an examination of 
the roles of PfAP2-exp and PfAP2Tel in sporozoite development and infectivity in 
the human malaria parasite would be enlightening, as these studies could 
corroborate results seen in the P. berghei rodent malaria model. Alternatively, 
examining transcriptional changes in knockouts of PbAP2-sp and PbAP2-sp3 may 
reveal as-yet-undetermined subtelomeric clonally-variant gene families in P. 
berghei. At the very least, a comparison of transcriptomic changes in P. 
falciparum PfAP2-exp or PfAP2Tel knockout lines (as the non-lethality of these 
knockouts has been demonstrated in P. berghei) may reveal gene families, or 
single genes, necessary for sporozoite development and invasion, these such 
proteins being targetable as vaccine candidates. 
 
Outside of the characterisation of PbAP2-sp (PfAP2-exp), PbAP2-sp3 (PfAP2Tel), 
and SIP2, other members of the AP2 transcription factor family have been shown 
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to be critical in maintaining developmental stage transitions throughout the 
Plasmodium life cycle. In P. berghei, AP2-L (AP2-liver) has been shown to be 
necessary for intrahepatocytic parasite development (Iwanaga et al., 2012), AP2-
O (AP2-ookinete) is responsible for control of ookinete morphogenesis, 
locomotion, and mosquito midgut penetration (Kaneko et al., 2015; Modrzynska 
et al., 2017), AP2-ookinete proteins 2 to 4 (AP2-O2 to AP2-O4) and AP2-sp protein 
2 (AP2-sp2) are also necessary for successful ookinete and sporozoite development 
respectively (Modrzynska et al., 2017), and AP2-gametocyte proteins 1 and 2 (AP2-
G and AP2-G2) are master regulatory factors of commitment to sexual 
development and gametocyte maturation (Sinha et al., 2014; Yuda et al., 2015; 
Modrzynska et al., 2017) (Figure 1.12).  
 
Despite this knowledge, the exact point at which commitment to sexual 
development is initiated is still unknown. We do know, however, that the 
mechanism for initiation of gametocytogenesis must lie upstream of AP2-G, AP2-
G2, and GDV1 (in human-infective Plasmodium spp.), and that these transcription 
factors are essential for correct development of the Plasmodium gametocyte. 
Undoubtedly, future experiments will shed light on the roles of other AP2 family 
proteins in the Plasmodium life-cycle, and that novel methods for genetic 
manipulation may aid in the examination of these transcription factors in the 
human malaria parasite. 
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Figure 1.12: An overview of the involvement of AP2 family proteins in the P. berghei life-
cycle. This image shows a simplified P. berghei parasite life-cycle with Apicomplexan AP2 (ApiAP2) 
transcription factors indicated at the point at which they have been shown to have a regulatory 
role. Beginning on the left of the image with the asexual blood stages in the host erythrocyte 
(merozoite invasion to intraerythrocytic schizont stage), 14 ApiAP2 protein knockouts failed to 
grow asexually and so it has been suggested that they play essential regulatory roles in asexual 
replication. Moving up to male and female gametocyte stages, AP2-G has been shown to be 
essential to gametocyte formation (both males and females), whereas AP2-G2 has shown to be 
essential for gametocyte maturation (Kafsack et al., 2014; Sinha et al., 2014; Yuda et al., 2015; 
Modrzynska et al., 2017). Modrzynska et al. (2017) also showed that AP2-G2 acts as a 
transcriptional repressor in both asexual and sexual stages, with liver- and sporozoite- stage genes 
dysregulated in asexual stages upon pbap2-g2 knockout.  
After zygote formation, the formation of the P. berghei ookinete is directed by the action of four 
AP2-ookinete transcription factors, AP2-O to AP2-O4. AP2-O proteins act in concert for the 
formation of an ookinete with motile capabilities and the capacity for oocyst development. The 
absence of any one of these transcription factors results in loss of ookinete formation, maturation 
or oocyst formation at a specific point in this developmental cycle. After oocyst formation, AP2-
sporozoite proteins 1 to 3 (AP2-sp to AP2-sp3) regulate normal development of the sporozoite from 
its development in the oocyst to the release of motile and infective sporozoites in the salivary 
glands of the mosquito. Once sporozoites have entered the mammalian host and have traversed 
to a suitable hepatocyte for intrahepatocytic growth, the AP2 transcription factor, AP2-liver (AP2-
L) regulates transcriptional changes necessary for exoerythrocytic form (EEF) development. 
Without AP2-L expression, the EEF developmental stage is lost and the parasite life-cycle cannot 
continue. Not shown are the roles of PbSIP2 and an as-yet-unnamed AP2 domain-containing protein 
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(corresponding to gene PBANKA_1313200) for which no knockout vector could be generated. 
Source: Image adapted from the graphical abstract of Modrzynska et al., 2017.        
 
1.6 Epigenetics and higher order genome organisation in Plasmodium  
 
1.6.1 Epigenetic regulation of Plasmodium virulence: telomere position effect 
 
The study of epigenetics in malaria parasites has stemmed almost solely from 
investigations into the molecular mechanisms responsible for monoallelic var gene 
expression in Plasmodium falciparum. At the heart of this immune evasion process 
is the intricate organisation and regulation of the family of ~60 var genes from the 
point of initiation of gene transcription (Kaestli et al., 2006; Kyes et al., 2003; 
Scherf et al., 1998; Su et al., 1995).   
 
Epigenetic regulation of var genes takes place via a number of different 
mechanisms, from the level of the gene itself to its location within the three-
dimensional chromatin structure of the Plasmodium nucleus. Telomere position 
effect, i.e. the reversible transcriptional repression of genes as a result of their 
relative position to the chromosome end, has been demonstrated as playing an 
important role on the silencing of var genes in Plasmodium (Gottschling et al., 
1990; Duraisingh et al., 2005). Var genes are predominantly located at 
subtelomeric regions of the genome and are clustered at the nuclear periphery, 
with transcriptional silencing being reversed upon physical repositioning of a var 
locus to a position that is permissive of transcriptional activation (Freitas-Junior 
et al., 2000; Voss et al., 2007; Marty et al., 2006). In P. falciparum, the 
transcriptional repression of var genes occurs at both subtelomeric regions of the 
chromosome and at so-called ‘chromosome-central’ regions, with both loci 
demonstrating variable rates of transcriptional switching and stochastic gene 
expression patterns (Frank et al., 2007). The lack of a pre-determined order of 
var gene transcription more than likely contributes to the heterogeneity of clonal 
parasite populations and the severity of P. falciparum-mediated malarial illness 
by contributing to the evasion of host immunity. 
 
In addition to being localised to specific chromosome regions, var genes are also 
regulated by distinct var gene promoters that correlate strongly with their 
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chromosomal location. Following completion of the P. falciparum genome, three 
separate classes of var gene promoter have been determined, all being highly 
conserved and upstream of their respective genes (hence the ups nomenclature): 
upsA, upsB and upsC (Voss et al., 2003). Variant var gene promoters mediate 
different in situ transcriptional effects through differential binding to nuclear 
proteins and different physical interactions between var introns and upstream 
elements within the gene sequence (Voss et al., 2006; Calderwood et al., 2003). 
In particular, the upsC-type var promoter has been implicated in epigenetic 
silencing through an interaction between AUG-rich, cis-acting promoter motifs 
and the silencing machinery of P. falciparum (Brancucci et al., 2012). 
 
Though positioning of genes within the nucleus and their position relative to 
telomeres is a decisive factor in the epigenetic regulation of virulence genes in P. 
falciparum, so too are factors that influence nucleosome structure and function: 
histone-modifying enzymes (Coleman et al., 2014; Brancucci et al., 2014; Chaal 
et al., 2010; Miao et al., 2010; Mancio-Silva et al., 2013; Merrick et al., 2015; 
Tonkin et al., 2009); histone modifications (histone “marks”) (Jiang et al., 2013; 
Lopez-Rubio et al., 2007; Chookajorn et al., 2007; Cabral et al., 2012; Karmodiya 
et al., 2015; Miao et al., 2006; Dastidar et al., 2013; Gupta et al., 2013; 
Sindikubwabo et al., 2017); the interchange between canonical and variant 
histones (Petter et al., 2013; Hoeijmakers et al., 2013; Bártfai et al., 2010); the 
activity of nucleosome assembly proteins (NAPs) that chaperone histone proteins 
to and from the nucleosome structures (Gill et al., 2010); and dynamic 
nucleosome positioning relative to transcription start sites (Bunnik et al., 2014; 
Kensche et al., 2015) (Figure 1.13). 
 
Figure 1.13: Epigenetic regulation of var genes. This image depicts a number of the known 
epigenetic mechanisms responsible for monoallelic var gene expression in the P. falciparum 
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parasite. Var genes are localised to the nuclear periphery of the parasite, with one active var gene 
isolated from a repressive cluster of silent var genes. Silenced var genes are associated with the 
repressive histone 3, lysine 9 trimethylation (H3K9me3) modification, which in turn recruits 
heterochromatin protein 1 (HP1) to form tightly compacted heterochromatin. Histone 
deacetylases such as histone deacetylase 2 (‘HDA2’ or ‘HDAC2’), silent information regulator 2A 
(SIR2A), and SIR2B are responsible for removing acetylation modifications, therefore contributing 
to heterochromatin formation by facilitating the action of methyltransferases such as SET2 
(Su(var)3–9, Enhancer of zeste, and Trithorax 2). H3 lysine 36 trimethylation (H3K36me3) is also 
associated with silenced var genes and is a product of the SET2/PfSETvs methyltransferase 
enzyme. The active var gene is marked by H3 lysine 4 trimethylation (H3K4me3) and H3K9 
acetylation (H3K9Ac). In addition, long non-coding RNAs (lncRNAs) are transcribed from a 
bidirectional promoter in var introns and contribute to var gene transcription. Source: Adapted 
from (Batugedara et al., 2017).  
 
1.6.2 Epigenetic regulation of Plasmodium transcription: histone acetylation 
 
In the malaria parasite, the discovery of the involvement of the histone 
deacetylase PfSIR2A in the transcriptional silencing of virulence-associated var 
and repetitive interspersed family (rif) genes marked the first instance that a 
histone-modifier was identified in Plasmodium gene regulation (Tonkin et al., 
2009). Since then, PfSIR2A and its paralogue, PfSIR2B, have been shown to 
mediate the silencing of subtelomeric var and rif genes by propagating the cis-
spreading of silent chromatin from telomeres to adjacent regions (Mancio-Silva et 
al., 2013; Merrick et al., 2015). 
 
In the past decade, a host of enzymes involved in modulating acetylation and 
deacetylation throughout the complex Plasmodium life cycle have been 
characterised. During the asexual intraerythrocytic parasite cycle, gene activation 
in P. falciparum is closely regulated by the activity of a single histone 
acetyltransferase of the MYST family of histone acetyltransferases, PfMYST, which 
is essential for cell cycle control (Miao et al., 2010). In addition, inhibiting global 
histone deacetylase (HDAC) activity by introducing a potent chemical inhibitor has 
profound detrimental effects on the intraerythrocytic transcriptional cascade; 
both disrupting the stage-specific histone modification profile, as well as 
producing a mass up-regulation of transcription factors that de-regulate normal 
parasite growth (Chaal et al., 2010).  
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The disruption of HDAC activity not only effects the asexual intraerythrocytic 
developmental cycle of Plasmodium, but also the rate of gametocyte conversion. 
In a study by Coleman (Coleman et al., 2014), epigenetic regulation of 
gametocytogenesis was demonstrated in an examination of the role of histone 
deacetylase 2 (HDAC2) on the level of gametocyte conversion in P. falciparum. 
HDAC2 depletion in P. falciparum results in a significant up-regulation in the 
expression of AP2-G, the transcriptional switch responsible for commitment to 
sexual development (Sinha et al., 2014; Kafsack et al., 2014). Peak HDAC2 
expression also coincides with late trophozoite and schizont parasite stages in 
wild-type strains, consistent with the point of the asexual intraerythrocytic cycle 
at which parasites must commit to gametocytogenesis (Bruce et al., 1990). In a 
complementary study, Brancucci et al. (2014) conditionally depleted the 
conserved regulator of gene silencing, heterochromatin protein 1 (HP1), which 
binds to H3K9Me3, stabilising this repressive mark (Zeng et al., 2010). The result 
of this was a dysregulation of var gene monoallelic expression, and an increase in 
PfAP2-G expression and gametocytogenesis (Brancucci et al., 2014). Together, 
these studies testify to a relationship between enzymes that modulate acetylation 
of histones and regulation of both the asexual and sexual life cycles in the malaria 
parasite, P. falciparum (Figure 1.14). 
 
Figure 1.14: Epigenetic regulation of Plasmodium sexual development. In P. falciparum 
parasite populations, only 10% or less of all parasites commit to gametocytogenesis, a process 
under control of the ‘master transcriptional regulator’, PfAP2-G (Kafsack et al., 2014; Sinha et 
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al., 2014). In the majority of the parasite population, the ap2-g locus is located in a 
heterochromatic region of the nucleus that is marked by methylation of H3K9 (Lopez-Rubio et al., 
2009). Depletion of both PfHda2 (Coleman et al., 2014) and heterochromatin protein 1 (HP1) 
(Brancucci et al., 2014) have been shown to result in an increase in Pfap2-g transcription and 
gametocyte conversion, though the exact mechanism by which PfHda2 elicits its effect is currently 
unknown. In the case of PfHP1, it is proposed that the opening of the Pfap2-g locus to transcription 
results in increased PfAP2-G expression which in turn maintains a positive feedback loop 
facilitating more PfAP2-G transcription, as well as activation and expression of its downstream 
effectors (Sinha et al., 2014). In a natural P. falciparum infection, it is not yet known whether the 
initial signal responsible for sexual commitment is stochastic, sporadic, or resulting from 
environmental triggers. Despite our current knowledge, there is still much about the regulation of 
gametocyte commitment and development that we have yet to uncover, not least about possible 
role of further unidentified regulatory factors such as histone methyltransferases and chromatin 
remodeling complexes. Source: (Josling & Llinas, 2015).  
 
Outside of P. falciparum histone acetyltransferases (HATs) and HDACs that have 
been characterised so far (PfMYST, PfSIR2A, PfSIR2B, and PfHDAC2), recent 
phylogenetic analyses of HATs and HDACs of the P. falciparum genome have 
revealed the presence of 10 putative HATs of the MYST and Gcn5-related N-
acetyltransferases (GNATs) families, 6 HDACs of the Class I, II and III families of 
HDACs, and a novel unclassified HDAC with homology to the eukaryotic 
chromodomain helicase DNA-binding (CHD) family of chromatin modifiers 
(Marfella and Imbalzano, 2007; Kanyal et al., 2018). A list of the genes encoding 
these potential P. falciparum HAT and HDAC proteins, alongside orthologous P. 
berghei genes, the enzyme family to which they belong, and the binding domains 
denoted by their sequence, can be found in Table 1.1.  
 
 




P. falciparum gene 
identifier 




PlasmoDB name (if given) Conserved domain (s) 
PF3D7_1003300 PBANKA_1201700 
 
GNAT N-terminal acetyltransferase A 
complex catalytic subunit ARD1, 
putative (ARD1) 
i) Acetyltransferase domain 
PF3D7_0109500 PBANKA_0204100 
 
GNAT N-acetyltransferase, putative i) Acetyltransferase domain 
ii) FR-47-like domain 
PF3D7_0805400 PBANKA_1225200 
 
GNAT Acetyltransferase, putative i) Acetyltransferase domain 
ii) RimL domain 
PF3D7_0629000 PBANKA_1127600 
 
GNAT N-acetyltransferase, putative i) Acetyltransferase domain 
PF3D7_1437000 PBANKA_0611800 
 
GNAT N-acetyltransferase, putative i) Acetyltransferase domain 
ii) NAT domain 
PF3D7_0823300 PBANKA_0707300 
 
GNAT Histone acetyltransferase GCN5 
(GCN5) 




GNAT Acetyltransferase, GNAT family, 
putative 
i) Acetyltransferase domain 
PF3D7_1227800 PBANKA_1442500 
 
GNAT Elongator complex protein 3, 
putative (ELP3) 
i) Radical SAM/HAT domain 




GNAT Histone acetyltransferase, 
putative 
i) Acetyltransferase domain 
ii) Helicase domain 
iii) tRNA-binding domain 
iv) tRNA(Met) cytidine acetyltransferase TmcA 
domain 
PF3D7_1118600  PBANKA_0929500 
 
MYST Histone acetyltransferase (MYST) 
$ 
i) Acetyltransferase domain 
ii) Chromodomain-like domain 
iii) C2HC-type zinc finger domain 
PF3D7_1472200 PBANKA_1335400 
 
HDAC Class II Histone deacetylase, putative 
(HDA1) 
i) Histone deacetylase domain (x3)  
ii) Ankyrin repeats 
PF3D7_0506600 PBANKA_1106200 
 
HDAC Class II Histone deacetylase, putative, 
pseudogene 
i) Histone deacetylase domain 
PF3D7_1008000 PBANKA_1206200 
 
HDAC Class II Histone deacetylase 2 
(HDA2/HDAC2) $ 
i) Histone deacetylase domain (x3)  
ii) DUF2981 domain 




binding protein 1 homolog, 
putative (CHD1) 
i) Chromo/chromo-shadow domain-like 
ii) Helicase family ATP-binding domain 
iii) SNF2-related, N-terminal domain 
iv) Helicase domain 
PF3D7_0925700 PBANKA_0826500 
 
HDAC Class I Histone deacetylase 1 (HDAC1) i) Histone deacetylase domain 
PF3D7_1328800 PBANKA_1343800 
 
HDAC Class III Transcriptional regulatory protein 
SIR2A (SIR2A) $ 
i) DHS-like NAD/FAD binding/sirtuin domain 




HDAC Class III Transcriptional regulatory protein 
SIR2B (SIR2B) $ 
i) Histone deacetylase domain (x2)  
 
Table 1.1: Histone acetyltransferases (HATs) and histone deacetylases (HDACs) identified in P. falciparum by Kanyal et al. (2018) and their orthologues in P. 
berghei. The table above details HATs and HDACs identified as such by Kanyal et al., 2018 in the format P. falciparum gene identifier; P. berghei gene identifier; 
protein superfamily into which the protein has been categorised; PlasmoDB name for protein (if one is present); and protein domains encoded by the P. falciparum 
gene sequence (as identified by Kanyal et al. 2018). A “$” symbol next to the name of the protein in the fourth column indicates that the protein has been 
characterised in Plasmodium previously. Table generated using PlasmoDB [up-to-date as of the 23rd of January, 2018] (The EuPathDB Project Team, 2018).  
GNAT: Gcn5-related N-acetyltransferase; MYST: MOZ, Ybf1/Sas3, Sas2, and Tip60; HDAC/HDA: Histone deacetylase; ELP: Elongator complex protein; SIR2: Silencing 
information regulator 2; CHD: Chromodomain helicase DNA-binding; SNF2: Sucrose non-fermentation 2; DUF2981: Domain of Unknown Function 2981; TmcA: 
tRNA(met) cytidine Acetyltransferase; NAT: N-acetyltransferase; NAD: nicotinamide adenine dinucleotide; FAD: flavin adenine dinucleotide; DHS: deoxyhypusine 
synthase.     
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1.6.3 Epigenetic regulation of Plasmodium transcription: histone methylation 
 
Histone lysine methylation may play an equally important role in the regulation 
of stage transitions in Plasmodium. Bioinformatic analysis has identified nine SET-
domain-containing genes (‘SET’ from the Drosophila chromatin-modifying 
enzymes Su(var)3–9, Enhancer of zeste, and Trithorax), each with putative histone 
lysine methyltransferase (HKMT) activity in P. falciparum, and two Jumonji C 
(JmjC)-domain-containing genes with putative histone lysine demethylase 
capabilities (Cui et al., 2008, Jenuwein et al., 2000).  
 
One silencing SET gene, encoding the P. falciparum SET2/PfSETvs 
methyltransferase, has been subject to comprehensive functional 
experimentation (Jiang et al., 2013). In an in vitro study of a SET2 knockout P. 
falciparum line, haemagglutinin (HA)-tagged SET2 specifically localised to 
transcription start sites and intronic promoters of var genes, and was associated 
with var family repression of these genes via H3K36 trimethylation. In contrast, 
P. falciparum SET10 (PfSET10), has been shown to localise to H3K4 mono-, di- and 
tri- methylation marks (H3K4me1, H3K4me2, and H3K4me3) at a euchromatic 
region of the nuclear periphery corresponding to the site of active var gene 
expression (Volz et al., 2010; Volz et al., 2012). In these PfSET10 studies, the 
authors propose that PfSET10 is likely required for the maintenance of the 
transcriptionally permissive chromatin state at the active var gene promoter, and 
the maintenance of the open chromatin state during increased active var gene 
transcription at the P. falciparum ring stage (6-8 hours post invasion (hpi)). 
Though undoubtedly a component of the active var gene expression site and a 
methyltransferase of H3K4, the role of PfSET10 will likely be elucidated further 
as more is learned about the roles of other SET-domain-containing proteins and 
their combined activities in regulating monoallelic var gene expression (Volz et 
al., 2012). 
 
The most recent Plasmodium methyltransferase to be enzymatically characterised 
has been P. falciparum SET7 (PfSET7), an s-adenosyl methionine (AdoMet)- 
dependent methyltransferase of histone 3, with highest activity towards lysines 4 
and 9 (Chen et al., 2016). Steady state enzyme kinetics were recorded for a codon-  
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optimised version of wild-type full-length PfSET7 (PfSET7FL), expressed as a 
recombinant protein using the baculoviral expression system in Spodoptera 
frugiperda clone 9 (Sf9) insect cells. Recombinant PfSET7 showed a specific 
substrate preference towards nucleosomes marked with H3 lysine 14 acetylation 
(H3K14ac), with fluorescently-tagged P. falciparum SET7 showing localisation to 
distinct foci adjacent to the cell nucleus in erythrocytic and liver stage parasites.  
 
In salivary gland sporozoites, PfSET7 expression was seen throughout the cell 
cytoplasm, suggesting an altered expression of this protein between the 
vertebrate host and insect vector, though the reasons behind this altered 
expression are not understood at present. As well as association with methylation 
of H3K9 and H3K4 (in the presence of H3K14ac), PfSET7 was also shown to 
methylate lysines 27 and 36 of histone 3 (H3K27 and H3K36) to a lesser extent 
(Chen et al., 2016). Considering that methylation of H3K9 is associated with 
silencing of var genes (Chookajorn et al., 2007), while K3K4 methylation is 
associated with transcribed var promoters (Lopez-Rubio et al., 2007) in P. 
falciparum, the role of PfSET7 in parasite virulence is almost certainly specific to 
location within the parasite cytoplasm or nucleus, the open or repressed 
chromatin state of the surrounding nuclear environment, and the presence or 
absence of additional histone modifications or their modifying enzymes. 
 
To add to the complexity of histone methyltransferases and their role in 
epigenetically regulating Plasmodium virulence and sexual development, an 
improved P. cynomolgi genome assembly has recently demonstrated a paralogous 
expansion of the Plasmodium interspersed repeat (pir) genes, genes encoding for 
merozoite surface proteins (MSPs), and an expansion of 36 subtelomeric 
methyltransferase pseudogenes (Pasini et al., 2017). All 36 pseudogenes cluster 
to one full-length core P. cynomolgi gene (PcyM_0947500) on chromosome 9, a 
gene with a conserved orthologue across all Plasmodium species. Evidence of a 
duplication of methyltransferases was also discovered in Plasmodium simiovale, a 
closely related simian malaria parasite (Cogswell et al., 1991; Pasini et al., 2017). 
It remains to be seen whether these paralogous genes are functional in either 
Plasmodium species.  
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Although it is clear that future studies regarding Plasmodium HKMTs and JmjC-
domain-containing genes will no doubt reveal further fascinating examples of 
epigenetic regulation (and perhaps a link between histone lysine methylation and 
regulation of gametocytogenesis), many more studies have endeavoured to map 
histone modifications across the Plasmodium life cycle irrespective of the 
enzymes that underlie their presence. For example, singularly active var genes 
are flanked by active marks H3K4me2 and H3K4me3 at their 5’ coding region, as 
well as the repressive H3K9me3 modification (Chookajorn et al., 2007; Lopez-
Rubio et al., 2007). Genome-wide profiles of histone modifications have identified 
H3K36me2 as a global repressive mark (Karmodiya et al., 2015), the association 
of H3K9ac and H3K4me2 with active rif loci (Cabral et al., 2012), steady 
acetylation of H4K5, H4K8, and H4K12 throughout the intraerythrocytic life cycle 
(Miao et al., 2006), an association of H4K8ac with promoter regions (Gupta et al., 
2013), and the presence of monomethylated H4K31 at inactive, pericentromeric 
promoter regions (Sindikubwabo et al., 2017), all in P. falciparum. Though known 
to be present as a histone modification, comprehensive genome-wide and stage-
specific analyses of histone phosphorylation patterns in P. falciparum remain to 
be undertaken (Dastidar et al., 2013).  
 
1.6.4 Regulation of Plasmodium gene expression by histone variation 
 
Another level of epigenetic control observed in Plasmodium parasites so far is the 
regulation of gene expression in a stage-specific manner via the exchange of 
canonical histones with alternative histone variants. As with other mechanisms of 
P. falciparum epigenetic regulation, the exchange of a canonical histone, in this 
case, PfH2A, with the variant histone, PfH2A.Z, was examined in the context of 
var gene antigenic variation (Petter et al., 2013). During the asexual 
intraerythrocytic cycle, PfH2A.Z associated with histone marks at transcriptionally 
active open chromatin regions, and in var genes, PfH2A.Z is enriched only at 
transcription start sites of the active gene. Chromatin immunoprecipitation (ChIP) 
in tandem with high-throughput sequencing (ChIP-seq) has shown co-localisation 
of PfH2A.Z with the active marks H3K9ac and H3K4me3 (Bártfai et al., 2010). With 
the apicomplexan-specific histone variant PfH2B.Z, PfH2A.Z has also been shown 
to establish a H2A.Z/H2B.Z double-variant nucleosome subtype that is enriched  
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at AT-rich promoter regions, including that of the single active var gene, 
highlighting its correlation with open chromatin and active gene transcription in 
this malaria parasite (Hoeijmakers et al., 2013).  
 
Though chromatin architecture has been hitherto discussed within the context of 
var gene monoallelic transcription, recent studies have demonstrated that the 
dynamicity of the nucleosome landscape is fundamental to the regulation of global 
transcriptional activity in P. falciparum throughout the entirety of the life cycle. 
By taking advantage of the capabilities of micrococcal nuclease (MNase) and 
subsequent high-throughput sequencing (MNase-seq), Bunnik et al. demonstrated 
a relationship between the absence of nucleosome occupancy and active gene 
transcription, with a particular focus on gene promoter regions (Bunnik et al., 
2014). Furthermore, in a recent study by Kensche (Kensche et al., 2015) it was 
shown that throughout the intraerythrocytic life cycle of P. falciparum, loss of 
nucleosome binding to transcription start sites and the structuring of the 
nucleosome landscape around TGCATGCA intergenic motifs could potentially be 
used to predict the functionality of regulatory DNA elements; an idea further 
developed by Lu et al. in their identification of putative novel genes based upon 
the nucleosome positioning landscape of P. falciparum (Lu et al., 2015).     
 
1.6.5. Epigenetic regulation by DNA methylation 
 
No analysis of the epigenetic regulation of a species can be complete without 
discussing the possibility of regulation via DNA cytosine methylation. So far, we 
have discussed epigenetic regulation as dictated by changes in nucleosome 
architecture and control of the histones that make up this DNA-packaging 
structure. The regulation of DNA transcription by cytosine methylation at gene 
bodies, promoters, or enhancers is fundamental for normal mammalian 
development (Chen & Riggs, 2011). However, in Plasmodium parasites, little 
information has been gleaned regarding possible methylation profiles across the 
genome. In an early study of DNA methylation at the DHFR-TS gene in mixed blood 
stages of P. falciparum using restriction enzyme analysis, Pollack et al. (1991) 
highlighted a complete lack of methylation at adenine residues and partial  
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cytosine methylation at a putative CpG island within the gene (Pollack et al., 
1991).  
 
A later study using an improved liquid chromatography/electrospray ionisation 
mass spectrometry (LC/ESI-MS) protocol for the detection of 5-methyl-2’-
deoxycytidine (5mC) on genomic DNA (gDNA) (Friso et al., 2002) disputed this 
previous claim, finding no evidence whatsoever for the presence of 5mC in P. 
falciparum mixed blood stage parasite DNA (Choi, Keyes and Horrocks, 2006). Choi 
et al. suggest that Plasmodium spp. parasites regulate expression of genes 
epigenetically by reversible histone modifications alone, and that the previous 
findings by Pollack et al. (1991) resulted from the inconsistency in the enzymatic 
activity of methyl-sensitive restriction enzymes.     
 
Taking into consideration the methods of examining gDNA methylation used by 
Pollack et al. (1991) and Choi et al. (2006), and the fact that both groups derived 
their results from mixed P. falciparum cultures, it is no surprise that the question 
of DNA methylation as a mechanism for gene expression in Plasmodium was raised 
again in later studies. With the advent of bisulfite conversion of methylated 
cytosines coupled to high-throughput sequencing methods (bisulfite-sequencing or 
‘Bis-Seq’), Ponts et al. (2013) set out to map the genome-wide DNA methylation 
profile of P. falciparum using this new technique, in combination with mass 
spectrometry (LC-MS/MS) and in vitro cytosine methylation assays (Cokus et al., 
2008; Ponts et al., 2013).  
 
In their study, Ponts et al. demonstrated asymmetrical DNA methylation of the P. 
falciparum genome from an asynchronous culture, in a manner similar to 
undifferentiated mammal and plant cells. Moreover, hypomethylation at core 
gene promoters and sharp methylation changes at nucleosome and intron-exon 
boundaries suggest a role for this epigenetic regulation in the malaria parasite. 
This study also suggested differential total DNA methylation profiles between 
synchronous P. falciparum ring (0 hpi), trophozoite (16 hpi), and schizont (30 hpi) 
stages of the IDC, though these results were determined by hypomethylating drug 
assays only, with Bis-Seq and LC-MS/MS only carried out on asynchronous mixed 
blood stage cultures (Ponts et al., 2013).        
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In the most recent study of quantitative detection and mapping of 5mC in 
Plasmodium gDNA, McInroy et al. (2016) highlighted some serious problems with 
the previously-utilised Bis-Seq protocol that throw the Ponts et al. (2013) results 
into question (McInroy et al., 2016). McInroy et al. discuss the facts that the Bis-
Seq protocol is incapable of distinguishing 5mC residues from 5-
hydroxymethylcytosine (5hmC) residues, and that the harsh bisulfite chemical 
treatment can induce gDNA strand scission, leaving up to 99.9% of the DNA 
fragments in a Bis-Seq library preparation unsequencable (Tanaka and Okamoto, 
2007; McInroy et al., 2016). To generate a non-biased, more accurate methylation 
analysis of a Plasmodium parasite, McInroy et al. (2016) developed a novel ReBuilT 
(Recovery after Bisulfite Treatment) method for PCR-free Bis-Seq.  
 
In a comparative analysis of PCR-based Bis-Seq DNA preparation, ReBuilT, and LC-
MS/MS, McInroy et al. observed low-level asymmetric methylation throughout the 
P. berghei genome (taken from an asynchronous culture of intraerythrocytic 
parasites), with no preference for methylation of cytosines at CG-rich regions (a 
feature of mammalian genome methylation) (Li and Zhang, 2014). To conclude, 
McInroy et al. (2016) suggest that data generated from the ReBuilT protocol 
provides compelling evidence for the superiority of PCR-free methylation analysis 
as a method, but that in P. berghei, methylation is either not highly conserved 
across the IDC; present at only key active or silenced genes; or that cytosine 
methylation across the genome is different between the four life stages accounted 
for in the asynchronous culture used (ring stage, trophozoite, schizont, or 
gametocyte).      
 
It is clear from these attempts at studying the Plasmodium spp. DNA methylome 
that progress has been hindered by shortcomings in DNA methylation analysis 
technology. The use of asynchronous cultures in all four studies (Pollack, Kogan 
and Golenser, 1991; Choi, Keyes and Horrocks, 2006; Ponts et al., 2013; McInroy 
et al., 2016), apart from a brief mention of in vitro cytosine methylation assays 
of synchronous P. falciparum ring stages, trophozoites, and schizonts by Ponts et 
al. (2013), also prevents 5mC changes from being compared between the parasite 
life-stages. The low level of cytosine methylation in the Plasmodium genome, and 
its asymmetric organisation, suggests that cytosine methylation of Plasmodium  
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DNA may not be as important a factor in the regulation of developmental stage 
transitions as, for example, transcription factors of the AP2 family (detailed in 
section 1.5) or epigenetic regulation via changes to chromatin conformation 
(sections 1.6.2 to 1.6.4). It remains to be seen whether direct methylation of 
cytosines in Plasmodium DNA correlates with changes to gene expression, or 
whether putative Plasmodium DNMTs show intrinsic methyltransferase activity, as 
was only just demonstrated in the related Apicomplexan parasite, T. gondii (Wei 
et al., 2017).   
 
1.7 Using a rodent model, P. berghei, to study epigenetic regulation of malaria 
parasites  
 
1.7.1 Rodent models of malaria 
 
This study was carried out using the Plasmodium berghei rodent model of malaria, 
the first rodent malaria parasite to be identified (Vincke & Lips, 1948), isolated, 
and maintained in a laboratory environment (Cox, 2010). Though sometimes 
controversial owing to the use of animal models in scientific research, P. berghei 
(in particular, the Antwerp/Kasapa (ANKA) strain) has been used extensively in 
malaria research to allow for more detailed investigations into multiple 
pathophysiological processes observed in human malaria patients (Craig et al., 
2012). Though ideal, studies of malaria pathogenicity using humans are limited by 
lack of access to relevant organs and tissue samples from infected patients; an 
inability to manipulate host immunity for mechanistic studies; the lethality of 
cerebral malaria to the host; and general ethical constraints (Langhorne et al., 
2011). At present, P. berghei infection of CBA or CB57BL/6 mice is a widely-used 
model of human cerebral malaria, despite different clinicopathological processes 
implicated in both human and murine malarial disease (White et al., 2010). 
 
In addition, studies of human-infective Plasmodium parasites using in vitro 
cultivation methods are limited. Continuous in vitro culturing systems differ 
substantially from the human host in vivo environment. In vitro P. falciparum 
cultures lack the temperature fluctuations, immune environment, shear force 
inside the host circulatory system, as well as additional metabolites and hormones  
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unique to the in vivo surroundings (LeRoux et al., 2009). Appropriate in vitro 
cultivation techniques to accurately mimic the host microvasculature and to 
enable the preservation of P. falciparum multiplication, invasion and rosetting 
phenotypes (significant contributing factors in human malaria pathology) have 
only recently been optimized and necessitate the addition of human serum and 
maintenance of a controlled micro-aerophilic environment (Ribacke et al., 2013). 
In the cases of the four remaining human malaria parasites, P. vivax, P. knowlesi, 
P. malariae, and P. ovale (both subspecies), continuous in vitro culturing 
conditions have been attempted with limited success (Schuster, 2002). The human 
malaria parasite with the highest morbidity and mortality outside of P. 
falciparum, P. vivax, has proven difficult to maintain consistently in vitro 
(Bermúdez et al., 2018).  
 
Rodent models of malaria also have the advantage of enabling immunological 
experiments as a result of the availability of inbred and congenic rodent strains 
with gene-targeted and well-defined natural immune deficits or conditions. 
Outside of P. berghei ANKA as a rodent model of the entire Plasmodium life-cycle, 
and as a model for human cerebral malaria, the three remaining rodent 
Plasmodium species (P. chabaudi, P. yoelii, P. vinckei, and their strains) display 
differences in parasite biology and pathogenicity in their hosts that can be suited 
to particular areas of malaria research. For example, P. yoelii yoelii strain YM is 
a lethal rodent parasite that infects both reticulocytes and mature red blood cells 
(RBCs), and is used to test vaccine candidates; whereas P. chabaudi chabaudi 
clone AS infections in BALB/c mice have been used as a model for severe malarial 
anaemia (Lamb & Langhorne, 2008; Wykes & Good, 2009).  
 
1.7.2 Methods of P. berghei genetic manipulation used in the present study  
 
The first genetic manipulation of a malaria parasite occurred with the expression 
of firefly luciferase in the bird malaria parasite, P. gallinaceum, following 
transfection of plasmid DNA into zygote and gamete parasites via electroporation 
(Goonewardene et al., 1993). Transfection of DNA into the haploid genome of the 
rodent P. berghei parasite followed soon after, with the additional transfection 
of a gene locus encoding a drug-selectable marker (a drug-resistant form of the  
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dihydrofolate reductase-thymidylate synthase (DHFR-TS) enzyme) allowing 
genetically modified parasites to be selected based on their resistance to the 
drug, pyrimethamine (van Dijk, Waters & Janse, 1995). In contrast to P. 
falciparum, P. berghei parasites cannot be cultured long-term in vitro, and so 
drug selection must be carried out only after reinfection of a rodent with live, 
electroporated merozoites. Since this first transfection, which resulted in the 
presence of stably-expressed, though episomally-located, drug-resistant plasmids, 
many more tools for genetic manipulation of malaria parasites have become 
available, often developed in the P. berghei or P. falciparum malaria parasites, 
and sometimes in tandem (de Koning-Ward et al., 2015).  
 
After the development of transfection capabilities in P. berghei, came many more 
techniques for genetic manipulation of malaria parasites: targeted gene deletion 
(or ‘knockout’ (KO)) (Ménard et al., 1997; Crabb et al., 1997); stable expression 
of fluorescent reporters (de Koning-Ward et al., 1998; de Koning-Ward et al., 
1999); complementation of gene KOs (Sultan et al., 2001); further advances in 
drug selection cassettes and transfection (Janse et al., 2006); and a host of 
techniques for conditional knockdown (KD) of genes and proteins (Carvalho et al., 
2004; Fonager et al., 2011; Lin et al., 2011; Pfander et al., 2011; Pino et al., 
2012; Wagner et al., 2014; Philip and Waters, 2015; Hughes and Waters, 2017). A 
selection of these methods were employed in the present study to investigate the 
function (or lack thereof) of a number of putative epigenetic regulators in the P. 
berghei genome. These methods are detailed below. 
 
1.7.2.1 Reverse genetics in P. berghei: positive and negative drug selection 
 
Much of our current knowledge of the molecular biology of the malaria parasite, 
Plasmodium, has been gleaned as a result of reverse genetics approaches, i.e. the 
investigation of a phenotype that arises after a known genetic change has been 
introduced, such as a complete gene knockout (KO). In contrast, forward genetics 
describes a study in which a known phenotype is examined in an attempt to 
determine the underlying genetic changes that arose before the phenotype was 
identified (Alonso and Ecker, 2006).  
 
Chapter 1  General Introduction 
 57 
 
The finding that revolutionised the study of Plasmodium parasites was the 
discovery that mutations in the bifunctional dihydrofolate reductase (DHFR) and 
thymidylate synthase (TS) (DHFR-TS) gene in P. falciparum resulted in resistance 
of the parasite to the DHFR reductase inhibitor, Pyrimethamine (Bzik et al., 1987; 
Cowman et al., 1988; Peterson, Walliker and Wellems, 1988; Zolg et al., 1989; 
Sirawaraporn et al., 1990). The antifolate antimalarial drug, Pyrimethamine, acts 
by binding and inhibiting the function of the DHFR-TS enzyme, therefore depleting 
deoxythymidine monophosphate (dTMP) production and disrupting DNA synthesis 
(Basco et al., 1995). A single amino acid substitution at position 108 of the DHFR-
TS amino acid sequence, a serine-to-asparagine change, was all that was 
necessary to confer Pyrimethamine resistance to the parasite, with the addition 
of alanine-to-valine substitution at position 16 also conferring resistance to a 
second antifolate antimalarial, Proguanil (Foote, Galatis and Cowman, 1990). 
Further investigations also revealed that dual alanine-to-valine (position 16) and 
serine-to-threonine (position 108) substitutions conferred resistance in P. 
falciparum to Proguanil but not Pyrimethamine. However, significant cross-
resistance to both drugs also occurred in the presence of dual serine-to-asparagine 
(position 108) and isoleucine-to-leucine (position 164) mutations (Peterson, 
Milhous and Wellems, 1990).  
 
The ability to confer drug resistance to the Plasmodium parasite via single point 
mutations to the DHFR-TS gene raised the possibility that a modified DHFR-TS gene 
could be used as a drug-selectable marker in future genetic studies of the 
parasite, a feat accomplished by van Dijk, Waters, and Janse, a number of years 
later (van Dijk, Waters and Janse, 1995). From this point forward in P. berghei, 
stable transfection of circular plasmids containing a DHFR-TS gene with a single 
serine-to-asparagine mutation in position 110 of the codon sequence (orthologous 
to the P. falciparum position 108), resulting in resistance of the parasite to 
Pyrimethamine, was used for genetic manipulation of the parasite. Although 
integration of linear vectors into the P. berghei genome via homologous 
recombination was attempted, at this time Pyrimethamine resistance was 
conferred through episomal replication of the mutated DHFR-TS gene (van Dijk, 
Waters and Janse, 1995).  
 
Chapter 1  General Introduction 
 58 
 
Since these studies, Plasmodium biology has benefitted greatly from further 
advances in both positive and negative drug selection protocols in P. berghei, and 
the ability to generate parasite lines in which drug selectable markers are 
integrated into the parasite genome (de Koning-Ward et al., 2000). In a positive 
drug selection protocol, parasites are selected that are resistant to a drug, for 
example, through introduction of a resistance-conferring gene to the parasite 
genome. In a negative drug selection protocol, drug sensitivity is conferred to a 
parasite through genetic manipulation and so parasites are killed upon drug 
administration.  
 
In P. berghei, three positive selectable markers are available: the mutated P. 
berghei DHFR-TS gene (pbdhfr-ts), conferring resistance to Pyrimethamine (van 
Dijk, Waters and Janse, 1995); the mutated T. gondii DHFR-TS gene (tgdhfr-ts), 
which also confers resistance to Pyrimethamine (Donald and Roos, 1993); and the 
human dihydrofolate reductase gene (hdhfr), that is innately resistant to both the 
antimalarial antifolate drug, Pyrimethamine, and a second antifolate inhibitor, 
WR99210 (de Koning-Ward et al., 2000). For negative selection in P. berghei, only 
one option is available: transgenic expression of a bifunctional gene containing 
the fused yeast cytosine deaminase and uridyl-phosphoribosyltransferase enzymes 
(yfcu). With the expression of the yFCU bifunctional protein in P. berghei, 
administration of the prodrug 5-fluorocytosine (5-FC) to the P. berghei-infected 
mice results in the conversion of 5-FC into the cytotoxic compound 5-fluorouracil 
(5-FU) by cytosine deaminase, and the subsequent conversion of this 5-FU to 5-
fluoro-uridine monophosphate (5-fluoro-UMP) by uridyl-
phosphoribosyltransferase. The combined effects of these enzymes is to inhibit 
RNA synthesis (Braks et al., 2006; Maier et al., 2006).  
 
Despite what appears to be a limited repertoire of drug selectable markers, 
strategies for positive- and negative- selectable marker ‘recycling’ have been 
developed in P. berghei. With the discovery that the yfcu negative selectable 
marker could be used in P. berghei, and that 5-FC was safe to administer to 
infected rodents in drinking water, came the development of positive-negative 
selectable marker systems (Braks et al., 2006; Orr, Philip and Waters, 2012). By  
 
Chapter 1  General Introduction 
 59 
 
introducing both a positive- and a negative- selectable drug marker together, a 
number of outcomes are possible.  
 
Taking pyrimethamine (hdhfr) and yFCU (yfcu) as examples; a transfected parasite 
expressing hdhfr::yfcu can initially be selected for by Pyrimethamine. All non-
transfected parasites are killed and only successfully-transfected parasites 
remain. Negative selection pressure is then applied by administering 5-FC to the 
parasites in vivo (Orr, Philip and Waters, 2012). All hdhfr::yfcu-containing 
parasites are then killed. The only surviving parasites following negative selection 
will be those in which the hdhfr::yfcu marker has been excised by homologous 
recombination around the drug selection cassette. This strategy made possible the 
integration of a modified locus (e.g. transgene, gene knockout, tagging epitope) 
in P. berghei that could be selected for by Pyrimethamine administration (positive 
selection) and then the subsequent generation of a marker-free, modified P. 
berghei line by negative selection with 5-FC. This ability to ‘recycle’ drug 
selectable markers meant that, for the first time, multiple sequential genetic 
manipulations could be made to this rodent malaria parasite, including 
complementation studies (Sultan et al., 2001; Braks et al., 2006; Orr, Philip and 
Waters, 2012). However, negative selection with 5-FC does not necessarily 
guarantee a population of parasites in which the hdhfr::yfcu cassette has been 
100% excised (perhaps the yfcu sequence alone was excised). To confirm a purely 
marker-free P. berghei line, cloning by limiting dilution in vivo was subsequently 
carried out, followed by PCR or Southern blot analysis to demonstrate loss of the 
drug cassette (Orr, Philip and Waters, 2012; Manzoni et al., 2015) (Figure 1.15).   
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Figure 1.15: A modified P. berghei genetic locus before and after positive and negative drug 
selection. This image from Orr, Philip, and Waters (2012) shows the integration of plasmid pL1186 
into the P. berghei p230p locus before (A) and after (B) both positive and negative drug selection. 
The p230p integration locus (an upstream paralogue to the P230 6-cysteine male gametocyte 
surface protein) is a P. berghei gene locus with a dispensable role during normal life cycle 
progression and is thus used for stable integration and expression of transgenes (Thompson, Janse 
and Waters, 2001; van Dijk et al., 2010; Matz and Kooij, 2015). The P. berghei p230p locus is split 
into three sites, each one a possible site for vector integration: p230pI, p230pII, and p230pIII. Sites 
p230pI (230pI) and p230pII (230pII) are labelled in the above image with the pL1186 plasmid 
inserted into the p230pI site (upstream of p230pII). In (A), the hdhfr::yfcu fusion gene is shown in 
orange and is flanked upstream by a 3’UTR of the P. berghei mutated dhfr-ts gene (3’UTR Pbdhfr-
ts) and a 5’ promoter of the constitutively-expressed P. berghei elongation factor 1 alpha 
(5’eef1D), and downstream by a second 3’UTR Pbdhfr-ts sequence (de Koning-Ward, Janse and 
Waters, 2000; Franke-Fayard et al., 2004). Downstream of the drug selection cassette is the 
desired transgene to be integrated into P. berghei. This transgene contains a 3’UTR from the P. 
berghei calmodulin gene (3’cam), an enhanced green fluorescent protein gene (egfp) being driven 
by the male gametocyte-specific heavy dynein chain promoter (upstream of PBANKA_0416100) 
(5’male), a red fluorescent promoter (rfp) being driven by the female gametocyte-specific LCCL-
domain-containing gene promoter (upstream of PBANKA_1319500) (5’female), and the 3’UTR of 
the p48/45 gene (3’48/45) (Ponzi et al., 2009). Fragment sizes (in kb) that resulted upon 
restriction digest are indicated (for enzymes PstI and NcoI) and the sites of primers for integration 
PCR analyses are indicated by the numbers 1 to 4. (A) depicts the P. berghei locus as it would 
appear in a successfully-transfected parasite before and after positive selection pressure by 
Pyrimethamine. If transfection had not been successful, the parasite would be killed under 
Pyrimethamine administration.  
(B) depicts the same P. berghei locus after negative selection with 5-FC. In this depiction, the 
drug selection cassette has been excised from the parasite genome. Parasites with the integration 
locus in this conformation only (or with an hdhfr sequence only) would survive 5-FC negative 
selection. PCR and restriction fragment analyses could then be used to confirm the loss of the  
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hdhfr::yfcu fusion gene, with retention of the desired transgene. Source: Image adapted from 
(Orr, Philip and Waters, 2012).      
  
1.7.2.2 Monitoring the production of male and female gametocytes in P. 
berghei: the ‘820’ background line 
 
As shown in figure 1.15 as an example of a construct containing both positive and 
negative drug-selectable markers, the construct used to create the ‘820cl1m1cl1’ 
P. berghei line warrants further discussion as a result of its pivotal role in the 
investigation of mechanisms underlying commitment to gametocytogenesis, and 
differences between male and female gametocyte conversion and maturation 
(Ponzi et al., 2009; Sinha et al., 2014; Yuda et al., 2015; Yeoh et al., 2017).  
 
Used extensively to study gametocytes in P. berghei ANKA, the 820cl1m1cl1 line 
was introduced originally by Ponzi et al. (2009) as a means of examining the role 
of the MDV1/PEG3 (male development protein 1/protein of early gametocyte 3) 
protein in egress of both male and female gametes from the host erythrocyte 
(Ponzi et al., 2009). As depicted in figure 1.15 (A), an enhanced green fluorescent 
protein sequence (egfp) is driven in this construct by the promoter of the male-
specific dynein heavy chain protein (encoded by PBANKA_0416100), discovered as 
highly male-specific in a proteomic study of separated male and female P. berghei 
gametocytes (Khan et al., 2005). In this way, when commitment to male 
gametocytogenesis begins, the GFP fluorescent reporter is also expressed in 
addition to the native dynein heavy chain protein, thus separating male sexual-
stage parasites from asexual parasites or female gametocytes by its green 
fluorescence.  
 
In a similar manner to the male gametocyte fluorescence strategy, the 
820cl1m1cl1 line construct contained a red fluorescent protein sequence (rfp) 
that is driven by the promoter of the predominantly female-specific Limulus factor 
C, Coch-5b2 and Lgl1 (LCCL) domain-containing protein, CCp2, (encoded by 
PBANKA_1319500), a female-specific protein again identified by proteomic 
analysis (Khan et al., 2005). The newly transfected line with the ‘820’ DNA 
construct integrated at the p230pI locus, as depicted in figure 1.15 (A), was  
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positively selected by Pyrimethamine and cloned by limiting dilution to generate 
the ‘820 clone 1’ P. berghei ANKA line (shortened to ‘820cl1’). This line was then 
negatively selected by 5-FC in another mouse (mouse 1) and cloned once more by 
limiting dilution to give the ‘820cl1 mouse 1, clone 1’ (called ‘820cl1m1cl1’) P. 
berghei line, a drug-selectable marker-free parasite line in which male 
gametocytes express GFP, and female gametocytes express RFP (as depicted in 
figure 1.15 (B) (Ponzi et al., 2009).  
 
Though highly enriched in male and female gametocytes respectively, it is 
important to note that both dynein heavy chain protein and CCp2 are present in 
parasites of the opposite sex, and so one must be careful when sexing parasites 
at early stages of commitment, when fluorescence of GFP and RFP are faint (Khan 
et al., 2005). In fact, fluorescence intensity is dependent upon gametocyte 
maturation, with early gametocytes having a fainter fluorescence than mature 
gametocytes (personal observation).     
 
1.7.2.3 Generating conditional gene knockout and protein knockdown systems 
in P. berghei for examination of putative epigenetic regulators      
 
1.7.2.3.1 Dimerisable Cre Recombinase (DiCre)-based inducible gene knockout 
or expression 
 
Site-specific recombination in the P. berghei genome can be achieved by using 
either a Flp/FRT system (Falae et al., 2010; Lacroix et al., 2011), or the analogous 
Cre/loxP recombination system (‘Cre’ standing for ‘creates recombination’ and 
‘loxP’ derived from ‘locus of crossover [x] in P1 bacteriophage’) (Kühn and Torres, 
2002). In both systems, a recombinase enzyme must be expressed and, in P. 
berghei, the recombinase must be expressed in background (‘mother’ or ‘deleter’) 
parasite lines before a target construct containing a FRTed or floxed (flanked by 
loxP sites) DNA construct is integrated into the genome by recombination. In the 
Flp/FRT system, Flp recombinase is generally stage-specific as constitutive 
recombinase expression would result in a target DNA sequence being excised or 
‘flipped’, or otherwise manipulated, at every parasite stage.  
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To overcome the limitations of these stage-specific recombination strategies, a 
new approach was developed in which the Cre recombinase enzyme was split into 
two inactive moieties that were then fused to an FK506-binding protein (FKBP12) 
(Siekierka et al., 1989) and the ligand-binding domain of FKBP12-rapamycin 
associated protein (FRB) (Chiu, Katz and Berlin, 1994) respectively. These fusions 
led to the production of a ligand-inducible dimerisable Cre (DiCre) recombinase 
that could be expressed at a desired time point upon rapamycin administration 
(Jullien et al., 2007). It was not long before this inducible site-specific 
recombination system was adapted for use in Apicomplexa, including Plasmodium 
(Andenmatten et al., 2013; Collins et al., 2013). 
 
To begin with, inducible DiCre expression was used as a means to conditionally 
knock out genes of interest in P. falciparum by excision of floxed sequences of 
interest (Collins et al., 2013; Yap et al., 2014). However, using the inducible DiCre 
site-specific recombination system, in combination with a pair of asymmetrical 
loxP sites (lox66 and lox71) that highly favour unidirectional inversion of a 
targeted DNA sequence (Oberdoerffer, 2003), rapamycin-induced, DiCre-based 
overexpression of a gene of interest was undertaken in P. berghei (Figure 1.16). 
To be specific, the unidirectional DiCre-based recombination was used as a means 
to induce gametocytogenesis in the parasite by overexpression of the pbap2-g 
transcriptional regulator (Kent et al., 2018).  
 




Figure 1.16: Strategies available for rapamycin-inducible genetic manipulation using a 
predominantly unidirectional DiCre-based recombination system. Drawn in the style of Lacroix 
et al., 2011 (in their explanation of possibilities for gene manipulation using the Flp/FRT system 
in Plasmodium), the above image shows how a target gene (or genes) can be manipulated using 
the rapamycin-inducible DiCre system (Andenmatten et al., 2013) in combination with the 
predominantly unidirectional (so far shown to be experimentally irreversible) pair of loxP 
sequences, lox66 and lox71 (Zhang and Lutz, 2002; Oberdoerffer, 2003). (a) shows the 5’ to 3’ 34 
bp nucleotide sequences of lox66, lox71, loxP, and lox72, with corresponding coloured arrows that 
are used to indicate these sequences in (b) to (d). In these sequences, the 8 bp ‘spacer’ sequence 
is indicated in bold letters, with the underlying white arrowhead indicating the orientation of this 
sequence. The remaining semi-palindromic sequences flanking the ‘spacer’ sequence are italicised  
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and underscored by a straight line. Where present, a mutated 5 bp sequence is indicated in the 
semi-palindromic sequences by being underlined. A single mutated 5 bp sequence is present in 
both lox66 and lox71. Following rapamycin-induced conglomeration of a complete dimerisable Cre 
recombinase (DiCre) (indicated by a blue tetramer), the semi-palindromic sequences of lox66 and 
lox71 are cut, with recombination resulting in the loxP and lox72 sequences. DiCre-mediated 
recombination results in a loxP sequence with no 5 bp inverted repeat and a lox72 sequence 
containing two mutated inverted repeats. In the presence of DiCre recombinase, the lox66 and 
lox71 to loxP and lox72 sequence recombination event is highly favoured over the reverse 
recombination event (as indicated by bold and thin arrows). As a result, induction of an almost 
irreversible genetic manipulation is possible by flanking genes of interest with lox66 and lox71 
sequences in a background cell line that expresses rapamycin-inducible DiCre.  
(b) depicts the excision of a gene by the DiCre-lox66/lox71 system. The target gene is flanked by 
lox66 and lox71. Recombination after DiCre induction (with both ‘spacer’ sequences in the same 
orientation) will result in excision of a gene with a loxP or lox72 sequence remaining in the 
genome.  
In (c), unidirectional inversion of a sequence of interest is depicted. Inversion is mediated by 
flanking the target sequence with lox66 and lox71, with ‘spacer’ sequences present in opposite 
orientations. DiCre recombination then results in an inverted sequence that is flanked by loxP and 
lox72 sites.  
Part (d) of the above image depicts a genetic manipulation that is possible, but has yet to be 
undertaken in a Plasmodium parasite. In this case, two different linear sequences, such as target 
sequences of adjacent chromosomes are flanked upstream by a lox66 site (one sequence) and a 
lox71 sequence (second target sequence). Rapamycin-induced DiCre recombination would then 
result in a predominantly unidirectional switching of lox66 and lox71 sites and their downstream 
sequences. The resulting linear sequences contain a loxP and a lox72 site. All of the above 
manipulations are almost irreversible, but in each case large, bold arrows are accompanied by an 
inverted thin arrow to highlight the fact that, though unlikely, recombination in reverse is not 
impossible and should therefore be considered.  
 
In P. berghei (ANKA strain), unidirectional recombination using the DiCre-
lox66/lox71 system was used as depicted in figure 1.16 (c) to generate a parasite 
line called ‘G1142’ (Glasgow 1142) (Kent et al., 2018). In this background parasite 
line, rapamycin-induced DiCre recombination resulted in inversion of a potent P. 
berghei heat shock protein 70 (hsp70) promoter (encoded for upstream of 
PBANKA_0711900) (Manzoni et al., 2015) which had been placed upstream of the 
pbap2-g gene (Figure 1.17). As a result, rapamycin-induced DiCre recombination 
was used to overexpress PbAP2-G, therefore having the overall phenotypic effect 
of inducing gametocytogenesis in P. berghei (Kent et al., 2018). 




Figure 1.17: Inducible pbap2-g expression in P. berghei ANKA using the rapamycin-inducible 
DiCre-lox66/lox71 recombination system. In this image, (a) depicts the pbap2-g locus in a 
background P. berghei ANKA line that already contains the sequences for both moieties of the 
rapamycin-inducible DiCre recombinase enzyme (at the p230p locus), in addition to the DNA 
construct used to introduce a drug-selectable marker and floxed hsp70 promoter upstream of the 
pbap2-g gene. The ‘overexpressor’ construct is integrated into the background P. berghei DiCre 
line by homologous recombination with the wild-type pbap2-g locus. In this construct, a silent 
(inverted) hsp70 promoter is flanked by lox66 and lox71 sequences in opposite orientations. (b) 
shows the P. berghei locus after the ‘overexpressor’ construct has been integrated (and selected 
for by Pyrimethamine). Upon rapamycin-induced DiCre recombination, the lox66 and lox71 sites 
are cut and recombined to generate an active hsp70 promoter that is flanked by loxP and lox72 
sequences respectively. Thick and thin arrows in this image are used to depict the predominantly 
unidirectional recombination event. The likelihood after DiCre recombination therefore, is that 
the hsp70 promoter drives downstream pbap2-g expression in the so-called ‘G1142’ P. berghei 
line, inducing gametocytogenesis.    
 
1.7.2.3.2 The auxin-inducible degron (AID) system 
 
Originally developed using a family of plant hormones (auxins) produced by 
Arabidopsis thaliana, the auxin inducible degron (AID) system was adapted for 
other eukaryotes by Nishimura et al. (2009) for targeted conditional depletion of 
proteins (Nishimura et al., 2009). In plants, hormones of the auxin family, which  
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includes the endogenous indole-3-acetic acid (IAA), or synthetic auxins such as 1-
naphthalenacetic acid (NAA), act by binding to the so-called ‘F-box’ transport 
inhibitor response protein 1 (TIR1) (Ruegger et al., 1998). Auxin-binding to TIR1 
promotes (or enhances) the interaction of the E3 ubiquitin ligase SCF-TIR1 (SCF 
standing for Skp1, Cullin and F-box complexes) with native plant auxin/IAA 
transcriptional repressors (Tan et al., 2007). The SCF-TIR1 complex recruits an E2 
ubiquitin-conjugating enzymes that polyubiquitylates the auxin/IAA 
transcriptional repressor, marking it for degradation by the 26S proteasome 
(Teale, Paponov and Palme, 2006). 
 
In P. berghei, the AID system takes advantage of the presence of the highly 
conserved SCF-complex-mediated protein degradation pathway. In P. berghei 
ANKA parasites, the introduction of a constitutively expressed thermostable TIR1 
protein from the rice plant Oryza sativa (OsTIR1), under control of the potent 
hsp70 promoter, enables the targeting of proteins of interest (POIs) for 
degradation if they are tagged with an auxin-inducible degron (i.e. an auxin/IAA 
response protein). In P. berghei, the AID tag used was the sequence of the A. 
thaliana auxin-responsive protein, IAA17 (gene IAA17_ARATH) (Nishimura et al., 
2009; Philip and Waters, 2015). Therefore, when an auxin hormone is administered 
to P. berghei in vitro, the fused POI::IAA17 complex interacts with the SCF-TIR1 
E3 ubiquitin ligase, resulting in proteosomal degradation of the target protein 
(Figure 1.18). The short half-life of an IAA17-fused protein (8-10 minutes in A. 
thaliana seedlings) (Dreher, 2006; Nishimura et al., 2009), and the need for auxin 
addition to elicit the degradation response, means that the AID system in P. 
berghei is useful for rapid, and reversible, conditional degradation of proteins 
(Philip and Waters, 2015). The reversibility of the AID system is very useful for 
functional characterisation of Plasmodium proteins in that a response phenotype 
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same experiment upon removal of auxin from parasite media. 
 
 
Figure 1.18: Conditional degradation of proteins of interest in P. berghei using the auxin-
inducible degron (AID) system. This image shows the SCF (Skp1, Cullin, F-box)-TIR1 E3 ubiquitin 
ligase complex (containing a RING-box protein 1 (Rbx1) E3 ubiquitin ligase component), bound to 
an E2 ubiquitin-conjugating enzyme before auxin addition, and then after auxin addition (+ auxin). 
In the presence of an auxin hormone (indole-3-acetic acid is shown here), the SCF-TIR1-E2 complex 
binds to an auxin-inducible degron (aid)-tagged protein of interest (POI). In this image, the POI::aid 
complex is also attached to a haemagglutinin (HA) tag for further experiments and Western blot 
analyses. Auxin-induced interaction of both complexes results in the addition of ubiquitin (Ub) 
proteins to the tagged protein, resulting in its degradation in the proteasome. OsTIR1: Oryza sativa 
transport inhibitor response 1 protein; F: F-box protein; Cul1: Cullin 1 protein. Sourse: Image 
adapted from (Trost, Blattner and Lehner, 2016).      
 
1.7.2.3.3 The Plasmodium Genetic Modification (PlasmoGEM) and Rodent 
Malaria Genetically Modified Database (RMgmBD) resources 
 
A considerable number of methods for the generation of genetically modified P. 
berghei lines are available, and many have been applied to specific proteins of 
interest in this rodent malaria parasite. Such an array of mutated P. berghei lines 
necessitates a platform by which knockout or knockdown lines can be searched, 
or by which P. berghei proteins can be searched to prevent experiments being 
duplicated unnecessarily. Fortunately, a number of databases do exist for this 
very purpose: the online Plasmodium Genomics Resource, PlasmoDB (Bahl et al., 
2003); the Rodent Malaria genetically modified DataBase (RMgmDB) (Khan et al., 
2013); the malaria parasite phenotype database, PhenoPlasm (Sanderson and  
Chapter 1  General Introduction 
 69 
 
Rayner, 2017); and the Plasmodium Genetic Modification (PlasmoGEM) database 
(Schwach et al., 2015).  
 
Of note among these databases are the RMgmDB and PlasmoGEM repositories, as 
both of these databases not only allow a search of P. berghei KO lines and 
phenotypes, but provide means by which vectors for genetic manipulation of the 
P. berghei parasite, and specific mutant P. berghei lines, can be ordered for 
further studies. In fact, the PlasmoGEM resource incorporates a high-throughput 
vector production pipeline that couples the generation of a bacteriophage N15-
based genome-scale plasmid library (Pfander et al., 2011) with Red recombinase-
based engineering (‘recombineering’) (Pfander et al., 2013) to produce barcoded 
P. berghei modification vectors on a large scale (Schwach et al., 2015). 
 
At present, the PlasmoGEM database includes nearly 2000 vectors for the 
complete or partial deletion of P. berghei genes, over 200 vectors for C-terminal-
tagging of proteins of interest with a triple haemagluttinin (3xHA) tag, and a near 
genome-scale P. berghei artificial chromosome (PbAC) vector resource (Schwach 
et al., 2015; PlasmoGEM, 2018). Production of all of these DNA constructs begins 
with the selection of the genomic DNA (gDNA) insert of interest from a library of 
bacteriophage N15-based pJAZZ-OK vectors that cover over 95% of the P. berghei 
ANKA genome in a fragmented form (Godiska et al., 2009; Pfander et al., 2011). 
These linear kanamycin-resistant pJAZZ-OK vectors are capable of propagating the 
AT-rich P. berghei inserts stably in Escherichia coli, with the resultant arrayed 
gDNA library being termed PbGO1 (Pfander et al., 2011).  
 
For the creation of a gene knockout vector, a PCR product containing a bicistronic 
bacterial drug-selectable cassette (zeo-PheS) and 50 bp homology regions at 
either side of the gene-of-interest (GOI) is transformed into the E. coli PbGO1 
library clone via lambda Red/ET recombineering (Wang et al., 2006; Pfander et 
al., 2013). At this point, positive drug selection selects for successfully-
transformed E. coli containing the intermediate vector. The zeo-PheS cassette is 
flanked by attR1 and attR2 sites of the Gateway LR Clonase system which are used 
to direct replacement of the bacterial drug selection cassette with a larger P. 
berghei negative-positive drug selection cassette upon activation of the Gateway  
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recombinase reaction. To select for bacteria containing the correctly-transformed 
final knockout vector, negative drug selection with p-chlorophenylalanine is 
carried out (Pfander et al., 2013) (Figure 1.19).  
 
To carry out transfection of a PlasmoGEM knockout vector to a P. berghei parasite 
line, the transfection vector (contained within kanamycin-resistant E. coli) is 
grown until sufficient DNA for transfection is generated. Isolation and purification 
of DNA, followed by a NotI restriction digest, releases the final knockout vector 
from the remaining pJAZZ-OK vector backbone and renders it capable of 
integration into the P. berghei ANKA genome by homologous recombination 
(Pfander et al., 2011; Pfander et al., 2013) (Figure 1.19).  
 




Figure 1.19: Large-scale, recombination-mediated genetic engineering of PlasmoGEM P. 
berghei ANKA knockout vectors. The above image, reproduced from Pfander et al., 2013, depicts 
the process of creating a PlasmoGEM vector from selection of the PbGO1 library clone (in a pJAZZ-
OK vector) (a) to the final product that can be transfected into a P. berghei ANKA line after NotI 
restriction digest (e). (a) shows the gDNA library (PbGO1) clone, a linear pJAZZ-OK vector (inside 
an E. coli cell) that contains the GOI insert, a kanamycin-resistance gene (kanR), and an E. coli 
origin of replication (ori) site. These cells are grown up at optimum temperature (37qC) and a 
pSC101gbdA-tet plasmid containing an arabinose-inducible recombinase (shown in red) is 
transformed into the E. coli cell by electroporation. E. coli colonies are then grown at the optimum 
pSC101gbdA-tet plasmid temperature (30qC) under both kanamycin and tetracycline drug 
selection. (b) shows propagation of the pSC101gbdA-tet-transformed E. coli once the recombinase 
is ‘switched on’ by the addition of arabinose. After arabinose induction of the recombinase  
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enzyme, the cells are transformed with a targeted attR1-zeo-PheS-attR2 PCR product, i.e. the 
bacterial positive-negative drug selection cassette flacked by Gateway LR Clonase att sites. 
Synthetic oligonucleotides with 5’ 50 bp extensions homologous to the GOI flanking sequences are 
used to produce the attR1-zeo-PheS-attR2 PCR product so that it can be integrated into the pJAZZ-
OK vector by homologous recombination, replacing a large section of the GOI insert. Recombined 
E. coli clones are then positively-selected under zeocin pressure at 37qC (zeocin resistance 
conferred by the ‘zeo’ fragment). At (c), the linear pJAZZ-OK vector of interest is isolated from 
E. coli and combined with the Gateway circular plasmid, pR6K attR1-hdhfr-yfcu-attR2. This pR6K 
plasmid contains the P. berghei positive-negative hdhfr::yfcu drug cassette which is recombined 
into the pJAZZ-OK vector at attR1 and attR2 sites, replacing the bacterial drug cassette. In (d), 
both pJAZZ-OK vectors (containing the bacterial and P. berghei drug selection cassettes) are 
transformed into Lucigen TSA electrocompetent E. coli cells. These TSA E. coli cells are then 
plated onto agar containing both kanamycin and p-chlorophenylalanine (YEG-Cl) and grown at 
37qC. This procedure removes any linear vectors that still harbor the zeo-PheS bacterial drug 
selection cassette, as the mutant phenylalanine tRNA synthase (PheS) sequence confers sensitivity 
to YEG-Cl. The final panel, (e) shows the linear pJAZZ-OK vector which now contains a P. berghei 
insert in which the GOI has been replaced by a hdhfr::yfcu drug cassette (in blue), and which 
contains long homology arms for recombination into the wild-type P. berghei ANKA genome for 
gene knockout. The pJAZZ-OK vector backbone must be cut from the linear plasmid of interest by 
a NotI digest that is carried out before transfection. Source: Pfander et al., 2013.  
 
This large-scale recombineering method produced PlasmoGEM vectors that are 
capable of disrupting or deleting approximately one third of genes in the P. 
berghei ANKA genome (Schwach et al., 2015). As such, the PlasmoGEM resource 
is invaluable in providing vectors for genetic manipulation (free-of-charge for non-
commercial institutions) for smaller studies in which time or resources are limited.                                   
 
1.8 Summary and study context  
 
As outlined in sections 1.4 to 1.6, the complex developmental changes required 
by Plasmodium spp. parasites to survive both mammalian and dipteran host 
environments (detailed in section 1.3), and to transmit successfully between 
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1. Regulation of transcription initiation by ‘TATA-box’-dependent or 
independent mechanisms, transcription factor binding (such as by AP2 
proteins), and pre-initiation complex (PIC) assembly. 
2. Regulation of transcription by RNA polymerase II and transcription-
associated proteins (TAPs). 
3. Regulation of nascent mRNA and cryptic short-lived mRNAs by 
exoribonuclease-mediated degradation, such as PfRNAse II. 
4. Regulation of gene expression by non-coding regulatory elements such as 
antisense long non-coding RNAs (lncRNAs) or circular RNAs (circRNAs). 
5. Alternative splicing of mRNA transcripts. 
6. Regulation of mRNA maturation by 5’ m7GpppN capping, and 3’ polyA-
tailing enzymes.  
7. Nuclear export of mature mRNA and transport to specific organelles for 
translation. 
8. Translational repression of mRNA transcripts by direct mRNA binding 
proteins such as poly(A)-binding proteins (PABPs), messenger 
ribonucleoprotein (mRNP) complexes containing DOZI, or the CCR4-POP2-
NOT deadenylase complex (resulting in polyA-tail removal). 
9. Translational repression of mRNA by proteins/factors that interact with 
core translational machinery, such as the proposed role of Puf3 (by 
associating with ribosomal proteins). 
10. Epigenetic regulation of gene accessibility by post-translational 
modifications on histone residues. 
11. Epigenetic regulation of gene accessibility by histone variation. 
12. Epigenetic regulation of gene accessibility by modifiers of higher order 
chromatin organisation, such as nucleosome assembly proteins (NAPs), an 
example of which are PfNAP-S and PfNAP-L in P. falciparum (Chandra et 
al., 2005; Navadgi et al., 2006). 
 
In light of the discovery of AP2-G (Kafsack et al., 2014; Sinha et al., 2014) as a 
transcriptional regulator of gametocytogenesis in Plasmodium, and the role of 
both HP1 and HDA2 in gametocyte conversion in P. falciparum (Brancucci et al., 
2014; Coleman et al., 2014), the present study was designed to further elucidate  
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the role of epigenetics in gametocytogenesis using the rodent malaria model, P. 
berghei ANKA and experimental techniques as described in section 1.7.   
 




Expression of the AP2-G transcription factor and commitment to sexual 
development in the rodent malaria model, P. berghei ANKA, is regulated by 
epigenetic mechanisms. 
 
1.9.2 Aim 1: 
 
A number of known and putative epigenetic regulatory proteins in P. berghei ANKA 
will be subject to both complete gene knockout by double crossover (DXO) 
homologous recombination and conditional protein degradation by the auxin-
inducible degron (AID) system. These experiments will be undertaken in a high-
gametocyte producer (HP) P. berghei ANKA line (820cl1m1cl1) expressing both 
green fluorescent protein (GFP) in male gametocytes and red fluorescent protein 
(RFP) in female gametocytes that will enable the subsequent effect of 
knockout/knockdown on gametocytogenesis to be examined and quantitated in a 
sex-specific manner by fluorescence microscopy and/or fluorescence-activated 
cell sorting (FACS) (Ponzi et al., 2009) (detailed in section 1.7.2.2). Where 
possible, cellular localization of tagged proteins will be assessed by fluorescence 
microscopy and interacting factors will be determined by co-immunoprecipitation 
and mass spectrometry (Chapter 3).  
 
1.9.3 Aim 2 
 
At present, histone modifications have been investigated only in P. falciparum, 
with no studies reported for P. berghei (Westenberger et al., 2009; Lopez-Rubio 
et al., 2009; Miao et al., 2006; Salcedo-Amaya et al., 2009; Ponts et al., 2010; 
Petter et al., 2011; Coetzee et al., 2017). To remedy this situation, histones will 
be purified from both asexual and sexual stages of the P. berghei ANKA parasite 
line (namely: mature schizont and mature gametocyte stages) by acid extraction  
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from chromatin and mass spectrometry to determine the repertoire of histone 
modifications and their stage-specificity in P. berghei (Longhurst & Holder, 1997; 
Miao et al., 2006; Shechter et al., 2007). Where possible, these modifications will 
be confirmed using commercial antibodies (e.g. Life Technologies). Common 
modifications that have not yet been tested nor seen in these analyses, and for 
which commercial antibodies exist, will also be sought. The outcome of this study 
will be a comprehensive catalogue of the type and stage-specificity of histone 
modifications in P. berghei (Chapter 4). 
 
1.9.4 Aim 3 
 
Histone modifications that appear to correlate with sex-specific expression (from 
Aim 2) will be examined further to determine their distribution across the P. 
berghei genome using chromatin immunoprecipitation-sequencing (ChIP-seq) and 
ChIP-seq in combination with Tn5 transposase library preparation 
(ChIPmentation), paying particular attention to ap2-g. A number of histone 
modifications that have previously been examined in P. falciparum and for which 
ChIP-grade commercial antibodies are available will also be examined. 
Optimisation of the ChIPmentation procedure will be carried out in P. berghei 
ANKA asexual-stage parasites (mature schizonts) to establish a standard 
experimental and bioinformatic analysis pipeline by which further P. berghei 
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2.1 Plasmodium berghei methods 
 
2.1.1 Experimental animals: ethical considerations 
 
All animal experimentation carried out during the present project was done so in 
accordance with the Animals (Scientific Procedures) Act 1986 (ASPA) and European 
Union Directive 2010/63/EU. This Directive is based on the Three ‘R’s principle: 
to replace, reduce, and refine the use of animal for scientific purposes. All animal 
experiments were carried out at the University of Glasgow Joint Research Facility 
(JRF) under Procedure Project Licence (PPL) No. 60/4443 and Procedure Individual 
Licence (PIL) No. I3F0B9C21. All animal experiments carried out were deemed as 
‘moderate’ according to Annex 8 criteria of ASPA.      
 
2.1.2 Infection of laboratory animals with P. berghei parasites 
 
Infection of laboratory animals (Theiler’s Original (TO) female mice, 26-30 g or 
Wistar female rats, 150-175 g) with P. berghei parasites was performed using 
cryopreserved parasite stocks, purified parasites from synchronous schizont 
(asexual parasite) culture, or, directly from heart or tail-vein blood from 
previously-infected animals. Taking into account the preference of P. berghei for 
immature red blood cells (RBCs), reticulocyte production was increased in 
experimental animals 2 days prior to infection using 100 Pl of phenylhydrazine-
hydrochloride at 12.5 mg/ml in solution administered via intraperitoneal 
injection. Injection of 100 Pl of phenylhydrazine-hydrochloride at 12.5 mg/ml in 
solution was not undertaken in the event of P. berghei samples to be used for 
fluorescence-activated cell sorting (FACS).  
 
2.1.3 Infection of animals with P. berghei parasites via intravenous injection 
 
Intravenous injection of P. berghei parasites was undertaken using restrained, un-
anaesthetised TO mice (female, 26-30 g). Intravenous injection of parasites was 
used for infection of animals with purified synchronous schizonts from culture; 
transfected merozoites following electroporation of plasmid DNA (see below); or 
when diluting parasite lines for cloning of a P. berghei line. Where possible, 
selection of fluorescently-labelled parasite populations using FACS was carried out 
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to produce isogenic parasite lines. This procedure reduced the number of animals 
used for cloning of P. berghei lines. Animals were placed in a temperature-
regulated transparent Perspex chamber for 15-20 min at 37°C prior to intravenous 
injection. After sufficient venodilation, 200 Pl of parasites in ‘rich’ phosphate-
buffered saline (PBS) (10 mM Na2HPO4, 1.8 mM KH2PO4, 137 mM NaCl, 2.7 mM KCl 
(1u PBS), supplemented with 20 mM HEPES, 20 mM glucose, 4 mM NaHCO3, 0.1% 
bovine serum albumin (BSA)) was injected using insulin syringes (Becton-
Dickinson, Micro-fine +, 0.5 ml; 0.30 mm (30G) x 8 mm, cat. No. 324870). 
Following all animal infections, parasitaemia of each animal was monitored daily 
by tail drop (venepuncture) and Giemsa-staining on a glass slide. Parasitaemia was 
counted as a percentage of infected red blood cells divided by the total red blood 
cell population.  
 
2.1.4 Cervical dislocation of terminally anaesthetised animals following 
cardiac puncture 
 
Upon induction of anaesthesia with vapourised isofluorane and collection of P. 
berghei-infected blood via cardiac puncture, anaesthetised animals were killed by 
cervical dislocation. For cervical dislocation, the mouse was turned over to the 
prone position and the neck manually broken by pinching of the cervical vertebrae 
just below the skull with a thumb and index finger, and the base of the tail pulled 
until the skull and vertebrae had completely separated. Once the neck was 
broken, the carcass was then deposited in a designated biohazard plastic bag and 
placed in the appropriate freezer for future disposal. All surfaces were disinfected 
upon completion of all animal procedures. 
 
2.1.5 Transfection of plasmid DNA to P. berghei parasites via electroporation 
 
2.1.5.1 Preparing a plasmid DNA sample for transfection 
 
For the present study, all plasmids were linearised before transfection into P. 
berghei merozoites. No circular plasmids were transfected, with no experiments 
resulting in episomal expression of plasmid DNA in parasites. Throughout this 
study, one or more restriction enzymes were used to cut out the Ampicillin 
resistance fragment of a circular plasmid from the remaining DNA, leaving the rest 
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of the plasmid in linear form (Figure 2.1). To ensure that all fragments were 
linear, the digested plasmid was run on a gel (1% agarose) and the desired linear 
fragment extracted using a QIAquick Gel Extraction Kit (QIAGEN). To ensure a 
correct cut, a small sample (~5 Pl) of the original cut plasmid was kept and run 
on a 1% agarose gel next to the gel-extracted fragment. The rest of the gel-
extracted linear plasmid was then used for transfection. For each transfection, 
~15-20 Pg of circular plasmid DNA was digested with the appropriate restriction 
enzymes for a final gel-extracted concentration of 1-10 Pg in sterile water. For 
transfection, 10-15 Pl of linear plasmid DNA at 5-10 Pg was ideal. 
 
Figure 2.1: Example restriction enzyme sites used for the linearization of circular plasmids for 
double crossover and single crossover homologous recombination. Image A is a schematic 
representation of a wild type gene of interest (PBANKA_133540; histone deacetylase 1 (HDA1)) and 
adjacent genes. Underneath is a schematic representation of a linearised plasmid to be integrated 
into the P. berghei wild-type genome. The location of a digested NotI restriction site is shown. 
The digestion of the circular plasmid with NotI linearised the sequence for transfection. Image B 
is a schematic shows a similar schematic representation of a gene of interest, in this case 
PBANKA_143610 (Heterochromatin protein 1 (HP1)), and the circular plasmid used to tag pbhp1 
with HA, AID, and BFP (as well as to incorporate drug resistance sequences (only the hdhfr gene 
shown here)). The restriction site used for linearization of the cicular plasmid was HpaI and its 
location is indicated in image B. More detailed descriptions of these plasmids and their design are 
located in Chapters 3 and 4 of the present study.    
 
2.1.5.2 Cultivating P. berghei merozoites for transfection 
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Once a plasmid was prepared for transfection, a donor animal was treated with 
100 Pl of phenylhydrazine-hydrochloride at 12.5 mg/ml in solution to facilitate 
the growth of host reticulocytes for infection with a P. berghei parasite line. After 
48 hours, the donor animal was infected with P. berghei parasites of the parasite 
line into which the linear plasmid was to be integrated, e.g. the 820 GFP/RFP 
reporter P. berghei line (Ponzi et al., 2009). Following infection of the donor 
animal with the P. berghei line, the animal is monitored daily by venepuncture 
and Giemsa staining until the P. berghei infection reaches a parasitaemia of 1-5%. 
At this point, the P. berghei-infected donor blood was harvested via cardiac 
puncture of the donor animal under terminal anaesthesia. Parasites were then 
cultured in vitro for 24 h in ‘schizont culture medium’ (RPMI-1640 medium with 
L-glutamine, supplemented with 20% heat inactivated fetal bovine serum (FBS), 
20 mM HEPES buffer solution, 7.3 mM NaHCO3, 0.007% HT supplement (u100), 
0.002% Pen-Strep, pH 7.3), gassed with a 5% CO2/5% O2/90% N2 mixture (0.5 bar), 
and shaking (50 rpm) at 37 qC to produce a synchronous P. berghei schizont 
culture. Synchronous P. berghei schizonts were then purified with a 55% 
Nycodenz/’rich’ PBS density gradient, the resulting parasites of which were 
carefully extracted and kept at 37qC before being subjected to electroporation 
using Amaxa™ Nucleofector™ Technology (Lonza). For P. berghei parasites, the 
Nucleofector™ ‘Human T-cell’ protocol was applied (Janse et al., 2006).  
 
2.1.5.3 General in vitro cultivation of mature schizonts  
 
One to 8 ml of infected blood was collected from an animal by cardiac puncture 
(using a 10 ml syringe in the case of a rat; 2 ml syringe in the case of a mouse). 
The blood was then transferred to 5-8 ml of complete ‘schizont’ culture medium 
to which 0.3 ml stock-solution of heparin had been added. After being transported 
back to the main laboratory, cells were then pelleted by centrifugation (8 min at 
450 ug) at 21qC. The supernatant was then discarded from the cell pellet. Cells 
were then re-suspended in complete culture medium and transferred to a 150 cm2 
cell culture flask. For a successful schizont culture, every 1 ml of blood was added 
to 120 ml of complete culture medium. 120 ml was the maximum amount of media 
added to each 150 cm2 culture flask. The culture flask was then placed in a sterile 
fume hood/cabinet and each culture gassed with a mixture of 5% CO2/5% O2/90% 
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N2. Each flask was gassed for exactly 60 seconds and then the lid closed and the 
flask immediately placed in a 37qC shaking incubator at 50 rpm for 24 h for 
synchronisation of P. berghei schizonts. 
 
After ~ 20 - 22 h, and again at 23.5 – 24 h, a small sample (0.5 ml) of parasite 
culture was taken and placed in a sterile microtube. Cells were then pelleted by 
centrifugation (maximum speed; 5s) and the supernatant discarded. A thin blood 
smear of the cells was then made on a glass slide, fixed with methanol, and 
stained with Giemsa to check the quality of the parasite culture and to ensure 
that development of schizonts has occurred. Schizont smears were examined using 
a light-microscope at a 1000u magnification (100u objective; immersion oil). 
Viable schizonts were distinguished by the presence of 12-24 ‘free’ merozoites 
within each infected red blood cell, usually with one or more clusters of ‘malaria 
pigment’ (haemozoin). Smearing of schizonts on the microscope slides often 
damaged the host red blood cell membranes and merozoites were visible as single, 
or clustered, free parasites. A pink/red-coloured nucleus and purple cytoplasm 
was characteristic of viable merozoites. Mature gametocytes were also seen in 
these smears. Degenerate schizonts often showed a compact morphology in which 
the separate merozoites were difficult to recognise. Once it had been determined 
that the cultured schizonts had reached maturity and that there was no 
contamination of the parasite culture, purification of synchronous schizonts from 
other parasite developmental stages and host cells was undertaken.  
 
2.1.5.4 Purification of mature schizonts  
 
Prior to transfection, schizonts (~1-3% of the total cell population) were separated 
from uninfected erythrocytes and other host cell debris by density gradient. For 
density gradients, Nycodenz was used as it does not affect the viability of P. 
berghei parasites after separation. Approximately 3u108 - 1u109 schizonts 
(equivalent to 3u109 – 1u1010 merozoites) could be separated from 5 - 6 ml of heart 
blood (1 rat cardiac puncture). A Nycodenz stock solution was made by dissolving 
27.6 g of Nycodenz powder (Progen Biotechnik; Cat. No. 1002424) in Nycodenz-
buffered medium (for a density at 20qC of 1.15 g/ml). This solution is autoclaved 
and stored at 4qC. Nycodenz-buffered medium consisted of sterile water with 5 
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mM Tris-HCl, pH7.5, 3 mM KCl, and 0.3 mM of calcium disodium versenate 
(CaNa2EDTA). For separation of mature schizonts, a 55% Nycodenz/rich PBS 
solution (v/v) was prepared. In general, a total volume of 50 ml Nycodenz stock 
solution/22.5 ml rich PBS was required for a culture suspension of 150 ml. To 
begin, the culture suspension containing the schizonts was separated into 50 ml 
centrifuge tubes (35 ml per tube). Then, using a 10 ml pipette, 10 ml of 55% 
Nycodenz-solution was gently added to the bottom of each tube, i.e. underneath 
the culture suspension, so that a sharp contrasting division is visible between the 
two suspensions (Figure 2.2). The suspension was then gently placed in a 
centrifuge and centrifugation carried out at 21qC for 30 min at 500 ug using a 
swing out rotor with no brake.  
 
Following centrifugation, the ‘brown’ layer at the interface between the two 
suspensions was collected using a 5 ml Pasteur/Dropping pipette (Figure 2.2). 
Uninfected cells and debris formed a pellet at the bottom of each tubes after 
centrifugation. Schizonts were then pelleted by centrifugation (450 ug for 8 min 
at 21qC). The resulting supernatant could then be discarded and the parasites 
taken to the next phase of experimentation. 
 
Figure 2.2: Purifying mature schizonts from a mixed culture using a Nycodenz density 
gradient. This image shows the same samples of synchronous schizont culture (a mixture of 
infected blood and ‘schizont’ complete culture medium) before and after separation of parasites 
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using a 55% Nycodenz density gradient. Image A shows the blood/medium mixture (35 ml) above 
a clear 10 ml volume of 55% Nycodenz solution (indicated by a white arrow). Image B shows the 
same sample as in A after centrifugation. The white arrow here indicated the clear Nycodenz 
solution with a brown layer of schizonts directly above it (indicated by the green arrow). Above 
the schizont layer is a layer of clear (yellow/orange in colour) complete culture medium from 
which blood and parasites had been separated out. In B, there was also blood cell debris in the 
form of dark red pellets in the base of the centrifuge tubes (not shown).  
 
2.1.5.5 Transfection of plasmid DNA into P. berghei merozoites via 
electroporation 
 
The parasite pellet obtained following Nycodenz-mediated separation of schizonts 
from culture medium was then re-suspended in fresh culture medium (warmed to 
37qC) and transferred to microtubes at a concentration of ~1u107 - 3u107 schizonts 
per tube. 1u107 - 3u107 schizonts were sufficient for one transfection. 100 μl of 
the ‘Human T-cell Nucleofactor™’ solution was then added to the (~10 μl) of re-
suspended plasmid DNA. P. berghei schizonts were then pelleted by centrifugation 
(5 s, maximum speed, in Eppendorf™ microcentrifuge) and the supernatant 
discarded. Each parasite pellet was gently re-suspended in the ~110 μl plasmid 
DNA/Nucleofactor™’ solution mix and this mixture then transferred to an Amaxa™ 
0.2 μl cuvette, being careful to avoid the production of any bubbles. Plasmid DNA 
was then transfected into parasite merozoites with the Amaxa™ gene pulser, using 
protocol U33. Immediately after transfection, 50 μl of culture medium was added 
to the cuvette.  
 
2.1.5.6 Intravenous injection of transfected merozoites to uninfected animals  
 
Animals to be injected intravenously were placed in a transparent temperature-
controlled Perspex chamber at 37°C for 15-20 min prior to injection of transfected 
P. berghei parasites. Rodent tail veins venodilated at this temperature, making 
the intravenous injection procedure easier to undertake. Transfected parasites 
were injected into tail veins of mice using insulin syringes (Becton-Dickinson, 
Micro-fine +, 0.5 ml; 0.30 mm (30 G) x 8 mm, cat. No. 324870). The ~160 μl 
suspension containing parasites transfected with the Amaxa™ gene pulser was 
injected immediately into one animal following transfection. 
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2.1.5.7 Selection of transfected parasites with pyrimethamine  
 
Animals infected with transfected parasites (in which the appropriate drug 
selection cassette was present) were provided with drinking water containing 
pyrimethamine 24 h after transfected parasites had been injected. Pyrimethamine 
was provided in drinking water for a period of 4-7 days, or until the parasitaemia 
had reached a percentage at which the blood could be harvested from the infected 
animal.  
 
2.1.6 Preparation of pyrimethamine for drug selection 
 
Pyrimethamine powder was dissolved in dimethyl sulfoxide (DMSO) to a final 
concentration of 7 mg/ml for a 100u stock solution. 10 ml of 100u stock solution 
was then diluted 100 times with tap water in a 1 litre glass bottle and the pH 
adjusted to between pH 3.5 and pH 5.0 using 1M HCl solution. 1u pyrimethamine 
(pH 3.5 - 5.0) was then immediately stored at 4°C and protected from light for 
future use. 
 
2.1.7 Preparation of 5-fluorocytosine for drug selection 
 
5-fluorocytosine (5-FC) is stored in white powder form at 4°C (Sigma-Aldrich; Cat. 
No. F7129). A disposable mask was worn when handling and measuring powdered 
5-FC as this substance is teratogenic. 5-FC powder is dissolved in tap water to a 
concentration of 1.5 mg/ml in solution. Usually 400 ml of tap water was sufficient 
for selection of resistant P. berghei in 1 animal (0.6 g of 5-fluorocytosine powder 
in 400 ml for a 1.5 mg/ml solution). 5-FC was stored at 4°C and the glass bottle 
container wrapped in tin foil to protect the sensitive solution from light. Animal 
drinking bottles were also covered in tin foil to maintain 5-FC activity for the 
duration of the drug selection process.  
 
2.1.8 Preparation of sulfadiazine in animal drinking water for gametocyte 
enrichment  
 
During the present study, sulfadiazine was used to enrich gametocyte populations 
from asynchronous P. berghei infections. Sulfadiazine selectively kills asexual 
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replicating parasites in a Plasmodium infection and so was used to enrich sexual-
stage (gametocyte) populations in this study (Beetsma et al., 1998). To prepare 
sulfadiazine, 1 litre of fresh tap water was added to a sterile 1 litre glass ‘Duran’ 
flask and 25 mg of sulfadiazine powder (Sigma-Aldrich; Cat. No. S8626-25G) added 
to the water. This solution was then mixed using a magnetic stirrer and pill for 8-
12 h continuously. A low heat was also applied to the stirring solution if the powder 
was not readily dissolving in solution. After 8-12 h, the solution turned clear and 
light yellow in colour. This indicated that the sulfadiazine powder had fully 
dissolved and the solution could then be removed from the stirrer and placed in a 
4°C fridge for storage and future use. 
 
2.1.9 Preparation of rapamycin for in vivo and in vitro experimentation using 
an inducible DiCre gametocyte overexpression P. berghei line 
 
A lab stock of rapamycin was made up to 4 mg/ml solution, dissolved in DMSO 
(Sigma-Aldrich; R0395 SIGMA; Rapamycin from Streptomyces hygroscopicus; >95% 
(HPLC); powder; C51H79NO13; Molecular weight 914.17; 1 mg per vial). When 
bought, this rapamycin stock was soluble in DMSO or 2 mM ethanol and was stored 
continuously at -20°C when not in use.  
 
2.1.9.1 In vivo rapamycin procedure 
 
For rapamycin-induction of gametocytogenesis in the DiCre ap2-g overexpression 
line (P. berghei line G1142), animals were first infected with the P. berghei line 
(G1142) and monitored until a parasitaemia of ~10% was observable in the test 
animal. This was to ensure that enough parasites were present to facilitate a high 
gametocyte conversion rate, which in turn produced a sufficient number of 
gametocytes for subsequent experiments. Animals were then weighed just prior 
to injection with rapamycin. Rapamycin (4 mg/ml stock) was first defrosted in a 
waterbath at 37°C and then a solution of 1 mg/ml rapamycin prepared by 
dissolving stock rapamycin solution in ‘rich’ PBS that had been warmed to 37°C. 
Solution volumes were prepared after the animal had been weighed. Each animal 
(TO mouse or Wistar rat) was injected with 1 mg/kg rapamycin from the 1 mg/ml 
solution in ‘rich’ PBS. The solution was kept at a temperature of 37°C until the 
moment of injection. Rapamycin was administered intraperitoneally in all cases. 
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2.1.9.2 In vitro rapamycin procedure 
 
Following induction of gametocyte conversion in vivo, animals infected with the 
ap2-g inducible overexpression line were monitored by Giemsa staining of blood 
tail drops from approximately 12 - 24 h after induction with rapamycin. Upon 
observation of a high gametocytaemia in infected animals at ~24 h post-induction, 
blood was harvested via cardiac puncture and transferred to a 150 cm2 culture 
flask at 1 ml of blood to 120 ml of complete culture medium. This culture was 
gassed with a mixture of 5% CO2/5% O2/90% N2 and placed in a shaking incubator 
at 37°C (shaking at 50 rpm). To keep this induced culture under rapamycin 
pressure, 100 nM rapamycin was added from a 100 mM stock solution and the 
culture incubated overnight (12–16 h in culture) to ensure complete gametocyte 
commitment and maturation of rapamycin-induced P. berghei parasites.  
To make a 100 mM stock solution of rapamycin to be added to cultures in vitro, 
100 mM rapamycin was made up from the 4 mg/ml solution in sterile water. 0.27 
μl of 4 mg/ml rapamycin was added to 9999.73 μl of sterile H2O to give 10 ml of 
100 mM rapamycin solution. Ten 1 ml aliquots of 100 mM rapamycin stock were 
then added to microtubes and frozen at -20°C until further use. Therefore, for a 
100 nM concentration of rapamycin in a culture of 120 ml, 120 μl of a 100 mM 
aliquot would be added. This culture was then monitored by Giemsa staining and 
gametocytes purified using a 53% Nycodenz/’rich’ PBS solution when appropriate. 
Nycodenz-purification of gametocytes from culture was carried out in the same 
manner as purification of mature schizonts from an in vitro culture (section 
2.1.5.4).   
 
2.1.10 Preparation of 3-indoleacetic acid (auxin) for conditional degradation 
using the auxin-inducible degron (AID) system in P. berghei  
 
Conditional degradation of proteins using the auxin-inducible degron (AID) system 
in P. berghei is carried out by addition of auxin (Sigma-Aldrich; Cat. No. 13750; 3-
indoleacetic acid 98% (IAA); C10H9NO2; Molecular Weight 175.18; 100 g) to parasite 
cultures in vitro. Stock solutions of auxin at different micromolar concentrations 
(50 mM, 100 mM, 250 mM, and 500 mM concentrations) for testing were made up 
by dissolving auxin powder in 95% ethanol and were then stored in 1 ml aliquots 
at -20°C. The most effective concentration of auxin in vitro was 500 μM (as 
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demonstrated in (Philip and Waters, 2015)). A 500 μM concentration in vitro was 
generated by addition of microlitre amounts of a 500 mM stock solution to a P. 
berghei culture in vitro. Cultures to which auxin had been added were incubated 
at 37°C in a shaking incubator at 50 rpm.     
 
2.1.11 In vitro auxin-induced degradation (AID) procedure  
 
A protocol for in vitro auxin-induced degradation of proteins was developed for 
use with synchronised schizont cultures of parasites transfected with 
OsTIR1/AID/HA sequences. Samples from parasite cultures were taken prior to 
addition of auxin to check parasite morphology via Giemsa stain and to check for 
the presence of complete protein prior to degradation by a HA-antibody-stained 
Western blot. Taking into account the number of microlitres of media in the 
culture flask, parasite cultures were incubated with 500 μM of auxin at 37°C in an 
incubator with mild shaking (50 rpm). Samples were then taken to test for protein 
concentration (via Western blot) at time-points such as every 15 min; or at the 
points: 30 min, 1 hour, 4 hours, 16 hours and 24 hours incubation with 500 μM 
auxin. The incubation process was carried out until maximal protein depletion was 
seen.  
 
2.1.12 Giemsa stain preparation for monitoring of P. berghei parasitaemia 
 
To prepare fresh (12.5%) Giemsa stain, 5 ml of Giemsa stain, modified solution 
(Fluka Analytical, Sigma-Aldrich; Cat. No. 48900-500ML-F) was added to 35 ml 
Giemsa buffer (Sörensen staining buffer) to give a total of 40 ml of fresh 12.5% 
Giemsa solution. Giemsa stain was then stored at room temperature for future 
use. To prepare a stock of 5 l of Giemsa buffer (Sörensen staining buffer), 2.541 
g of KH2PO4 and 0.5507 g of Na2HPO4.2 were dissolved in 5 l of de-ionised water. 
The pH of the solution was then adjusted to 7.2 with NaOH. Prior to staining, 
slides on which parasites are present were fixed in methanol for 5 s before staining 
in 12.5% Giemsa stain for 10 min. Slides were then allowed to air-dry at room 
temperature.   
 
2.1.13 Freezing P. berghei-infected blood stabilates for long-term storage  
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To make an undiluted stabilate, a 2 ml cryotube (Cryogenic vial, graduated, 
internally threaded with silicone O-ring, Alpha Laboratories Limited; Product No. 
LW3534) was labelled and 250 μl of blood added to an equal volume of 30% 
glycerol/’rich’ PBS solution, supplemented with 10 I.U./ml heparin. Stabilates 
were frozen slowly at -80°C by wrapping the sample tube in tissue and then 
placing this at -80°C overnight. Once the initial slow-freeze had taken place, the 
stabilate was then moved to a regular -80°C Cryovial storage box (Alpha 
Laboratories Limited; Product No. LW3440B) or transferred to liquid nitrogen. To 
make a diluted stabilate if the starting P. berghei parasitaemia was high (e.g. 
>5%), 125 μl of blood was diluted in 125 μl of ‘rich’ PBS, and then 250 μl of sterile 
freezing solution (30% glycerol/’rich’ PBS solution, supplemented with 10 I.U./ml 
heparin) added to the diluted blood. These stabilates were then slow-frozen as 
described for undiluted stabilates. Each stabilate was made up to 500 μl as this 
volume provided enough material for infection of 2 mice via intraperitoneal 
injection (200 μl each).  
 
2.1.14 Removal of contaminating host leukocytes from P. berghei infected 
blood using Plasmodipur filters 
 
In advance of all histone extraction and sequencing experiments, contaminating 
host leukocytes were removed from P. berghei-infected red blood cells 
immediately after harvesting of blood by cardiac puncture and before infected 
blood was cultured in vitro. At present, removal of leukocytes by Plasmodipur 
filters (EuroProxima BV) has been shown to be effective in removing 
contaminating cells from the host, while retaining a good yield of Plasmodium-
infected red blood cells for further analyses (Auburn et al., 2011; Li et al., 2017).  
 
To begin with, the Plasmodipur filter was mounted on a 20 ml syringe with the 
plunger removed. The Plasmodipur filter was then pre-wet with 5 ml of ‘rich’ PBS 
that had been warmed to 37°C. The pre-warmed ‘rich’ PBS was then passed 
through the filter at a gentle pressure. Each 1 ml of P. berghei-infected blood was 
diluted in 20 ml of complete culture medium. This diluted blood sample was then 
gently passed through the Plasmodipur filter at constant pressure, with the 
filtered material collected in a 50 ml centrifuge tube. Each Plasmodipur filter was 
used only once and then discarded, as was the syringe. Each diluted 1 ml of whole 
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blood was purified by passing through 2 clean Plasmodipur filters in sequence to 
ensure that all possible contaminating leukocytes were removed (or as much as 
possible using this method). Purified samples were then pelleted by centrifugation 
before further experimentation (8 min at 450 ug; 21°C).  
 
2.1.15 Purification of P. berghei parasites by magnetic separation 
 
In some cases, where purification by Nycodenz of P. berghei parasites from culture 
or directly from cardiac puncture had resulted in a low parasite yield, diluted 
whole blood containing P. berghei-infected red blood cells was passed through a 
magnetic MACS® LD column (Miltenyi Biotec; 25 LD columns; Order No. 130-042-
901) held within a strong magnetic stand. These magnetic separation columns 
were effective in separating intraerythrocytic haemozoin-producing P. berghei 
parasite stages (schizonts or gametocytes) from solution as a result of their high 
iron content (Ribaut et al., 2008).  
 
To begin with, MACS® LD columns were placed in a very strong custom-built 
magnetic stand within a fume cupboard (to prevent any contamination). Infected 
host blood was diluted (1 ml of blood to 20 ml of complete culture medium) before 
being added to the magnetic separation columns in 10 ml increments. Magnetic 
columns were suspended above a plastic waste tray (as shown in Figure 2.3) and 
the parasites suspended in culture medium allowed to pass through the column 
over time (without the use of the provided plunger).   
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Figure 2.3: Purification of P. berghei-infected red blood cells from host blood by magnetic 
separation. The image above was taken during the present study and shows the magnetic 
separation of synchronous schizonts from a blood/culture medium mixture using MACS® LD columns 
placed inside a strong magnet. The solution (without parasites) is dripping into a plastic waste 
tray, leaving the schizonts adhered to the magnetic column. These would then be washed out with 
‘rich’ PBS into a clean centrifuge tube when the columns were removed from the magnetic stand.  
 
Each column was used to purify approximately 50 ml of parasites in suspension 
(each column can hold up to 1u108 cells as per manufacturers recommendations). 
After all of the parasite suspension had passed through the column, the column 
was removed from the magnetic stand and placed over a sterile 15 ml or 50 ml 
centrifuge tube (depending on the volume into which the magnetically-bound 
parasites were to be eluted). The parasites attached to the sides of the column 
were then eluted by pipetting 10 ml of ‘rich’ PBS to the column and allowing it to 
drip through until the solution coming through was clear. If it was thought that 
more parasites were still adhered to the sides of the magnetic column, a further 
10 ml of ‘rich’ PBS was added and allowed to drip through. After this purification 
stage was complete, parasites were pelleted by centrifugation at 450 ug for 8 min 
(21°C) before further analyses were carried out. 
 
2.1.16 Preparation of live P. berghei parasites from tail blood drops (mice or 
rats) for fluorescence microscopy 
 
Hoechst stain (Hoechst 33258, pentahydrate (bis-benzimide), 10 mg/ml in water, 
16.0 mM solution; Thermo Scientific™; Cat. No. H3569) was prepared before 
staining of nuclei by adding 3.4 μl of Hoechst stain to 5 ml of ‘rich’ PBS to make a 
10 μmol solution. Hoechst solution was kept away from light at all times and stock 
solution stored at 4°C. For each separate blood sample, 100 μl of 10 μmol Hoechst 
was added to a microtube and a tail drop taken via venepuncture. Blood drops 
were collected via sterile glass capillary tube (Brand® Micro-haematocrit Capillary 
tubes; Thermo Scientific™; Cat. No. 11383994) and then blood drops pushed from 
the capillary tube into the Hoechst solution using a 1 ml dropper. Blood drop 
samples in Hoechst solution were then transported to the main laboratory and 
incubated at 37°C for 15 min. Following incubation, blood drops were pelleted by 
centrifugation at 9500 ug for 2 min at room temperature. The supernatant was 
discarded and the blood pellet re-suspended in 10 μl of ‘rich’ PBS. Approximately 
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6 μl of this re-suspension was then dropped onto a clean glass slide and a cover 
slip placed on top. The cover slip was then sealed to the glass slide using clear 
nail varnish before parasites were viewed under a fluorescence microscope.    
 
2.1.17 Preparation of P. berghei samples for fluorescence-activated cell 
sorting (FACS) 
 
Before analysis of P. berghei samples by FACS, Hoechst stain was prepared in ‘rich’ 
PBS and warmed to 37°C in an incubator (kept away from light at all times). The 
purpose of the Hoechst stain in this case was to dye the nuclei of P. berghei-
infected red blood cells. Host uninfected red blood cells do not contain nuclei, 
and so any stained nuclei are indicative of P. berghei-infected red blood cells and 
can be identified by FACS. Prior to taking blood drops from infected animals, 6.8 
μl of Hoechst stain solution was added to 10 ml of ‘rich’ PBS and 1 ml aliquots of 
this diluted Hoechst solution placed in microtubes. Once heated to 37°C, one tail 
drop from an infected animal with the parasite line of interest was added to 1 ml 
of diluted Hoechst solution. Samples were incubated in Hoechst stain at 37°C in a 
shaking incubator (50 rpm) for 30 minutes. Following incubation, 500 μl of stained 
sample was passed through Nitex mesh (45 micron Nitex microfibre Nylon cloth; 
Cadisch Precision Meshes) to filter out any contaminating leukocytes or debris. 
Samples were filtered into 5 ml round-bottom Falcon® tubes (Corning®; 12 u 75 
mm Polystyrene test tubes, Product No. 352058) containing 500 μl of FACS buffer 
(1u Phosphate-buffered saline (1u PBS) with 5mM EDTA, pH 8.0). All FACS buffer 
was sterile and had been passed through a 0.22 μm pore vacuum filter unit (Merck; 
Stericup-GP, 0.22 μm, polyethersulfone, Cat. No. SCGPU05RE) prior to use. These 
filtered samples were then transported to the FACS laboratory (protected from 
light at all times).  
 
2.1.18 Protocol for FACS using a BD FACSCelesta™ flow cytometer  
 
Once P. berghei samples had been prepared as described in section 2.1.17, FACS 
analysis of many lines was carried out using a BD FACSCelesta™ flow cytometer 
(BD Biosciences). For this machine, the FACS facility room was kept at a 
temperature of 21-22ºC at all times. FACS data was analysed at the time of running 
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samples using BD FACSDiva Software (BD Biosciences) and then afterwards using 
FlowJo® software (FlowJo®, LLC). 
 
To begin, samples were run at a maximum of 10,000 events per second and the 
forward scatter area (FSC-A) (x-axis), which determines cell size, plotted against 
side scatter area (SSC-A) (y-axis), which determines the granularity of cells. From 
this plot, the parasite population was gated, excluding any very large or highly 
granular cells. Next, the FSC-A (x-axis) was plotted against the forward scatter 
height (FSC-H) (y-axis). This plot was used to gate singlet cells (single cells) from 
doublet cells (aggregated cells or multiply-infected cells). Infected red blood cells 
were then gated by selecting only cells that were positive for Hoechst nuclear 
stain (corresponding to BD Horizon Brilliant™ Violet 421 (BV421) on the 
FACSCelesta™ cytometer). Infected red blood cells could then be analysed/gated 
according to their fluorescence spectra. For example, parasites transfected with 
sequences encoding mCherry or TagBFP could be gated from background non-
fluorescent parasites by selecting for emission spectra corresponding to BD 
Horizon™ PE-CF594 and BD Horizon Brilliant™ Violet 421 (BV421) respectively. In 
the case of TagBFP fluorescence, no Hoechst staining was carried out prior to 
FACS; successfully transfected parasites were identified based on their 421 nm 
emission spectra. To examine parasite lines emitting RFP and GFP, cell 
populations were gated according to emission spectra that corresponded to R-
phycoerythrin (PE) (578 nm maximum emission) and BD Horizon Brilliant™ Blue 515 
(BB515) (515 nm maximum emission) respectively (Figure 2.4).  




Figure 2.4: Gating strategy used when examining the P. berghei 820 TBB parental line. This 
image shows an example of the gating strategy applied to an 820 TBB P. berghei parental line 4 
days post infection (dpi). 1 million events were recorded in this instance. In female gametocytes 
of this parasite line, RFP is driven by a female-specific promoter (PBANKA_131950), while GFP is 
present in male gametocytes, as the GFP sequence is driven by a male-specific promoter 
(PBANKA_041610). Image A depicts all cells (SSC-A versus FCS-A). Image B then shows the gating 
of singlets, in this case, the majority of cells sorted were singlets. Singlets are then gated further 
in Image C: only infected red blood cells are chosen based on the staining of their nuclei with 
Hoechst. Image D shows the final gating of male and female gametocytes from the infected red 
blood cell population. Using the BD FACSCelesta™ flow cytometer, GFP fluorescence corresponds 
to BD Horizon Brilliant™ Blue 515 (BB515) (515 nm maximum emission) and RFP fluorescence 
corresponds to R-phycoerythrin (PE) (578 nm maximum emission). Further FACS analysis and gating 
strategies can be found in Chapters 3 and 4.  
 
2.1.19 P. berghei competition growth curve protocol (for analysis by FACS) 
 
To begin a competitive growth curve analysis of P. berghei lines by FACS, 2 animals 
were infected with P. berghei: one with the parasite line of interest in which a 
fluorescent tag has been incorporated via transfection (in the present study: Tag-
Chapter 2  Materials and Methods 
 94 
BFP or mCherry fluorescent proteins), and the second animal with a 507 TBB P. 
berghei parasite line in which GFP is expressed constitutively. After 48 - 72 h of 
parasite growth in vivo, the parasitaemia of each animal was carefully counted 
(usually an average parasitaemia generated after 10 separate counts was used). 
Three clean TO female mice were then infected with an equal number of parasites 
from both lines. Mice were infected with low numbers of parasites to begin with 
to maintain a low starting parasitaemia. This produced an infection that could be 
monitored by FACS over the course of 4 - 5 days post-infection (dpi) before the 
animals needed to be killed.      
 
Each animal in a competitive growth curve experiment was inoculated 
intravenously with a 0.01% total parasitaemia (0.005% parasitaemia from each 
parasite line), assuming a volume of 2.3 ml of blood in each mouse. Tail drops of 
live P. berghei parasites from donor animals were taken via venepuncture and 
added to 1 ml of ‘rich’ PBS warmed to 37°C. Parasites were counted and then the 
correct number of microlitres of each P. berghei line in solution added to warmed 
‘rich’ PBS to make a total volume of 200 μl for intravenous injection into each 
mouse. Enough of the mixture of P. berghei lines in ‘rich’ PBS was made up to 
infect n+2 animals to account for any loss of solution while preparing syringes. 
The 3 mice to be monitored by FACS were then inoculated with the P. berghei mix 
from this solution. Infection with a 0.01% total parasitaemia resulted in a 
subsequent infection that was just about detectable by FACS after 24 h and could 
be monitored by FACS for a period of 4 -5 days. The ratio of GFP-fluorescent 
parasites to mCherry/Tag-BFP-fluorescent parasites was then recorded every 24 
h. The parasite population could also be followed over a longer period of time if 
the infection was inoculated again via mechanical passage to clean animals.  
 
After infection, samples were collected after every 24 h and analysed by FACS 
where 500,000 – 1 million events were recorded for GFP, mCherry/Tag-BFP and 
Hoechst. Gating was carried out on Hoechst positive cells (nuclei indicated P. 
berghei-infected red blood cells) and then GFP-positive and mCherry/Tag-BFP-
positive parasites counted. Some double-positive parasites where sometimes 
collected, resulting from multiply-infected host red blood cells. Mechanical 
passage or cull of animals was carried out once a parasitamia reached ~5%. In the 
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event that FACS could not be carried out on the same day as sample collection; 
the samples were stored in ‘rich’ PBS at 4ºC and analysed the following day. 
 
2.1.20 Generating a clonal P. berghei line by limiting dilution 
 
Following transfection and drug selection of a P. berghei parasite line with an 
integrated genetic construct, cloning by limiting dilution was carried out to ensure 
a clonal population of parasites without contamination with wild-type parasites 
that may have survived transfection and drug treatment. After confirming the 
presence of wild-type genes and integration of the desired sequence by PCR, one 
phenylhydrazine-treated mouse was infected with a stabilate of the parasite line 
to be cloned via intraperitoneal injection. After 24 h, a parasite line had usually 
grown to a red blood cell parasitaemia of 0.1-0.5%. Limiting dilution was always 
carried out when a donor mouse had reached a low parasitaemia without any 
multiply-infected cells.  
 
Using a light microscope, 25 fields of view with ~300 parasites in each field were 
counted, and an average parasitaemia calculated in this manner. Ten mice were 
then placed in a transparent temperature-controlled Perspex chamber at 37°C for 
15-20 min prior to intravenous injection. From the donor mouse, ~5 μl of blood 
was taken by venepuncture and placed in 1 ml of ‘rich’ PBS (warmed to 37°C to 
maintain parasite viability). Approximately 10 μl of this blood/’rich’ PBS mixture 
was placed on a haemocytometer and 10 counts of red blood cells taken (usually 
a new 4 nl section was counted each time). From these counts, an accurate 
measure of red blood cells per nl was calculated. Red blood cell concentration per 
µl was then calculated and, using the previously obtained parasitaemia 
percentage, an approximate number of infected red blood cells per µl was 
determined. A limiting dilution of the blood mixture in warm ‘rich’ PBS was carried 
out until a sample with ~0.8 parasites per 200 µl was obtained. Each of the 10 
mice were then injected with 200 µl of solution as detailed in section 2.1.3, to 
infect approximately 0.8 parasites into each mouse.  
 
Infected mice were monitored from ~7 days post-infection by Giemsa staining of 
blood from tail drops. On average, 3 mice out of 10 that had been used for cloning 
became infected with a P. berghei parasite. Parasites were harvested via cardiac 
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puncture under terminal anaesthesia. PCR was then carried out to confirm the 
presence of a clonal parasite line.   
      
2.1.21 Generating an isogenic P. berghei line by FACS 
 
In an effort to reduce the number of animals used in scientific experiments, 
attempts to produce isogenic P. berghei lines were made by selecting 
fluorescently-active parasite lines using a BD FACSAria II Cell Sorter (BD 
Biosciences), followed by immediate infection of selected parasites into mice via 
intravenous injection. This method was used in the production of isogenic cell 
lines when a genetically-modified P. berghei parasite line expressed a fluorescent 
protein that distinguished it from background P. berghei wild-type parasites. 
When preparing parasites for selection followed by re-injection into new animals, 
nuclear staining with Hoechst stain was not carried out as this could be 
detrimental to cell viability. Parasites were only selected based on their 
transfected fluorescent marker (e.g. mCherry or TagBFP). On the cell sorter, 
singlet red blood cells were identified by their size (forward scatter) and 
granularity (side scatter) and gated according to these cytometric events. P. 
berghei parasites with the desired genetic background were then identified by 
their fluorescence and this population gated and sorted from background cells. 
Selected parasites (usually 100 single parasites) were sorted into 1.5 ml 
microtubes containing 250 µl of ‘rich’ PBS (sterile) that had been warmed to 37°C. 
These tubes were then placed into a 37°C heat block for transport to the animals 
to be infected. Unlike cloning by limiting dilution, only 2 mice would be infected 
intravenously with sorted parasites and often, 100% of infected animals developed 
a parasite infection after this procedure was used. However, this method was not 
as successful as limiting dilution in producing lines devoid of wild-type P. berghei 
contamination.  
 
2.2 Molecular biology methods 
 
2.2.1 Genomic DNA isolation from P. berghei parasites 
 
After cardiac puncture, 200 μl of blood was placed directly into 12 ml of 1u 
erythrocyte lysis (eLysis) buffer (1.5M NH4Cl, 0.1M KHCO3, 0.01M EDTA) on ice. 
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This mixture of blood was then allowed to lyse on ice for 5-10 min until the 
solution had become clear. The mixture was then pelleted by centrifugation at 
400 ug for 10 min and the resulting supernatant discarded. The parasite pellet was 
then re-suspended in 0.5 ml eLysis buffer and transferred to a clean microtube. 
This solution was then centrifuged at maximum speed for 1 min and the 
supernatant removed and discarded. This parasite pellet was then stored at -20 
ºC for later DNA isolation or the DNA isolated immediately. 
 
To isolate DNA, the parasite pellet was re-suspended in 350 µl of TNE buffer (10 
mM Tris pH 8.0, 5 mM EDTA pH 8.0, 100 mM NaCl) and then 100 µg of RNase A (10 
µl of a 10 mg/ml solution; acquired from Sigma-Aldrich; Cat. No. LSKPMRN30) and 
1% (v/v) sodium dodecyl sulfate (SDS) (50 µl of a 10% solution) was added. This 
solution was then made up to 500 µl with demineralised water. These parasites in 
solution were then incubated for 10 minutes at 37ºC before 200 µg of Proteinase 
K from Tritirachium album (10 µl of a 10 mg/ml solution; Sigma-Aldrich; Cat. No. 
P6556) was added and the mixture incubated for 1 h at 37ºC. Following incubation, 
0.5 ml of buffered phenol (Sigma-Aldrich; Cat. No. P4557) was added and the tube 
inverted several times. Centrifugation for 3 min at 10,000 ug was carried out at 
room temperature and the resultant aqueous upper phase transferred to a clean 
microtube. 0.5 ml of buffered phenol:chloroform:isoamylalcohol (25:24:1) was 
then added to this aqueous phase and the tube inverted several times. This tube 
was then centrifuged for 3 min at 10,000 ug. Again, the resulting aqueous upper 
phase was transferred to a clean microtube. To this solution, 0.5 ml 
chloroform:isoamylalcohol (24:1) was added and the tube inverted several times 
before being centrifuged for 3 minutes at 10,000 ug. The resulting aqueous upper 
phase was transferred to a clean microtube and 0.1 volume (~50 µl) of 3 M NaAc, 
pH 5.2, and 2 volumes (~1 ml) of ice cold 96% ethanol added to precipitate the 
DNA.  
 
The solution was inverted several times and the DNA precipitated at –20ºC for a 
couple of hours to overnight. To isolate the DNA from the NaAc/ethanol solution 
after this period, the DNA microtube was centrifuged for 20 min at maximum 
speed at 4ºC. The DNA pellet was then washed with 150 µl ice cold 70% ethanol 
and centrifuged for 5 min at maximum speed at 4ºC. The supernatant was then 
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discarded and the DNA pellet air-dried for 5-10 min. Parasite DNA was then re-
suspended in 50 µl demineralised water if the procedure started with a small 
parasite pellet, and up to 250 µl water if started with a large parasite pellet. DNA 
was dissolved at 37ºC for 30 min and then the concentration calculated using a 
NanoDrop spectrophotometer. If the DNA solution was very viscous or if the 
concentration was greater than 1 µg/µl, then the sample could be diluted further. 
Diluted DNA stocks at a concentration of 50-100 ng/µl were created for analysis 
by PCR. 
 
2.2.2 Whole protein extraction from P. berghei parasites 
 
After blood was extracted by cardiac puncture, 200 μl of blood (or more if 
necessary) was placed directly into 12 ml of 1u erythrocyte lysis (eLysis) buffer on 
ice. Once the blood/buffer mixture had become clear, the mixture was 
centrifuged at 400 ug for 10 min. The parasite pellet was then re-suspended in 0.5 
ml eLysis buffer and transferred to a clean microtube before being pelleted once 
more at maximum speed in a centrifuge for 1 min. At this point, the pellet was 
either frozen and stored at -20ºC or protein extraction undertaken.  
 
To complete whole protein extraction, the parasite pellet was re-suspended in 50 
µl of RIPA buffer (50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 1% IGEPAL CA-630, 0.5% 
sodium deoxycholate, 0.1% SDS) with 1 mM DTT and 1u complete protease 
inhibitor tablet in solution. This sample was then incubated on ice for 30 min with 
frequent re-suspension. The sample was then centrifuged at 14,000 ug for 15 min 
and the supernatant transferred to a clean microtube. To this supernatant 
(containing extracted whole protein), 2u SDS-PAGE protein sample buffer (80 mM, 
2% SDS, 10% glycerol, 0.0006% Bromophenol blue, 0.1 M dithiothreitol (DTT)) or 2u 
Laemmli protein sample buffer (4% SDS, 20% glycerol, 10% 2-mercaptoethanol, 
0.004% Bromophenol blue, 0.125 mM Tris-HCl pH 6.8) was added. The suspended 
parasite pellet was then boiled for 10 min at 95ºC. After boiling, the parasite 
suspension was placed on ice to cool. Supernatant from this pellet could then be 
run on an SDS-PAGE gel.   
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2.2.3 Nuclear fractionation of proteins from P. berghei parasites 
 
All steps of a nuclear fractionation procedure were carried out at 4ºC. To begin, 
blood extracted from an infected animal was placed into 1u eLysis buffer and 
incubated on ice for 5 min (or until solution was clear). Parasites were then 
pelleted by centrifugation (450 ug for 8 min; Acc. 6, Dec. 4) and 5 volumes of 
nuclear fractionation buffer (‘nuclear lysis buffer’) added to the blood pellet. This 
was then incubated on ice for 5 min. The solution was then centrifuged at 2500 
ug for 5 min at 4oC. The supernatant from this step was kept as the cytosolic 
protein fraction. 
 
To extract nuclear proteins, 2 volumes of ‘nuclear extraction buffer’ were added 
to the parasite pellet and this suspension incubated on ice for 1 h. Following 1 h 
incubation on ice, the suspension was centrifuged at full speed for 30 min at 4oC. 
The supernatant from this step was retained as the ‘nuclear protein fraction’. The 
remaining pellet was re-suspended in 1u PBS and kept as the ‘insoluble fraction’.  
 
Buffer name  Composition 
‘Nuclear lysis buffer’ 20 mM HEPES, 10 mM KCl, 1 mM EDTA, 
0.65% Tergitol® type NP-40, 1 mM DTT 
and 1u Complete Protease Inhibitor 
cocktail added just before use 
‘Nuclear extraction buffer’ 10 mM Tris-HCl pH 8.0, 2% SDS, 5 
U/ml Benzonase® endonuclease, 1 mM 
DTT and 1u Complete Protease 
Inhibitor cocktail added just before 
use 
 
Table 2.1: Composition of buffers for nuclear fractionation from whole proteins. 
 
2.2.4 Acid extraction of P. berghei histones  
 
This  protocol is adapted from acid extraction methods tested in P. falciparum for 
the maximal retention of native histone post-translational modifications (as 
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published in (Miao et al., 2006) and (Moll et al., 2013)). All step were performed 
at 4ºC.  
 
P. berghei parasites of the desired developmental stage were extracted by 
Nycodenz purification (discribed in section 2.1.5.4) or magnetic separation (see 
section 2.1.15) following the removal of contaminating host leukocytes from 
blood using Plasmodipur filtration (section 2.1.14). Ideally, 1-3 u 109 parasites 
(Miao et al., 2006) at either synchronized asexual stage or mature gametocyte 
stage were harvested for acid extraction of histones to obtain enough material for 
identification of proteins and histone modifications via mass spectrometry. After 
centrifugation of parasites following Nycodenz separation or magnetic extraction 
from host blood, parasite pellets were washed twice with cold 1u PBS. Re-
suspended pellets were centrifuged at 450 ug for 8 min at 4ºC after each wash. 
Parasite pellets were then washed twice with a wash buffer (25 mM Tris-HCl, pH 
7.8, 1 mM EDTA, 0.2% IGEPAL CA-630) to remove haemoglobin and re-pelleted at 
450 ug for 8 min at 4ºC. Parasite pellets were then washed three times with 0.8% 
NaCl to remove excess haemoglobin and IGEPAL CA-630 detergent from the 
previous wash steps. Parasites were re-pelleted at 450 ug for 8 min at 4ºC each 
time. 
 
Histones were then extracted twice with 0.25 M HCl. To do this, 10 volumes of 
0.25 M HCl was added to the parasite pellet and incubated on ice for 1 h with 
frequent re-suspension. After 1 h, this sample was centrifuged at 12,000 ug for 2 
min to pellet acid-insoluble contaminants. The acid-soluble fraction (supernatant) 
was then transferred to a clean 1.5 ml microtube. This fraction was kept on ice 
while a second acid extraction of the remaining pellet was carried out. To the 
remaining pellet, 10 volumes of 0.25 M HCl was again added and the sample 
incubated on ice for 1 hour with frequent re-suspension. This parasite pellet was 
then centrifuged at 12,000 ug for 2 min (or longer if needed) and remove acid-
soluble fraction (supernatant). This supernatant was then pooled with the 
previous acid-soluble fraction on ice. This acid-soluble supernatant pool contained 
the extracted P. berghei histones. Pooled acid-soluble fractions were then mixed 
with an equal volume of 25% TCA and incubated on ice for 1 hour. This step 
precipitated the parasite histones. Acid extracted samples were then centrifuged 
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at 12,000 ug for 15 min at 4ºC. When finished, precipitated histones were pelleted 
at the bottom of the centrifuge tube and the supernatant was discarded. 
 
Parasite pellets were then washed with acetone and allowed to dry completely on 
ice overnight at -20ºC. To facilitate drying at -20ºC, parafilm was placed over the 
open cap of the microtube and a hole pierced in this with a needle. This allowed 
the pellet to dry overnight at -20ºC without ice formation. Dried histones could 
then be analysed by 15% SDS-polyacrylamide gel electrophoresis (PAGE) the 
following day after boiling the pellet in 2u SDS protein sample buffer or 2u 
Laemmli sample buffer at 95ºC for 10 min (as described when extracting whole 
protein in section 2.2.2). Acid extracted histones could subsequently be examined 
by SDS-PAGE, Western blotting, or mass spectrometry. Histone gel bands could 
also be excised individually and digested with trypsin for analysis of individual 
histones by mass spectrometry.  
 
2.2.5 Preparation of P. berghei samples for immunofluorescence microscopy  
 
To observe fluorescent proteins or tagged proteins of interest by fluorescence 
microscopy, blood or parasite culture samples were smeared onto glass 
microscope slides and fixed in 4% paraformaldehyde (made up in sterile water this 
study, 16% paraformaldehyde single-use ampoules were used in each case 
(Paraformaldehyde 16% solution, EM grade; Electron Microscopy Sciences; Cat. No. 
15710). In the case of P. berghei parasites in whole blood; addition of 4% 
paraformaldehyde lysed red blood cells and so the smear appeared clear after 
fixation. However, parasites had been successfully fixed to the glass slide. After 
10 min staining, the 4% paraformaldehyde was poured from the slides and disposed 
of appropriately. Slides were then rinsed once in 1u PBS and permealised by 
incubating in a 0.1% Triton in 1u PBS (1u PBST) solution for 5 min with gentle 
agitation. Slides were then rinsed once more in 1u PBS. Blocking of non-specific 
antibody binding was then achieved by incubating the slides for 45 min in 1% 
BSA/1u PBS on an orbital shaker. After this, slides were incubated with a primary 
antibody diluted in 1% BSA/1u PBS for 1 h at room temperature (with slides in a 
slide box in the dark). For staining with primary and secondary antibodies, just 
100 µl to 200 µl of antibody solution/dilution was pipetted onto each slide and 
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covered with a long cover slide. Primary and secondary antibodies were often 
diluted 1:400 or 1:500 in 1% BSA/1u PBS solution.  
 
Following primary antibody staining, the slides were again rinsed in clean 1u PBS 
before being incubated with a fluorescently-labelled secondary antibody in 1% 
BSA/1u PBS solution for 45 min at room temperature. After a final rinse in 1u PBS, 
slides were then mounted on the slide with 1-2 drops of Vectashield mounting 
medium with 4',6-Diamidino-2-Phenylindole, Dihydrochloride (DAPI) (Vector 
Laboratories, Inc.; Cat. No. H01200). A cover slip was then placed onto each glass 
slide and the outer edges of the cover slips sealed to the slides with clear nail 
varnish. Slides were then visualised using a fluorescence microscope or stored at 
4ºC until use.   
 
2.2.6 Co-immunoprecipitation of P. berghei proteins using antibody-bound 
magnetic beads 
 
2.2.6.1 Cell lysis procedure  
 
In the present study, co-IPs were often carried out at schizont stages of P. berghei 
lines to maximise the amount of tagged protein available. For a large (120 ml) 
culture, or more than one large culture, material from culture flasks was poured 
into 50 ml centrifuge tubes and centrifuged at 450 ug for 8 min at room 
temperature. Centrifugation was repeated in this manner until all samples were 
pooled in 10 ml of complete culture medium in a single 50 ml centrifuge tube. 
Cold 1u eLysis buffer was then added to the sample to bring to a volume of 50 ml. 
This suspension was then incubated on ice for 10 min, or until the solution was 
clear. Once clear, the 50 ml of suspended parasites were spun down at 450 ug for 
8 min at 4ºC. The supernatant was then discarded and the pellet washed in 50 ml 
1× PBS, with re-pelleting by centrifugation at 450 ug for 8 min at 4ºC (6 
acceleration; 4 deceleration). The supernatant was then discarded and the pellet 
re-suspended in 1 ml 1× PBS and transferred to a clean microtube. Parasites were 
then pelleted by centrifugation at 14,000 ×g for 1 min. The supernatant was 
discarded and the pellet re-suspended in 500 µl ice-cold ‘Co-IP Lysis buffer’ (20 
mM Tris-HCl pH 8.0, 137 mM NaCl, 10% Glycerol, 1% Tergitol® Type NP-40, 2 mM 
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EDTA, 1× Complete Protease Inhibitor cocktail added just before use). This re-
suspended parasite pellet was then incubated on ice for 30 min.  
 
The amount of ice-cold ‘Co-IP lysis buffer’ added to each sample was adjusted in 
cases where there was a very large parasite pellet. During incubation on ice, the 
tube was inverted several times to mix the sample. Samples were never vortexed 
at this stage: this prevented disruption of any protein-protein interactions. After 
30 min incubation, the sample was centrifuged for 15 min at 14,000 ×g (4qC). The 
supernatant was then transferred to a clean microtube. This lysate contained the 
proteins to be immunoprecipitated. An aliquot of lysate was kept for future 
Western blot analysis, with the remaining lysate proceeding to the Co-IP 
procedure. Lysate samples were never frozen for storage at this point; again to 
prevent the disruption of protein-protein interaction.  
 
Buffer name Composition 
‘Co-IP lysis buffer’ 20 mM Tris-HCl pH 8.0, 137 mM NaCl, 
10% Glycerol, 1% Tergitol® Type NP-40, 
2 mM EDTA, 1× Complete Protease 
Inhibitor cocktail added just before use 
 
Table 2.2: Chemical composition of P. berghei co-IP lysis buffer.   
 
2.2.6.2 Co-immunoprecipitation procedure 
 
To prepare anti-HA magnetic beads (Pierce™ Anti-HA Magnetic Beads; Thermo 
Scientific; Cat. No. 88836), 175 µl of 1× PBST was placed in a 1.5 ml microtube to 
which 25 µl of re-suspended anti-HA magnetic beads were then added (Anti-HA 
magnetic beads were vortexed well before use). Magnetic beads were then placed 
in a magnetic microtube stand and the supernatant discarded after beads had 
separated to the side of the tube. Beads were then re-suspended in 200 µl 1× 
PBST, vortexed, and placed back in the magnetic stand. After separation of beads 
to the side of the tube, beads were once more washed in 200 µl of ‘Co-IP lysis 
buffer’ and the supernatant discarded. These magnetic anti-HA beads were then 
re-suspended in the protein lysate from section 2.2.6.1. Beads were re-suspended 
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in the lysate by gentle pipetting and this mixture incubated for 4 h to overnight 
at 4°C in a rotator.         
 
Following incubation, the tube was placed in the magnetic stand, the beads 
separated, and the supernatant removed and stored for future Western blot 
analysis. Anti-HA beads were then washed 4 times with 400 µl of ‘Co-IP lysis 
buffer’.  Washed fractions were stored for western blot analysis. Anti-HA beads 
(now bound to proteins containing a HA-tag) were re-suspended in 100 µl of ‘Co-
IP lysis buffer’ and transferred to a new tube (this step helped to prevent carry 
over of contaminating proteins from previous incubation steps). The tube was 
placed in a magnetic stand, supernatant removed, and the bound proteins eluted 
by incubation of beads with 50-100 µl 2× SDS sample buffer or 2× Laemmli sample 
buffer for 10 min at 95°C. The tube was then cooled on ice. Magnetic beads were 
then separated in the magnetic stand and the eluted proteins transferred to a 
clean microtube. 1% 2-mercaptoethanol was then added to the sample to reduce 
disulphide bond formation. Co-immunoprecipitated proteins were then analysed 
or stored at -20°C for future analyses. 
 
2.2.7 Western blotting (immunoblotting) 
 
2.2.7.1 SDS-PAGE protocol for separation of proteins 
 
SDS-PAGE was used in the present study to separate protein mixtures following 
acid extraction of histones from P. berghei, and to visualise proteins following 
whole protein extraction, nuclear fractionation, and co-immunoprecipitation of 
tagged proteins. Throughout this study, all SDS-PAGE and subsequent 
immunoblotting/Western blotting procedures were carried out using the Bio-Rad 
Mini-PROTEAN® Tetra Vertical Electrophoresis Cell and accessories for this 
module. 15% SDS-PAGE resolving gels were prepared for analysis of histones in this 
study. For standard protein SDS-PAGE (e.g. tagged protein analyses), pre-cast 4-
20% Mini- PROTEAN® TGX™ gels were used (Bio-Rad Laboratories, Inc.; Cat. No. 
4561093). All reagents used for casting of a 15% SDS-PAGE gel are listed in Table 
2.3 below.  
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Reagent/Buffer name  Composition (volumes) 
15% resolving gel (for one 1.5 mm gel) 3.75 ml Bis-acrylamide (30%), 1.9 ml 
1.5 M Tris-HCl pH 8.8, 37.5 µl 20% SDS, 
1.8 ml H2O, 100 µl 10% ammonium 
persulfate (APS), 10 µl N,N,N′,N′-
tetramethylethylenediamine (TEMED) 
5% stacking gel (for four 1.5 mm gels) 650 µl Bis-acrylamide (30%), 1.25 ml 
0.5 M Tris-HCl pH 6.8, 25 µl 20% SDS, 3 
ml H2O, 100 µl 10% ammonium 
persulfate (APS), 10 µl N,N,N′,N′-
tetramethylethylenediamine (TEMED) 
 
Table 2.3: Reagents used for casting a 15% SDS-PAGE gel for analysis of P. berghei ANKA 
histones.  
 
Protein samples to be run on an SDS-PAGE gel were denatured by boiling at 95ºC 
for 10 min in 2´ SDS protein sample buffer or 2´ Laemmli sample buffer. The inner 
chamber of the vertical electrophoresis cell was then filled with SDS running 
buffer (1´ Tris/Glycine/SDS buffer from a 10x stock) until the buffer level reached 
over the top of the gels (but making sure not to overfill the inner chamber). The 
‘lower’ chamber, or the electrophoresis tank as a whole, was then filled with ~200 
ml of SDS running buffer or until the tank was ~1/3 full. Protein samples were 
then loaded into the wells in the stacking gel next to a protein ladder. Gels were 
then run at 90 V for ~1 h, or until samples had run to the base of the gel. The 
chemical composition of buffers used for SDS-PAGE in the present study are listed 
below in Table 2.4.  
 
Reagent/Buffer name  Composition  
1´ TAE buffer 40 mM Tris (pH 7.6), 20 mM acetic 
acid, 1 mM EDTA 
2´ SDS-PAGE protein sample buffer 80 mM, 2% SDS, 10% glycerol, 0.0006% 
Bromophenol blue, 0.1 M 
dithiothreitol (DTT) 
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2´ Laemmli protein sample buffer 4% SDS, 20% glycerol, 10% 2-
mercaptoethanol, 0.004% 
Bromophenol blue, 0.125 mM Tris-HCl 
pH 6.8 
  
Table 2.4: Buffers used during SDS-PAGE experiments in the present study. 
 
2.2.7.2 Transfer of proteins from SDS-PAGE gel to membrane and antibody 
binding  
 
In the present study, protein samples were solubilised in 2´ SDS protein sample 
buffer or 2´ Laemmli sample buffer before being separated on an SDS-PAGE gel 
(section 2.2.7.1). For immunodetection purposes, proteins on an SDS-PAGE gel 
were first transferred to polyvinylidene fluoride (PVDF) membrane (Amersham™ 
Hybond™ P0.45 PVDF; GE Healthcare Life Sciences; Cat. No. 10600023) using a 
Mini-PROTEAN® Tetra Cell tank (Mini Trans-Blot® Module; Bio-Rad Laboratories, 
Inc; Cat. No. 1658033).  
 
To begin, transfer buffer (1´ Tris/Glycine buffer from a 10x stock) was cooled on 
ice and 4 pieces of blotting paper (Whatman™ 3MM Chr Chromatography Paper; 
ThermoFisher Scientific) cut to 9 ´ 7 cm and soaked in pre-cooled transfer buffer. 
Blotting fibre pads were then soaked in cold transfer buffer with the blotting 
paper. A section of PVDF membrane (large enough to cover the surface of the gel) 
was then cut and activated by placing in methanol for 10 s. The PVDF membrane 
was then washed in distilled water for 5 min on an orbital shaker before being 
placed in pre-cooled transfer buffer for 10 min (again, on an orbital shaker). The 
SDS-PAGE gel was then removed from the electrophoresis tank and placed in 
transfer buffer for 10 minutes (with shaking). 
 
Immunoblotting transfer cassettes were then placed in the transfer tank with an 
ice pack inserted to maintain a cold temperature, and then the tank filled to the 
top with ice-cold transfer buffer. Transfer of proteins was then carried out at 90 
V for 1 h or at 20 V overnight. Following transfer, the PVDF membrane (now 
containing proteins of interest) was removed from the cassette and placed in 
blocking solution for 1-2 h on an orbital shaker at 4ºC in a cold room. Once the 
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membrane had been blocked, blocking buffer was poured off and the membrane 
washed three times (5 min each) with 1´ TBST. The membrane was then incubated 
with a primary antibody diluted in 5 ml or 10 ml of antibody dilution buffer with 
agitation on an orbital shaker overnight at 4ºC. After incubation with the primary 
antibody, the membrane was washed 3 times with 1´ TBST (5 min each). A 
secondary horseradish peroxidase (HRP)-conjugated antibody was then diluted in 
5-10 ml dilution buffer and the membrane incubated with this at room 
temperature for 1-2 h with gentle agitation. Following the final incubation, the 
membrane was washed 3 times with 1´ TBST (5 min each) before being imaged 
using a commercial chemiluminescence kit and X-ray detection (Medical X-ray 
Blue/MXRE Film 18 ´ 24 cm; Carestream Healthcare, Inc.; Product No. 814 3059). 
Solutions used for transfer of proteins from SDS-PAGE gels to PVDF membranes are 
listed in Table 2.5. 
 
Reagent/Buffer name  Composition  
10´ Tris-buffered saline (TBS) 0.2 M Tris, 1.5M NaCl 
1´ Tris-buffered saline, 0.1% Tween-20 
(1´ TBST) 
20 mM Tris, 150 mM NaCl, 0.1% 
Tween-20 
1´  SDS-PAGE Transfer buffer 190 mM glycine, 25 mM Tris, 20% 
methanol 
Western blot blocking/Antibody 
dilution buffer 
20 mM Tris, 150 mM NaCl, 0.1% 
Tween-20, 5% (w/v) non-fat milk 
powder 
 
Table 2.5: Solution compositions for transfer of proteins to a PVDF membrane prior to 
immunoblotting. 
 
2.2.7.3 Detection of antibody-bound proteins by chemiluminescence 
 
To proceed with the detection step of the Western blot, the peroxidase solution 
(with luminol) and Acridan solution, from a commercial chemiluminescence kit 
were mixed together according to the manufacturers guidelines. This mixture of 
solutions was then pipetted onto the membrane that had previously been probed 
with a HRP-conjugated antibody. The solution mixture was kept on the membrane 
for the length of time indicated in the kit guidelines. The membrane was then 
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wrapped in plastic (‘cling film’. This blot was then placed in an autoradiography 
cassette (Amersham™ Hypercassette™; GE Healthcare Life Sciences; Product No. 
RPN11629) and brought to a darkroom for development. To detect proteins using 
X-ray film, the X-ray film was placed over the chemiluminescent Western blot for 
increments of 10 s, 30 s, 1 min, 5 min, 10 min, or longer if necessary; until protein 
bands were observed. Western blot membranes were then discarded after 
detection. X-rays were scanned and stored in a dark place. 
 
2.2.8 Protein sample preparation for LC-MS using a FASP protein digestion kit 
 
In the present study, all samples to be analysed by liquid chromatography-mass 
spectrometry (LC-MS) were prepared using a filter-aided sample preparation 
(FASP) digestion kit (FASP Protein Digestion Kit; Expedeon Ltd.; Cat. No. 44250) 
with a maximum capacity of 0.4 mg of protein in 30 µl of solution.   
 
2.2.8.1 Preparation of urea sample solution 
 
Fresh urea sample solution was prepared before each new protein sample 
digestion. 1 ml of Tris-HCl was added to one tube of urea (provided in the FASP 
kit). This tube was then vortexed until all urea powder had dissolved.  
 
2.2.8.2 Preparation of 10× Iodoacetamide solution  
 
10× iodoacetamide solution was prepared fresh before each protein sample 
digestion. To begin, 100 µl of the urea sample solution was added to one tube of 
iodoacetamide from the FASP kit. Iodoacetamide powder was dissolved in solution 
by pipetting up and down approximately 15 times (or until powder had fully 
dissolved). The fresh solution was then transferred to a clean microtube.  
 
2.2.8.3 Preparation of digestion solution  
 
Digestion solution was prepared fresh for each sample (75 µl each time) by 
dissolving 4 µg of trypsin powder in 75 µl of 50 mM ammonium bicarbonate solution 
to a final concentration of 0.05 µg/µl.  
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2.2.8.4 FASP digestion procedure 
 
To begin digestion, up to 30 µl (at 0.4 mg) of protein extract was mixed with 200 
µl of urea sample solution in a spin filter and centrifuged at 14,000 ×g for 15 min 
at room temperature. An additional 200 µl of urea sample solution was then added 
to the spin filter and centrifuged at 14,000 ×g for 15 min once more. The flow-
through was then discarded (from the collection tube) and 10 µl 10× 
iodoacetamide solution and 90 µl urea sample solution added to the filter. This 
was vortexed for 1 min and then the spin filter incubated for 20 min at room 
temperature in the dark (without mixing). After incubation, the spin filter was 
centrifuged at 14,000 ×g for 10 min at room temperature. 100 µl of urea sample 
solution was then added to the spin filter and centrifuged 14,000 ×g for 15 min.  
 
This step was then repeated twice more and the flow-through discarded. After 
this, 100 µl of 50 mM ammonium bicarbonate solution was added to the spin filter 
and centrifuged at 14,000 ×g for 10 min at room temperature. Again, this step was 
repeated twice more and the flow-through discarded. 75 µl of digestion solution 
(enzyme-to-protein ratio: 1:100) was added to the spin filter and the filter 
vortexed for 1 min. Parafilm was then wrapped around the top of the tube to 
prevent evaporation from the spin filter. The spin filter was then incubated at 
37°C for 4-18 h. Following incubation, the spin transfer was then transferred to a 
clean collection tube and 40 µl of 50 mM ammonium bicarbonate solution added. 
The spin filter was then centrifuged at 14,000 ×g for 10 min at room temperature. 
A further 40 µl of 50 mM ammonium bicarbonate solution was then added and the 
filter centrifuged at 14,000 ×g for 10 min at room temperature once more and the 
flow-through discarded. Digested protein extract was then eluted by the addition 
of 50 µl 10% acetonitrile solution to the spin filter and centrifugation of this spin 
filter at 14,000 ×g for 10 min at room temperature. The eluted filtrate was then 
acidified by adding 1.0% trifluoroacetic acid (TFA) to the desired pH and desalting.  
 
2.2.9 LC-MS/MS procedure for histone analysis 
 
All samples in the present study were analysed on an Orbitrap™ Elite™ mass 
analyser coupled with an UltiMate™ 3000 RSLCnano ultra high performance liquid 
chromatography (UHPLC) system. Samples (5 µl) were loaded onto an Acclaim™ 
Chapter 2  Materials and Methods 
	 110	
PepMap100™ column (75 µm i.d. x 15 cm, 3 µm C18; Thermo Scientific™) at a flow 
rate of 5 µl min-1 by the UltiMate™ 3000 RSLCnano autosampler (Thermo 
Scientific™). Loading solution composition was 0.1% formic acid and acetonitrile 
(98:2). Loaded sample was then washed into an Acclaim™ PepMap100™ trap 
column (100 µm i.d. x 2 cm, 5 µm, 100Å C18; Thermo Scientific™) at a flow rate 
of 0.3 µm min-1. One-hour linear HPLC gradients were performed from 0-35% 
solvent B to 35% solvent B (A = 0.1% formic acid; B = 80% acetonitrile 0.08% formic 
acid). Nano flow and trap columns were maintained at 35°C.  
 
Column eluate was directed to a Triversa NanoMate® electrospray ionisation (ESI) 
source (Advion™) operating in positive ion mode (2+) and then into the Orbitrap™ 
Elite™ mass analyser. Ionisation voltage was 2.5 kV and the capillary temperature 
was 230°C. Tandem mass spectrometry (MS/MS) was carried out from 300-2000 
atomic mass units (amu) and the top 20 multiply-charged ions were selected from 
each full scan for MS/MS analysis. Fragmentation was by collision-induced 
dissociation (CID) at 35% collision energy. Ions were selected for MS2 using a data-
dependent method with a repeat count of 1 s and an exclusion time of 60 s. 
Precursor ions with unassigned charged states or a charge state (z) of 1 were 
rejected. The resolution of ions in the first stage (MS1) was 60,000 and 7500 for 
the second stage (CID MS2). Data were acquired using XCalibur™ software (version 
2.1) (Thermo Scientific™).     
 
2.2.10 LC-MS/MS data analysis 
 
Raw LC-MS/MS data files (‘.RAW’ files from XCalibur™) were processed using 
Proteome Discoverer™ software (version 2.0; Thermo Scientific™). Raw files were 
converted to Mascot Generic Format (MGF) files in Proteome Discoverer™ and 
probability-based identification of histone peptides and PTMs from MS/MS data 
was carried out using the Mascot search engine (version 2.6 with patch release 
2.6.2) (Perkins et al., 1999). Peptide information for P. berghei ANKA was derived 
from the PlasmoDB database (version 35). Searches were performed with a 
peptide tolerance of 5 parts per million (ppm) (#13C = 1; monoisotropic mass 
values), a fragment mass tolerance of ±0.3 Da, and a maximum of 5 missed 
cleavages by trypsin. Mascot search settings were for the fixed modification, 
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carbamidomethyl (C), and variable modifications of N-terminal acetylation (N-
term), lysine acetylation (K), lysine mono-, di-, and tri- methylation (K), arginine 
mono-, di-, and tri- methylation (R), and phosphorylation (ST, Y). Error tolerant 
searches for all significant (P < 0.05) protein hits were displayed as shown in 
Figure 2.5. Comparative analysis of significant (P < 0.05) histone PTMs between 
P. berghei ANKA mature asexual and sexual stage parasites is described in Chapter 
4.  
 
     
 
Figure 2.5: Example Mascot output following LC-MS/MS of acid-extracted histone samples. This 
image is a screenshot of the Mascot (version 2.6) search engine output for a sample of G1142 
mature gametocyte histones following LC-MS/MS as described in section 2.2.8. The display is 
showing a selection of MS/MS spectra that have mapped to the putative P. berghei ANKA histone 
2B (H2B) variant (H2B.Z) (PBANKA_1420600.1-p1) as described in PlasmoDB (version 35). In this 
instance, H2B.Z was the highest scoring protein (according to the Mascot scoring algorithm) with 
a score of 5911.  
 
In the example experiment shown in Figure 2.5, the expected histone H2B.Z mass 
was 13741 atomic mass units/Daltons (amu/Da). The number of ‘matches’ 
describes the number of MS/MS spectra that matched to this protein, with the 
number of significant matches in brackets. In this case, all 228 matched spectra 
were significant. The ‘sequences’ value describes a count of matches to distinct 
peptide sequences, with significant matches in brackets. Again, in this example 
protein (H2B.Z), all 12 distinct peptide sequences had significant matches. To the 
very right is the emPAI (Exponentially Modified Protein Abundance Index) value, 
an approximate quantitation of this protein in the sample mixture based on 
protein coverage by peptide matches (Ishihama et al., 2005). An emPAI value is 
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given only if 100 MS/MS spectra or more are present within the sample. In the 
example above, the 852.41 value was derived from 10(Nobserved/Nobservable)-1, where 
‘Nobserved’ was the number of experimentally-derived peptides for H2B.Z and 
‘Nobservable’ was the calculated number of observable peptides for the H2B.Z 
protein.  
 
Below the protein descriptor from PlasmoDB in Figure 2.5, all matched queries 
are shown, with each query (an MS/MS spectrum ‘queried’ against PlasmoDB 
known sequences) given a unique identifying number (on the left in blue). The 
experimentally-derived mass/charge (m/z) value for each peptide is labelled in 
the ‘observed’ column, followed by values showing the experimental m/z value 
transformed to a relative molecular mass (Mr(expt)) and the calculated relative 
molecular mass (Mr(calc)) based on the matched peptide sequence. The parts per 
million (‘ppm’) value shows the difference between (Mr(expt)) and (Mr(calc)). In 
the ‘miss’ column, the number of missed protease cleavage sites are shown, with 
the ‘score’ value showing the Mascot-assigned ‘ion score’ (a measure of how well 
the observed MS/MS spectrum matches to the peptide). ‘Score’ values in brackets 
are scores for duplicate MS/MS spectra, but ones with lower ion scores than their 
duplicate.  
 
In Figure 2.5, the expectation value (‘Expect’) is a measure of the likelihood that 
the given score would be seen by chance, with the ‘rank’ column showing a rank 
for the ion match from 1-10 (1 being the best match). A letter ‘U’ is assigned in 
the ‘Unique’ column if a query is unique to the protein hit. The final column then 
shows the amino acid sequence, with a period indicating a cleavage site, and a 
dash indicating the end of the protein sequence (a carboxyl or amino terminus). 
The Mascot output (Figure 2.5) also provides links to variable modifications on 
each peptide. These are shown in blue and in brackets to the right of the peptide 
single-letter sequence. Variable modifications in each sequence are underlined 
and those that correspond to PTMs are underlined in the main ‘peptide’ sequence. 
Red text indicates that the peptide shown is the highest-scoring match for a given 
MS/MS spectrum, with bold text indicating the highest scoring protein to which 
the peptide sequence appears (out of all proteins identified in the sample run) 
(Perkins et al., 1999). Results such as those seen in Figure 2.5 were obtained for 
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all mature schizont and gametocyte histone samples run in the present study, with 
results described in Chapter 4.        
 
2.2.11 Chromatin immunoprecipitation coupled with high-throughput DNA 
sequencing (ChIP-seq) protocol for P. berghei parasites 
 
A standard ChIP procedure for the examination of DNA regions bound to 
specifically-modified histones in P. berghei ANKA cells is depicted in Figure 2.6 
(original ChIP protocol provided by Dr Agnieszka Religa at the University of 
Glasgow, in collaboration with Dr Valerie M. Crowley of the University Health 
Network, Toronto General Hospital, Canada).  
 
 






Figure 2.6: Chromatin immunoprecipitation (ChIP) of P. berghei ANKA parasites: from cell 
culture to library preparation. The stages of chromatin immunoprecipitation (ChIP) from 
collection of infected blood from a TO mouse to the point at which ChIP-seq and ChIPmentation 
procedures diverge (the point just after immunoprecipitation (IP) of fragmented chromatin-DNA) 
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are shown in the images above. In the present study, only mature asexual P. berghei ANKA 
parasites were examined by ChIP-seq or ChIPmentation to maximise genetic material with which 
to work with, and to optimise both ChIP-seq and ChIPmentation protocols for future ChIP studies 
in P. berghei. To begin with, infected blood was collected from animals via cardiac puncture and 
filtered through Plasmodipur filters as described in section 2.1.14. Mature asexual parasites 
(schizonts) were then purified from culture using a 55% Nycodenz gradient, and samples split into 
microtubes containing 5 million parasites each (equating to ~30 million merozoites, assuming  each 
P. berghei ANKA schizont contained 12 segmented merozoites). These tubes were then placed on 
ice and remained at this cooled temperature (or roughly 4ºC) for the remainder of the ChIP 
procedure. Erythrocyte lysis buffer and ice-cold 1x PBS washes were then used to remove host red 
blood cells contaminants and any remaining culture medium contaminants. Crosslinking, 
quenching and fragmentation of chromatin-DNA was then carried out as described in sections 
2.2.11.1 and 2.2.11.2. In the cartoon above, free proteins/chromatin (in yellow) are shown being 
bound by glycine molecules (represented by red circles). In each case, some unbound DNA strands 
are shown, as it is always possible that not all chromatin-DNA interactions are preserved, even 
after formaldehyde treatment.           
 
In Figure 2.6, the initial ChIP procedure is shown up to the pre-clearing and 
immunoprecipitation steps. At this point, i.e. just following sonication, input 
samples are chosen that are not subject to immunoprecipitation. For ChIP analyses 
of histone modifications and their associated DNA regions, mock antibody controls 
or a histone 3 (H3) antibody pulldown could also be used as a control for ChIP 
samples (Flensburg et al., 2014). In the present study, an anti-GFP mock antibody 
control was used in an initial pilot study of ChIPmentation in P. berghei schizonts. 
All remaining experiments were carried out with input ChIP-DNA controls, i.e. 
sonicated chromatin-DNA after de-crosslinking, with no immunoprecipitation 
step.     
 
Though the ‘ChIPmentation’ protocol described in section 2.2.12 also 
incorporates a ChIP component (as depicted in Figure 2.6) and culminates in DNA 
sequencing of amplified ChIP-DNA libraries, a standard ChIP-seq protocol is 
defined by its library preparation method, incorporating end-repair of de-
crosslinked DNA fragments, dA-tailing, adapter ligation, and library 
amplifications, size selections, and purifications (Furey, 2012) (Figure 2.7).  










Figure 2.7: Standard ChIP-seq procedure in P. berghei ANKA from immunoprecipitation to 
sequencing on an Illumina platform. In the sequence of images above, the complete protocol for 
a standard P. berghei ANKA ChIP-seq is shown. The complete materials and methods for ChIP-
sequencing using standard library preparation procedures are described from section 2.2.11.1 to 
section 2.2.11.12.  
 
The ChIP-seq library preparation method detailed below is modified from a 
protocol provided by Dr David Vetrie as part of the ‘Chromatin Structure and 
Function’ Wellcome Trust Advanced Course, held at the Wellcome Genome 
Campus, Hinxton, Cambridge, UK: ‘PROTOCOL 3: Preparation of ChIP DNAs for 
sequencing on the Illumina Genome Analyzer IIe’.  
 
Buffer name Buffer components  
Lysis Buffer (non-SDS) (kept cold) 10 mM HEPES (pH 7.9), 10 mM KCl, 0.1 
mM EDTA (pH 8.0), 0.1 mM EGTA (pH 
8.0), 1 mM DTT (just before use), 1× 
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protease inhibitor cocktail (from 25× 
stock- added just before use), 0.25% 
Tergitol® Type NP-40 (added just 
before use directly into sample) 
1% SDS Lysis Buffer 1% SDS, 10 mM EDTA (pH 8.0), 50 mM 
Tris-HCl (pH 8.1)  
Dilution buffer 0.01% SDS, 1.1% Triton-X100, 1.2 mM 
EDTA (pH 8.0), 16.7 mM Tris-HCl (pH 
8.1), 167 mM NaCl, 1× protease 
cocktail inhibitor 
Low Salt Wash Buffer 0.10% SDS, 1% Triton X-100, 2 mM 
EDTA (pH 8.0), 20 mM Tris-HCl (pH 
8.1), 150 mM NaCl 
Salty Wash Buffer 0.10% SDS, 1% Triton X-100, 2 mM 
EDTA (pH 8.0), 20 mM Tris-HCl (pH 
8.1), 500 mM NaCl  
LiCl Wash Buffer 250 mM LiCl, 1% Tergitol® Type NP-40, 
1% sodium deoxycholate (from fresh 
5% stock), 1 mM EDTA (pH 8.0), 10 mM 
Tris-HCl (pH 8.0)  
Elution Buffer 1% SDS, 0.1 M NaHCO3 (from single use 
aliquots) 
TE Buffer 10 mM Tris-HCl (pH 8.0), 1 mM EDTA 
(pH 8.0)  
 
Table 2.6: Composition of buffers for a standard ChIP-seq procedure in P. berghei.  
  
2.2.11.1 Crosslinking of chromatin to DNA  
 
The procedure began by chilling glass dounce tissue grinder sets (Sigma-Aldrich; 
Cat. No. D8938) on ice and pre-cooling a centrifuge to 4°C. All stages of this 
protocol were carried out on ice unless otherwise stated. Parasites of a 
synchronised asexual or sexual stage population (Plasmodipur filtered and 
Nycodenz/magnetically separated) were washed twice in 1 ml of ice-cold 1´ PBS 
and then re-suspended in 150 µl to 500 µl  of ice-cold 1´ PBS, depending upon 
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parasite numbers (cell number guidelines were taken from (Schmidl et al., 2015)), 
with small cell numbers being up to 5 ´ 105 cells and large cell numbers from 5 ´ 
105 cells up to 10 ´ 106 cells. If parasite numbers were larger, samples were split 
into smaller cell numbers and the ChIP DNA pooled after the procedure. Re-
suspended parasites were crosslinked with 1% formaldehyde (from a 16% stock of 
methanol-free formaldehyde). The samples were mixed by inversion of the 
microtube and incubated at 37°C for 5 min, inverting occasionally. After 
incubation, the samples were briefly spun in a microfuge to pool any evaporated 
material to the base of the microtube. The crosslinking reaction was then 
quenched with 125 mM glycine from a 2 M glycine stock. The samples were mixed 
well by gentle inversion of the tubes and then incubated on ice for 5 min. After 
this incubation period, samples were then centrifuged at 2500 ´g for 5 min at 4°C 
and the supernatant discarded.  
 
Samples were then washed 3 times with 1 ml 1´ PBS (each time re-pelleting the 
sample at 2500 ´g for 5 min at 4°C). The pellet was then re-suspended in cold 
non-SDS lysis buffer (without Tergitol® Type NP-40) to a concentration of ~3.33 ´ 
105 parasites/µl, or fewer in the case of small cell numbers. Samples were 
incubated on ice for 30 min before Tergitol® Type NP-40 was added to a final 
concentration of 0.25%. One sample at a time was then transferred to a dounce 
(up to 2 ml) on ice and the sample homogenised with 200 strokes of the dounce 
(repeated with more of the sample if the sample was greater than 2 ml). For very 
small cell numbers, samples were retained within the microtubes on ice and 
homogenised using single-use disposable pestles (Fisherbrand™ RNase-Free 
Disposable Pellet Pestles; Fisher Scientific; Cat. No. 13236679). The samples were 
pipetted from the dounce (if glass dounce was used) and placed into clean 
microtubes. Samples greater than 2 ml were pooled together once more if 
separated for douncing. Tubes were then centrifuged at maximum speed for 10 
min at 4°C to pellet any insoluble material. The supernatant was then transferred 
to a clean microtube.   
 
Note: In the case of cell types that were difficult to lyse, or if the ‘insoluble’ 
pellet appears quite large, the process of douncing in non-SDS, cold lysis buffer 
was repeated to obtain more sample. At this point, SDS, or any other 
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denaturing detergent was not used, as it may have disrupted protein-protein 
or protein-DNA interactions. Additional supernatant could then be added to 
the previous eluate.  
 
Samples were topped up to a total of 300 µl per microtube in cold non-SDS lysis 
buffer prior to sonication. 
 
2.2.11.2 Sonication of crosslinked chromatin/DNA 
 
Aliquots of 300 µl per microtube of cross-linked chromatin/DNA were sonicated 
using a Bioruptor® Plus sonication device (Diagenode; Cat. No. B01020001) at the 
‘high power’ setting in ice water. The following sonication sequence was used 
each time: 20 sec ON, 2 min OFF, 20 sec ON, 3 min OFF, 30 sec ON, 15 sec OFF, 
15 sec ON, 2 min OFF, 30 sec ON. 
 
2.2.11.3 Determination of DNA fragment size and concentration 
 
After sonication, samples were centrifuged at 10,000 ´g for 10 min at 4°C. The 
supernatant (sonicated chromatin/DNA) was then transferred to a clean microtube 
and kept on ice. Chromatin/DNA concentration was checked using a NanoDrop at 
OD260. The concentration of DNA in µg/ml is OD260 ´ 10,000. This method was used 
to calculate the DNA concentration of the chromatin preparation. A 5-10 µl sample 
of chromatin/DNA was also run on a 1% agarose gel to check DNA fragment size 
after sonication. A majority of chromatin/DNA at ~200 bp is ideal but a smear on 
an agarose gel may stretch from 150 bp to 2000 bp. If fragments were too large, 
samples were sonicated once more according to the sequence in section 2.2.11.2. 
After determination of fragment size and concentration, ~1 µg of DNA (or as close 
to 1 µg as possible) per sample was used for immunoprecipitation. 
 
2.2.11.4 Chromatin/DNA pre-clearing  
 
Prior to pre-clearing, fresh dilution buffer was made up and kept on ice. Samples 
of chromatin/DNA were then diluted in dilution buffer to a concentration of 1 µg 
of DNA in 500 µl. Magnetic Protein G Dynabeads™ (Thermo Scientific™; Cat. No. 
10003D) were vortexed until mixed well and 50 µl of beads per sample separated 
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from solution using a magnetic rack. Each 50 µl of beads was then re-suspended 
in 250 µl blocking buffer (1× PBS with 5% BSA) and placed at 4°C rotating for 1 h. 
After blocking, tubes containing magnetic Protein G beads were placed in the 
magnetic tube rack and the beads separated from solution. The blocking buffer 
was then discarded and beads re-suspended in the 500 µl chromatin/DNA sample. 
Chromatin/DNA samples were then pre-cleared by rotating at 4°C for 1 h. After 
pre-clearing, the magnetic beads were separated from the chromatin/DNA 
solution using a magnetic tube rack. Pre-cleared samples were then pipetted from 
this tube into a clean microtube for immunoprecipitation.  
 
2.2.11.5 Immunoprecipitation  
 
To each sample, the antibody of interest was added at a 1:100 antibody dilution. 
All samples were incubated overnight at 4°C on a rotator. A non-antibody control 
(input) was also incubated overnight in the same manner.  
 
2.2.11.6 De-crosslinking and DNA purification  
 
Following overnight incubation with antibodies (or no antibody in the case of the 
control), fresh wash buffers were made up and kept on ice. Fresh elution buffer 
(TE buffer) was then made up and kept at room temperature. A heating block was 
pre-warmed to 65°C. Samples were then taken from the rotator at 4°C and briefly 
spun in a microfuge to ensure that no solution remains in the lid of the microtubes. 
40 µl of fresh Protein G magnetic beads were then added to each sample and 
control tube. These tubes were then rotated once more at 4°C for 1 h. After this 
incubation, samples were placed in a magnetic microtube rack and each sample 
washed with 1 ml of the following solutions in sequence:        
 
1) Once in low salt wash buffer 
2) Once in salty wash buffer 
3) Once in LiCl wash buffer 
4) Twice in TE buffer 
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The chromatin/DNA complexes were then eluted by adding 100 µl of the fresh TE 
buffer to each sample and vortexed briefly at low speed. Tubes were then spun 
briefly in a microfuge and the samples tapped to re-suspend the beads in TE 
solution. All samples were then placed in the 65°C heat block for 15 min. After 15 
min, the samples were vortexed at low speed and spun in a microfuge briefly. The 
samples were tapped to re-suspend beads in solution and then the samples 
incubated at room temperature for 1 min. Samples were then placed in the 
magnetic tube rack and the beads separated from solution. Chromatin/DNA that 
was eluted in the 100 µl TE buffer was removed from these tubes and placed in 
clean microtubes (kept on ice). The microtubes containing the beads were then 
filled with another 100 µl of fresh TE buffer and the samples vortexed at low 
speed, spun on a microfuge briefly and the tubes tapped to re-suspend beads. 
These beads in solution were then once again incubated at 65°C, this time for 5 
min.  
 
After incubation, the samples were vortexed, spun on a microfuge and the beads 
separated from solution using the magnetic tube rack as had been done previously. 
The new 100 µl of chromatin/DNA in solution was then pooled with the previous 
100 µl, creating 200 µl samples of eluted chromatin/DNA. Inputs were also brought 
to 200 µl with the appropriate amount of dilution buffer. All 200 µl samples and 
inputs were then placed at 65°C overnight for de-crosslinking. After de-
crosslinking, tubes were removed from 65°C heat block and 1 µl of Proteinase K 
(10 mg/ml) added to each tube (including inputs). Samples were then placed at 
37°C for 1 h. Following this final digestion step, DNA was purified using the Zymo 
DNA Clean and Concentrator™-5 kit. DNA was eluted in 100 µl of distilled water. 
Samples were stored at -20°C at this point or immediately taken forward to the 
library preparation procedure for sequencing (preparation for Illumina sequencing 
in this study).      
 
2.2.11.7 ChIP DNA fragment end repair 
 
To begin, Klenow DNA polymerase (DNA polymerase I, Large (Klenow) Fragment; 
New England BioLabs, Inc.; Cat. No. M0210S) was diluted 1:5 in distilled water for 
a final concentration of 1 U/µl. T4 DNA Polymerase (New England BioLabs, Inc.; 
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Cat. No. M0203S) was then diluted 1:3 in distilled water to give a final 
concentration of 1 U/µl also. A T4 polynucleotide kinase (New England BioLabs, 
Inc.; Cat. No. M0201S) and T4 DNA ligase buffer with 10 mM ATP (10× T4 DNA 
Ligase Reaction Buffer; New England BioLabs, Inc.; Cat. No. B0202S) were also 
used in the end repair procedure. The following reaction was then prepared:  
 
Reagent  Volume (for 50 µl total reaction) 
ChIP DNA  20 µl 
Distilled water  20 µl 
T4 DNA ligase buffer with 10 mM ATP  5 µl 
dNTP mix  2 µl 
T4 DNA polymerase (1:3) 1 µl 
Klenow DNA polymerase (1:5) 1 µl 
T4 polynucleotide kinase (T4 PNK) 1 µl 
 
Table 2.7: Reagents necessary for one ChIP DNA end repair reaction.  
 
Each 50 µl reaction was then placed in a thermal cycler and incubated at 20ºC for 
30 min. For DNA clean-up after end repair, the QIAquick® PCR Purification Kit 
(QIAGEN; Cat. No. 28106) was used. 250 µl of Buffer PB was added to 1 volume of 
the end repair sample and mixed. A QIAquick® spin column was then placed in a 
provided 2 ml collection tube and the sample added to this column. Samples were 
then centrifuged at 13,000 rpm (as per manual) for 60 s. The flow-through was 
discarded and then the QIAquick® spin column washed with 750 µl of Buffer PE. 
Samples were then spun once more at 13,000 rpm for 60 s. The flow-through was 
discarded and the column spun again at 13,000 rpm for 60 s in the collection tube 
to remove residual buffer or ethanol. The QIAquick® spin column was then placed 
in a clean 1.5 ml microtube and 34 µl of Buffer EB added to elute DNA. The sample 
was then spun at 13,000 rpm for 60 s and the QIAquick® spin column discarded.   
 
2.2.11.8 ChIP DNA fragment dA-tailing 
 
For preparation of Illumina libraries for sequencing, a deoxyadenosine 5’-
monophosphate (dAMP) was incorporated onto the 3’ end of blunted DNA 
fragments, a process known as dA-tailing. This process enabled the ligation of 
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adapters with complementary dT-overhangs to the ChIP DNA fragments and 
prevented concatamer formation at downstream ligation steps. In the present 
study, a truncated DNA Polymerase I (Klenow Fragment 3’->5’ exo-; New England 
BioLabs, Inc.; Cat. No. M0212S) was used. The dA-tailing reaction was prepared as 
follows:  
 
Reagent  Volume (for 50 µl total reaction) 
End-repaired DNA sample 34 µl 
Klenow buffer  5 µl 
dATP  10 µl 
Klenow Fragment 3’->5’ exo-  1 µl 
 
Table 2.8: Reagents for one ChIP DNA fragment dA-tailing reaction. 
 
Samples were then incubated at 37ºC for 30 min. Purification of dA-tailed ChIP 
DNA was then undertaken using a MinElute® PCR Purification Kit (QIAGEN; Cat. No. 
28004). For this clean-up step, 250 µl of Buffer PB was added to 1 volume of dA-
tailed DNA and the sample mixed. A MinElute® spin column was then placed in a 
provided 2 ml collection tube and the dA-tailed DNA added to the column. To bind 
DNA, the MinElute® spin column was centrifuged at 13,000 rpm for 60 s (according 
to manual recommendations). The flow-through was discarded and 750 µl of Buffer 
PE buffer added and then the sample spun at 13,000 rpm for 60 s once more. The 
flow-through was discarded and the MinElute® spin column placed back into the 
empty collection tube and centrifuged at 13,000 rpm for 60 s to remove residual 
buffer and ethanol. The MinElute® spin column was then placed in a clean 1.5 ml 
microtube. dA-tailed ChIP DNA was then eluted by addition of 10 µl Buffer EB to 
the column and the column spun at 13,000 rpm for 60 s. The column was then 
discarded.  
 
2.2.11.9 Ligation of adapters to ChIP DNA 
 
Adapters and reagents for this step were provided in the Illumina TruSeq ChIP 
Library Preparation Kit (Illumina; Cat. No. IP-202-1012) in the present study as all 
sequencing was undertaken using Illumina platforms. If a non-ChIP Illumina DNA 
preparation kit was used instead of a ChIP Library Preparation kit (e.g. a standard 
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NextSeq 500/550 High Output v2 kit), the adapter solution was diluted 1:10 to 
account for the lower DNA amount present in ChIP samples. Once an adapter 
set/kit is chosen, following reaction was prepared: 
 
Reagent Volume (for 30 µl reaction) 
ChIP DNA sample 10 µl 
DNA ligase buffer 15 µl 
Adapter oligonucleotide mix (possibly 
1:10)  
1 µl 
DNA ligase  4 µl 
 
Table 2.9: Reagents required for ligation of adapters to dA-tailed ChIP DNA.  
 
These samples were then incubated for 15 min at room temperature. Purification 
of DNA following adapter ligation was carried out using a MinElute® PCR 
Purification Kit (QIAGEN; Cat. No. 28004). To begin, 150 µl of Buffer PB was added 
to 1 volume of the ligation sample and mixed well. A MinElute® spin column was 
then placed in a provided 2 ml collection tube and the adapter-ligated DNA added 
to the column. To bind DNA, the MinElute® spin column was centrifuged at 13,000 
rpm for 60 s. The flow-through was then discarded and 750 µl of Buffer PE buffer 
was added to the sample. The sample was spun at 13,000 rpm for 60 s and the 
resulting flow-through discarded. The MinElute® spin column was then placed back 
into the empty collection tube and centrifuged at 13,000 rpm for 60 s to remove 
residual buffer and ethanol. The MinElute® spin column was then placed in a clean 
1.5 ml microtube and the adapter-ligated ChIP DNA eluted by adding 10 µl Buffer 
EB to the column and the column spun at 13,000 rpm for 60 s. The column was 
then discarded.  
 
2.2.11.10 Agarose gel size selection of ChIP library 
 
To begin, a 50 ml 2% agarose gel was prepared using 1´ TAE buffer and ~5 µl of 
Sybr Safe. Loading dye was then added to the 10 µl of adapter-ligated ChIP DNA. 
Approximately 500 ng of DNA ladder (1 kb Plus DNA Ladder) was added in lanes at 
either side of the wells to contain DNA samples and samples the loaded to the 2% 
gel. Gaps of 1-2 wells were left between each sample and between each sample 
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and ladder well. The gel was then placed in an electrophoresis tank and run for 
~120 min (or more if necessary) at 60-70 V. The gel was then viewed on a UV 
transilluminator and bands of ~200 bp in size excised from the gel using 
GeneCatcher disposable gel excision tips (6.5 mm ´ 1.0 mm; Gel Company; Cat. 
No. PKB6.5) attached to a P1000 pipette. New disposable tips were used for each 
sample to avoid contamination. Each excised piece of gel was then placed in a 
clean 1.5 ml microfuge tube. The gel was imaged before being discarded (after 
excision of all gel slices).  
 
Purification of DNA from gel slices was then undertaken using a QIAquick® Gel 
Extraction Kit (QIAGEN; Cat. No. 28706). The gel slice was weighed in a microfuge 
tube prior to beginning purification and then 3 volumes of Buffer QG was added 
to 1 volume of gel (assume 100 mg = 100 µl). The samples were then incubated at 
50ºC for 10 min with frequent vortexing until the gel slice had completely 
dissolved. If the sample was not yellow in colour, 10 µl of 3 M sodium acetate was 
added to adjust the pH. 1 gel volume of isopropanol (assume 100 mg = 100 µl) was 
then added to each sample and the sample then placed into a QIAquick® spin 
column that had been placed inside a 2 ml collection tube. The samples were then 
centrifuged at 13 000 rpm for 60 s and the flow-through discarded. The column 
was then placed back into the tube and 0.5 ml of Buffer QG added to the column. 
Samples were then centrifuged at 13 000 rpm for 60 s and the flow-through 
discarded. To wash samples, 750 µl of Buffer PE was added and then the sample 
spun at 13,000 rpm for 60 s once more. The flow-through was discarded and the 
QIAquick® spin column placed back into the empty collection tube and centrifuged 
at 13,000 rpm for 60 s to remove residual buffer and ethanol. The QIAquick® spin 
column was then placed in a clean 1.5 ml microtube and 36 µl of Buffer EB added 
to the column to elute DNA. The sample was eluted by centrifugation at 13,000 
rpm for 60 s.  
 
2.2.11.11 PCR amplification of the ChIP library 
 
For ChIP library amplification, Phusion® High-Fidelity DNA Polymerase (New 
England BioLabs, Inc.; Cat. No. M0530S) was used. The reaction was set up as 
follows:  
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Reagent  Volume (for 50 µl total reaction) 
ChIP DNA  36 µl 
5´ Phusion buffer 10 µl 
dNTP mix  1.5 µl 
PCR primer 1.1 (index primer of 
choice from Illumina kit) 
1 µl 
PCR primer 2.1 (index primer of choice 
from Illumina kit) 
1 µl 
Phusion polymerase  0.5 µl 
 
Table 2.10: Reagents required for PCR amplification of ChIP DNA library following adapter 
ligation. 
 
The sample reactions were amplified according to the following PCR protocol: 
 
30 s at 98ºC 
18 cycles of: 
10 s at 98ºC 
30 s at 65ºC 
30 s at 72ºC 
5 min at 72ºC 
Hold at 4ºC 
 
2.2.11.12 Agarose gel size-selection of amplified ChIP library 
 
A 50 ml 2% agarose gel was prepared with 1´ TAE buffer and ~5 µl of Sybr Safe. 
Loading dye was then added to the 50 µl samples of amplified ChIP DNA. 
Approximately 500 ng of DNA ladder (1 kb Plus DNA Ladder) was added in lanes at 
either side of the wells to contain DNA samples and samples the loaded to the 2% 
gel. Gaps of 1-2 wells were left between each sample and between each sample 
and ladder well. The gel was then placed in an electrophoresis tank and run for a 
minimum of 120 min at 60-70 V. The gel was then viewed on a UV transilluminator 
and sample lanes corresponding to DNA of ~175 +/- 25 bp in size excised from the 
gel. New disposable tips/razors were used for each sample excision to avoid 
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contamination. Each excised piece of gel was then placed in a clean 1.5 ml 
microfuge tube. The gel was imaged before being discarded. 
 
Amplified ChIP DNA in excised gel slices was then extracted and purified using a 
QIAquick® Gel Extraction Kit. After cleaning, the amplified ChIP DNA library was 
eluted in 30 µl Buffer EB. The 30 µl Buffer EB was added to the QIAquick® spin 
column and let to soak into the membrane for ~60 s. The samples were then 
centrifuged for 60 s at 13 000 rpm. The eluted DNA was then quantified and 
assessed using a Qubit 3.0 fluorimeter (Thermo Scientific™) and 2100 Bioanalyzer 
Instrument (Agilent Technologies) before being sequenced on an Illumina 
platform.  
 
2.2.12 Chromatin immunoprecipitation coupled with high-throughput DNA 
sequencing and library preparation by Tn5 transposase ‘tagmentation’ 
(‘ChIPmentation’) protocol for P. berghei parasites 
 
As shown in Figure 2.7, the process of creating ChIP DNA libraries from P. berghei 
samples using a standard ChIP-seq protocol required a considerable number of 
clean-up steps and size selections, all with fewer cells than a conventional ChIP-
seq protocol (Furey, 2012). In an effort to reduce the loss of genetic material 
through the multiple DNA purification steps required for standard ChIP-seq library 
preparation, a novel ChIP-seq method was employed in which 
immunoprecipitation of chromatin-DNA fragments of interest was immediately 
followed by the addition of a hyperactive Tn5 transposase that allowed 
simultaneous in vitro DNA fragmentation and adapter tagging (‘tagmentation’): a 
process termed ‘ChIPmentation’ (Adey et al., 2010; Schmidl et al., 2015).   
 
Unlike the standard ChIP-seq protocol shown in Figure 2.7, ChIPmentation of P. 
berghei ANKA parasites (in this study, mature asexual schizonts), is a shorter 
procedure, with the end-repair to adapter ligation stages of the library 
preparation protocol substituted with a single Tn5 transposase-mediated reaction 
(Schmidl et al., 2015) (Figure 2.8).  










Figure 2.8: Depiction of a ‘ChIPmentation’ protocol in P. berghei ANKA parasites from 
immunoprecipitation to DNA sequencing on an Illumina platform. The sequence of images above 
show the ChIPmentation protocol that follows on from the ChIP preparation depicted in Figure 
2.6. Though pre-clearing with Protein G Dynabeads™ and immunoprecipitation are identical to 
that of a standard ChIP-seq procedure (Figure 2.6), Protein G-bound chromatin-DNA fragments 
are not de-crosslinked before addition of adapter-loaded Tn5 transposase. DNA fragments attached 
to chromatin are both fragmented, and then ligated at 5’ ends with Illumina adapters in a single 
transposase-mediated in vitro reaction (Adey et al., 2010). Only following this ‘tagmentation’ 
procedure, are all samples digested with Proteinase K and de-crosslinked for 6-10 h (or overnight) 
at 65°C alongside input samples or mock IP controls. A complete list of steps for a ChIPmentation 
procedure are described from section 2.2.12.1 to 2.2.12.9.   
 
Buffer name Buffer components 
Lysis Buffer (non-SDS) (store at 4ºC) 10 mM HEPES (pH 7.9), 10 mM KCl, 0.1 
mM EDTA (pH 8.0), 0.1 mM EGTA (pH 
8.0), 1 mM DTT (just before use), 1× 
protease inhibitor cocktail (from 25× 
stock- added just before use), 0.25% 
Tergitol® Type NP-40 (added just 
before use directly into sample) 
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1% SDS Lysis Buffer 1% SDS, 10 mM EDTA (pH 8.0), 50 mM 
Tris-HCl (pH 8.1)  
5% (w/v) sodium deoxycholate stock 
(store at room temperature) 
5% (w/v) sodium deoxycholate, 
powder 
1´ Tris-EDTA (TE) buffer (store at 4ºC) 10 mM Tris-HCl (pH 8.0), 1 mM EDTA 
(pH 8.0)  
RIPA-LS buffer (store at 4ºC) 10 mM Tris-HCl (pH 8.0), 140 mM 
NaCl, 1 mM EDTA (pH 8.0), 0.1% SDS, 
0.1% sodium deoxycholate, 1% Triton 
X-100        
RIPA-HS buffer (store at 4ºC) 10 mM Tris-HCl (pH 8.0), 1 mM EDTA 
(pH 8.0), 500 mM NaCl, 1% Triton X-
100, 0.1% SDS, 0.1% sodium 
deoxycholate   
RIPA-LiCl buffer (store at 4ºC) 10 mM Tris-HCl (pH 8.0), 1 mM EDTA 
(pH 8.0), 250 mM LiCl, 0.5% Tergitol® 
Type NP-40, 0.5% sodium 
deoxycholate      
ChIP elution buffer (store at room 
temperature) 
10 mM Tris-HCl (pH 8.0), 5 mM EDTA 
(pH 8.0), 300 mM NaCl, 0.4% SDS    
 
Table 2.11: Composition of buffers for a ‘ChIPmentation’ procedure in P. berghei. 
 
2.2.12.1 Crosslinking of chromatin to DNA  
 
The procedure began by chilling glass dounce tissue grinder sets (Sigma-Aldrich; 
Cat. No. D8938) on ice and pre-cooling a centrifuge to 4°C. All stages of this 
protocol were carried out on ice unless otherwise stated. Parasites of a 
synchronised asexual or sexual stage population (Plasmodipur filtered and 
Nycodenz/magnetically separated) were washed twice in 1 ml of ice-cold 1´ PBS 
and then re-suspended in 150 µl to 500 µl of ice-cold 1´ PBS, depending upon 
parasite numbers, with small cell numbers being up to 5 ´ 105 cells and large cell 
numbers from 5 ´ 105 cells up to 10 ´ 106 cells. If parasite numbers were larger, 
samples were split into smaller cell numbers and the ChIP DNA pooled after the 
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procedure. Re-suspended parasites were crosslinked with 1% formaldehyde from 
a 16% stock of methanol-free formaldehyde. Samples were mixed by inversion of 
the microtube and incubated at 37°C for 5 min, inverting occasionally. After 
incubation, the samples were briefly spun in a microfuge to pool any evaporated 
material to the base of the microtube. The crosslinking reaction was then 
quenched with 125 mM glycine from a 2 M glycine stock. The samples were mixed 
well by gentle inversion of the tubes and then incubated on ice for 5 min. After 
this incubation period, samples were then centrifuged at 2500 ´g for 5 min at 4°C 
and the supernatant discarded.  
 
Pellets were then washed 3 times with 1 ml 1´ PBS (each time re-pelleting the 
sample at 2500 ´g for 5 min at 4°C). The pellet was then re-suspended in non-SDS 
cold lysis buffer (without Tergitol® Type NP-40) to a concentration of ~3.33 ´ 105 
parasites/µl, or fewer in the case of small cell numbers. Samples were incubated 
on ice for 30 min before Tergitol® Type NP-40 was added to a final concentration 
of 0.25%. One sample at a time was then transferred to a dounce (up to 2 ml) on 
ice and the sample homogenised with 200 strokes of the dounce (repeated with 
more of the sample if the sample was greater than 2 ml). For very small cell 
numbers, samples were retained within the microtubes on ice and homogenised 
using single-use disposable pestles (Fisherbrand™ RNase-Free Disposable Pellet 
Pestles; Thermo Scientific™; Cat. No. 12-141-364). The samples were pipetted 
from the dounce (if glass dounce was used) and placed into clean microtubes. 
Samples greater than 2 ml were pooled together once more if separated for 
douncing. Tubes were then centrifuged at maximum speed for 10 min at 4°C to 
pellet insoluble cell debris. The supernatant was then transferred to a clean 
microtube.   
 
Note: In the case of cell types that were difficult to lyse, or if the ‘insoluble’ 
pellet appears quite large, the process of douncing in non-SDS, cold lysis buffer 
was repeated to obtain more sample. At this point, SDS, or any other 
denaturing detergent was not used, as it may have disrupted protein-protein 
or protein-DNA interactions. Additional supernatant could then be added to 
the previous eluate.  
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Samples were topped up to a total of 300 µl per microtube in cold non-SDS lysis 
buffer prior to sonication. 
 
2.2.12.2 Sonication of crosslinked chromatin/DNA 
 
Aliquots of 300 µl per microtube of cross-linked chromatin/DNA were sonicated 
using a Bioruptor® Plus sonication device (Diagenode; Cat. No. B01020001) at the 
‘high power’ setting in ice water. The following sonication sequence was used 
each time: 20 sec ON, 2 min OFF, 20 sec ON, 3 min OFF, 30 sec ON, 15 sec OFF, 
15 sec ON, 2 min OFF, 30 sec ON. 
 
Following sonication, inputs and samples were chosen and the chromatin/DNA 
topped up with non-SDS cold lysis buffer to volumes of 500-1000 µl for large cell 
numbers and 300-500 µl for small cell numbers per IP. To each sample, the 
antibody of interest was added to the desired dilution (e.g. a 1:100 or 1:500 
antibody dilution). No antibody was added to inputs. All samples were incubated 
overnight at 4°C on a rotator. 
 
2.2.12.3 Preparation of magnetic beads for ChIP 
 
For each IP, 10 µl of Magnetic Protein G Dynabeads™ (Thermo Scientific™; Cat. No. 
10003D) and 25 µl of Protein G Dynabeads™ (for small or large cell numbers 
respectively) were added to 175 µl of 0.1% BSA/RIPA buffer solution and incubated 




After an overnight incubation with a blocking buffer, Protein G beads were 
separated from blocking solution by placing in a magnetic microtube rack. Using 
10 µl of beads for small cell numbers and 25 µl of beads for large cell numbers; 
antibody-bound chromatin/DNA was added to the beads and the tubes inverted to 
mix samples well. These samples were then incubated at 4ºC for 2 h on a rotator. 
During the incubation of antibody-bound chromatin/DNA and beads, a magnetic 
rack was cooled on ice and protease inhibitors were added to fresh buffers (also 
kept on ice). After the 2 h incubation, beads were washed (150 µl per small cell 
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number and 1000 µl per large cell number) with wash buffers in the following 
sequence: 
 
1) Twice in RIPA-LS 
2) Twice in RIPA-HS 
3) Twice in RIPA-LiCl 
4) Once in 10 mM Tris-HCl, pH 8.0 
 
After these washing steps, the beads were gently re-suspended in 150 µl 10 mM 
Tris-HCl, pH 8.0 and transferred to a clean tube. These tubes were then placed in 
a magnetic microtube rack and, after separation of beads from solution, the 
supernatant was discarded.  
 
2.2.12.5 ‘Tagmentation’ reaction with chromatin/DNA (‘ChIPmentation’) 
 
For each ChIP sample, the following reaction was prepared using components from 
a Nextera® DNA Library Preparation Kit (Illumina; Cat. No. FC-121-1030): 
 
Reagent Volume 
5´ ‘Tagmentation’ buffer   5 µl  
Nuclease-free water 19 µl 
‘Tagment’ DNA Enzyme 1 µl 
 
Table 2.12: Reagents required for a single ‘tagmentation’ reaction. 
 
Each sample (bound to magnetic beads) was re-suspended in the 25 µl reaction 
mixture and incubated for 10 min at 37ºC (with a re-suspension by gentle pipetting 
at 5 min). Once incubation had been completed, the reaction tubes were placed 
on ice to cool. After this, 150 µl of RIPA-LS (for small cell numbers) or 1000 µl of 
RIPA-LS (for large cell numbers) was added to samples (ice-cold) and the samples 
washed in the following sequence:   
 
1) Twice in RIPA-LS 
2) Twice in 1´ TE buffer 
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2.2.12.6 De-crosslinking and DNA purification 
 
After the final 1´ TE buffer wash, beads were then re-suspended in 48 µl ChIP 
elution buffer and 2 µl of Proteinase K (10 mg/ml) added to each sample. These 
samples were then incubated at 65ºC for 6-10 h to de-crosslink DNA from 
chromatin. Input samples were also brought to 48 µl with 0.4% SDS, 300 mM NaCl 
solution (final concentrations) and then 2 µl Proteinase K (10 mg/ml) added. The 
inputs were then incubated at 65ºC for 6-10 h. After de-crosslinking at 65ºC, the 
beads were separated from solution using a magnetic microtube rack and the 
supernatant transferred to a clean 1.5 ml DNA Lo-Bind tube. A further 19 µl of 
ChIP elution buffer and 1 µl of Proteinase K were added to each sample of beads 
and these beads were once more incubated at 55ºC for 1 h. After this incubation, 
the beads were separated on the magnetic microtube rack and the supernatant 
removed and pooled with the previous eluate. All samples were then cleaned using 
a MinElute® PCR Purification Kit (QIAGEN; Cat. No. 28004) with elution of DNA in 
22 µl of EB buffer or 10 mM Tris-HCl, pH 8.0. An additional clean-up with Agencourt 
AMPure XP Beads (Beckman Coulter, Inc.; Cat. No. A36880) at 1.8´ DNA volume 
was then carried out. 
 
For the Ampure XP bead clean-up, 1.8´ DNA volume of beads was added to each 
reaction and gently mixed by pipetting. Samples were then incubated at room 
temperature for 10 min. The beads were then separated from solution using a 
magnetic microtube rack (leaving 10 min to allow all beads to separate) and the 
supernatant discarded. Beads were then washed twice with 100 µl of 80% ethanol 
(5 s washes) and then the beads air-dried at room temperature on the magnet. 
Sample tubes were then removed from the magnet and 22 µl of distilled water 
added to the beads. Beads and water were mixed gently by pipetting before the 
samples were left to incubate at room temperature for 10 min. The samples were 
then added to the magnetic rack, and the beads separated out for 5 min. The 
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2.2.12.7 ChIP DNA library amplification 
 
To begin, a PCR master mix (n+1 reactions) was made up using NEBNext® High-
Fidelity 2X PCR Master Mix (New England BioLabs, Inc.; Cat. No. M0541S) as 
follows: 
  
Component Volume for 35 µl master mix 
NEBNext® High-Fidelity 2X PCR Master 
Mix 
25 µl 
Distilled water  10 µl 
     
Table 2.13: PCR master mix composition for ChIP DNA library amplification.  
 
For each sample, the following was combined in one PCR tube:  
 
Component Volume for 50 µl reaction 
NEBNext® High-Fidelity 2X PCR Master 
Mix diluted in water 
35 µl 
PCR primer 1.1 (index primer of choice 
from Illumina Nextera kit) (25 µM) 
2.5 µl 
PCR primer 2.1 (index primer of choice 
from Illumina Nextera kit) (25 µM) 
2.5 µl 
Purified ChIP DNA  10 µl  
  
Table 2.14: Complete reagent list for PCR ChIP DNA library amplification after ‘tagmentation’.  
 
These samples were then incubated in a thermal cycler according to the following 
sequence: 
 
68ºC for 5 min 
98ºC for 30 s  
5 cycles of: 
98ºC for 10 s 
63ºC for 30 s 
68ºC for 1 min 
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Hold at 4ºC 
 
Samples were then removed from the cycler and either stored at 4ºC or 
immediately used for qPCR. A qPCR reaction master mix (for n+1 reactions) was 
set up for each sample as follows:  
 
Component Volume for 9.5 µl master mix 
NEBNext® High-Fidelity 2X PCR Master 
Mix 
5 µl 
Distilled water  4.32 µl 
50´ Sybr Green 0.18 µl 
     
Table 2.15: qPCR master mix composition for ChIP DNA library amplification.    
 
Each sample was then combined with qPCR master mix in a 48 well plate (with a 
H2O control) with the final 15 µl reactions made up as shown below: 
 
Component Volume for 15 µl reaction 
qPCR master mix 9.5 µl 
PCR primer 1.1 (index primer of choice 
from Illumina Nextera kit) (25 µM) 
0.25 µl 
PCR primer 2.1 (index primer of choice 
from Illumina Nextera kit) (25 µM) 
0.25 µl 
Amplified ChIP DNA (from previous PCR 
reaction) 
5 µl  
 
Table 2.16: Complete qPCR reaction mixture for determining optimal amplification of 
individual ChIP DNA libraries.  
 
The qPCR reaction was then carried out in the following sequence: 
 
98ºC for 30 s  
40 cycles of: 
98ºC for 10 s 
63ºC for 30 s 
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68ºC for 1 min 
Hold at 4ºC 
 
For ChIP DNA, 40 cycles were always necessary to reach a plateau in the qPCR 
amplification curve. For an Assay for Transposase-Accessible Chromatin with high 
throughput sequencing (ATAC-seq) protocol, 20 cycles were sufficient (from 
collaborative work with Dr Sebastian Kirchner). qPCR data was then used to inform 
the number of cycles to be used for ChIP DNA library amplification (using 
remaining pre-amplified DNA). The minimal and maximal intensity for each sample 
amplification curve was noted and the signal corresponding to one third of 
maximal fluorescence was used to infer the number of cycles with which to 
amplify the remaining pre-amplified ChIP DNA samples.  
 
The remaining pre-amplified ChIP DNA (that had been amplified for only 5 cycles 
previously) was then placed back in the thermal cycler and amplified for the 
specific number of cycles obtained for each sample by qPCR: 
 
98ºC for 30 s  
‘X’ number of cycles of: 
98ºC for 10 s 
63ºC for 30 s 
68ºC for 1 min 
Hold at 4ºC  
 
2.2.12.8 Final DNA clean-up before high throughput sequencing 
 
The amplified ChIP DNA library obtained following the procedures carried out in 
section 2.2.12.7 was immediately cleaned once more with Agencourt AMPure XP 
Beads (Beckman Coulter, Inc.; Cat. No. A36880) as detailed in section 2.2.12.6 
with DNA libraries eluted in 35 µl of 10 mM Tris-HCl, pH 8.0. These samples were 
then stored at -20ºC for long-term storage, or immediately examined using a 
Qubit™ 3.0 fluorimeter (with Qubit™ dsDNA High Sensitivity (HS) Assay Kit; Thermo 
Scientific™; Cat. No. Q32851) and 2100 Bioanalyzer (Agilent Technologies). 1 µl of 
each sample was examined using each machine and the sample then sent for 
sequencing on an Illumina platform, or cleaned once more if necessary. In the 
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case of adapter dimer peaks from the Bioanlyzer analysis, a further DNA clean-up 
with SPRISelect beads (Beckman Coulter, Inc.; Cat. No. B23317) was carried out 
and then the DNA re-examined by Qubit and bioanalyzer to assess ChIP DNA library 
quantity and quality. Samples to be sent for sequencing had at least 10 ng of DNA 
suspended in 10-30 µl 10 mM Tris-HCl, pH 8.0. 
 
2.2.12.9 Illumina index adapter sequences and primers 
 
The following primers (de-salted) with Illumina adapter sequences were used in 
the present study. Primer sequence construction was based on Illumina guidelines 

















































N504 AGAGTAGA GU4405 AATGATACGGCGACCACCGAGATCTACAC 
AGAGTAGATCGTCGGCAGCGTCAGATGTG 






-------- GU4106 AATGATACGGCGACCACCGAGATCTACACT 
CGTCGGCAGCGTCAGATGTG 
 
Table 2.17: List of Illumina index adapter sequences used for P. berghei ChIPmentation sample 
sequencing.  
 
2.2.13 ChIP-seq and ChIPmentation analysis: sequencers, read number, and 
software  
 
Following library preparation by ChIP-seq (depicted in Figure 2.7), or 
ChIPmentation (depicted in Figure 2.8) methods, both DNA library quantity and 
fragment length were analysed using a Qubit® 3.0 Fluorometer with double-
stranded DNA high-sensitivity (HS) reagents (Thermo Scientific™) and an Agilent 
2100 Bioanalyzer with Agilent High Sensitivity DNA kit reagents (Agilent 
Technologies). No samples prepared using a standard ChIP-seq protocol (2.2.10) 
were suitable for high-throughput sequencing. However, successfully amplified 
ChIPmentation libraries were sent for whole genome paired-end sequencing to the 
Glasgow Polyomics Facility, specifying 25 M, 75 bp paired-end reads using the 
NextSeq 500 system (Illumina, Inc.). Output was provided in FASTQ format.  
   
All ChIPmentation analysis was carried out with help from Dr Kathryn Crouch and 
Sejal Modha of the bioinformatics group within the Wellcome Centre for Molecular 
Parasitology. Raw data quality (in FASTQ format) for all samples was assessed 
using FastQC (www.bioinformatics.babraham.ac.uk). Sequencing adapters were 
removed from sample data (in FASTQ format) using Trim Galore! 
(www.bioinformatics.babraham.ac.uk) and trimmed reads were aligned to the P. 
berghei ANKA genome (version 34; PlasmoDB) using Bowtie2 (Langmead and 
Salzberg, 2012). Bowtie2-generated BAM (binary sequence alignment/map) files 
were then normalised to a ChIP input sample using ‘bamCompare’ (Ramírez et al., 
2016). The ‘bamCompare’ tool  generated input-normalised ChIP coverage files in 
‘bigWig’ format which could be visualised using the IGV or Artemis genome 
browsers (Robinson et al., 2011; Carver et al., 2012).  
 
To find P. berghei ANKA genome regions to which paired-end fragments aligned, 
i.e. genome regions at which a ‘peak’ of reads was present, specifically-designed 
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peak-calling software was used. To optimise peak-calling within the AT-rich P. 
berghei ANKA genome, and for the relatively ‘broad’ peaks generated by ChIP 
antibodies to histone modifications, comparative analyses of four peak-calling 
tools was carried out by Sejal Modha at the Wellcome Centre for Molecular 
Parasitology (Heinig et al., 2015). As peak-calling software required input in ‘.bed’ 
format, BAM files were converted to BED files using the ‘bamtobed’ script within 
SAMtools (Li et al., 2009). Peaks were called using MACS2 (‘--broad’ parameter 
selected) (Zhang et al., 2008), HOMER (findPeaks with ‘--style histone’ parameter) 
(Heinz et al., 2010), SICER (Xu et al., 2014), and Epic (a diffuse domain ChIP-seq 
caller based on SICER) (Xu et al., 2014). The complete bioinformatic pipeline used 




Figure 2.9: Sequencing analysis of ChIPmentation data from an Illumina platform. This image 
shows the bioinformatics software used to process and then compare ChIPmentation results in the 
present study. In the centre, a flow chart shows the names of software used and to the left are 
the names of the file formats that are required as input to generate data using the next program 
in the sequence. To the right of the image, a number of examples are provided for the type of 
results generated at a number of stages in the analysis. To the right of the FastQC step is an 
example of the FastQC (Babraham Bioinformatics) output, in this case, a chart depicting the 
quality of each base (A,T,G, or C) corresponding to sequence reads in the sample (by Illumina 
sequencing). In the example shown (one sample from this study), almost all reads have bases with 
high quality scores (shown in green). The blue line that runs through each sample represents the 
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mean quality score, with yellow and red areas of the graph indicating reasonable quality or poor 
quality bases respectively. Below this is a screenshot of the IGV browser showing 3 separate 
‘bigwig’ files (ChIP/input) being compared in individual tracks. Tracks in IGV show BAM or ‘bigwig’ 
files aligned to the reference genome. In this image (from the present study), peaks are already 
visible by IGV visualisation alone. The final two screenshots in this image, stemming from the 
‘Comparative Analyses’ step of the flowchart, show two methods by which ChIPmentation data 
can be compared: firstly, by visualising the Epic peaks (with or without corresponding BAM or 
‘bigwig’ files) in IGV, and, secondly, by using the ‘UpSetR’ R-based package which generates a 
chart comparing the number of peaks called using each number of cells, sequencing conditions, or 
peak-calling software used.      
 
Peaks called using three of these tools (SICER had been superseded by Epic and so 
Epic was used for comparative analysis) were visualised in comparison to one 
another using the ‘UpSetR’ R-based package (Conway, Lex and Gehlenborg, 2017) 
based on the ‘UpSet’ technique showing intersections of multiple sets and their 
sizes (Lex et al., 2014) (Figure 2.9) (Chapter 5). Following the choice of Epic as 
primary peak-calling software for this study (as a result of most shared peaks 
between samples), shared peaks between two or more Epic output files were 
identified using ‘epic-merge’. Epic-derived BED files were used as the input for 
these comparisons. Annotation of ChIP peaks for both individual and merged files 
was undertaken using a modified HOMER (Hypergeometric Optimization of Motif 
Enrichment) script. The original HOMER annotation script was downloaded from 
http://homer.ucsd.edu/homer/ngs/annotation.html. The original script was 
modified for use with Epic parameters in Perl with the resulting file labelled 
‘annotatePeaks.pl’. Epic software provided output files for both individual and 
merged peak results as BED files which could be visualised using the IGV genome 
browser. All programming scripts (in ‘Bash’) used to run bioinformatic analysis of 
ChIPmentation data in the present study are provided in Supplemental File 2 (S2).   
 
2.2.14 RNA-sequencing analysis for comparison with ChIPmentation results 
 
To correlate ChIPmentation data to gene expression, analysis of RNA-sequencing 
results from a previous study was carried out to compare these with 
ChIPmentation results from the present study. To facilitate this, duplicate RNA-
seq results for both 16 h P. berghei ANKA trophozoites and 22 h P. berghei ANKA 
schizonts were downloaded from NCBI 
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(https://www.ncbi.nlm.nih.gov/sra/SRX325688) (Otto, Böhme, et al., 2014). In 
each case, sequencing adapters were trimmed and reads that became shorter than 
20 bp were discarded. Cleaned and trimmed reads were aligned to the P. berghei 
ANKA reference genome (version 34) using HISAT2 which was downloaded from 
https://ccb.jhu.edu/software/hisat2/index.shtml (Kim et al., 2016).  
 
Differentially expressed genes between 22 h schizonts and 16 h trophozoites were 
identified using edgeR (Robinson, Mccarthy and Smyth, 2010). Raw edgeR results 
are listed in Electronic Supplemental Material 4 (ES4), with more detailed 
differential expression analyses displayed in the Supplemental Material RNA-seq 
glimma-plots folder as interactive graphics (Su et al., 2017).  
 
A multi-dimensional scaling (MDS) analysis was also undertaken to investigate the 
similarity between both 22 h schizont and 16 h trophozoite RNA-seq samples and 
their replicates. By default, the top 500 genes in each group are used to generate 
each representative MDS display point. Distances between two display points 
reflects the leading log-fold-change (logFC) separating samples (Su et al., 2017). 
Final differential RNA-seq results identified by paired edgeR analysis are then 
displayed as interactive MA (log ratio/mean average) and volcano plots for easy 
visualisation of data (Supplemental Material RNA-seq glimma-plots). All RNA-seq 
analysis was carried out by Sejal Modha at the Wellcome Centre for Molecular 
Parasitology.     
 
2.2.15 Multi-dimensional scaling (MDS) analysis of ChIPmentation results 
 
Upon completion of all ChIPmentation analysis and peak calling, MDS analysis of 
the similarity between all samples used in the present study was carried out using 
edgeR (Robinson, McCarthy and Smyth, 2010). This analysis was carried out to 
inform as to which ChIPmention datasets were consistent between replicates of 
2.5 million P. berghei schizonts, and to identify any outlying datasets that might 
skew findings incorrectly. The ‘plotMDS’ function of edgeR was applied which 
produced a two-dimensional scatter plot in which distances between samples 
represented the leading log2 fold-change (log2FC) between samples (for the top 
500 genes that distinguish those samples). When generating the MDS plot, 
sequence reads were counted for each bin in the genome with a genomic bin size 
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of 1000. In this case, the gene selection method was ‘pairwise’, meaning that a 
different set of top genes is selected for each pair of samples (as opposed to a 
‘common’ gene selection approach in which the top genes are always chosen as 
those with the largest standard deviation between samples). (Ritchie et al., 2015). 
The resulting MDS plot for all triplicate ChIPmentation samples carried out in the 
present study (2.5 million P. berghei ANKA schizonts in triplicate) is shown in 
Chapter 5 alongside comprehensive analysis of ChIPmentation results.  
 
2.2.16 Generation of P. berghei constructs for double-crossover or single-
crossover homologous recombination  
 
2.2.16.1 Restriction digest of background DNA vector and DNA fragments  
Restriction enzymes were used in the present study for the generation of cloning 
vectors and to then linearise vectors prior to transfection. Restriction enzymes for 
cloning were carefully chosen using vector maps and genomic DNA maps in the 
CLC Genomics Workbench, version 7 (QIAGEN). High fidelity restriction enzymes 
were sourced from New England BioLabs, Inc. (NEB). In most double-crossover 
(DXO) constructs, two identical restriction sites were placed at either side of an 
Ampicillin sequence to facilitate fast removal of the bacterial drug selection 
sequence before plasmid linearisation. If this was not possible, separate 
restriction sites and enzymes were used. In all reactions, the restriction enzyme 
volume was <10% of the total reaction volume, with reaction solutions gently 
mixed by pipetting. Restriction sites were incorporated into primer design to 
create fragments with compatible ends for ligation into a cut plasmid. Restriction 
digests were undertaken on both plasmids and PCR fragments to make sequence 
ends compatible for ligation. 
 
After amplification of a sequence of interest from P. berghei genomic DNA, e.g. 
fragments homologous to sequences at either side of a gene (for DXO 
recombination), PCR products were cleaned up using a QIAquick® PCR Purification 
Kit (QIAGEN; Cat. No. 28106) before restriction digest. After PCR fragment 
purification, the fragment DNA was eluted in 50 µl of distilled water.  5 µl of the 
reaction was checked on a gel to ensure that the PCR had worked before digesting 
the rest of the PCR product. 40 µl of this 50 µl volume was used for cloning 
(corresponding to 2-5 µg of DNA). Volumes were adjusted as necessary. Restriction 
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enzyme digestion reactions were usually 50 µl in volume, containing 2 µl of each 
enzyme. Example restriction digest reactions for both plasmids and PCR fragments 
are shown below. 
 
Reagent Volume (for a 50 µl total reaction) 
Distilled water  33 µl 
Buffer (10´) 5 µl 
Plasmid DNA (~4.5 µg DNA) 10 µl 
Restriction enzyme  2 µl 
 
Table 2.18: General reagent mixture for a single plasmid vector restriction digest. 
 
Reagent Volume (for a 50 µl total reaction) 
Distilled water  3 µl 
Buffer (10´) 5 µl 
PCR product DNA (2-5 µg DNA) 40 µl 
Restriction enzyme  2 µl 
 
Table 2.19: General reagent mixture for a single PCR product restriction digest.    
 
Samples were digested at the appropriate restriction enzyme temperature for a 
minimum of 1 h (~1-2 h). Digestion reactions were checked before ligation by 
running ~5 µl (~350 ng of DNA) from each reaction on a 1% agarose gel alongside 
a 1 kb Plus DNA ladder. Approximately 1 µl of uncut plasmid was run alongside the 
digested plasmid to determine if digestion had occurred. After 2 h of incubation, 
a top-up of restriction enzyme in buffer was added to each 50 µl reaction: a 10 µl 
top-up of 1 µl buffer, 0.5 µl restriction enzyme, and 8.5 µl distilled water. After 
the enzyme top-up, the reaction was incubated for a further 30 min. Once the 
incubation was completed, the enzyme was heat inactivated (if required) and the 
PCR product or plasmid fragment purified using the QIAquick® PCR Purification Kit 
or the QIAquick® Gel Extraction Kit (QIAGEN; Cat. No. 28706).  
 
Often, if a single double-cutting enzyme was used, the linearised vector was 
dephosphorylated with calf intestinal phosphatase (CIP) (New England BioLabs, 
Inc.; Cat.No. M0290S) to prevent self-ligation. To achieve this, 1 µl CIP was added 
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to the 50 µl digest reaction (after heat-inactivation of enzymes) and the reaction 
incubated at the appropriate temperature for an additional 30 min. Before 
ligation, the dephosphorylated plasmid fragment was purified using a PCR 
purification kit or gel extraction. At the end of the purification process, digested 
fragments were re-suspended in 30 µl of sterile, distilled water.  
 
2.2.16.2 Ligation of DNA fragments 
 
Ligation reactions were carried out in this study to form circularised plasmids from 
a linearised plasmid backbone and a PCR product. Experiments were planned to 
ensure that compatible sticky ends were present on the insert and vector by using 
the same restriction enzyme(s). Alternatively, the restriction sites would need to 
be blunted i.e. using Klenow (DNA polymerase large fragment) to fill in 5’ 
overhangs. 3’ overhangs could be digested back with T4 polymerase. However, 
this latter method was not necessary for plasmid construction in the present 
study. After, plasmid and PCR fragment clean-up, DNA concentrations were 
checked using a NanoDrop. For the ligation reaction, vector: insert ratios were 
calculated using an online ligation calculator (in silico; Universität Düsseldorf) or 
according to the table below. 
 
Insert Size 500bp 1kb 2kb 3kb 4kb 5kb 
Vector (ng) 150ng 150ng 150ng 150ng 150ng 150ng 
Insert (ng) 22.5ng 45ng 90ng 135ng 180ng 225ng 
 
Table 2.20: Standard grid of examples for 3:1 ratio of PCR product to plasmid for ligation 
reactions.   
 
After choosing the correct vector:insert ratio, 30 µl ligation reactions were carried 
out using the Rapid DNA ligation kit (Sigma-Aldrich (formerly Roche); Cat. No. 
11635379001), with reactions set up as follows: 
 
Example Amount Generic Amounts 
Vector (10kb, 150ng at 
~20ng/µl) 
8 µl Vector (150ng) 
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Insert (500bp, 22.5ng at 
~12ng/µl) 
2 µl Insert (calculated for a 
3:1 ratio) 
Buffer (2×) 12.5 µl Buffer (2×): 12.5 µl 
Ligase 1 µl DNA ligase: 1 µl 
Distilled water 6.5 µl Distilled water (to make 
up to 30 µl) 
 
Table 2.21: Components for a standard 30 microlitre DNA ligation reaction.   
 
When prepared, the 30 µl reaction was incubated at room temperature for 10 min 
to 1 h. This reaction was then transformed into competent E. coli cells for 
propagation of the new plasmid.  
 
2.2.16.3 Transformation of ligated constructs into E. coli  
 
In the present study, transformations were carried out using Fusion-Blue 
Competent E. coli (Clontech Laboratories, Inc.). A water bath was warmed to 42ºC 
and then microtubes containing the ligation reaction and E. coli were placed on 
ice (E. coli stocks were stored at -80ºC in aliquots when not in use). 65 µl of E. 
coli was then added to each ligation reaction and the reactions incubated on ice 
for 10 min. Each tube was then transferred to the 42ºC water bath for 1 min 
exactly (heat shock). After this, tubes were then incubated on ice for 5 min. 400 
µl of sterile LB broth (or Super Optimal Broth with catabolite repression (SOC 
medium)) was then added to each reaction tube and the samples incubated for 45 
min at 37ºC in a shaking incubator. After incubation, samples were then 
centrifuged at 8500 rpm for 2 min and 350 µl of supernatant discarded. The 
remaining supernatant was then used to re-suspend the pellet, and this E. coli 
sample spread on an Ampicillin agar plate using sterile techniques. Agar plates 
were then placed at 37ºC overnight. A control Ampicillin agar plate was also 
incubated with each batch of transformations.  
  
2.2.16.4 E. coli colony PCR  
 
To check for successfully transformed E. coli colonies, PCRs were carried out on 
samples taken from colonies that had grown on agar plates after transformation. 
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Usually, 8-10 bacterial colonies were picked from an Ampicillin/Kanamycin agar 
plate using clean P2 pipette tips and these colonies then placed in microtubes 
containing 25 µl sterile water. The microtube lids were closed and the samples 
incubated at room temperature for 30 min. Controls were taken from the control 
agar plate (i.e. a fragment of LB agar) and treated in the same manner as samples. 
A PCR master mix was then prepared (in the present study, the KAPA HiFi PCR kit 
was used; KAPA Biosystems; Cat. No. KR0368). For a 200 µl master mix, the 
following solutions were added:    
 
Reagent Volume (for a 200 µl total reaction) 
Distilled water  120 µl 
KAPA HiFi Buffer (5´) 40 µl 
Forward primer 6 µl 
Reverse primer 6 µl 
dNTP mix 6 µl 
KAPA HiFi DNA polymerase 2 µl 
 
Table 2.22: Standard components for an E. coli colony PCR master mix.     
 
This reaction was then split over 10 PCR tubes (18 µl per tube) and 2 µl of each 
colony/water mixture then added to one tube. The PCR was then run according 
to the following sequence:  
 
• 95ºC: 4 min 
• 95ºC: 30 s 
• XºC: 30 s (primer Tm) 
• 68ºC: 30 s per kb 
• GO TO 2: 29 times 
• 68ºC: 4 min 
• 10ºC: Hold 
 
PCR products were then run on a 1% agarose gel after loading dye added. Positive 
E. coli colonies were then grown up in larger LB broth cultures and the plasmids 
purified using a HiSpeed® Plasmid Midi Kit (QIAGEN; Cat. No. 12643) or QIAprep 
Spin Miniprep Kit (QIAGEN; Cat. No. 27106), depending on the culture volume. To 
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confirm the correct integration of restriction sites in the new plasmid, a 
restriction digest was sometimes also performed and fragment size observed on 
an agarose gel.  
 
2.2.17 Storing transformed E. coli as glycerol stocks 
 
To store E. coli samples for future propagation of a plasmid of interest, glycerol 
stocks were made and stored at -80ºC. To make a glycerol stock, 700 µl of bacterial 
culture was added in a cryotube to 200 µl 100% glycerol. The sample and glycerol 
were mixed and then the cryotubes stored in a -80ºC freezer for long-term 
storage. 
 
2.2.18 Concentration of DNA by ethanol precipitation 
 
To concentrate DNA samples, 10 volumes of 100% ethanol was added to a DNA 
sample along with 0.1 volume of 3 M NaAc, pH 5.2. The sample was then left to 
precipitate overnight at -20ºC. After precipitation overnight, a centrifuge was 
then pre-cooled to 4ºC and the samples centrifuged at this temperature at 
maximum speed for 20-30 min. Samples were then taken from the centrifuge and 
the supernatant discarded, being careful to avoid dislodging the DNA pellet at the 
base of the tube. The pellet was then washed once with 150 µl ice-cold 70% 
ethanol and allowed to air-dry for ~10-15 min. The DNA pellet was then re-
suspended in distilled water.    
    
2.2.19 Preparation of Ampicillin for selection of resistant E. coli  
 
To make up an Ampicillin stock (100 mg/ml), 1 g of Ampicillin sodium salt (Sigma-
Aldrich; Cat. No. A0166) was dissolved in 10 ml of sterile, distilled water (within 
a fume cupboard to maintain sterility). The dissolved Ampicillin solution was then 
passed through a single-use filter (Minisart filters, 0.2 µm pore size; Sigma-Aldrich; 
Cat. No. 16534K) using a 10 ml syringe. Aliquots of 1 ml 100 mg/ml Ampicillin were 
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3.1 Chapter Aim 
 
The aim of this chapter was to knockout or conditionally knockdown a number of 
known and putative epigenetic regulatory proteins in P. berghei to examine their 
potential role in gametocytogenesis.   
 
3.2 Introduction  
 
Plasmodium epigenetic research has focussed largely on enzymes involved in the 
post-translational modification of histones, such as histone lysine 
methyltransferases (HKMTs), histone demethylases (HDMs), histone 
acetyltransferases (HATs), and histone deacetylases (HDACs) (Duffy et al., 2013). 
The full complement of epigenetic regulators so far identified in Plasmodium spp. 
is listed in Supplemental Table S1.  
 
In the present study, P. berghei ANKA histone deacetylases (HDACs) and histone 
acetyltransferases (HATs) were targeted based upon knowledge at the outset of 
the study; such as the fact that HDAC2/IPK1 conditional degradation, and that of 
HP1, resulted on an increase in gametocyte conversion relative to background P. 
falciparum lines (Brancucci et al., 2014; Coleman et al., 2014). As such, it was 
postulated that histone acetylation and deacetylation may play a role in 
commitment to gametocytogenesis in P. berghei.   
 
Putative epigenetic regulators to be subject to complete gene knockout or 
conditional protein degradation via the auxin-inducible degron (AID) system are 
listed in Table 3.1. In addition to histone acetyltransferases (HATs) and histone 
deacetylases (HDACs) described in Supplemental Table S1, an examination of 
genes encoding for P. berghei ANKA heterochromatin protein 1 (HP1), chromatin-
associated exoribonuclease, RNAseII (Zhang et al., 2014), and inositol 
polyphosphate kinase 2 (IPK2), were also carried out. A study of IPK2 was chosen 
owing to this protein’s similarity to the IPK1 region of the HDAC2/IPK1 combined 
gene (Coleman et al., 2014) (Table 3.1).  
 





Table 3.1: Complete list of putative epigenetic modifiers in P. berghei ANKA that were subject 
to investigation in this study. This table lists the Gene identifier (ID) for each putative P. berghei 
epigenetic modifier examined in the present study, alongside those investigated in tandem by Drs 
Kirchner and Vaikkinen. The plasmid availability for each protein chosen, either as a knockout 
(KO) or auxin-inducible degron (AID) tagging/knockdown (KD) DNA construct (or both), is indicated 
next to the protein name in columns 3 and 6. ‘No vector available’, as is shown for protein SET5, 
indicates that no KO vector or tagging/KD vector was available for this protein. SET: Su(var)3-9, 
Enhancer of zeste, and Trithorax; JmjC: Jumonji C-terminal.          
 
To completely knock out the gene of a putative epigenetic modifier from P. 
berghei, and to assess the effect of this gene knockout on both asexual growth 
and gametocytogenesis, KO vectors were transfected into parasites of two 
background lines: the ‘820’ line (previously discussed in section 1.7.2.2), and a 
novel ‘early gametocyte marker’ line, termed ‘PbEGAM’, in which green 
fluorescent protein (GFP) was constitutively expressed, and a red fluorescent 
protein (RFP) was expressed under control of a previously unexploited early 
gametocyte gene promoter (promoter of gene PBANKA_1018700) (Lee, Waters and 
Brewer, 2018).  
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For conditional degradation of an epigenetic modifier of interest, two P. berghei 
ANKA background lines were generated for integration of targeted auxin-inducible 
degron (AID)-tagged proteins. Conditional degradation of a protein of interest by 
endogenous or synthetic auxins requires the constitutive expression of an ‘F-box’ 
transport inhibitor response protein (TIR1) within the host cell. Therefore, to 
facilitate auxin-induced proteasomal degradation in the P. berghei ANKA parasite, 
which does not express a TIR1 protein endogenously, a TIR1-encoding sequence 
from the rice plant, Oryza sativa (ostir1) was inserted into the P. berghei ANKA 
high-gametocyte-producer (HP) genome at the p230pI locus (Nishimura and 
Kanemaki, 2014; Philip and Waters, 2015). Using conventional positive and 
negative drug selection, and cloning of the OsTIR1-expressing P. berghei ANKA line 
by limiting dilution, the ‘G615cl1m1cl1’ P. berghei background line was produced 
in which an ostir1 sequence (tagged by a 9xmyc sequence) was constitutively 
expressed under control of the 5’ promoter of the HSP70 gene (PBANKA_0711900) 
(Manzoni et al., 2015). 
 
A second OsTIR1-expressing P. berghei background line was also generated (the 
G1448cl1m0cl1, or ‘AID 820’ line) in which the male- and female- specific 
fluorescent reporter sequences of the 820 line were expressed upstream of the 
ostir1::9xmyc sequence. With the creation of this background line, the effects of 
conditional degradation of a protein of interest could be monitored in both male 
and female gametocytes, as well as asexual growth stages.  
 
All P. berghei background lines used or generated for complete gene knockout or 
conditional degradation via the AID system are listed in Table 3.2. Detailed linear 
plasmid maps are provided in Supplemental Images S1A to S1O.  
 





Table 3.2: Complete list of P. berghei ANKA parasite lines used and generated in the present 
study. This table provides an overview of all complete gene knockout (KO) or conditional gene 
knockdown (KD) P. berghei ANKA lines created during the present study. The background lines 
used, into which linear plasmid vectors were integrated, are also listed. The first column lists the 
common number or name given to the P. berghei line, alongside a more detailed description in 
the case of KO and KD lines. The second column lists the gene identifier (ID) of the gene to be 
targeted (in the case of a KO or KD line). The third  column indicates if successful integration of 
the linear KO or KD vector into the genome of the chosen background line was demonstrated by 
PCR after transfection (all integration primers are listed in Appendix, Table 7.1). In the case of 
the heterochromatin protein 1 (HP1) background line, an asterisk in the third column (N*) indicates 
that integration was only ever shown at the 3’ UTR of the gene and not the 5’ UTR, despite multiple 
primer designs being attempted. The fourth column indicates whether a successful clonal or 
isogenic line was generated for the KO or KD parasite line in question (either by limiting dilution 
or FACS). The fifth and final column listed the location of a more detailed plasmid map for the 










3.3.1 Creation of KO vectors and confirmation of restriction site integrity 
 
At the outset of this study, an attempt was made to generate KO plasmids for 
genes of interest (GOIs) using a pL0035 background plasmid (containing a 
hdhfr::yfcu drug selection sequence) and homology arms to facilitate double-
crossover homologous recombination with the endogenous gene. Upstream and 
downstream homology arms for the final KO vectors were amplified from native 
genes (from the P. berghei ANKA high-gametocyte producer (HP) background line 
genomic DNA). All experimental methods used for the generation of KO and KD 
plasmids are detailed in section 2.2.15. To confirm the presence of the correct 
GOI-specific homology arms in each pL0035-based KO construct, both 
confirmatory PCR and restriction digests were carried out. Restriction digest 
results for five such KO vectors are shown in Figure 3.1.  
 
Figure 3.1: Confirmatory restriction digest of five pL0035-based KO constructs for P. berghei 
ANKA transfection. This figure shows five pL0035-based KO vectors and their expected product 
sizes after linearisation of the circular plasmid with XhoI and HindIII (a). Upon restriction digestion 
with these two enzymes, a background pL0035 sequence containing the bacterial Ampicillin 
resistance gene (amp) was excised, leaving behind a linearised vector in which the hdhfr::yfcu 
drug selection cassette, alongside its 5’eef1a promoter and 3’pbdhfr-ts UTRs, was flanked by 
homology arms that mapped to upstream and downstream regions adjacent to the GOI. In (b), the 
results of these restriction enzyme cuts are shown on an agarose gel. An untargeted pL0035 vector 
is shown next to the linearised pL0035-based vectors for comparison. All XhoI/HindIII restriction 
digests result in two bands: the amp-containing background plasmid sequence of 2676 bp, and the 
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larger fragment to be gel extracted for transfection experiments. All linearised plasmids in (b) 
produced products of the correct size with the exception of the pG425 vector for targeting of 
HDAC2/IPK1 in P. berghei. The linearised vector in this case seemed slightly smaller than the 
expected 4658 bp.  
 
In a different manner to pL0035-based DXO KO constructs, the two PlasmoGEM KO 
constructs for HDA1 (PbGEM-250987) and HAT1 (PbGEM-236544) needed only to be 
digested with NotI to remove the bacteria-specific kanamycin resistance gene and 
remnants of the pJAZZ-OK background vector prior to transfection (Pfander et al., 
2013; Schwach et al., 2015). Both PlasmoGEM vectors were NotI digested and 
transfected into P. berghei ANKA background lines to create new KO lines as 
depicted in Supplemental images S1L to S1O.  
 
3.3.2 Creation of KD vectors and confirmation of restriction site integrity 
 
In this study, 7 knockdown (KD) DNA constructs were successfully created using 
the pG364 background plasmid (six of which were transfected and the modified 
genetic loci of resultant lines are depicted in Supplemental images S1E to S1I). 
Three more DNA constructs were created in the pG472 BFP-containing plasmid for 
examination of the effects of three of these same proteins on both male and 
female gametocytogenesis after conditional degradation (two of which were 
transfected and the modified genetic loci of these lines are shown in 
Supplemental images S1J and S1K). 
 
For three of the genes-of-interest targeted for degradation via the AID system 
(heterochromatin protein 1 (HP1), histone deacetylase 1 (HDAC1), and the joint 
histone deacetylase 2/inositol phosphate kinase 1 (HDAC2/IPK1) gene), 
endogenous unique restriction sites were used for linearisation of the final circular 
DNA construct (restriction sites HpaI, PmlI, and BglII respectively (Supplemental 
images S1E-S1G)). For all other genes-of-interest, a SalI restriction site was 
inserted at the centre of the chosen single-crossover (SXO) homology sequence 
(Supplemental images S1H-S1I). Following PCR amplification of SXO homology 
sequences for all 7 successfully-generated pG364-based KD plasmids, the unique 
restriction sites of all 7 final plasmids were confirmed by sequencing and 
restriction digest (sequencing results not shown).  
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Following successful creation of 7 DNA constructs that were capable of targeting 
7 separate putative epigenetic modifiers via auxin-induced conditional 
degradation, transfection of linearised plasmids into the P. berghei ‘AID’ 
background line were carried out. At a later stage in this study, the first three 
SXO inserts created (targeting genes for HP1, HDAC1, and HDAC2/IPK1) were 
amplified again and ligated into the pG472 BFP-expressing plasmid (with 2 
successful results, as depicted in Supplemental images S1J and S1K). These 
ligation reactions were carried out by Dr Heli Vaikkinen following creation of the 
‘AID 820’ background line (Supplemental image S1D).  
 
3.3.3 Integration of KO constructs into the P. berghei ANKA genome: essential 
and dispensable gene identification 
 
Using both PlasmoGEM and in-house KO DNA constructs (as shown in Figure 3.1), 
complete knockout of five putative epigenetic modifiers (HP1, HDAC1, 
HDAC2/IPK1, HDA1 and HAT1) and two related proteins (RNAseII and IPK2) was 
attempted in P. berghei ANKA. Methods for the transfection of linearised 
constructs and drug selection of positively-transfected KO parasites are described 
in section 2.1.5. Upon confirmation of positive integration of a KO construct, the 
positively drug-selected KO P. berghei line was cloned by limiting dilution 
(detailed in section 2.1.20). 
 
In the cases of P. berghei genes encoding for HP1, RNAseII, IPK2, HDAC1, and 
HDAC2/IPK1, three attempts each to transfect these KO constructs into the P. 
berghei ANKA 820 line resulted in either no parasites being produced after 
transfection, or generation of wild-type P. berghei ANKA parasites only (data not 
shown). In the cases of HP1, RNAseII, HDAC1, and HDAC2/IPK1, the failure to 
completely knock out these genes correlated with previous attempts in P. 
falciparum and P. berghei ANKA (Brancucci et al., 2014; Coleman et al., 2014; 
Zhang et al., 2014).  
 
However, in the case of IPK2, failure to knockout this gene did not correlate with 
the observed dispensable phenotype previously identified during PlasmoGEM 
screening (Bushell et al., 2017). It is possible however, that the pL0035-based IPK2 
KO construct was not as successful at integrating into the P. berghei ANKA genome 
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as a result of the shorter gene homology arms, which give the pJAZZ-OK-based 
PlasmoGEM constructs greater advantage when attempting to mediate gene 
knockout via double-crossover homologous recombination (Schwach et al., 2015). 
The necessity for longer homology arms when attempting a complete KO of a P. 
berghei protein kinase, such as those of a pJAZZ-OK-based PlasmoGEM construct, 
has been observed previously (Tewari et al., 2010).   
 
In the cases of HDA1 and HAT1 complete knockout using PlasmoGEM vectors, 
transfection into both the 820 and PbEGAM background lines yielded positive 
integration PCR results, and generated P. berghei ANKA KO lines in which the role 
of both HDA1 and HAT1 in asexual growth and gametocytogenesis could be 
investigated. Details of P. berghei lines in which the HAT1 PlasmoGEM KO 
construct was integrated are shown in Figure 3.2. Details of HDA1 PlasmoGEM KO 
construct integration into both P. berghei ANKA background lines are similarly 

















Figure 3.2: Integration of the HAT1 KO construct into P. berghei ANKA 820 and PbEGAM 
background lines. Images (a) and (b) together describe the homologous recombination of the HAT1 
PlasmoGEM KO construct (PbGEM-236544) into the genome of two P. berghei ANKA background 
lines, 820 and PbEGAM. (a) is a schematic representation of the wild-type P. berghei HAT1 gene 
(PBANKA_0718400) before and after integration of the KO construct. Regions flanking the GOI that 
are targeted for homologous recombination include part of the upstream and downstream genes 
(PBANKA_0718300 and PBANKA_0718500 respectively), and part of the 5’ and 3’ untranslated 
regions (5’ and 3’ UTRs) of the HAT1 gene itself. The sites of NotI restriction digest are indicated 
in the linear plasmid and primer sites are represented by small green arrows and the ‘GU’ number 
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given to the primer. All primers are listed in Table 7.1 as an appendix and the size of the resulting 
fragments in base pairs (bp) are listed in part (b) of this image. 
(b) Table listing the primer products used to assess successful integration of the KO construct, 
with the PCR results shown below for all of the lines used, including controls and clones of the 
positively-transfected P. berghei KO lines. Transfection of the HAT1 KO construct was attempted 
three times into the 820 TBB line, generating lines G1529, G1561, and G1689. As G1529 yielded 
the strongest KO to WT ratio of all three lines, this line was cloned by limiting dilution to produce 
lines G1529 clone 6 (G1529cl6) and G1529 clone 7 (G1529cl7). Transfection of the HAT1 KO construct 
into PbEGAM was attempted twice, with both attempts resulting in successful integration, 
generating P. berghei lines G1693 and G1694. Both of these lines were cloned to give clonal HAT1 
KO lines G1694 clone 6 (G1694cl6) and 4 clones of G1693 (clones 1, 5, 6, and 8). Generating clonal 
lines in both P. berghei ANKA backgrounds enabled confirmation of the HAT1 KO phenotype with 
regard to both asexual growth, and the production of male and female gametocytes.             
 
As shown in Figure 3.2, complete KO of the HAT1 gene produced P. berghei ANKA 
lines that were capable of asexual propagation and cloning via limiting dilution in 
mice. In Figure 3.3, repeated attempts to generate HDA1 KO lines in both 820 
and PbEGAM did result in some success. However, the apparent slow asexual 
multiplication rate of recombinant parasites produced in HDA1 KO lines prevented 
cloning of the lines by limiting dilution in mice (7 attempts). The possible reasons 
















Figure 3.3: Integration of the HDA1 KO construct into P. berghei ANKA 820 and PbEGAM 
background lines. Images (a) and (b) detail the homologous recombination of the HDA1 
PlasmoGEM KO construct (PbGEM-250987) into the genome of two P. berghei ANKA background 
lines, 820 and PbEGAM. (a) is a schematic representation of the wild-type P. berghei HDA1 gene 
(PBANKA_1335400) before and after integration of the KO construct. Regions flanking the GOI that 
are targeted for homologous recombination include part of the upstream and downstream genes 
(PBANKA_1335300 and PBANKA_1335500 respectively), and part of the 5’ and 3’ untranslated 
regions (5’ and 3’ UTRs) of the HDA1 gene itself. NotI and primer sites are indicated in black and 
green. The sizes of PCR fragments in base pairs (bp) are listed in part (b) of this image. 
(b) lists the primer products used to assess successful integration of the KO construct, with the 
PCR results shown below for all of the lines used, including 820 and PbEGAM controls. Unlike the 
PlasmoGEM HAT1 KO construct, the HDA1 KO vector has a much longer downstream homology arm 
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and so integration was assessed at the 5’ end of the construct. As seen in (b), transfection of the 
HDA1 KO construct was attempted five times into the 820 line, generating lines G1511, G1560, 
G1613, G1687 and G1688. From G1511 to G1688, the ratio of wild-type (WT) P. berghei parasites 
to HDA1 KO parasites decreases, with G1687 and G1688 having the highest number of HDA1 KO 
parasites. These WT:hda1- ratio differences reflect the point at which parasites were harvested 
from mice after transfection. As a result of continuously low parasitaemia counts in mouse blood 
smears, transfected lines G1511, G1560 and G1613 were only harvested from mice from 10-14 dpi 
(all while under positive Pyrimethamine selection pressure). It became apparent from these 
transfection attempts that HDA1 KO parasites were being outgrown by WT parasites over time. To 
combat this, two more transfection attempts into 820 were made, with G1687 and G1688 lines 
being harvested from mice at 7 dpi (after Giemsa staining from 3 dpi). In these lines, integration 
of the HDA1 KO construct was much clearer. One transfection of the HDA1 KO construct resulted 
in line G1579 which showed positive integration of the KO vector.  
 
It is noticeable in Figure 3.3 that the HDA1 KO construct could be integrated into 
the 820 and PbEGAM background lines, but no successful clonal lines were 
generated. In repeated attempts to create clonal lines of G1687, G688, and 
G1579, identical methods to grow synchronous schizonts for cloning by limiting 
dilution were carried out as detailed in sections 2.1.5.4 and 2.1.20. In all cases, 
very few mature asexual (schizont) parasites could be cultivated, and 2 attempts 
each to clone lines G1687, G1688, and G1579 failed to yield any positive results. 
The combination of the outgrowth of transfected HDA1 KO parasites by WT 
parasites after transfection, and the failure to produce mature asexual parasites 
that could propagate in vivo after limiting dilution, pointed to a deficiency of 
asexual growth in the HDA1 KO P. berghei lines. Further analyses of non-clonal 
HDA1 KO lines are shown below. 
 
3.3.4 Integration of KD constructs into the P. berghei ANKA genome 
 
In the present study, KD vectors were linearised and transfected into the OsTIR1-
expressing background line, G615cl1m1cl1 (the AID background line; as depicted 
in Supplemental image S1C). Following successful integration of a number of KD 
constructs, cloning via limiting dilution was attempted in some cases, with 
generation of isogenic lines by FACS also attempted to reduce animal usage 
(detailed in section 2.1.21). All lines generated from these experiments in the 
present study are shown in Figure 3.4.  
 






Figure 3.4: P. berghei ANKA conditional knockdown (KD) lines generated in the present study. 
Images (a) to (d) show expected and obtained PCR fragment sizes for integration of 4 KD plasmids 
into background lines: the pG439 vector targeting HDAC1; the pG440 vector targeting histone 
HDAC2/IPK1; the pG474 vector targeting HDA1; and the p475 vector targeting another putative 
histone deacetylase (termed ‘HDAP’). Image (a) shows the successful integration of the HDAC1 KD 
plasmid into both the AID and AID 820 background lines, creating P. berghei ANKA lines G1513 and 
G1624 respectively. In each case, a WT gene fragment is shown next to fragments confirming both 
5’ and 3’ integration of the KD construct into the parasite genome. In (b), integration of the 
HDAC2/IPK1 KD plasmid into the AID background line is shown, creating line G1514. Adjacent to 
agarose gel images confirming correct PCR fragment sizes in this line are results of both FACS-
aided G1514 enrichment and cloning by limiting dilution. In this case, FACS-aided selection of 
G1514 parasites only (without WT background parasites) produced isogenic line G1514m3 (m3 
indicating ‘mouse 3’) in which no WT PCR fragment could be detected. At the same time, cloning 
of this line was undertaken by limiting dilution, and clonal lines G1514cl2 and G1514cl8 were 
generated.  
In (c), integration of the HDA1 KD plasmid into the AID background line is confirmed in the first 
gel image (creating line G1516), with an attempted FACS-selected isogenic line (G1516m3) shown 
in the adjacent gel image. Unlike in the case of G1514m3, G1516m3 did not remain isogenic over 
time, with some WT parasites growing back, even under Pyrimethamine drug pressure. In (d), the 
HDAP KD plasmid is shown to be integrated into the AID background line also, generating line 
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G1517. As with G1514, both an isogenic line (G1517m5), and two clonal lines (G1517cl0 and G1517cl7) 
were produced through FACS-aided selection of mCherry-fluorescent transfected parasites and 
cloning by limiting dilution in mice.  
 
In addition to the P. berghei ANKA lines shown in Figure 3.4, attempts were made 
to transfect three more KD plasmids (for HP1 (shown in Supplemental image S1E), 
SIR2A, and HAT1 (latter two not shown) into the AID and AID 820 background lines, 
but to no avail. In the case of HP1, transfection of the KD vector into P. berghei 
lines 507, AID, and AID 820 background P. berghei ANKA lines were undertaken, 
creating parasite lines G1304, G1512, and G1623. In each case, 3’ integration was 
observed following transfection. However, repeated primer redesign and PCR 
amplification under various conditions failed to confirm both 5’ and 3’ integration 
of this plasmid and so further experiments were undertaken with the successfully-
transfected parasite lines shown in Figure 3.4.        
 
3.3.5 Characterising P. berghei ANKA hat1- and hda1- KO lines by FACS 
 
With each experiment of a P. berghei KO line by FACS, the equivalent background 
line (820 or PbEGAM) was run in parallel as a control. Under FACS analysis, the 
820 background line produced three populations: GFP/RFP double-negative 
asexual-stage parasites and uninfected erythrocytes, GFP+ male gametocytes, and 
RFP+ female gametocytes (Figure 3.5). When examining the PbEGAM background 
line, four cell populations can be observed: GFP/RFP double-negative uninfected 
erythrocytes, GFP+ asexual-stage parasites, GFP+/RFP+ male gametocytes, and 
GFP++/RFP+ female gametocytes. The enhanced GFP signal in the female 
gametocyte population is a result of the increased 5’eef1a promoter expression 
in female gametocytes, in comparison to male gametocytes (Franke-Fayard et al., 
2004; Lee, Waters and Brewer, 2018). Therefore, in both the 820 and PbEGAM P. 
berghei lines, male-to-female gametocyte ratios could be characterised (Figure 
3.5). 




Figure 3.5: FACS analysis of P. berghei 820 and PbEGAM background lines. This image shows P. 
berghei ANKA background lines 820 and PbEGAM by FACS, 5 days after inoculation of the animal 
with 0.01% asynchronous parasites. Overall parasitaemias were 2.20% (820) and 3.24% (PbEGAM). 
Intensity of red fluorescent protein (RFP) is shown on the y-axis in both plots, with intensity of 
green fluorescent protein (GFP) shown on the x-axis of both FACS plots. GFP fluorescence 
corresponded to BD Horizon Brilliant™ Blue 515 (BB515) (515 nm maximum emission) and RFP 
fluorescence corresponded to R-phycoerythrin (PE) (578 nm maximum emission). Each plot 
represents 1 million events (cells) after gating. With regard to the 820 FACS plot, all cells shown 
represent Hoechst-stained singlets (to separate infected from uninfected erythrocytes; detailed 
in section 2.1.18). In the PbEGAM FACS plot, all cells shown represent singlets alone, with infected 
erythrocytes identified by the constitutive expression of GFP in this background line. Population 
percentages of male and female gametocytes in these FACS plots are percentages of the gated 
population shown in the plot, and do not represent the percentages relative to all 1 million events.  
 
In the 820 line, female gametocyte presence is based upon RFP fluorescence, 
which is under the control of the female gametocyte-specific LCCL-domain-
containing gene 5’ promoter (upstream of PBANKA_1319500) (Ponzi et al., 2009). 
Both the 820 female- and male- specific promoters are based upon a proteomic 
study which showed that the LCCL-domain-containing protein, CCP2, is heavily 
female-specific, with the heavy dynein chain protein (encoded for by gene 
PBANKA_0416100) being heavily expressed in male gametocytes in P. berghei 
(Khan et al., 2005). In the PbEGAM background line, gametocytes are 
differentiated from asexual parasites based upon RFP expression, driven by an 
‘early gametocyte marker’, the 5’ promoter of PBANKA_1018700, a conserved 
Plasmodium gene of as-yet unknown function (Lee, Waters and Brewer, 2018). 
Transcription of the ‘early gametocyte’ gene itself (PBANKA_1018700) was initially 
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noted during a study of differentially expressed genes between sexually-
committed and asexual P. berghei ANKA parasites, which then led to the discovery 
of the AP2-G transcriptional regulator (Sinha et al., 2014).     
 
In the PbEGAM parasite line, RFP expression could be detected from 8-12 hours 
post-invasion (Lee, Waters and Brewer, 2018), with male and female gametocytes 
detectable as shown in Figure 3.6. When assessing total gametocytaemia in the 
PbEGAM background line by FACS, total gametocytaemia was determined to be all 
GFP+/RFP+ cells. When two separate GFP+/RFP+ populations became 
distinguishable, the GFP++/RFP+ population was counted as the female gametocyte 
population, and the separate GFP+/RFP+ population was labelled as the male 
gametocyte population. Because not all gametocytes were clearly distinguishable 
as either male or female, three gametocytaemia counts were made when using 
the PbEGAM background P. berghei line: total gametocytaemia; male 
gametocytaemia; and female gametocytaemia (as percentages of the overall 
infected-erythrocyte population) (Figure 3.6). 
 
Figure 3.6: Determining total gametocytaemia, male gametocytaemia, and female 
gametocytaemia in the PbEGAM P. berghei line. This image shows an identical FACS plot of GFP+ 
cells in a PbEGAM infection after 4 days (4 dpi). As in all cases in the present study, infection 
began at 0.01% parasitaemia in a female Theiler’s Original (TO) mouse. In the left-hand panel, a 
population of GFP+/RFP+ cells is highlighted inside a circle. This population of GFP+/RFP+ cells as a 
whole is labelled as the total gametocytaemia in this particular sample. In the right-hand FACS 
plot, the same population of GFP+ cells is shown, but in this case, the distinguishable male and 
female gametocyte populations are indicated. Male gametocytes are GFP+/RFP+ in the PbEGAM 
line. Female gametocytes are distinguished as the GFP++/RFP+ cells (Lee, Waters and Brewer, 
2018), with the 5’ promoter of the constitutively-expressed P. berghei ANKA elongation factor 1 
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alpha protein (5’eef1a) (encoded for by PBANKA_1133300 and PBANKA_1133400) being expressed 
to a greater degree in female gametocytes. However, not all GFP+/RFP+ gametocytes can be 
separated into male or female categories, and so the ‘total gametocytaemia ‘counts in the present 
study account for male, female, and early gametocyte populations as a whole.      
 
3.3.6 hat1- P. berghei ANKA lines show reduced asexual growth and 
gametocytogenesis 
 
Following repeated FACS analysis of clonal hat1- P. berghei lines G1529cl6 (HAT1 
KO in 820), G1693cl6 (HAT1 KO in PbEGAM) and G1694cl6 (HAT1 KO in PbEGAM from 
second transfection), a phenotype for P. berghei ANKA lines in which HAT1 had 
been knocked out became apparent. After 4 days, the population of male 
gametocytes makes up 3.86% of the overall Hoechst-stained singlet population in 
820. RFP-fluorescing female gametocytes represent 2.75% of the overall 820-
infected erythrocyte population. In the adjacent plot showing the same 
populations after HAT1 KO, the percentage of male gametocytes has fallen to 
0.9%; with female gametocytes making up only 0.63% of the overall population. 
Taking these representative FACS samples alone, the HAT1 KO line has 76.7% 
fewer male gametocytes, and 77% fewer female gametocytes, than its HAT1-
expressing background line (Figure 3.7 (a), (c) and (d)).  
 
When characterising HAT1 KO in the 820 P. berghei ANKA line, 10 independent 
infections with 0.01% 820 over four days were examined to determine wild-type 
parasitaemia and gametocytaemia over time. Five independent infections with 
the HAT1 KO, G1529cl6, again at a starting parasitaemia of 0.01%, were then 
examined. A comparison of wild-type P. berghei ANKA 820 parasitaemia and 











Figure 3.7: The hat1- phenotype in P. berghei ANKA 820 and PbEGAM lines. (a) and (b) show 
representative examples of FACS results from all HAT1 KO P. berghei ANKA lines. RFP fluorescence 
is shown on the y-axis in all plots, with GFP fluorescence displayed at the x-axis of all FACS plots. 
In (a), the 820 line is shown at 4 dpi next to a clonal HAT1 KO line in this background, G1529cl6, 
again at 4 dpi. Each of these FACS plots represents a population of Hoechst-stained singlet cells, 
with male and female gametocyte populations represented by GFP fluorescence and RFP 
fluorescence respectively. (b) shows a FACS plot of the PbEGAM line at 4 dpi next to two examples 
of 820 hat1- in the same line at 4 dpi also. (c) and (d) show a comparison of mean asexual growth 
and gametocytaemia in an 820 HAT1 KO line over four days. (c) shows the average percentage 
parasitaemia of both 820 and 820 hat1- P. berghei lines over four days and image (d) shows the 
percentage of male and female gametocytes within these populations over the same four-day 
period. In (c), values used to generate a four-day growth curve of percentage parasitaemia in the 
820 line were mean percentages (and standard deviations) from 10 independent infections starting 
at 0.01% parasitaemia. On the same graph, the mean percentage parasitaemia from 5 independent 
820 hat1- infections (including standard deviations) is shown. In (d), the percentage of infected 
erythrocytes that can be designated as either male or female gametocytes are shown. Bars shown 
in green represent gametocyte percentages for the 820 background line, while yellow bars 
represent the percentage male and female gametocytaemias for 820 hat1-. The percentage 
gametocytaemias at 4 dpi are shown (mean values and standard deviations). As with (c), mean 
values are taken from 10 independent 820 experiments and 5 independent 820 hat1-  experiments. 
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Finally, (e) and (f) show a comparison of mean asexual growth and gametocytaemia in two PbEGAM 
HAT1 KO lines over four days. Similarly to (c), (e) shows the average percentage parasitaemia of 
PbEGAM and both HAT1 KO clonal lines, G1693cl6 (line 1) and G1694cl6 (line 2), over four days. 
Counts of the total, male, and female gametocyte populations over the same four-day period are 
shown in (f). In both (e) and (f), percentage parasitaemias over 4 days of growth, and percentage 
gametocytaemias at 4 dpi are shown with mean values and standard deviations indicated also.   
 
At days 1, 2, and 4 in Figure 3.7 (c), the mean percentage parasitaemia is higher 
in the wild-type 820 line when compared to the HAT1 KO line. At day 3, the mean 
parasitaemia is 1.042% greater in the HAT1 KO line when compared to the wild-
type, though standard deviations account for this difference. Further experiments 
may shed more light on the G1529cl6 growth curve and explain this anomaly. At 
present asexual growth changes shown in Figure 3.7 (c) are not statistically 
significant (unpaired, two-tailed t-test; P<0.05). With regard to percentage 
gametocytaemias, the decrease in female gametocytes after HAT1 KO in this line 
was significant (P=0.0048; unpaired two-tailed t-test). However, the decrease in 
male gametocytes observed in Figure 3.7 (d) is not significant (P=0.29; unpaired 
two-tailed t-test).  
 
With repeated infections and FACS analysis of 820 and G1529cl6 asexual and sexual 
growth over repeated four-day periods, it became apparent that there was 
attenuated asexual growth in the HAT1 KO clonal line, G1529cl6, as was 
determined previously by PlasmoGEM screening (data not shown). However, more 
striking than this non-statistically significant growth attenuation was the 
significant decrease in female gametocytes over four days of growth, when 
compared to the wild-type line (Figure 3.7 (c) and (d)).  
 
In the PbEGAM background line, the male and female gametocyte (GFP+RFP+ and 
GFP++RFP+) populations make up 0.059% and 0.1% of the total GFP+ singlet 
population. In the G1693cl6 FACS plot, these populations have fallen to 0.028% 
male gametocytes and 0.033% female gametocytes. In the G1694cl6 line at 4 dpi, 
male and female gametocyte populations are also lower than the background P. 
berghei line, at 0.056% and 0.055% of overall GFP+ singlets respectively. Taking 
these FACS plots alone, the G1693cl6 line shows 53% fewer male gametocytes and 
67% fewer female gametocytes than the background line. The G1694cl6 line shows 
populations of 5% fewer male gametocytes and 45% fewer female gametocytes. 
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These examples alone indicated a decreased gametocytaemia in hat- P. berghei 
lines relative to background levels. These experiments were then replicated to 
confirm the existence of a HAT1 KO-induced, gametocyte-depleted phenotype 
(Figure 3.7 (b), (e), and (f)).  
 
Using the PbEGAM P. berghei line, and counting gametocyte populations as shown 
in Figure 3.6, two HAT1 KO lines were examined: P. berghei ANKA clonal lines 
G1693cl6 and G1694cl6. Following an infection of four days, three independent 
biological replicates were studied. All results from the HAT1 KO lines are shown 
in Figure 3.7 (e) and (f). As in line G1529cl6 (the 820 hat1- line), an attenuated 
growth phenotype over 4 days is seen in Figure 3.7 (e) and (f), though the 
decreases in growth in both cases are not statistically significant (unpaired, two-
tailed t-test; P<0.05; n=3 each). In Figure 3.7 (e), taking gametocyte counts at 4 
dpi, clonal line G1693cl6 had a decreased overall gametocytaemia, though this was 
not statistically significant (P=0.0675; unpaired, two-tailed t-test).  
 
The male gametocyte population was also decreased in a non-statistically 
significant manner (P=0.0550; unpaired, two-tailed t-test). Unlike in the 820 HAT1 
KO, the decrease in female gametocytaemia in clonal line G1693cl6 was not 
statistically significant (P=0.27; unpaired, two-tailed t-test). With regard to clonal 
line G1694cl6, the HAT1 KO line showed an increase in overall gametocytaemia (in 
all populations), which differed to previous KO lines G1529cl6 and G1693cl6. This 
line showed an increase in gametocytaemia in all cases, though no change was 
statistically significant (unpaired, two-tailed t-test; P<0.05; n=3).  
 
To summarise, HAT1 KO in both 820 and PbEGAM background lines resulted in a 
decreased rate of growth compared to wild-type P. berghei lines (Figure 3.7), 
though this attenuated growth rate was not statistically significant (using 
unpaired, two-tailed t-tests; P<0.05). In the 820 KO, G1529cl6, repeated 
independent experiments concluded that the only statistically significant 
decrease in growth or gametocyte conversion regarded the generation of female 
gametocytes (Figure 3.7 (d)). After 5 independent experiments, a significant 
decrease in female gametocytes was observed (P=0.0048; unpaired two-tailed t-
test).  
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Although these results were not observed when repeated in PbEGAM (G1693cl6 and 
G1694cl6), further experiments using these early-gametocyte marker lines may 
prove useful in providing a clearer picture of the effects of HAT1 KO on P. berghei 
sexual commitment. It may also be possible that a second mutation had occurred 
in the PbEGAM HAT1 KO line, G1694cl6, which would account for the inconsistency 
of results when comparing this line to both HAT1 KO lines, G1529cl6 and G1693cl6. 
Further discussion of the potential effects of HAT1 KO on P. berghei asexual and 
sexual stage maturation can be found in section 3.4 below.           
 
3.3.7 Characterising asexual growth and gametocytogenesis in hda1- P. 
berghei ANKA lines   
 
As mentioned previously in section 3.3.3, integration of the HDA1 KO construct 
into both the 820 and PbEGAM background lines was successful, though repeated 
attempts to clone these lines proved futile. As demonstrated in Figure 3.3, failure 
to harvest peripheral blood immediately upon observation of a positive 
transfection experiment (as in lines G1511 and G1560), resulted in a greater ratio 
of wild-type 820 parasites when compared to the HDA1 KO line. As this asexual 
parasite growth deficiency was realised, later transfections were harvested from 
the moment parasites were observed in peripheral blood under Giemsa staining. 
These considerations resulted in lines G1613, G1687, and G1688, the latter two of 
which were chosen for cloning by limiting dilution.  
 
After three attempts to clone line G1579, and two attempts each to clone lines 
G1687 and G1688, one mouse each was infected with an asynchronous 0.01% 
parasitaemia from non-clonal lines, G1687 and G1688, in an attempt to discern 
some information about the possible asexual growth defect effecting these HDA1 
KO lines (Figure 3.8).        
 
 






Figure 3.8: The hda1- phenotype in P. berghei ANKA 820 and PbEGAM lines. In both (a) and (b), 
representative examples of FACS results from all HDA1 KO P. berghei ANKA lines are shown. 
Intensity of RFP fluorescence is shown on the y-axis in all plots, with intensity of GFP fluorescence 
shown on the x-axis. (a) shows an example of an 820 line is shown at 4 dpi next to FACS plots from 
two non-clonal HDA1 KO lines in this background: G1687 and G1688 (both at 4 dpi). Each of these 
FACS plots represents a population of Hoechst-stained singlet cells, with male and female 
gametocyte populations represented by GFP fluorescence and RFP fluorescence respectively. (b) 
shows representative FACS plots after 4 dpi from a WT PbEGAM sample and a G1579 HDA1 KO line 
(in the PbEGAM background). (c) and (d) show a comparison of asexual growth and gametocytaemia 
in two 820 HDA1 KO lines over four days. (c) depicts the average percentage parasitaemia of 10 
820 experiments over four days of growth (the same 820 results used for comparison of 820 hat1- 
KO parasite lines (Figure 3.7), alongside asexual growth of two P. berghei HDA1 KO lines over four 
days. (d) shows the percentage of male and female gametocytes within these populations over the 
same four-day period. In (c), values used to generate a four-day growth curve of percentage 
parasitaemia in the 820 line were mean percentages (and standard deviations) from 10 
independent infections starting at 0.01% parasitaemia. On the same graph, the percentage 
parasitaemia from two single G1687 and G1688 infections are shown, again having started with a 
0.01% parasitaemia.  
In (c), a clear attenuated growth phenotype can be observed in both HDA1 KO lines when compared 
to the 820 background line. At 4 dpi, decreases in total parasitaemia seen in both HDA1 KO lines 
are striking, though only with repeated experiments can the significance of this attenuated growth 
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phenotype be assessed. In (d), again showing the mean values of 10 independent 820 experiments 
versus both single HDA1 KO samples, female gametocyte populations are decreased at 4 dpi in 
both HDA1 KO samples when compared to the background line, with the male gametocyte 
populations in both cases showing little decrease in population (G1687 KO) or even an increase in 
population (G1688 KO). (e) and (f) show a comparison of mean asexual growth and gametocytaemia 
in a PbEGAM HDA1 KO line over four days. Similarly to Figure 3.8 (c) and (d), (e) and (f) show a 
comparison of asexual growth and percentage gametocytaemia in a HDA1 KO (G1579) line versus 
its background line (PbEGAM) over 4 days infection, beginning at a parasitaemia of 0.01%. Taking 
the mean and standard deviations acquired over 3 independent experiments in each line, a 
decrease in overall parasitaemia over 4 days can be observed, in line with the attenuated growth 
phenotype seen in 820 HDA1 KO lines (Figure 3.8 (a) and (c)).  
 
In the 820 FACS plot in Figure 3.8 (a), two very distinguishable RFP+ and GFP+ 
populations can be observed. In the 820 background line, RFP+ female gametocytes 
account for 3.71% of the total infected-erythrocyte population, with GFP+ male 
gametocytes making up 3.40% of the total infected-erythrocyte population (Figure 
3.8 (a)). Next to this FACS plot are corresponding plots from HDA1 KO lines, G1687 
and G1688, showing drastically different results to those of the 820 line.  
 
In addition to a considerable decrease in total infected-erythrocyte cell numbers, 
the RFP+ female gametocyte populations at 4 dpi in these lines were 0.37% and 
1.63% respectively. In complete contrast to this, the GFP+ male gametocyte 
population made up 9.64% and 5.93% of the total infected-erythrocyte population 
in G1687 and G1688 respectively. Taking these representative FACS plots alone, 
the G1687 and G1688 HDA1 KO lines harboured female gametocyte populations 
that were 90% and 56% decreased in comparison to the 820 background P. berghei 
line. With regard to male gametocyte populations, the G1687 and G1688 KO lines 
showed male gametocytaemias that were 65% and 43% greater than that of WT 
820 respectively.  
 
Although attempts to clone all HDA1 KO lines were unsuccessful, 3 independent 
FACS analyses of G1579-infected erythrocytes were carried out as a result of this 
particular transfection showing no observable WT contamination upon PCR 
integration analysis (Figure 3.3). As shown in Figure 3.8 (b), PbEGAM GFP+/RFP+ 
male gametocytes and GFP++/RFP+ female gametocytes make up 2.34% and 3.68% 
of the total GFP+ infected-erythrocyte population respectively. In the G1579 KO 
sample, taking the same populations, GFP+/RFP+ male gametocytes and 
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GFP++/RFP+ female gametocytes make up only 0.85% and 0.80% of the overall GFP+ 
infected-erythrocyte population respectively, though this population as a whole is 
greatly reduced in comparison to the background line. Though the decrease in the 
GFP++/RFP+ female gametocyte population is conserved among all HDA1 KO lines, 
the increased GFP+/RFP+ male gametocyte population observed in the HDA1 KO in 
820 is not replicated in the PbEGAM background line. Further analyses of these 
changes to asexual and sexual growth in HDA1 KO lines are shown in Figure 3.8 
(c) to (f).  
 
Initial observation of HDA1 KO lines by FACS, alongside monitoring of peripheral 
blood parasitaemia by Giemsa staining, revealed considerably attenuated asexual 
growth in these lines when compared to their wild-type background lines (Figure 
3.8 (c) and (e)). Though experiments require replication (preferably with a clonal 
P. berghei line), initial comparison of asexual growth from 10 independent 820 
experiments and single samples of both G1687 and G1688 HDA1 KO lines are shown 
in Figure 3.8 (c).                  
 
As a result of an inability to clone either the G1687 or G1688 KO lines, it is difficult 
to ascertain whether the growth seen at 4 dpi in both G1687 and G1688 (Figure 
3.8 (c)) was a result of growth of the HDA1 KO line, or overgrowth of the 
background 820 asexual population. In either case, the lowered hda1- results 
indicate that the growth of a P. berghei ANKA line with this particular gene 
deletion is attenuated. However, to determine such a growth phenotype, a 
competitive growth assay with a P. berghei ANKA background line that 
constitutively expresses GFP throughout the entire life cycle should be carried out 
(detailed in section 2.1.20). However, to undertake such an assay of asexual 
growth, a clonal HDA1 KO line would again be required, and no such line could be 
generated in the present study.  
 
Despite a failure to successfully clone 820 P. berghei ANKA lines in which HDA1 
was completely knocked out, transfection into the PbEGAM background line 
yielded slightly more promising results. Though cloning by limiting dilution was 
again attempted three times with no success, the lack of a visible wild-type 820 
PCR fragment when checking integration of the HDA1 KO construct (Figure 3.3) 
warranted repeated investigation of the non-clonal G1579 line by FACS. The 
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results of 3 independent infections of PbEGAM in comparison to 3 independent 
infections of a PbEGAM hat1- line (G1579) are shown in Figure 3.8 (e) and (f).           
 
In the case of HDA1 KO in the PbEGAM background line, the total percentage 
parasitaemia at 4 dpi is not significantly different to that of the wild-type 
(unpaired, two-tailed t-test; P<0.05; n=3) (Figure 3.8 (e)). In Figure 3.8 (f), total 
gametocytaemia (taking into account the entire GFP+/RFP+ population of 
immature and mature male and female gametocytes) at 4 dpi in G1579 are 
significantly lower than that of the wild-type line (P=0.0109; unpaired, two-tailed 
t-test). Female percentage gametocytaemia is significantly lower in G1579 when 
compared to the PbEGAM background line also (P=0.0415; unpaired, two-tailed t-
test), with male percentage gametocytaemia also lowered significantly (P=0.0402; 
unpaired, two-tailed t-test).  
 
However, without a clonal HDA1 KO in either the 820 or PbEGAM background lines, 
it is difficult to attribute these changes to a complete knockout of the HDA1 gene. 
However, with the observable attenuated growth phenotype after transfection 
(Figures 3.8 (c) and (e)), and an inability to produce a clonal line after seven 
independent attempts at cloning by limiting dilution, it should be suggested that 
complete KO of HDA1 is indeed affecting asexual replication in P. berghei, with a 
drop in gametocytaemia perhaps being attributable to this overall decrease in 
parasitaemia. To study this gene further, a HDA1 conditional knockdown (KD) line 
was generated using the auxin-inducible degron (AID) system, with the findings 
from these experiments detailed below. 
 
3.3.8 Monitoring auxin degradation of epigenetic regulatory proteins by 
Western blot 
 
All successfully-created P. berghei KD plasmids shown as Supplemental Figures 
S1E-S1K contained sequences for the expression of a Pyrimethamine resistance 
gene (hdhfr), a fluorescent protein (mCherry or BFP), and a hemagglutinin tag 
(HA). The main aim of these KD P. berghei lines was to assess the effect of putative 
epigenetic regulators on asexual growth and gametocytogenesis by conditional 
protein degradation. In previous studies in P. berghei (Philip and Waters, 2015), 
P. falciparum (Kreidenweiss, Hopkins and Mordmüller, 2013), and Toxoplasma 
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gondii (Brown, Long and Sibley, 2017), degradation of abundant cytoplasmic 
proteins (calcineurin, yellow fluorescent protein (YFP), and protein kinase G 
(PKG)) was assessed by a combination of fluorescence microscopy and Western 
blot analysis, and so this process was attempted in this study. 
  
To begin with, Western blot analyses of each parasite line shown in Figure 3.4 
were carried out using whole protein lysates (extraction described as in section 
2.2.2), and later with separate nuclear, cytosolic, and insoluble fractions being 
run alongside one another (nuclear fractionation method described in section 
2.2.3). Protein detection on Western blots was carried out using both standard 
chemiluminescence reagents and Ponceau-staining. Samples from each line were 
run before and after the addition of auxin (3-indolacetic acid; Sigma-Aldrich) as 
detailed in section 2.1.11.  
 
In the present study, repeated attempts to conditionally degrade proteins of 
interest by auxin degradation failed. Instead, the fact that KD constructs 
contained a hemagglutinin (HA) tag, was exploited, and both fluorescence 
microscopy and co-immunoprecipitation (Co-IP) experiments were undertaken to 
determine the localisation of a tagged-protein within the parasite cell, and to 
discover proteins with which the putative epigenetic regulators interacted.  
 
3.3.9 Organellar localisation of tagged epigenetic modifiers  
 
With repeated failure to conditionally degrade putative epigenetic regulatory 
proteins by auxin degradation, HA-tagged proteins were subjected to fluorescence 
microscopy to determine whether they were localised to certain foci surrounding 
the parasite nucleus, as was the case with HP1, HDAC2/IPK1, and gametocyte 
development protein 1 (GDV1) in P. falciparum (Brancucci et al., 2014; Coleman 
et al., 2014; Filarsky et al., 2018). In this study, P. berghei samples from 
asynchronous infections in vivo and synchronous mature schizonts in vitro were 
prepared for fluorescence microscopy as described in section 2.2.5.   
 
Taking all three proteins for which two tagged P. berghei ANKA lines existed 
(HDAC2/IPK1, HDA1, and ‘HDAP’), and combining a primary rabbit anti-HA 
antibody (Sigma-Aldrich) with either an AlexaFluor® 488 or AlexaFluor® 594 
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secondary antibody, clear and reproducible results were seen for all three 
putative epigenetic modifiers at trophozoite and schizont asexual stages (Figure 
3.9). As demonstrated in P. falciparum 3D7 (Coleman et al., 2014), HDAC2/IPK1 
was concentrated in foci at the nuclear periphery, a largely heterochromatic 
subcompartment of the parasite cell. These results were reproduced in both 
HDAC2/IPK1 P. berghei lines from in vivo asynchronous infections and in vitro 
synchronous schizonts (Figure 3.9 (a) and (b)).  
     
With P. berghei histone deacetylases, HDA1 and HDAP, clear localisation of 
proteins to the nuclear subcompartment in the same manner as HDAC2/IPK1 was 
not observed. Under fluorescence microscopy, HDA1-tagged parasites from 
asynchronous in vivo infections showed no intracellular fluorescence, but rather, 
faint fluorescence at the cell membrane of trophozoites in each sample (Figure 
3.9 (d)). Upon examination of HDA1-tagged synchronous schizonts, this faint 
membrane fluorescence was lost, with no striking fluorescence seen in any 
particular cell compartment (Figure 3.9 (c)). In the image shown in Figure 3.9 
(c), the HDA1-tagged schizont cell contains some faint fluorescence in one 
merozoite. This observation was made on more than one occasion but was not 
constant, and the significance of such a result could not be speculated upon at 
such an early stage in the characterisation of HDA1.  
 
With regard to HDAP P. berghei lines (G1517cl7), clearest images were produced 
when analysing the clonal G1517 line in which HDAP was tagged and integrated 
into the AID background line (Figure 3.9 (e) and (f)). In parasites from both 
asynchronous in vivo infections and synchronous in vitro schizont cultures, faint 
fluorescence was observed diffusely within the parasitophorous vacuole of 
trophozoites, and diffusely within the cytosol of merozoites (Figure 3.9 (e) and 
(f) respectively).   
 







Figure 3.9: Fluorescence microscopy of putative epigenetic regulatory proteins HDAC2/IPK1, 
HDA1, and ‘HDAP’ in P. berghei. Clear representative images taken following fluorescence 
microscopy of three HA-tagged putative epigenetic proteins in P. berghei are shown in images (a) 
to (f) above. In (a), parasites from an asynchronous in vivo infection with clonal line G1514cl2 
(AID::HA-tagged HDAC2/IPK1) are shown after primary binding of an anti-HA antibody and 
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secondary incubation with an AlexaFluor® 488 anti-rabbit IgG secondary antibody. Parasites have 
also been incubated with a DAPI (4’,6-diamidino-2-phenylindole) nuclear stain. In each image, a 
white scale bar indicates 5 µm in length. Single images with DAPI and anti-HA fluorescence are 
shown, followed by a merged image. A differential interference contrast (DIC) image of the same 
microscopic plane is then shown, followed by a merged image of all separate staining and DIC 
results. In this image, HDAC2/IPK1-staining is located in concentrated foci around the nuclear 
periphery. In (b), the same HA-tagged protein is shown (HDAC2/IPK1), this time at a later stage of 
asexual development. In G1514cl2, stained synchronous schizonts from an in vitro culture showed 
striking arrangement of multiple HDAC2/IPK1 foci around the nuclear periphery in all merozoites. 
In this image, an anti-HA primary antibody was bound to a secondary AlexaFluor® 594 anti-rabbit 
IgG antibody. In all cases, HDAC2/IPK1 appeared as concentrated foci around the parasite nuclear 
periphery.  
Images (c) and (d) are representative examples of synchronous schizonts (c) and asynchronous 
trophozoites (d) from a P. berghei parasite line in which HDA1 has been AID::HA-tagged (line 
G1516m3). In both cases, anti-HA antibody staining has been followed by a staining with a secondary 
AlexaFluor® 488 antibody. As in (a) and (b), all scale bars represent 5 µm. In schizonts (c), HA-
tagged HDA1 appeared only very faintly in the cytosol of an occasional merozoite, and it remains 
to be seen whether this result was significant, or just background fluorescence. In (d), faint 
antibody-staining at the outer membranes of trophozoites can be observed.   
Images (e) and (f) are representative examples of asynchronous trophozoites (e) and synchronous 
schizonts (f), taken from the same clonal P. berghei parasite line in which HDAP had been AID::HA-
tagged and cloned by limiting dilution (G1517cl7). In (e), only faint, if any, fluorescence can be 
detected within the trophozoite parasitophorous vacuole after anti-HA and AlexaFluor® 488 
antibody staining. In parasites from an in vitro synchronous schizont culture (f), diffuse 
fluorescence can be seen in the cytosol of merozoites within the whole schizont, indicating a 
diffuse spread of HA-tagged HDAP within the cell cytosol. 
 
As seen in Figure 3.9, fluorescence microscopy confirmed the localisation of 
HDAC2/IPK1 to the nuclear periphery of asexual parasite cells, as had been 
previously observed in P. falciparum 3D7 (Coleman et al., 2014). Fluorescence 
imaging also determined that both HDA1 and HDAP in P. berghei ANKA do not 
localise in this manner, suggesting that these proteins are not associated with HP1 
or GDV1 at asexual stages, certainly not in the same manner as HDAC2/IPK1 
(Brancucci et al., 2014; Coleman et al., 2014; Filarsky et al., 2018). The possible 
localisation of HDA1 to trophozoite cell membranes may be indicative of a role at 
this area of the parasite cell. The loss of this membrane localisation in the mature 
schizont (Figure 3.9 (c)) may also indicate that its function has ceased at this 
stage in the parasites development, with the protein moving to the cell membrane 
only at earlier asexual stages. Only further experiments will determine in future 
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the exact role of this putative epigenetic regulator. With regard to HDAP, the 
diffuse spread of this protein simply suggested that this protein is cytosolic at 
asexual parasite stages (Figure 3.9 (e) and (f)). 
 
Though further examination is necessary, additional imaging of these AID::HA-
tagged P. berghei lines in a timed fashion may lead to observation of patterns of 
protein movement within such life-cycle stages as rings, gametocytes or 
sporozoites. The successful tagging of these proteins, alongside HDAC1 (Figure 
3.4), could also provide a useful starting point for studies into each epigenetic 
modifier’s protein-protein interactions or enzyme activity by FRET (fluorescence 
resonance energy transfer) analysis (Bajar et al., 2016).   
 
3.3.10 Determining protein-protein interactions by co-immunoprecipitation 
and LC-MS/MS 
 
With the failure of the conditional degradation system (section 3.3.8), and the 
limited capacity to which fluorescence microscopy can add to our understanding 
of a protein’s biology (section 3.3.9), co-immunoprecipitation experiments were 
carried out to shed more light on the possible mechanism of action of putative 
epigenetic regulators HDA1, and HDAP. To maximise protein content, all co-
immunoprecipitation (co-IP) experiments were carried out on purified, 
synchronous schizonts, with preparation for LC-MS/MS carried out as described in 
sections 2.2.6 and 2.2.8 to 2.2.10. One exception came with the analysis of 
HDA1-interacting proteins, as co-IP was also carried out on gametocytes derived 
from in vivo sulfadiazine treatment, with gametocytes additionally purified by 
magnetic separation (method described in section 2.1.15).  
 
All co-IP results were compared to two background P. berghei ANKA high 
gametocyte producer (HP) line controls: one control co-IP undertaken with the 
standard procedure as described in section 2.2.6, and one control co-IP in which 
an additional Protein G dynabead (ThermoFisher) pre-clear had been carried out. 
All co-IP LC-MS/MS results are listed in Electronic Supplemental Material 1 (ES1). 
These results will guide future co-IP experiments, along with additional 
experiments to characterise the possible interactions between epigenetic 
regulatory proteins examined in this study, and their interacting protein partners.  




In the case of HDA1, promising KO results and the suggestion that this putative 
epigenetic regulator might be involved in segmentation of sexually-committed 
schizonts in P. falciparum (Poran et al., 2017), led to investigation of both 
schizont and gametocyte stages of an HA-tagged HDA1 P. berghei ANKA line 
(G1516m3) by co-IP. With this protein, shared unique results were seen at both 
schizont and gametocyte stages in comparison with control samples (Table 3.3). 
Two independent infections were carried out at each life-cycle stage, with all 
experiments carried out as described from sections 2.2.6 and 2.2.8 to 2.2.10, 




Table 3.3: Unique protein identification from co-immunoprecipitation of HA-tagged HDA1 
schizonts and gametocytes. This table lists 16 unique proteins that were identified in two or more 
co-IP experiments of HA-tagged HDA1 in schizonts or gametocytes. All P. berghei samples in these 
experiments came from the FACS-enriched G1516m3 line (HA-tagged HDA1 in the AID background 
line). Sample type is listed at the head of each column and a check-mark indicates if the protein 
was found in this co-IP experiment.  
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When examining unique proteins co-immunoprecipitated with HA-tagged HDA1, 6 
were conserved Plasmodium proteins and 2 were 40S ribosomal proteins that were 
also immunoprecipitated with HDAP (Table 3.4). Of the remaining 8 unique 
proteins, 2 were high mobility group proteins (B1 and B2), non-histone 
architectural chromosomal proteins that are highly conserved among eukaryotes 
and have been shown to bind DNA in P. falciparum (Kumar et al., 2008; Reeves, 
2015). High mobility group protein B2 (PBANKA_0712900) in particular has been 
implicated in transcriptional and translational control of sexual stage gene 
expression and oocyst formation (Gissot et al., 2008). On the other hand, little is 
known at present about the role of vacuolar protein sorting-associated protein 51 
(VSP51) in Plasmodium, though it may be involved in the transport of vesicles from 
endosomes to the trans-Golgi network (Jimenez-Ruiz et al., 2016). 
 
With regard to plastid replication-repair enzyme (PBANKA_1031100) and putative 
protein mpv17 (PBANKA_1102000), the former is associated with replication of the 
malarial plastid genome (Seow et al., 2005), while the latter was found to be 
upregulated in ap2-g2-negative P. berghei 820 parasites and was suggested as a 
target of AP2-G2 (Yuda et al., 2015). In fact, 7 of the 16 unique proteins from 
HDA1 co-IP experiments were identified as potential AP2-G2 targets by repeated 
ChIP-seq analysis: both 40S ribosomal proteins, S117 and S11, high-mobility group 
protein B2, putative mpv17, and three of the conserved Plasmodium proteins 
(PBANKA_1340500, PBANKA_1131300, and PBANKA_0315500) (Yuda et al., 2015).  
 
Of the remaining unique proteins identified, origin recognition complex subunit 2 
(ORC2) may play a role in centrosome copy number control, and has been shown 
to bind tightly to heterochromatin protein 1 (HP1) in humans (Prasanth et al., 
2004). With regard to multiple RNA-binding domain-containing protein 1 (MRD1), 
no information has been gleaned so far about this protein’s role in Plasmodium, 
though it has been marked as refractory to complete knockout in P. berghei 
(PlasmoGEM; 24/03/18), and so may be essential for asexual development.  
Conversely, a complete gene knockout of leucine-rich repeat protein 2 (LRR2) 
(encoded for by PBANKA_1108800) in P. berghei showed no difference in 
phenotype at asexual stages (PlasmoGEM; 24/03/18). However, LRR2 has been 
shown as having high nucleosome occupancy in ring stage P. falciparum 3D7 
parasites, with low nucleosome occupancy at trophozoite and schizont stage 
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(Westenberger et al., 2009). If a role for HDA1 in schizont segmentation is to be 
believed (Poran et al., 2017), an association of HDA1 with LRR2 would be feasible, 
as low nucleosome occupancy at trophozoite and schizont stage, but not in ring-
stage parasites, indicates that this protein could function at the same point in the 
Plasmodium life cycle as HDA1.  
 
In the second group of co-IP experiments, carried out on a clonal line of G1517 in 
which the putative histone deacetylase, ‘HDAP’, has been HA-tagged, results 
listed in Table 3.4 show unique proteins that were shared between two 
independent co-IP experiments. In the case of HDAP, only synchronous schizonts 




Table 3.4: Unique protein identification from co-immunoprecipitation of HA-tagged HDAP from 
synchronous schizonts. In the table above, unique proteins are listed that were shared between 
two independent co-IP experiments of line G1517cl7 schizonts. As was the case with HDA1, the top 
two unique proteins identified were 40S ribosomal proteins S17 and S11. All 10 proteins listed were 
shared between both co-IP experiments. Complete lists of proteins pulled down and their Mascot 
(Matrix Science) scores are listed in Electronic Supplemental Material 1 (ES1).  
 
As noted previously, both 40S ribosomal proteins S17 and S11 were pulled down 
from all HDA1 and HDAP co-IPs (Electronic Supplemental Material 1 (ES1)). 
Taking into consideration that these proteins may be contaminants, it is also 
possible that they both interact with HDA1 and HDAP. Both of these ribosomal 
proteins were also suggested as possible targets of AP2-G2 (Yuda et al., 2015).  
Chapter 3  P. berghei epigenetic regulators 
 
 184 
With this putative epigenetic regulator however, co-IP experiments pulled down 
merozoite surface protein 1 (MSP1), an early protein of merozoite invasion into 
host erythrocytes (Kadekoppala and Holder, 2010), and a dynein heavy chain 
protein (encoded for by PBANKA_0601200), the complete knockout of which 
resulted in a slow growth phenotype in asexual stages (PlasmoGEM; 24/03/18). In 
addition, genes transcribing the essential proteins, nucleolar preribosomal GTPase 
(PBANKA_1243400) and GTP-binding protein (PBANKA_1135200) are expressed to 
the greatest degree in 4 h ring-stage parasites and 16 h trophozoites (Otto et al., 
2014), further indicating that the function of HDAP is at early asexual stages in 
Plasmodium development.    
 
The remaining two unique proteins of which there is a putative function, DNA 
polymerase epsilon catalytic subunit A (PBANKA_1129100) and RNA-binding 
protein (PBANKA_1200800) are expressed in both asexual and sexual stages, with 
the DNA polymerase epsilon subunit A (encoded for by PBANKA_1129100) 
particularly highly expressed in male gametocytes (Otto et al., 2014; Yeoh et al., 
2017). Taken together, proteins co-immunoprecipitated with HDAP primarily 
indicate that this protein function in early asexual development, though its role 





The key findings from this chapter are: 
 
• Histone acetyltransferase 1 (HAT1; PBANKA_0718400) is dispensable for P. 
berghei asexual, intraerythrocytic growth. 
• Complete HAT1 KO in the P. berghei 820 line resulted in a statistically 
significant decrease in mature female gametocytes (P = 0.048; n = 5). 
• Histone deacetylase 1 (HDA1; PBANKA_1335400) knockout was possible in 
both P. berghei 820 and PbEGAM lines, but these lines were refractory to 
cloning by limiting dilution. 
• Complete HDA1 knockout in a PbEGAM line resulted in a significant decrease 
in overall gametocytaemia (P = 0.0109; n = 3); a decrease in female 
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gametocytes from 2.93% ± 1.09 % to 1.03% ± 0.22% of total parasitaemia (P 
= 0.0415), and a decrease in male gametocytes from 2.07% ± 0.38% to 1.21% 
± 0.32% of total parasitaemia (P = 0.0402).  
• Four putative P. berghei histone deacetylases were successfully AID::HA-
tagged: histone deacetylase 1 (HDA1; PBANKA_1335400), a second so-called 
‘histone deacetylase 1’ (HDAC1; PBANKA_0826500), histone deacetylase 
2/IPK1 combined gene (HDAC2/IPK1; PBANKA_1206200), and histone 
deacetylase, putative (‘HDAP’; PBANKA_1106200).  
• Auxin degradation of AID::HA-tagged lines was not possible for any of the 
proteins examined. 
• HDAC2/IPK1 showed nuclear localisation in P. berghei asexual-stage 
parasites, while HDA1 and HDAP showed no discernible nuclear localisation.  
• HDA1 co-immunoprecipitated with 16 unique proteins at mature schizont 
and gametocyte stages compared to control samples. 
• HDAP co-immunoprecipitated with 10 unique proteins at mature schizont 
stage.  
 
3.4.1 In context: epigenetic regulatory proteins and sexual development 
 
It has recently been shown unequivocally that the AP2-G transcriptional regulator, 
responsible for Plasmodium gametocytogenesis, is controlled epigenetically, by 
the binding of heterochromatin protein 1 (HP1) to the promoter and 3’ end of the 
ap2-g gene (Fraschka et al., 2018). In addition, in P. falciparum, HP1 binding to 
pfap2-g is antagonised by the action of a protein known as gametocyte 
development protein 1 (GDV1), possibly forming a regulatory complex with 
chromodomain-helicase-DNA-binding protein 1 (CHD1) and a protein of unknown 
function encoded for by gene PF3D7_1451200 (homologous to PBANKA_1314900) 
(Filarsky et al., 2018).  
 
In a separate study in which single-cell transcriptomic analysis of a P. falciparum 
line producing ap2-g, in comparison to a line in which ap2-g was conditionally 
degraded, it was shown that four putative chromatin-remodelling proteins were 
expressed alongside pfap2-g, with all upstream regions of these genes containing 
an average of 2.6 AP2-G-binding motifs. These proteins were two SNF2 family 
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helicases (ISWI and SNF2L), the putative histone deacetylase, HDA1, and a 
putative histone lysine-specific demethylase, LSD2 (Poran et al., 2017). Despite 
RNA co-expression, co-immunoprecipitation of tagged-HDA1 in P. berghei during 
this study did not reveal interactions between HDA1 and AP2-G, ISWI, SNF2L, or 
LSD2 (Table 3.3). This study did reveal however, that HDA1 did in fact co-
immunoprecipitate with 7 potential targets of the AP2-G2 transcriptional 
repressor, a protein that represses genes involved in asexual reproduction, paving 
the way for gametocytogenesis (section 3.3.10) (Yuda et al., 2015). Therefore, if 
HDA1 is interacting with genes that are targeted for repression upon sexual 
commitment (and more proteins besides), HDA1 may be a crucial facilitator of 
asexual development. HDA1 involvement in preparing asexually-committed cells 
for optimum proliferation would in some way explain the phenotype of attenuated 
asexual growth seen in Figure 3.8 upon complete KO of the gene (Figure 3.10).      
 
3.4.2 The potential role of histone deacetylase 1 (HDA1) in Plasmodium spp. 
 
In a recent single-cell transcriptome analysis of wild-type P. falciparum NF54 
(AP2-G+), an AP2-G-DD line (a P. falciparum NF54 parasite line in which removal 
of the stabilising Shield1 ligand resulted in AP2-G depletion), and an AP2-G-DD 
line in which Shield1 had been removed (AP2-G-), histone deacetylase 1 (HDA1) 
was identified as a gene that was upregulated in AP2-G+ parasites relative to the 
AP2-G-depleted line (Poran et al., 2017). In this study, an increase in AP2-G 
transcript abundance during schizont segmentation resulted in a sharp increase in 
transcription of HDA1, the histone demethylase LSD2, and the AP2 gene, 
PF3D7_1139300 (homologous to P. berghei ANKA gene, PBANKA_0909600; not yet 
named (Modrzynska et al., 2017)). The authors of this study propose that sharp 
upregulation of these three genes upon pfap2-g expression at a time-point just 
prior to schizont segmentation and merozoite egress from the erythrocyte 
(determined by P. falciparum calcium-dependent protein kinase 5 (PfCDPK5) 
expression (Dvorin et al., 2010)) prepares sexually-committed Plasmodium 
schizonts for segmentation and gametocyte development in the subsequent cell 
cycle, and that this gene may play a role in mating-type determination (Poran et 
al., 2017). 
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In line with the findings of this recent study (Poran et al., 2017), HDA1 depletion 
in P. berghei ANKA carried out in the present study (section 3.3.6) did result in a 
significant decrease in total gametocyte production (P = 0.0109) (Figure 3.8), 
though more striking was the asexual growth deficit seen in all HDA1 KO lines, and 
the complete inability to clone any of these KO lines by limiting dilution, despite 
several attempts in three successfully transfected lines (G1579, G1687 and G1688) 
(Figure 3.3). One could propose, based on the present experimental findings, that 
HDA1 is not only necessary for segmentation of schizonts in sexually-committed 
Plasmodium parasites, but that HDA1 is necessary in both asexual and sexually-
committed Plasmodium parasites for schizont segmentation or preparation of the 
schizont-enclosed merozoites for replication upon egress from the erythrocyte. 
The complete inability to clone HDA1 KO lines could be a product of inability of 
synchronous schizonts to segment, resulting in loss of asexual replication. 
However, a defect in P. berghei hda1- merozoites to complete invasion of 
erythrocytes is also possible, as is a defect in the growth of the ring-stage parasite 
or trophozoite. Although HDA1 transcript abundance steadily increased 
throughout schizogony alongside pfap2-g expression, protein abundance at each 
point was not examined during the Poran et al. study and so it remains to be seen 
whether HDA1 is in fact translated and exerting its downstream effects (Poran et 
al., 2017).  
 
In keeping with the suggestion that HDA1 is required during schizont segmentation 
in Plasmodium spp. (Poran et al., 2017), a recent comparative analysis of male 
and female gametocytes to asexual stage parasites in P. berghei ANKA listed HDA1 
as being downregulated in female gametocytes relative to asexual parasites (Yeoh 
et al., 2017). If the hypothesis that HDA1 is involved in schizont segmentation is 
true, it would be correct that mature female gametocytes would not be expressing 
HDA1 to the same extent as asexual-stage parasites that may be preparing for 
schizogony. However, a down-regulation of HDA1 expression in female 
gametocytes may also indicate that the primary role for HDA1 is to regulate or 
maintain correct DNA expression throughout asexual replication in Plasmodium.  
 
With regard to previously-characterised histone deacetylases in Plasmodium spp., 
depletion of PfSIR2A and PfSIR2B resulted in de-repression of var genes and 
increased telomeric length in P. falciparum (Tonkin et al., 2009), while 
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HDAC2/IPK1 was determined as being essential for asexual replication and 
repression of commitment to sexual development in P. falciparum, with 
conditional knockdown resulting in both var gene and ap2-g dysregulation 
(Coleman et al., 2014). In the present study, complete KO of HDAC2/IPK1 and 
HDAC1 in P. berghei ANKA could not be carried out, with HDA1 KO lines showing 
severely attenuated asexual growth after transfection. Cloning of HDA1 KO lines 
by limiting dilution after synchronisation of mature schizonts in culture, or 
generation of an isogenic line by fluorescence-activated cell sorting (FACS) of 
single cells, was not possible. Taken together, these findings show that, in 
general, histone deacetylases are important regulators of both asexual and sexual 
development in Plasmodium spp., and that HDA1 is potentially involved in 
regulating asexual parasite growth, with transcription of the hda1 gene increasing 
steadily until a point just prior to merozoite egress from the schizont, whether 
the schizont be committed to asexual or sexual replication (Poran et al., 2017) 
(Figure 3.10).  
 




Figure 3.10: What we know about histone deacetylase 1 (HDA1) so far. In this figure, (a) depicts 
our current knowledge of the life-cycle stages of Plasmodium spp. at which hda1 gene transcription 
occurs in greatest abundance, the genes that appear to be transcribed alongside hda1 in P. 
falciparum, and the phenotypic traits that occurred upon repeated attempts to knockout hda1 in 
P. berghei. To begin on the left, and moving right along the diagram, HDA1 transcript expression 
appears to co-inside with transcription of ap2-g, lsd2, and Pf3D7_1139300 (an AP2 family protein) 
in P. falciparum (cells that are free to express AP2-G (pfap2-g + cells)). The abundance of these 
transcripts increases alongside increasing expression of PfCDPK5, a marker of schizont egress 
(Poran et al., 2017). After sexually-committed merozoites have been released and have become 
mature female and male gametocytes, mature female gametocytes have been shown to have a 
downregulation of hda1 transcripts, this study being carried out using single-cell sequencing (sc-
seq) of P. berghei parasites (Yeoh et al., 2017). Below this is shown what occurred in the present 
study with repeated attempts to KO HDA1 in P. berghei ANKA and clone the resulting parasite 
lines. Following transcription of a linearised hda1 KO plasmid into a WT asexual (o) merozoite by 
electroporation, growth and gametocytogenesis were both reduced (taking the PbEGAM KO repeat 
results into consideration (section 3.3.7)). Attempts to clone these hda1- lines by both 
synchronisation of parasite cultures and limiting dilution, or by fluorescence-activated cell sorting 
(FACS) of 1 or 50 single asexual parasites, failed to yield any resulting clonal or isogenic lines 
(section 3.3.7). (b) shows pbhda1- transcription, translation to the PbHDA1 protein, and the 
interacting factors with which tagged-HDA1 co-immunoprecipitated in the present study. The 
genes are depicted by white arrows, with the 7 AP2-G2 motif-associated proteins indicated.          
 
Taking all of the information contained in Figure 3.10 (a) into consideration, it 
would appear that HDA1 expression occurs just prior to schizont egress. These 
results also correspond to P. berghei ANKA transcriptome data which show 
greatest expression of pbhda1 at the 4-hour ring stage (Otto et al., 2014) and 
greater abundance in asexual parasites when compared with male and female 
sexual-stage parasites (Yeoh et al., 2017). The defect in asexual growth and 
inability to produce a clonal line in P. berghei upon complete gene KO also 
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indicates an asexual role for HDA1. In Figure 3.10 (b), HDA1 co-
immunoprecipitating factors are shown, 7 of which are potential targets of the 
AP2-G2 transcriptional repressor (Yuda et al., 2015). If the repression of these 
genes is a requirement for sexual development, so too would their expression 
indicate asexual growth. Again, these findings hint at a function of HDA1 in asexual 
development in P. berghei. In addition, immunofluorescence results did not show 
nuclear localisation of HDA1 at mixed asexual or mature schizont stage (Figure 
3.9 (c) and (d)). If HDA1 function is required at an early stage in asexual 
development, such as in 4-hour ring-stage parasites, examination of this parasite 
stage by immunofluorescence microscopy may be of greater use in revealing any 
localisation of the HDA1 protein.     
 
Proteins that co-immunoprecipitated with HDA1 might also provide insight into 
HDA1 function. Of the 16 HDA1 co-immunoprecipitated proteins, 10 have a known 
or putative role. Two proteins that are co-immunoprecipitated with both HDA1 
(Table 3.3) and HDAP (Table 3.4) are the putative 40S ribosomal subunit proteins 
S17 (RPS17; PBANKA_1456100) and S11 (RPS11; PBANKA_1231000), both of which 
are transcribed in greatest abundance in intraerythrocytic asexual 4-hour ring-
stage parasites compared to later asexual stages or gametocytes (Otto et al., 
2014; Yeoh et al., 2017). Of note also is the fact that in a P. berghei ANKA KO line 
in which the DDX6 class RNA helicase, DOZI (development of zygote inhibited), has 
been knocked out (pbdozi-), RPS11 transcript expression is significantly 
upregulated compared to a P. berghei WT line (Mair et al., 2006). With DOZI’s 
role as a translational repressor of mRNAs prior to zygote formation in the 
mosquito midgut, these results suggest that RPS11 mRNA is translationally 
repressed by DOZI prior to sexual development. Remarkably, the RPS11 gene was 
also noted as having an upstream AP2-G2 binding site (Yuda et al., 2015). 
Together, an AP2-G2 binding site at the RPS11 gene, and association of DOZI with 
RPS11 mRNA, suggest that this ribosomal protein must be repressed prior to sexual 
development in P. berghei, and as such, it is a protein heavily associated with 
asexual replication, i.e. this protein must be repressed to enable sexual 
development to occur.    
 
Along with RPS17 and RPS11, HDA1 co-immunoprecipitated with HMGB1 
(PBANKA_0601900) and HMGB2 (PBANKA_0712900), the first protein of which is 
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transcribed predominantly in 22 h schizonts (Otto et al., 2014) and mature male 
gametocytes (Yeoh et al., 2017), and the second of which is transcribed chiefly in 
mature female gametocytes (Otto et al., 2014; Yeoh et al., 2017) and is both a 
regulator of oocyst development, and a contributor to the pathogenesis of 
cerebral malaria in mouse models (Gissot et al., 2008; Briquet et al., 2015). Unlike 
RPS11 and RPS17, co-immunoprecipitation of HDA1 with these factors suggests a 
role for this epigenetic regulatory protein in modulation of gametocytogenesis. 
Perhaps HDA1 transcription at the point of merozoite egress from the schizont and 
its interaction with proteins that are instrumental to the choice between asexual 
and sexual development in P. berghei, suggests that this protein is involved in 
sexual commitment or sex determination.  
 
Of the remaining HDA1 co-immunoprecipitating proteins with a putative or known 
function; mpv17, ORC1, MRD1, LRR2, VSP51, and plastid replication-repair enzyme 
(PREX), 2 are transcribed predominantly in male gametocytes, ORC2 
(PBANKA_0803000) and LRR2 (PBANKA_1108800). In eukaryotes, and in P. 
falciparum, ORC2 is a DNA replication initiation protein (Sharma et al., 2018). 
With regard to LRR2, relatively little is known, however, a difference appears to 
be present between the expression of LRR2 in human-infective P. falciparum and 
the P. berghei ANKA rodent malaria parasite. Using real-time quantitative PCR 
throughout the P. falciparum asexual intraerythrocytic development, LRR2 was 
expressed with greatest relative abundance in late trophozoites (Daher, Pierce 
and Khalife, 2007). In P. berghei ANKA, with RNA-sequencing analysis and the 
addition of transcriptome data from sexual stage parasites (both male and female 
gametocytes), LRR2 expression was seen predominantly in 22 h schizonts and male 
gametocytes (Otto et al., 2014; Yeoh et al., 2017). Although late trophozoite and 
22 h schizonts are relatively close within the Plasmodium spp. asexual cycle, it 
remains to be seen whether LRR2 is transcribed, translated, or otherwise exerting 
an effect in P. falciparum male gametocytes.  
 
Finally, transcription of mvp17, MRD1, VSP51, and PREX in P. berghei ANKA was 
greatest throughout the asexual cycle; at 4 h ring-stage for both mvp17 and MRD1, 
and at 16 h trophozoite stage for both VSP51 and PREX (Otto et al., 2014; Yeoh et 
al., 2017).  
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Taking all HDA1 data from this study and Plasmodium spp. literature at present, 
it appears that this histone deacetylase is necessary for optimal asexual and sexual 
parasite development, though the precise epigenetic mechanism by which it 
exerts its effects are still unknown. From examination of all co-
immunoprecipitated proteins and their roles in the Plasmodium life cycle, it is 
likely that the downstream effects of HDA1 are far-reaching, and an alternative 
conditional protein or gene degradation system is required to pinpoint the exact 
point at which HDA1 elicits its effects, and what these effects are.  
 
3.4.3 The role of histone acetyltransferase 1 (HAT1) in Plasmodium spp. 
 
With regard to HAT1 experiments carried out in this study, all HAT1 KO P. berghei 
ANKA clonal lines showed attenuated asexual growth in both the 820 and PbEGAM 
background lines, though this decrease was not statistically significant in any 
experiment despite repeated independent infections (Figure 3.7). In vivo 
competition growth assays comparing mutant and WT parasites are required to 
truly quantify the apparent growth defect of the mutant. With regard to 
gametocytaemia in HAT1 KO lines, 2 out of 3 KO lines showed a decreased 
gametocytaemia (in both males and females) (G1529cl6 and G1693cl6). In a HAT1 
KO in an 820 background P. berghei ANKA line, the decreased percentage of 
female gametocytes was significant (P = 0.0048; unpaired, two-tailed t-test) when 
compared to the WT 820 line (Figure 3.7).  
 
When comparing the results of this study to a comparative transcriptomic analysis 
of male and female P. berghei ANKA gametocytes (Yeoh et al., 2017), both mature 
male and female gametocytes showed decreased HAT1 transcription (log fold 
changes of -2.06 and -0.63 in males and female gametocytes respectively) when 
compared to asexual-stage parasites (Yeoh et al., 2017). When comparing data 
from the AP2-G-DD study (Poran et al., 2017), HAT1 (encoded by PF3D7_0416400 
in P. falciparum) was not flagged as being differentially expressed between AP2-
G+ and AP2-G-depleted P. falciparum NF54 lines.  
 
With these observations, it may be that the decreased gametocytaemia seen in 
HAT1 KO lines resulted from the overall attenuated asexual growth phenotype, 
and not as a direct effect of HAT1 on gametocyte commitment or maturation. In 
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a study of the P. falciparum PfMYST histone acetyltransferase, disruption of the 
pfmyst gene was not possible, suggesting that this histone acetyltransferase was 
essential for intraerythrocytic parasite growth (Miao et al., 2010). Similarly, 
histone H3 acetylation by the PfGCN5 histone acetyltransferase is essential for 
gene expression and cell cycle progression in P. falciparum (Cui et al., 2007).  
 
Though not as detrimental to Plasmodium spp. parasite growth as a HDA1 KO 
(section 3.3.7), HAT1 KO does appear to result in attenuated asexual growth in P. 
berghei (Figure 3.7). With regard to the downregulation of HAT1 in both 
gametocyte sexes upon comparative transcriptomic analysis (Yeoh et al., 2017), 
it may also be possible that HAT1 function is disproportionately involved in 
commitment to female gametocytogenesis at some point during asexual growth in 
Plasmodium. HAT1 expression as an important component of female gametocyte 
commitment would explain a greater decrease in female gametocytaemia in a 
HAT1 KO line when compared to asexual parasites and male gametocyte numbers. 
Involvement in commitment to gametocytogenesis at this early stage would also 
explain the decreased presence of HAT1 transcripts observed in mature 
gametocytes (Yeoh et al., 2017) and an absence of changes to HAT1 expression in 




Figure 3.11: Current knowledge of Plasmodium spp. histone acetyltransferases. This image 
summarises known Plasmodium spp. histone acetyltransferase molecular mechanisms at the 
present time. On the left, the first Plasmodium spp. histone acetyltransferase to be functionally 
characterised, the P. falciparum GCN5 (general control of amino acid synthesis 5) histone 
acetyltransferase (PfGCN5), is shown in complex with P. falciparum adenosine deaminase 2 
(PfADA2) and a P. falciparum Spt (suppressor of Ty) homologue. Together, these proteins form an 
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‘Spt-ADA-GCN5-acetylatransferase’ (‘SAGA’) complex that, in P. falciparum, is currently known to 
acetylate histone 3 (H3), lysines 8 and 14 (Fan, An and Cui, 2004), though the SAGA complex has 
been shown to mediate further chromatin modification in Drosophila (Li et al., 2017). In the centre 
of the image, the P. falciparum MYST (MOZ, Ybf1/Sas3, Sas2, and Tip60) (PfMYST) histone 
acetyltransferase is shown with its known interacting partner in P. falciparum, the RuvB-like 
protein 3 (PfRUVBL3). Alone, recombinant PfMYST showed a predilection for acetylation of histone 
4 (H4), lysines 5, 8, 12, and 16 (Miao et al., 2010). With its interacting partner, PfRUVBL3, PfMYST 
appears to co-localise with H3K9me1 during the ring stages of intraerythrocytic P. falciparum 
development (Sen et al., 2018). To the right of the image, the findings from the present study into 
P. berghei histone acetyltransferase 1 (HAT1) function are shown. In this study, though no 
molecular mechanism is known, a complete KO of PbHAT1 resulted in a reduction in asexual 
growth, male gametocytaemia, and a statistically significant decrease in the production of mature 
female gametocytes (section 3.3.6).  
 
As summarised in Figure 3.11, three histone acetyltransferase domain-containing 
proteins in Plasmodium, GCN5, MYST, and HAT1, have been characterised in P. 
falciparum or P. berghei, out of a total of 11 proteins with putative N-
acetyltransferase or histone acetyltransferase domains (listed in Supplemental 
Table S1). Of these three proteins, only HAT1 contains more than one histone 
acetyltransferase domain (it has 2 HAT domains), and only HAT1 is dispensable 
during asexual growth (Figure 3.7) (Bushell et al., 2017). In P. berghei ANKA, the 
GCN5 acetyltransferase (PBANKA_0707300) is essential for asexual growth of the 
parasite, and is transcribed throughout asexual stages of the life-cycle (Otto et 
al., 2014; Bushell et al., 2017; Yeoh et al., 2017). The P. berghei MYST protein 
(encoded for by PBANKA_0929500), is similarly transcribed predominantly 
throughout the asexual parasite life-cycle, being downregulated in mature male 
and female gametocytes comparatively (Otto et al., 2014; Yeoh et al., 2017). It 
is also an essential protein for asexual intraerythrocytic growth (Bushell et al., 
2017).  
 
In the case of P. berghei HAT1, this enzyme was shown to be transcribed 
predominantly at 16 h trophozoite stage, decreasing in abundance as the cycle 
progressed towards schizogony, and downregulated, though still present, in 
gametocytes (Otto et al., 2014). In keeping with the phenotype seen upon 
complete KO (section 3.3.6), comparative transcriptome analysis revealed that 
HAT1 is expressed to a greater extent in both mature female gametocytes and 
mixed asexual stages (Yeoh et al., 2017). With these findings, it may be that this 
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HAT1 acetyltransferase is disproportionately involved in asexual growth and 
female gametocytogenesis when compared with male gametocytogenesis. In 
keeping with the findings of the present study, a large screening of essential genes 
in P. berghei ANKA also noted a slow growth rate when Pbhat1 was knocked out 
(66% growth rate compared to WT; 95% CI: 0.38-0.93) and a disruption at the 
gametocyte, oocyst, ookinete, and liver stages (Bushell et al., 2017). Remarkably, 
of all 11 putative N-acetyltransferases or histone acetyltransferases currently 
identified in P. berghei; the former three proteins plus PBANKA_1201700, 
PBANKA_0204100, PBANKA_1225200, PBANKA_1127600, PBANKA_0611800, 
PBANKA_1338500, PBANKA_1442500, and PBANKA_0504900, only one more 
acetyltransferase domain-containing protein, the GNAT family N-
acetyltransferase encoded by PBANKA_1225200, has been shown to be dispensable 
for asexual growth (Bushell et al., 2017). And similarly to PbHAT1, this GNAT 
acetyltransferase also showed attenuated growth in asexual stages (96% growth 
compared to WT; 95% CI: 0.86-1.06), and a disruption of sexual development at 
gametocyte and mosquito sexual stages.                              
 
To summarise, further experimentation is needed to shed light on the exact 
mechanism of action of HAT1 in Plasmodium. ChIP and co-IP experiments in future 
could elucidate the downstream effects of this acetyltransferase, the identity of 
the epigenetic modification(s) that HAT1 meditates, and interaction partners of 
HAT1. Furthermore, with HAT1 KO clonal lines, competitive growth assays and 
comparative transcriptomic analyses are also possible, as are experiments in 
transmission of HAT1 KO lines through mosquitoes. Initial experiments in 
transmission of the G1529cl6 P. berghei ANKA line have shown a decrease in 
ookinete conversion compared to a WT 820 line (personal correspondence with Dr 
Scott Millar, Wellcome Centre for Integrative Parasitology), which again suggests 
that HAT1 KO may have a detrimental effect on sexual-stage growth in P. berghei. 
A second HAT1 KO in the 820 background line was also successfully generated by 
transfection (G1689; Figure 3.2), which may prove to be a useful resource for 
future experimentation. When cloned, the G1689 clonal line could confirm the 
female gametocyte-specific phenotype observed upon G1529cl6 examination 
(Figure 3.7).  
 
Chapter 3  P. berghei epigenetic regulators 
 
 196 
In conclusion, both HDA1 KO and HAT1 KO in P. berghei ANKA background lines 
proved to be incredibly useful tools in the elucidation of the function of these 
putative epigenetic modifiers. With the ability to successfully clone HAT1 KO 
lines, histone extraction and PTM analysis by LC-MS/MS could be used to identify 
HAT1-mediated acetyl marks on histones in future. These KO studies were also 
able to confirm the essentiality of previously screened epigenetic modifiers by 
PlasmoGEM (Table 3.1), with the HDA1 KO providing compelling evidence for the 
role of this protein in early development of the parasite, just prior to, or at the 
point of merozoite egress from the schizont, in both asexually- and sexually-
committed cells (Poran et al., 2017). Future studies using these P. berghei ANKA 
lines may contribute significantly to our knowledge of both early intraerythrocytic 
development and gametocyte commitment in the malaria parasite. 
 
3.4.4 Localisation of putative epigenetic modifiers in P. berghei ANKA 
 
Following failure to conditionally degrade the putative epigenetic regulators of 
interest, fluorescence microscopy was used to determine any organellar 
localisation of successfully tagged proteins from both asynchronous infections in 
vivo and synchronous mature schizonts in vitro (section 3.3.9). Using anti-HA 
primary antibodies with two different secondary antibodies demonstrated that 
HDAC2/IPK1 was indeed concentrated at foci adjacent to the nucleus, as had 
previously been observed in P. falciparum (Figure 3.9 (a) and (b)) (Coleman et 
al., 2014). However, neither HDA1 or HDAP showed the same nuclear localisation 
in P. berghei asexual-stage cells. HDA1 appeared to faintly localise to the outer 
trophozoite membrane; whereas HDAP was located diffusely throughout the 
parasite cytoplasm at both trophozoite and schizont stage (Figure 3.9). 
  
It should be mentioned that in this study, live imaging of parasites in a timed 
manner throughout the entire parasite life-cycle was not carried out. However, 
taking into account both KO and fluorescence microscopy results upon tagging 
with HA and mCherry (section 3.9), live imaging of mCherry fluorescence from 
HDA1-tagged parasites in the AID background line (G1516) may provide powerful 
results in determining if HDA1 does in fact function at the point of schizont 
segmentation, or during early ring-stage development of the asexual parasite 
(Poran et al., 2017). It may also be of particular benefit to future studies to 
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generate conditional protein or gene knockdown lines using a different molecular 
system from auxin degradation, such as the rapamycin-inducible knocksideways 
(KS) system in P. berghei (Hughes and Waters, 2017). Should this conditional 
displacement system prove successful, the role of HDA1 in P. berghei ANKA could 
be determined in greater detail and the presence of a HDA1::GFP-containing line 
could complement previous imaging results.  
    
3.4.5 Co-immunoprecipitation findings: putative interacting factors and issues 
 
In co-IP experiments with tagged HDA1 and HDAP, unique proteins identified from 
LC-MS/MS of independent biological samples provided consistent results, though 
in all cases, the ‘bait’ protein used, i.e. HA-tagged HDA1 and HDAP, were not 
pulled down with their putative interacting factors (full lists of results in 
Electronic Supplemental Material 1 (ES1)).  
 
To combat all of these issues in one fell swoop, the homology regions with unique 
restriction sites created as shown in Supplementary Images 1E-1I could be re-
digested and inserted into the pG0079 KS vector by Gibson Assembly (Hughes and 
Waters, 2017), facilitating further conditional degradation attempts, particularly 
those that would complement HDA1 and HAT1 KO studies. The additional tagging 
of putative epigenetic modifying enzymes with GFP would enable further 
confirmatory studies to be carried out by both fluorescence imaging and co-IP. In 
recent studies, anti-GFP antibodies have been used successfully to precipitate 
tagged Plasmodium proteins, though issues with proteins of high molecular 
weight, low abundance, and unusual solubility characteristics have been noted, 
and may account for the loss of large tagged histone deacetylases during co-IP 
sample preparation, as was seen in the present study (Zhao et al., 2016; Zhang et 
al., 2017; Filarsky et al., 2018). Further conditional protein degradation systems 
that may aid in characterisation of both HDA1 and HAT1 are discussed in Chapter 
6.   
 
In the present study, co-IP experiments were important providers of data to aid 
in determining the functions of both HDA1 and HDAP in P. berghei, in cases where 
complete KO lines could not be cloned (HDA1) or where the protein-of-interest 
was essential or no KO plasmid was available (as was the case with HDAP) (section 
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3.3.10). To confirm the findings of these results, GFP- or HA-tagging of the either 
of the shared co-immunoprecipitated ribosomal proteins, RPS11, or RPS17, could 
provide a method by which HDA1 and HDAP could be pulled-up in a co-IP 
experiment. The interaction of these proteins, and at what stage in the P. berghei 
life-cycle they come together, could provide valuable data in elucidating the 














































4. Identification of histone modifications during asexual and 











































Chapter	4	 	 P. berghei histone modifications	
	 200	
	
4.1 Chapter Aim 
 
The aim of this chapter was to map all histone post-translational modifications 
(PTMs) for asexual- and sexual-stage P. berghei ANKA parasites. These data 
were then used to identify histone PTMs that were specific to sexual-stage 
parasites (gametocytes).  
 
4.2 Introduction  
 
4.2.1 Histones and their modifications  
 
In eukaryotes, DNA strands are packaged with histone proteins to form 
chromatin, the basic unit of which is the histone octamer around which ~146 
bp of DNA are wrapped, i.e. the nucleosome (Hammond et al., 2017). In 
eukaryotes, the DNA-nucleosome complex occurs in a repeated fashion at 
approximately 200 ± 40 bp intervals, with each nucleosome composed of two 
copies each of histone 2A (H2A), histone 2B (H2B), histone 3 (H3), and histone 
4 (H4) (Figure 4.1 (a)) (Luger et al., 1997; Luger, Dechassa and Tremethick, 
2012). Nucleosome complexes further assemble into higher order chromatin 
structures, and are the primary determinant of DNA accessibility in the nucleus 
(Luger et al., 1997).  
 
 
Figure 4.1: An overview of histone conformation within the nucleosome and histone 
‘crosstalk’. Image (a) is a cartoon depiction of the structure of a eukaryotic nucleosome, 
showing histone pairs (colour-coded). The primary structure of chromatin is the DNA-
nucleosome nucleoprotein complex, with a chromatin fibre on average being 10 nm in diameter 
(Fussner, Ching and Bazett-Jones, 2011). In (a), DNA is shown wrapped around the nucleosome. 
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Nucleosomes consist of two canonical or variant H3-H4 ‘tetramers’ and two canonical or 
variant H2A-H2B ‘dimers’ to create the final histone octamer (Hammond et al., 2017). In this 
image, N- or C-termini of histones are shown extending from the nucleosome in the same 
colour as the histone of origin. Histone post-translational modifications (PTMs) often occur at 
these amino acid termini. In (b), examples of PTMs to N- or C-termini of histones H2B, H2A, 
H3, and H4 are shown. Termini extend from the nucleosome (in orange) and a number of 
histone modifications are shown on histone lysines (K), arginines (R), and single proline (P) and 
serine (S) residues. Black lines are used to indicate interacting histone ‘marks’, with arrows 
indicating a positive effect, and flat ends indicating a negative association between ‘marks’. 
Modifications to histones shown include methylation (me), acetylation (ac), phosphorylation 
(ph), ubiquitination (ub), and isomerisation (iso). Source for (a): stock image from 
irbbarcelona.org. Source for (b): Bannister and Kouzarides, 2011.                  
  
The incorporation of variant histones and the organisation of chromatin fibres 
into secondary and tertiary structures play a large role in determining the 
accessibility of DNA to transcriptional machinery, as do the vast array of post-
translational modifications available to histone amino acid side-chains 
(Bannister and Kouzarides, 2011; Luger, Dechassa and Tremethick, 2012). In 
addition, recent studies have also shown that PTMs to the histone amino acid 
core may determine overall DNA accessibility by affecting histone-histone and 
histone-DNA interactions (Tessarz and Kouzarides, 2014). 
 
At present, a vast number of post-translational histone modifications have 
been identified, including, but not limited to, methylation, acetylation, 
phosphorylation, citrullination (deamination), ubiquitination/ubiquitinylation, 
SUMOylation, formylation, succinylation, and ADP-ribosylation (Bannister and 
Kouzarides, 2011; Tessarz and Kouzarides, 2014). The role of many of these 
histone modifications (also referred to as histone ‘marks’) and the enzymes 
that are responsible for their manifestation, are currently under investigation, 
and may differ between species (Bannister and Kouzarides, 2011; Luger, 
Dechassa and Tremethick, 2012; Tessarz and Kouzarides, 2014; Prakash and 
Fournier, 2017). It is also accepted that histone PTMs influence each other, a 
concept referred to as ‘histone cross-talk’ (Figure 4.1 (b)) (Kouzarides, 2007; 
Bannister and Kouzarides, 2011), for example, the disruption of a histone 
modification by an adjacent, antagonistic histone ‘mark’ or competition of 
different histone modifications for the binding site of the same enzyme. 
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4.2.2 The histones of P. berghei  
 
It is known from studies into the human P. falciparum parasite, and from later 
comparative analyses of encoding genes, that Plasmodium parasite 
nucleosomes are made up of four canonical histones (14-18 kDa) (H2A, H2B, 
H3, H4), with four possible variant histones (H2A.Z, H2B.Z (sometimes referred 
to as H2Bv), H3.3, and centromere-specific H3 (CenH3)) (Longhurst and Holder, 
1997; Miao et al., 2006). A great number of histone modifications have also 
been identified on Plasmodium histones, and it has been determined that 
Plasmodium parasites do not contain a ‘linker’ histone 1 (H1), but do possess 
a heat-unstable (HU) bacterial histone-like protein (denoted PfHU in P. 
falciparum) that is capable of DNA condensation, particularly in the apicoplast 
(Miao et al., 2006; Ram et al., 2008; Salcedo-Amaya et al., 2009; Trelle et al., 
2009; Luah et al., 2010; Jiang et al., 2013; Coetzee et al., 2017; Gupta et al., 
2017; Sindikubwabo et al., 2017). The nucleosomes of P. falciparum have also 
been shown to have reduced histone octamer stability in comparison to the 
nucleosomes of other eukaryotes, and have a nucleosome repeat length of ~155 
bp both in vitro and in vivo (Silberhorn et al., 2016). 
 
A complete comparative analysis of all eight P. berghei ANKA core and variant 
histones with those of all five Plasmodium species known to infect humans is 
located in Supplemental Section S1. These comparisons of peptide sequences 
and structures also include the orthologous host histones from Homo sapiens 
sapiens (modern human), Rattus norvegicus (the rat species used in the present 
study as a P. berghei host), and Mus musculus (the mouse species commonly 
used as a P. berghei host in the present study). (Supplemental section S1).     
 
4.2.3 Experimental methods for the isolation and extraction of histones 
from whole proteomes  
 
As a result of their importance in the regulation of gene expression among all 
eukaryotes, a number of methods have been tried and tested for the 
extraction, isolation, and purification of histones from animal, plant, or other 
eukaryotic cell types (Shechter et al., 2007). Histones are highly alkaline, acid-
insoluble proteins and most histone extraction protocols focus on extraction 
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using acids, mainly dilute hydrochloric acid (HCl) or dilute sulphuric acid 
(H2SO4) (Shechter et al., 2007). Alternatively, high-salt extraction of histones 
may prove useful as a result of the neutral pH environment, which may protect 
acid-labile post-translational modifications, such as phosphorylation marks, 
from being lost. Procedures have also been developed in which increasing 
levels of salt (NaCl) concentration have been used to separate H2A/H2B 
nucleosome components from the even more insoluble H3/H4 nucleosome 
component, allowing these fractions to be analysed separately thereafter 
(Shechter et al., 2007; Rodriguez-Collazo, Leuba and Zlatanova, 2009).  
 
Furthermore, both acid and high-salt techniques may differentially extract the 
histone components from different chromatin environments depending on the 
heterochromatic or euchromatic conformation of the chromatin. As such, 
tandem extractions of histones using both methods may provide a more 
complete picture of the histone PTM profile of a particular cell type (Shechter 
et al., 2007). After extraction of histones by the chosen method, histones can 
be analysed by sodium dodecyl sulphate polyacrylamide gel electrophoresis 
(SDS-PAGE), acid-urea (AU) gel electrophoresis, or mass spectrometry (MS), 
with or without purification by any of a number of liquid chromatography 
procedures (Figure 4.3).  
 
 
Figure 4.2: Sequence of techniques used for the extraction, purification, and analysis of 
histones from eukaryotic cells. The image above is a cartoon representation of the processes 
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involved in extracting and analysing the histones of eukaryotic cells. To begin with, cells are 
cultured in the appropriate manner (dependent upon cell type) and the nuclear fraction or 
whole cells taken at the life cycle stage of interest for either acid- or high-salt extraction. 
Acid-extracted or high-salt-extracted histones can be purified by liquid chromatographic 
methods (such as reversed-phase high-performance liquid chromatography (HPLC)). Both 
purified or non-purified histones can be analysed by SDS-PAGE electrophoresis, acid-urea gel 
electrophoresis, followed by staining or immunoblotting as desired. Examination of histone 
PTMs is often carried out by combining extraction and purification with mass spectrometry 
(not shown as an option in this diagram). Source: Shechter et al., 2007. 
 
In the present study, P. berghei ANKA histones were extracted from asexual 
(mature, synchronous schizont) stage or sexual (mature gametocyte) stage, 
using acid-extraction with dilute HCl as described in Miao et al., 2006 (Miao et 
al., 2006). Acid-extracted histones were then examined, first by SDS-PAGE to 
confirm isolation of histones, and then by liquid chromatography-coupled 
tandem mass spectrometry (LC-MS/MS). The procedure used for the extraction 
of histones from P. berghei ANKA cells is described in section 2.2.4, with 
sample preparation, LC-MS/MS, and analysis of histone PTMs carried out as 
described from section 2.2.8 to 2.2.10 inclusive.  
 
4.3 Results     
 
4.3.1 Optimising schizont and gametocyte production in a P. berghei ANKA 
line 
 
In the present study, acid extraction of histones was carried out on mature 
asexual P. berghei ANKA schizonts and mature P. berghei ANKA gametocytes 
(male and female gametocyte mix), followed by examination of histone PTMs 
by LC-MS/MS data. To ensure enough histone material to investigate PTMs at 
both asexual and sexual stages of the P. berghei ANKA life cycle, infection of 
Wistar rats was carried out, with asexual parasites synchronised in vitro (after 
Plasmodipur filtration of blood; described in section 2.1.14) to mature 
schizont stage, followed by purification from culture by a 55% Nycodenz density 
gradient (detailed in section 2.1.5.4) or magnetic separation (detailed in 
section 2.1.15). To ensure that a parasite culture was not contaminated by P. 
berghei parasites of other life cycle stages (such as ring stages or trophozoites), 
synchronisation and maturation of a high-producer of gametocytes (HP) P. 
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berghei ANKA line in culture was carried out in the first instance, with two 
biological replicates carried out using the G1142 AP2-G overexpressor line, in 
which transcription of AP2-G was not induced by rapamycin addition. These 
protocols ensured that minimal (in the case of HP), or absolutely no 
contaminating gametocytes (in the case of G1142) were present in the samples 
(the G1142 gametocyte overexpressor line is discussed further in section 
1.7.2.3.1).  
 
Conversely, initial examination of P. berghei ANKA gametocytes was carried 
out using a HP P. berghei line in which asexually replicating parasites were 
killed off by treatment with sulfadiazine for 24 hours at 25mg/l (Beetsma et 
al., 1998). The preparation of sulfadiazine for administration to infected 
animals is detailed in section 2.1.8. With the development of the G1142 AP2-
G overexpressor line, 2 biological replicates were carried out in which 
gametocyte production was ensured by rapamycin induction (procedure 
detailed in section 2.1.9). All parasites were purified from blood or culture 
following removal of contaminating blood products by Plasmodipur filtration 
(section 2.1.14) by a 53% Nycodenz density gradient (detailed in section 
2.1.5.4) or magnetic separation (section 2.1.15).  
 
4.3.2 P. berghei ANKA schizont and gametocyte samples  
 
After optimisation of in vivo and in vitro methods to ensure a maximal amount 
of the desired parasite stage with no contamination by other life-cycle stages, 
maturation of asexual and sexual P. berghei ANKA parasites was monitored by 
Giemsa staining (section 2.1.12). Images of Giemsa stains taken just prior to 
acid extraction of histones are shown in Figure 4.3. A selection of five 
parasites from each culture were imaged as a representation of the parasites 
that were seen throughout the entire in vitro culture (in the cases of all 
schizont samples and G1142 gametocytes) and gametocytes seen in vivo after 
Sulfadiazine selection are shown in Figure 4.3 (B).     
 





Figure 4.3: Giemsa staining of P. berghei ANKA mature asexual-stage parasites (schizonts) 
and mature sexual-stage parasites (gametocytes). Each row of images from A-F shows a 
selection of the mature asexual parasites (schizonts) and mature sexual-stage gametocytes 
taken as representative examples of parasites observed throughout an entire in vitro culture 
(A and C-F) and after in vivo Sulfadiazine enrichment of gametocytes (row B). All scalebars (in 
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white) in the right-hand bottom corner of each image represent 10 µm in length. Row A shows 
P. berghei ANKA mature schizonts from an in vitro culture (~24 h in vitro). These schizonts 
were taken from a P. berghei ANKA HP line after in vitro synchronisation and growth. P. 
berghei ANKA schizonts typically contain ~12-18 merozoites and, though some schizonts have 
been partially burst by the Giemsa staining procedure (smearing on a glass slide), the schizonts 
in row A were mature and ready for purification and acid-extraction of histones. The selection 
of parasites in Row B are gametocytes taken from a rat infection after in vivo growth to a 
parasitaemia of ~5%, followed by 24 h treatment with 25 mg/ml Sulfadiazine in vivo. After 
these images were taken, blood was taken from the rat, Plasmodipur-filtered, and the 
gametocytes purified by 53% Nycodenz density gradient.  
Row C and row E both show images of Giemsa-stained schizonts from P. berghei ANKA line 
G1142 (the rapamycin-inducible AP2-G overexpressor line). These schizonts were taken from 
in vivo infections of rats with no rapamycin induction, followed by Plasmodipur filtration of 
blood and maturation in vitro. In both cases, all parasites in culture followed asexual growth, 
with no AP2-G expression in the background line, and therefore, no gametocytes to 
contaminate the culture.  
Rows D and F show a selection of gametocytes after rapamycin-induction in vivo (using the P. 
berghei ANKA G1142 overexpressor line), followed by Plasmodipur-filtration and culturing in 
vitro under rapamycin pressure. These rapamycin-induced gametocytes resembled native P. 
berghei ANKA HP gametocytes closely (row B), with the only difference being that, after 
rapamycin-induction, the in vitro cultures did contain some gametocytes with multiple nuclei, 
i.e. an erythrocyte that had been infected with multiple merozoites which were then induced 
to become gametocytes after rapamycin-induction. Such gametocytes with multiple nuclei 
were not visible in P. berghei ANKA HP native samples (as shown in Row B).     
 
4.3.3 P. berghei ANKA schizont and gametocyte histones 
 
Before either schizont or gametocyte histones were sent for analysis by LC-
MS/MS, acid-extracted histones were denatured at 95ºC for 10 min and run on 
a 15% SDS-PAGE gel that was then stained with Coomassieâ Brilliant Blue R-
250 (Sigma-Aldrich). Samples were run next to a commercial 10-250 kDa 
prestained protein ladder (PageRulerÔ Plus Prestained Protein Ladder, 
ThermoFisher Scientific) and a sample of re-suspended calf thymus histones at 
a known concentration of 1 mg/ml (also denatured at 95ºC for 10 min; 
lyophilised calf thymus histone from Sigma-Aldrich). An example of acid-
extracted G1142 P. berghei schizont and gametocyte histones is shown in 
Figure 4.4.       
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Figure 4.4: Acid-extracted P. berghei schizont and gametocyte histones. The image above 
depicts a Coomassie-stained 15% SDS-PAGE gel (image taken under white light using a Gel Doc® 
XR+ Gel Documentation System, Bio-Rad Laboratories, Inc.) to which 5 ul of protein ladder, 3 
ul of calf histone (at 1 mg/ml) and 5 ul each of a sample of G1142 schizont and G1142 
gametocyte histones were added (all proteins denatured at 95ºC for 10 min; histone samples 
of an unknown concentration). Protein ladder standards are measured in kiloDaltons (kDa) to 
the left of the image. Histones are labelled H1-H4, with two subtypes of H1 (H1.1 and H1.2) 
seen in the calf thymus sample. Loss of the H1 histone in both P. berghei ANKA schizonts and 
gametocytes is consistent with previous findings in P. falciparum (Miao et al., 2006). The 
masses of the H3, H2A, H2B, and H4 histones in kDa (roughly 11-15 kDa) are consistent with 
predicted masses of 15.4, 14.1, 13.3, and 11.5 kDa respectively (PlasmoDB). Variant histones 
(H2A.Z, H2B.Z, H3.3, and CenH3) could not be distinguished from canonical histones by SDS-
PAGE, and H4 appeared to be the most abundant histone present in the acid-extracted samples 
(again consistent with findings in P. falciparum (Miao et al., 2006)). From examination of this 
gel, it could be determined that both P. berghei histone samples were of ~0.75-1 ug/ul (or 
mg/ml) concentration in solution. These samples were then sent for LC-MS/MS. 
 
As can be seen in Figure 4.4, no histone H1 isoforms were isolated from P. 
berghei schizont or gametocyte acid extracts. This SDS-PAGE image was a clear 
indication that no contaminant histones from rat cells were present in these 
extracts (clear H1 sub-fractions are visible when acid extraction is carried out 
on rat cells) (Bucci, Brock and Meistrich, 1982). Visible P. berghei histones 
ranged from 11.5 kDa (H4) to 16.5 kDa (H2A.Z) in mass, with the P. berghei 
centromeric H3 protein (CenH3) not visible in this image above the H3 band 
(CenH3 has a mass of 19.1 kDa). These results are again consistent with the 
findings of Miao et al. (2006) upon extraction of P. falciparum histones. In P. 
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falciparum, CenH3 gene expression remained relatively unchanged across the 
intraerythrocytic parasite life-cycle apart from a clear reduction at mid to late 
trophozoite stages (Miao et al., 2006). However, the lack of a CenH3 band in 
Figure 4.4 may not be a result of stage-specific decreases in CenH3 abundance 
at mature schizont or gametocyte stages of the life-cycle. Rather, this protein 
displays relatively low expression across all eukaryotic cell types. CenH3 is 
found exclusively at functioning centromeres during cell division, with even 
pericentromeric chromosome regions being devoid of this protein in lieu of 
canonical or variant H3 (Maheshwari et al., 2017). As such, failing to observe 
a CenH3 band upon histone extraction from P. berghei cells was not 
unexpected.  
 
Another clear difference between the calf thymus histones seen in Figure 4.4 
and the histones of P. berghei (line G1142) schizonts and gametocytes was the 
greater abundance of H4 in P. berghei samples. This dark staining of the H4 
band on an SDS-PAGE gel was also observed when histones were acid extracted 
from P. falciparum intraerythrocytic cells in the same manner as in this 
experiment (Miao et al., 2006). A number of reasons may be responsible for 
the relatively dark band of H4 in P. berghei samples. To begin with, 0.25 HCl 
acid extraction of all eight alkaline histones (isoelectric points ranging from pH 
10.84 to pH 11.8) should not result in the greater isolation of one histone over 
another, though H4 is the most alkaline of the histones in P. berghei. Histone 
acid extraction with HCl twice (as described in section 2.2.4) should have 
successfully extracted all histones from protein lysates. The SDS-PAGE gel in 
Figure 4.4 was also a 15% polyacrylamide gel, a standard percentage used for 
both the visualisation and extraction of histones from eukaryotic cells, 
including Plasmodium spp. (Miao et al., 2006; Shechter et al., 2007). Despite 
this, 4-20% or 4-25% gradient SDS-PAGE gels could also be used, and in this 
case, may be beneficial in isolating any alkaline proteins of a similar mass from 
H4 out of the extract (Shechter et al., 2007; Coetzee et al., 2017). A Western 
blot of the gel shown in Figure 4.4 with an anti-H4 antibody may also be 
beneficial in discerning the presence of any contaminating alkaline proteins of 
similar mass to P. berghei H4.  
 
Outside of technical reasons for the greater Coomassieâ staining of H4 in 
Figure 4.4 (the Coomassieâ stain itself is also acidic), a greater abundance of 
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H4 may result from the fact that it is the only histone within the P. berghei 
extract of which there is no variant histone of a slightly different size and 
isoelectric point (as with H3, H2A, and H2B). Isolation of histones at mature 
schizont and mature gametocyte stage show that H4 was equally abundant in 
the merozoite-filled schizont prior to egress and in mature sexual stages prior 
to transmission, with DNA replication having ceased at these points within the 
parasite life-cycle. Histone 4 acetylation is required for chromatin 
decompaction during DNA replication in eukaryotes, though the amount of 
total H4 protein remains unchanged (Ruan et al., 2015). One other possibility 
for the relative H4 abundance in P. berghei samples (Figure 4.4), was that 
canonical and variant H3, H2A, and H2B histones were somehow being 
degraded during either the P. berghei cell lysis or acid extraction processes, 
with the same happening upon cell lysis and acid extraction of P. falciparum 
histones (Miao et al., 2006). To rectify this issue, further experiments may 
require that cell lysis buffers and SDS-PAGE sample buffers contain additional 
protease inhibitors, such as a mixture of phenylmethylsulfonyl fluoride (PMSF), 
Aprotinin, Leupeptin, and Pepstatin that has been suggested for rapid 
purification of recombinant histones (Klinker et al., 2014).  
 
4.3.4 Identification of P. berghei ANKA schizont and gametocyte histone 
PTMs by MS/MS 
 
Post-translational modifications (PTMs) on P. berghei ANKA schizont and 
gametocyte histones are shown in the figures below. The procedures used for 
preparation of acid-extracted histones for LC-MS/MS, the LC-MS/MS procedure 
itself, and the software used for identification of histones and their PTMs are 
described from section 2.2.8 to section 2.2.10. In all samples examined, no 
peptides from H3-like centromeric protein CSE4 (CenH3) were identified, most 
likely due to the low abundance of this histone-like protein in parasites as 
discussed above (section 4.3.3), and the fact that these mature parasite stages 
would not be expressing CenH3 (mitosis has ceased in these mature stages) 
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4.3.4.1 P. berghei ANKA schizont histone PTMs 
 
 




Figure 4.5: Complete profile of PTMs on P. berghei ANKA mature schizont histones. Listed 
above are the peptides identified by LC-MS/MS using Mascot protein identification software 
version 2.6.2 (Matrix Science) (Perkins et al., 1999) and searching a P. berghei ANKA amino 
acid database (version 35). Numbers at the start and end of each peptide refer to the amino 
acid position of the first and last residues shown. In each histone, the first methionine (M) 
(corresponding to the start codon of each sequence) is not counted and sequences beginning 
with this amino acid have a starting number of zero (0) to the left of the first peptide. Full 
stops after the first amino acid and before the last amino acid in each peptide sequence 
indicate where trypsin cut each peptide from the complete protein sequence. Modifications to 
histone amino acid residues are labelled in subscript to the right of the modified residue. In 
cases where peptides had more than one modification present at a particular amino acid 
residue, a forward slash is used (/) to separate modifications. An asterisk to the right of the 
peptide indicates that this peptide was not unique to the histone in question, but shared with 
the variant histone; for example, shared peptides between histones H3 and H3.3, or between 
H2B and H2B.Z. Separate searches were run for mono-methylation (me1), di-methylation 
(me2), tri-methylation (me3), phosphorylation (ph), acetylation (ac) and protein N-terminal 
acetylation (NtermAc).  





Table 4.1: The histone modifications of P. berghei ANKA mature schizonts. This table lists 
all histone PTMs identified in P. berghei ANKA schizonts. All histone amino acid modifications 
that have previously been identified in P. falciparum studies are shown in bold text. An asterisk 
(*) next to a histone modification indicates that this particular amino acid is unique to P. 
berghei, or that the corresponding amino acid in P. falciparum is at a different position of the 
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4.3.4.2 P. berghei ANKA gametocyte histone PTMs  
 
 




Figure 4.6: Complete profile of PTMs on P. berghei ANKA gametocyte histones. Listed above 
are mature gametocyte histone peptides identified by LC-MS/MS using Mascot protein 
identification software version 2.6.2 (Matrix Science) (Perkins et al., 1999) and searching a P. 
berghei ANKA amino acid database (version 35). Numbers at the start and end of each peptide 
refer to the amino acid position of the first and last residues shown. In each histone, the first 
methionine (M) (corresponding to the start codon of each sequence) is not counted and 
sequences beginning with this amino acid have a starting number of zero (0) to the left of the 
first peptide. Full stops after the first amino acid and before the last amino acid in each 
peptide sequence indicate trypsin cleavage. Modifications to histone amino acid residues are 
labelled in subscript to the right of the modified residue. In cases where peptides had more 
than one modification present at a particular amino acid residue, a forward slash is used (/) 
to separate modifications. An asterisk to the right of the peptide indicates that this peptide 
was not unique to the histone in question, but shared with the variant histone; for example, 
shared peptides between histones H3 and H3.3, or between H2B and H2B.Z. Separate searches 
were run for mono-methylation (me1), di-methylation (me2), tri-methylation (me3), 
phosphorylation (ph), acetylation (ac) and protein N-terminal acetylation (NtermAc).  
   
 




Table 4.2: The histone modifications of P. berghei ANKA mature gametocytes. This table 
lists all histone PTMs identified in P. berghei ANKA mature gametocytes. All histone amino acid 
modifications that have previously been identified in P. falciparum studies are shown in bold 
text. An asterisk (*) next to a histone modification indicates that this particular amino acid is 
unique to P. berghei, or that the corresponding amino acid in P. falciparum is at a different 
position of the histone amino acid chain.  
 
4.3.5 Differences between P. berghei schizont and gametocyte histone 
PTMs  
 
The aim of these acid extractions was to identify histone PTMs in both P. 
berghei ANKA mature asexual-stage parasites (schizonts) and mature sexual-
stage parasites (gametocytes) to reveal the identity of shared and differing 
histone modifications between parasite life stages (Table 4.3). Although some 
histone modifications may simply have not been detected by LC-MS/MS, other 
changes appeared to be consistent between samples, and differed to histone 
PTMs seen at the opposing life-cycle stage. Changes to the P. berghei ANKA 
histone modification profile can clearly be seen when comparing figures 4.5 
and 4.6, with all differences listed again in Table 4.3.  
       




Table 4.3: Differences between P. berghei ANKA asexual (schizont) and sexual 
(gametocyte) histone modifications. The table above lists all histone modification differences 
that were identified between P. berghei ANKA mature asexual-stage parasites (schizonts) and 
mature sexual-stage parasites (gametocytes). An asterisk (*) next to a histone modification 
indicates that this particular amino acid is unique to P. berghei, or that the corresponding 
amino acid in P. falciparum is at a different position of the histone amino acid chain. Shared 
histone PTMs are not shown. All histone modifications listed underneath the P. berghei ANKA 
schizont column were seen only in schizonts and not gametocytes. Conversely, all histone 
modifications listed in the P. berghei ANKA gametocyte PTMs column were only found at this 
parasite stage and not in mature schizonts. Bold black text indicates that the PTM appeared 
in 2 out of 3 histone extract samples. Red and bold histone PTMs were observed from all three 
histone extract samples of the same parasite stage.  
 
In total, 430 histone PTMs were identified from P. berghei ANKA schizonts and 
gametocytes together, 267 of which had been observed in P. falciparum and 
were shared with this parasite (Coetzee et al., 2017). This P. berghei study 
identified 163 newly identified histone PTMs, 44 of which were unique to P. 
berghei, with 39 of these unique marks related to the H2B variant histone, 
H2B.Z. Importantly, H2A.Z/H2B.Z variant nucleosomes have been shown to be 
involved in the active transcription of var genes in P. falciparum, and PTMs to 
these histones could exert important effects in the maintenance of 
euchromatin (Hoeijmakers et al., 2013; Petter et al., 2013). Identification of 
histone PTMs on the H2B.Z variant of P. berghei ANKA is important to our 
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understanding of human-infective Plasmodium species because this variant 
histone is 100% identical to the H2B.Z histones of P. knowlesi, P. vivax Sal-1, 
and P. ovale curtisi GH01 (Supplemental section S1; Figure S8).  
 
Of the 430 identified histone PTMs, 281 were observed in mature P. berghei 
schizonts, 197 of which had previously been determined in P. falciparum. From 
mature gametocytes, 323 histone PTMs were identified, 211 of which had 
previously been determined in P. falciparum (Coetzee et al., 2017). Of 
particular interest in this study were the differential histone marks shown in 
Table 4.3 above. These differential histone marks may provide clues as to the 
epigenetic regulatory proteins involved in commitment to gametocytogenesis. 
To identify histone PTMs that were heavily involved in sexual development, 
histone modifications that appeared in two or more samples are highlighted in 
Table 4.3. These histone PTMs are shown again in Table 4.4, though in this 





Table 4.4: Repeat differential histone PTMs between asexual- and sexual stage P. berghei 
parasites. This table shows the histone PTMs that were unique to either P. berghei ANKA 
mature schizonts or P. berghei ANKA mature gametocytes, and appeared in at least 2 biological 
replicates. PTMs listed under each heading appeared at one life cycle stage and not the other. 
PTMs listed in black text were observed in two of three biological replicates. PTMs listed in 
red were observed in all three biological replicates. A red asterisk indicates that this histone 
PTM was not observed in P. falciparum previously. A black asterisk indicates that that 
particular amino acid position differs in P. falciparum and so is unique to P. berghei.  
 
Of all differential histone PTMs identified in this study (Table 4.3), one histone 
PTM consistently appeared in all schizont samples and was not present in 
mature gametocyte samples: H3.3 K18 trimethylation (H3.3K18me3). As with 
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the H2A.Z/H2B.Z variant nucleosome in P. falciparum, PfH3.3 also appears to 
be a variant histone with specific activity, primarily demarcating euchromatic 
regions and subtelomeric repetitive sequences, including that of the active and 
poised var gene (Fraschka, Henderson and Bártfai, 2016). With regard to the 
specific trimethylation of lysine 18 on this histone (and not on the canonical 
H3); little is known besides the fact that H3.3 in eukaryotes appears to 
accumulate as cells age (Tvardovskiy et al., 2017), and that acetylation of 
H3.3K18 is also an indicator of active transcription (McKittrick et al., 2004). In 
P. falciparum, this histone modification was identified, though its stage-
specificity was not monitored throughout the life cycle of the parasite (Coetzee 
et al., 2017).  
 
In P. berghei mature gametocytes, three differential histone PTMs appeared in 
all three biological replicate samples: H2BK19ac, H2B.ZS9ph, and 
H2B.ZR95me1 (Table 4.4). All three of these marks were identified in P. 
falciparum previously, though the stage-specificity of these marks was not 
commented upon, and these PTMs were not evaluated quantitatively or shown 
to be co-occurring with other histone PTMs (Coetzee et al., 2017). The first 
gametocyte-specific mark, H2BK19ac, occurs at the Plasmodium-specific H2B 
lysine 19 with no obvious analogous lysine in either Mus musculus, Rattus 
norvegicus, or Homo sapiens (Supplemental Section S1; Figure S7). Both 
H2B.ZS9ph and H2B.Z95me1 are equally located at Plasmodium-specific amino 
acid residues, meaning that, at present, these gametocyte-specific marks have 
no known enzyme linked to their function and appear to be specific to 
Plasmodium spp.  
 
Outside of these marks that appeared in all biological replicates, a further 27 
histone PTMs were identified only at P. berghei mature schizont stage from 
two biological replicates, and a further 23 histone PTMs appeared solely in 
gametocyte samples in two biological replicates (Table 4.4). All of these 
histone PTMs and any known associations to biological function in eukaryotes 
are listed in Table 4.5 below.  
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P. berghei ANKA 
schizont PTMs 
Function  P. berghei ANKA 
gametocyte PTMs 
Function 
H4 N-term Ac Regulator of arginine methylation and 
chromatin silencing in S. cerevisiae (Schiza et 
al., 2013). 
H4 K20me1 A function of SET8 in other eukaryotes (the only mono-
methyltransferase of H4K20); implicated in DNA damage response 
and cell cycle progression (Izzo and Schneider, 2010; van Nuland 
and Gozani, 2016). 
R3me3 Asymmetric dimethylation of H4R3 is a 
function of Hmt1 (PbSET1) methyltransferase 
activity which associated with decreased N-
terminal acetylation. This promotes rDNA 
silencing (Schiza et al., 2013). 
R23me1 H4R23 is recognised by SET8 in other eukaryotes to facilitate 
H4K20 mono-methylation (Weirich et al., 2015). When R23 is 
mutated, SET8 affinity for H4 increased exponentially (Couture et 
al., 2005). Mono-methylation of H4R23 may therefore also 
facilitate mono-methylation of H4K20 by SET8.  
K8me3 Acetylation of H4K5 counteracts H4R3 
methylation. As with H4K5me3, H4K8me3 
should facilitate chromatin silencing as 
mediated by H4R3me3 (Feng et al., 2011). 
K59me1 H4K59 is located at the solvent-accessible surface of the 
nucleosome and in S. cerevisiae, replacing this lysine with a 
different amino acid reduced heterochromatin stability and 
disrupted telomeric silencing at specific loci (Yu et al., 2011). 
Substitutions to H4K59 also lead to hypersensitivity to DNA-
damaging agents and the positive charge on an unmethylated 
H4K59 is necessary for effective ribosomal DNA silencing (Hyland 
et al., 2005). 
H3 R2ac Unknown role in transcription; site is 
conserved across eukaryotes and bound by 
PHD12 zinc finger protein when unmodified 
(Qiu et al., 2012). 
H3 R2me1 Transcriptional repression; antagonises H3K4me3 in other 
eukaryotes (Hyllus et al., 2007). 
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R17me2 Asymmetric di-methylation of H3R17 is 
essential for mammalian DNA demethylation, 
i.e. transcriptional activation (Bauer et al., 
2002; Di Lorenzo and Bedford, 2011; Hatanaka 
et al., 2017). 
K36me1 The role of H3K36me1 is unclear. Trimethylation and 
dimethylation of H3K36 have been associated with both 
transcriptional activity and chromatin silencing mechanisms 
(Wagner and Carpenter, 2012; Suzuki et al., 2016). In P. 
falciparum, H3K36me3 (but not H3K36me2) was associated with 
transcriptional silencing of var genes, with trimethylation 
mediated by the SET2 methyltransferase (Jiang et al., 2013). 
Unlike P. falciparum, the P. berghei ANKA genome does not 
encode for a SET2 protein.  
R26me2 Transcriptional activation (Wu et al., 2012). 
K27me1 Transcriptional repression (Wiles and Selker, 
2017). 
R42me1 Transcriptional activation (Casadio et al., 
2013). 
R49ac Unknown; conserved arginine in eukaryotes. 
R53ac Unknown; H3R53 mutations in model 
eukaryotic systems result in defects in 
telomeric and rDNA silencing (Mersfelder and 
Parthun, 2006). 
K56ac In eukaryotes, H3K56 acetylation increases the 
binding affinity of CAF-1 and Rtt106 chromatin 
assembly proteins to package DNA into 
nucleosomes during DNA replication (Li et al., 
2008). H3K56 acetylation in yeast acts as a 
marker for new nucleosome synthesis  during 
DNA replication and repair (Stejskal et al., 
2015).  
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R63ac This conserved eukaryotic arginine lies at the 
lateral surface of the histone octamer next to 
H3K64, which, when acetylated, marks 
transcriptionally active chromatin (Di Cerbo et 
al., 2014). No studies of R63 acetylation alone 
have so far been carried out. 
Y41ph Transcriptional activation (Dawson et al., 2009). 
T45ph Associated with DNA replication (Baker, 2010) 
R116me1 This conserved eukaryotic arginine is located within the L1L2 loop 
at the nucleosome dyad, and a substitution of this residue is lethal 
to S. cerevisiae. H3R116 forms a salt bridge with H3D123, 
stabilising the L1L2 loop (Hainer and Martens, 2011). The specific 
effects of mono-methylation of this amino acid are unknown.  
H3.3 S10ph Phosphorylation of H3.3 serine 10 occurs during 
the prophase of mitosis in eukaryotes and, 
alongside H3.3S28ph, these marks localise to 
the outermost peripheral region of condensed 
DNA (Hake et al., 2005). Phosphorylation of 
H3.3S10 is a function of ‘checkpoint kinase 1’ 
(ChK1) in other eukaryotic cell lines, with 
H3S10ph playing a role in chromosome 
condensation and transcriptional activity 
(Liokatis et al., 2012; Chang et al., 2015).   
H3.3 R2me1 Transcriptional repression (as in H3R2me1) (Hyllus et al., 2007).  
R17me2/me3 Possible transcriptional activation (as in 
H3R17me2). 
R8me1 Possibly transcriptional repression; may be associated with 
decreased acetylation of H3K9 (Schwämmle et al., 2016). 
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K18me3 Active transcription (McKittrick et al., 2004).   36me1 Unclear; as in H3K36me1.  
K23me2 Unknown; conserved arginine in eukaryotes. 
Trimethylation of H3K23 in eukaryotes is 
associated with protection from DNA damage 
in pericentric heterochromatin during meiosis 
(Papazyan et al., 2014).  
H2A R32me1 Unknown; conserved arginine in eukaryotes. H2A S1ph In eukaryotic cell lines, H2AS1ph is a function of mitogen- and 
stress-induced kinase 1 (MSK1), also known as ribosomal protein S6 
kinase A5 (RPSKA5) in human cells. Phosphorylation of serine 1 on 
H2A is negatively associated with transcription, making MSK1 an 
inhibitor of transcription (Zhang et al., 2004), In Xenopus, H2A 
and H4 S1 phosphorylation events are highly enriched at distinct 
points in embryo development: H2AS1ph is associated with 
repression of zygotic gene expression, while H4S1 phosphorylation 
correlates with the beginning of maternal gene expression (Wang 
et al., 2014).  
K5ac Transcriptional activation (associated with gene promoters) 
(Rajagopal et al., 2014). Associated with early response to DNA 
damage (Ikura et al., 2007).  
K9me1 Unknown; conserved lysine in eukaryotes. 
K10ac Unknown; conserved lysine in eukaryotes. 
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K35ac Unknown; Plasmodium-specific lysine. 
K95me2 Unknown; K95 conserved across all eukaryotes. 
K41me1 Unknown; Plasmodium-specific lysine. 
H2A.Z K5ac Transcriptional activation (Draker et al., 2012) H2A.Z K37me1/me2 Unknown; K37 is conserved across eukaryotes and is located at the 
nucleosome a1-helix (Liang et al., 2016).  
K27me1 Unknown; Plasmodium-specific lysine. K155ac Unknown; Plasmodium-specific lysine. 
H2B K7me2 Unknown; equivalent K6 in higher eukaryotes is 
suggested in transcriptional activation when 
acetylated (Parra et al., 2006). 
H2B K10me2 Unknown; Plasmodium-specific lysine. 




Unknown; P. berghei-specific threonine. 
K21me1* Unknown; P. berghei-specific lysine. 
S84ph* Unknown; P. berghei-specific serine. 
T89ph* Unknown; P. berghei-specific threonine. 
H2B.Z K18me3 Unknown; Plasmodium-specific lysine. H2B.Z S9ph Unknown; Plasmodium-specific serine. 
R23me3 Unknown; Plasmodium-specific arginine. R23me1 Unknown; Plasmodium-specific arginine. 
K104me1 Unknown; Plasmodium-specific lysine. R95me1 Unknown; Plasmodium-specific arginine. 
 
Table 4.5: Summary of the roles of stage-specific histone modifications between P. berghei ANKA schizonts and gametocytes (current knowledge). This table lists 
all histone modification differences that were identified between P. berghei ANKA mature asexual-stage parasites (schizonts) and mature sexual-stage parasites 
(gametocytes) in at least two biological replicates next to their known functions in eukaryotes. An asterisk (*) next to a histone modification indicates that this particular 
amino acid is unique to P. berghei, or that the corresponding amino acid in P. falciparum is at a different position of the histone amino acid chain. Shared histone post-
translational modifications (PTMs) and those that did not appear in two or more biological replicates are not shown. All histone modifications listed underneath the P. 
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berghei ANKA schizont column were seen only in schizonts and not gametocytes. Conversely, all histone modifications listed in the P. berghei ANKA gametocyte PTMs 
column were only found at this parasite stage and not in mature schizonts. References are provided next to the reported function of each histone modification. 
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4.3.6 Confirming a number of PTMs by immunoblotting 
 
In addition to determining the histone modification profiles for mature asexual 
(schizont) and mature sexual (gametocyte) P. berghei ANKA parasites, the present 
study aimed to identify differences in the epigenetic marks underlying asexual 
and sexual development, and to take a number of these histone modifications 
forward into chromatin immunoprecipitation experiments with the aim of 
identifying genes of DNA loci that are regulated by these histone modifications. 
 
To confirm a number of histone modifications that were identified in this study, 
in combination with a number of histone modifications identified as having a role 
in regulating gene expression in P. falciparum, commercial chromatin 
immunoprecipitation (ChIP)-grade antibodies were obtained for H3K122ac 
(Abcam; Cat. No. ab33309), H4K8ac (Merck Millipore; Cat. #07-328; Lot #2301651), 
H3K9ac (Merck Millipore; Cat. #07-352; Lot #2658782), H3K9me3 (Merck Millipore; 
Cat. #07-442; Lot #2664282), H3K27me3 (Merck Millipore; Cat. #07-449; Lot 
#2653203), H3K36me3 (Abcam; Cat. No. ab9050), H3K4me3 (Merck Millipore; Cat. 
#17-614; Lot #2618837), and H3K64me3 (Abcam; Cat. No. ab195483). All 
antibodies were tested against acid-extracted histones from the same G1142 
schizont and gametocyte samples. Images of Western blots in which antibody-
binding could be discerned are shown in Figure 4.7 (the distribution of acid-
extracted histones on an SDS-PAGE gel from these samples is also provided in this 
figure).    
 
Figure 4.7: Immunoblotting to confirm a number of histone PTMs for chromatin 
immunoprecipitation experiments. This image shows the combined results of three successful 
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Western blots and a Coomassie-stained 15% SDS-PAGE gel showing the distribution of histone in 
the same schizont and gametocyte samples. The top panel shows the results of a H3K4me3 
commercial antibody, confirming the presence of this histone modification in both asexual and 
sexual stage P. berghei ANKA parasites (this modification was detected by LC-MS/MS in both 
asexual- and sexual-stage parasites (see figures 4.5 and 4.6)). Below that, the results of H3K9ac 
antibody-staining is shown, showing a stronger presence of this modification in asexual stages 
when compared to sexual-stage parasites. Below H3K9ac-staining is shown the H4K8ac commercial 
antibody staining of schizonts and gametocytes, with a strong signal seen in asexual parasites, and 
no signal observed in gametocytes.  
 
After determining their ability to bind P. berghei histones (Figure 4.7), 
commercial antibodies for H4K8ac and H3K9ac were chosen for ChIP experiments. 
H4K8 acetylation would also later be identified as playing an important regulatory 
role in the intraerythrocytic developmental cycle of P. falciparum (Gupta et al., 
2017). Both H4K8ac, H3K9ac were detected in both asexual and sexual-stage P. 
berghei ANKA parasites by LC-MS/MS, with H3K9me3 detected in only one 
gametocyte replicate by LC-MS/MS (Figure 4.5 and Figure 4.6). Despite only 
being observed once, the H3K9me3 antibody was taken forward for ChIP 
experiments to complement the opposing H3K9ac ChIP results, in line with 
previous ChIP-on-ChIP and ChIP-sequencing experiments undertaken in P. 
falciparum (Cui et al., 2007; Salcedo-Amaya et al., 2009; Karmodiya et al., 2015).  
 
Though low in abundance, and undetectable by Western blot, the identification 
of H3K122ac as a potential differential histone modification between asexual and 
sexual P. berghei parasites (only seen in one gametocyte sample, with H3K122me1 
in one schizont sample (Table 4.3)), and its discovery as a mark of active 
enhancers and transcriptional activation (Tropberger et al., 2013; Pradeepa et 
al., 2016) compelled a study of ChIP using H3K122ac to be undertaken. It should 
also be noted that a study in which this commercial H3K122ac antibody was used 
in Drosophila melanogaster experiments, demonstrated non-specific binding of 
the antibody in vivo (Graves et al., 2016). The authors of this study suggest that 
acetylation of H3 residues outside of K122 may be sufficient for antibody binding 
in metazoans, though in later studies, issues with H3K122ac antibody cross-
reactivity were not reported (Devaiah et al., 2016; Pradeepa et al., 2016; Assiri 
et al., 2017).  
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To conclude, four commercial antibodies corresponding to histone modifications; 
H4K8ac, H3K9ac, H9K9me3, and H3K122ac, were used to determine the global 
distribution of these epigenetic marks throughout the mature asexual (schizont) 
genome in P. berghei by both ChIP-sequencing and ChIP-sequencing coupled to 




The key findings from this chapter were: 
 
• 430 histone PTMs were identified from both P. berghei schizonts and 
gametocytes. 
• 182 histone PTMs were shared between both asexual- and sexual- stage P. 
berghei parasites. 
• 248 differentially-expressed histone PTMs were identified; 104 PTMs unique 
to schizonts and 144 PTMs unique to gametocytes. 
• 28 schizont-specific histone PTMs were identified from 2 or more of three 
biological replicates. 
• 26 gametocyte-specific histone PTMs were identified from 2 or more of 
three biological replicates.  
• H3.3K18 trimethylation was enriched in all P. berghei schizont samples.  
• H2BK19ac, H2B.ZS9ph, and R95me1 were all enriched only at mature 
gametocyte stages. 
 
4.4.1 Differential histone PTMs and potential epigenetic regulatory enzymes 
in P. berghei.  
 
Just as separation of male and female gametocytes and analysis of their respective 
proteomes can provide an insight into the proteins involved in sexual development 
and sex-specificity in Plasmodium (Khan et al., 2005), determination of sex-
specific histone PTMs can provide information about the nucleosome landscape 
and epigenetic regulators involved in sexual commitment and maturation of 
gametocytes. In the present study, the focus was to identify histone PTMs that 
may be involved in gametocytogenesis in P. berghei, and, using either enrichment 
by sulfadiazine treatment, or the use of a parasite line in which the promoter of 
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the ap2-g transcriptional regulator was irreversibly induced by rapamycin 
administration (section 4.3.2), gametocytes were selected and subjected to acid 
extraction of histones and LC-MS/MS to determine histone PTMs. Twenty-six 
differential histone PTMs were discovered in P. berghei gametocytes (shared 
between 2 or more biological replicates): 5 acetyl marks, 14 methyl marks, 2 
dimethyl marks, and 5 phosphoryl marks. A summary of known associations of 
these particular histone modifications can be found in Table 4.5. However, of 
considerable interest, in addition to merely mapping the histone PTM landscape, 
was to identify potential epigenetic regulatory enzymes that may be responsible 
for deposition of these marks, and therefore, may play a role in 
gametocytogenesis in P. berghei. Listed in Table 4.6, are the 26 histone 
modifications, known enzyme responsible for their presence in other eukaryotes, 
and enzymes that share homology with known epigenetic regulators outside of 
Plasmodium spp. In addition, where a potential homologous enzyme is determined 
in P. berghei ANKA, their shared identity to the known protein, and any stage 
specificity of the transcript of this gene are shown adjacent to the result.  
 
 




Table 4.6: Gametocyte-specific histone PTMs and potential regulatory enzymes based on 
homology. This table listed all gametocyte-specific histone PTMs that were identified in 2 or more 
biological replicates. The histone type is listed on the left, followed by the histone modification 
written in standard Brno nomenclature (Turner, 2005). Any enzymes known to deposit the histone 
modification in question, in any eukaryote, is listed to the right of the modification with 
references. Any P. berghei ANKA protein with homology to the known epigenetic regulator (based 
upon a blastp search of the enzyme’s amino acid sequence) is listed to the right of the enzyme, 
with the sequence identity for the nearest P. berghei homologue in brackets. The sequence 
identity was the number of amino acids that were exactly identical between the query sequence 
and the P. berghei protein, taking no gaps into account, and with the total number based on the 
shorter of two sequences. Notes and possible stage-specificity of gene transcripts or proteins from 
previous data are detailed in the furthest right-hand column.  
 
In total, only 6 enzymes were identified that may be responsible for these 
differential gametocyte-specific PTMs (based on current knowledge). In the 
absence of SET2 in rodent lineages of the Plasmodium genus (including P. 
berghei), SET1 is the nearest homologous methyltransferase enzyme that may be 
responsible for lysine 36 mono-methylation on both canonical histone H3, and 
variant histone H3.3 (Table 4.6), though the P. berghei ANKA genome encodes for 
eight other SET domain-containing methyltransferases (Supplemental Table S1), 
and none of these enzymes can be ruled out as possible regulators of the H3/H3.3 
K36me1 modification.  
 
With the H4K20me1 histone modification, much more information is available 
from studies in other eukaryotic cell lines and model organisms. H4K20 is a 
conserved eukaryotic lysine that can be mono-, di-, or tri-methylated, with each 
methylation state being representative of a different point in mitosis. H4K20 
mono-methylation occurs at the initial mitotic (M) phase of mitosis in dividing 
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cells, and only one mono-methyltransferase of H4K20 is known: SET8 (Evertts et 
al., 2013; Jørgensen, Schotta and Sørensen, 2013). SET8 and H4K20 methylation 
are crucial for maintaining chromatin compaction during the transition from M to 
Gap 1(G1) phases of mitosis (Evertts et al., 2013; Shoaib et al., 2018). Mono- and 
di-methylated H4K20 are involved in DNA replication and DNA damage repair 
respectively, with tri-methylation of H4K20 marking silenced heterochromatic 
regions (Jørgensen, Schotta and Sørensen, 2013).  
 
In P. falciparum, a ChIP-on-chip study identified H4K20me1 as being positively 
associated with transcription and occupancy at open reading frames (ORFs) during 
the intra-erythrocytic asexual cycle, though gametocytes were not examined 
during this study (Gupta et al., 2013). In all other studies in Plasmodium however, 
methylation of H4K20 is associated with heterochromatin, though SET8 loss does 
not disrupt var gene silencing (Duffy et al., 2013). SET8 has mono-, di-, and tri-
methylation capabilities (Sautel et al., 2007) and is dispensable during the P. 
berghei life cycle, with disruption effecting sexual stages, and transcription 
comparatively upregulated in asexual stages parasites and female gametocytes 
(Bushell et al., 2017; Yeoh et al., 2017). These results warrant further 
elaboration, and an assay of P. berghei SET8 methyltransferase activity, taking 
the full protein or the methyltransferase catalytic core, with unmethylated H4 as 
a substrate, could easily determine the specific activity of SET8 (Sautel et al., 
2007). In addition, immunoblotting with a H4K20me1 antibody or fluorescent 
tagging of SET8 would add to our knowledge of this enzymes stage-specificity, and 
the association of H4K20me1 with gametocytogenesis.  
 
Certain phosphorylation modifications also differ between asexual and sexual 
stage P. berghei histones. Dual phosphorylation of tyrosine 41 (H3Y41ph) and 
threonine 45 (H3T45ph) only occurred at the gametocyte stage, as did 
phosphorylation of H2A serine 1 (H2AS1ph), H2B threonine 81 (H2BT81ph), and 
H2B.Z serine 9 (H2B.ZS9ph). Though both H2BT81 and H2B.ZS9 were P. berghei 
and Plasmodium spp.-specific amino acids respectively, and therefore their 
regulatory enzymes remain unknown, that was certainly not the case for H3Y41ph, 
H3T45ph, and H2AS1ph. In a study of human peripheral blood stem cells, Janus 
Kinase 2 (JAK2) was shown to directly phosphorylate H3Y41, a conserved 
eukaryotic tyrosine (Dawson et al., 2009). The direct result of this histone PTM 
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was to block heterochromatin protein 1 a (HP1a), but not human HP1b, from 
binding to this region of H3. In Plasmodium spp. parasites, only one HP1 protein 
is encoded for, and its regulation is essential for parasite asexual and sexual 
development (Fraschka et al., 2018). Remarkably, in P. falciparum, regulation of 
sexual commitment by the ap2-g transcription factor is dependent upon removal 
of HP1 from the ap2-g locus, a function of gametocyte development 1 (GDV1) 
protein (Filarsky et al., 2018). However, as with SET2, the GDV1 protein is not 
encoded for in rodent Plasmodium spp. genomes. In addition, the trigger for GDV1 
activation remains unknown.  
 
However, removal of HP1a from H3 upon phosphorylation of H3Y41 by JAK2 may 
be a conserved process in eukaryotes. Taking the JAK2 amino acid sequence and 
comparing it to the protein sequences of P. berghei (full blastp results not shown), 
the closest homologous protein sequence belonged to Nima-related kinase 4 
(NEK4), a kinase that is indispensable for sexual development in P. berghei 
(Reininger et al., 2005). In a complete KO of NEK4 from P. berghei, gametocyte 
and gamete development occurred as normal, though measurements of nuclear 
DNA content indicated that in the zygote, the point of DNA replication from two 
fused haploid genomes (microgamete and macrogamete haploid genomes) to a 
tetraploid ookinete nucleus was inhibited (Reininger et al., 2005). This phenotype 
also appeared to originate from a developmental issue in the female 
macrogamete, with male nek4- microgametes capable of fertilising WT 
macrogametes, with subsequent zygote and ookinete development. Despite 
pinpointing the point at which sexual development fails, this study could not 
determine the exact function of NEK4. It should therefore be investigated whether 
NEK4 functions in the phosphorylation of H3Y41, and that this process effects HP1 
binding downstream.  
 
In addition to H3Y41 phosphorylation, H3T45 phosphorylation was also identified 
in mature gametocytes but not in mature schizonts of P. berghei. Like H3Y41, 
H3T45 is located at a point of DNA entry/exit into the nucleosome (Tropberger 
and Schneider, 2010), and phosphorylation of this amino acid in human cells 
antagonises HP1-mediated transcriptional repression (Jang et al., 2014). In other 
eukaryotic cells, H3T45 phosphorylation was mediated by a dual specificity 
tyrosine phosphorylation regulated kinase 1A (no homologue in P. berghei), AKT 
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serine threonine kinase 1 (AKT1) (homologous to PKB (PBANKA_1460000) in P. 
berghei), and human protein kinase C d (PKCd) (PKB/PBANKA_1460000 was closest 
homologous gene in P. berghei) (Baek, 2011; Jang et al., 2014; Lee et al., 2015). 
In P. berghei, the homologous protein kinase B (PKB) was not amenable to KO, 
was shown to be essential to parasite growth in P. falciparum (Kumar et al., 2004), 
and was picked up in a proteomic study in male gametocytes (in comparison with 
female gametocytes) (Khan et al., 2005). Together, phosphorylation of both 
H3Y41 and H3T45 likely alter DNA accessibility at the aN loop of H3 within the 
nucleosome, leading to DNA unwrapping (Bowman and Poirier, 2015). If the effect 
of these PTMs on nucleosome dynamics hold true in P. berghei, the enzymes that 
regulate these modifications may play a crucial role in DNA transcription in 
gametocytogenesis.  
 
One final gametocyte-specific phosphorylation mark, H2AS1ph, is again a function 
of a protein in which the nearest homologous gene was PKB (PBANKA_1460000) in 
P. berghei (Table 4.6). In multiple eukaryotes, dual H2A/H4 serine 1 
phosphorylation was shown to be indicative of chromosome condensation during 
mitosis (Barber et al., 2004). The roles of these histone PTMs were further 
elucidated using X. laevis eggs and embryos. In X. laevis, H2AS1ph was highly 
enriched in blastula chromatin during repression of zygotic gene expression, with 
the beginning of maternal gene expression marked by H4S1 phosphorylation (Wang 
et al., 2014). With H2S1ph being identified differentially in P. berghei 
gametocytes, it is possible that the role of this mark is conserved. In Plasmodium 
spp., mRNAs responsible for zygote development have been shown to be 
translationally repressed by DOZI-CITH ribonucleoprotein complexes (Vembar, 
Droll and Scherf, 2016), and so the presence, in gametocytes, of a histone PTM 
associated with repression of zygotic gene expression is not unexpected. In P. 
berghei, LC-MS/MS identified H4S1ph at both schizont and gametocyte stages 
(Table 4.1 and Table 4.2), and so combinatorial H2AS1/H4S1 phosphorylation is 
present in P. berghei gametocytes. In yeast, in response to DNA double-strand 
breaks (DSBs), H4S1 is phosphorylated by casein kinase II (CK2) (Cheung et al., 
2005), sporulation-specific protein 1 (SPS1) (Krishnamoorthy et al., 2006), or both.  
 
The P. falciparum genome also contains one protein kinase CK2 alpha subunit 
orthologue (PF3D7_1108400; PBANKA_0938600 in P. berghei ANKA) and two CK2 
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beta subunit orthologues, PfCK2b1 and, PfCK2b2 (PF3D7_1103700 and 
PF3D7_1342400; PBANKA_0943200 and PBANKA_1355500 in P. berghei ANKA) with 
roles in both asexual parasite development and chromatin assembly (Holland et 
al., 2009; Dastidar et al., 2012). The essentiality of CK2 has resulted in its 
catalytic alpha subunit becoming a promising target for novel antimalarial 
therapies, though a possible role for this protein in Plasmodium 
gametocytogenesis remains undetermined (Ruiz-Carrillo et al., 2018).  
 
Remarkably, taking the SPS1 gene of S. cerevisiae and comparing it to the kinases 
of Plasmodium spp. resulted in two potential SPS1 orthologues: Nima-related 
kinase 2 (NEK2) (PBANKA_1240700) and Nima-related kinase 4 (NEK4) 
(PBANKA_0616700) (blastp results not shown). Studies in both P. falciparum and 
P. berghei have already determined that NEK2 is not essential for 
gametocytogenesis, but is required for ookinete development (Reininger et al., 
2009). As previously discussed regarding phosphorylation of H3Y41, NEK4 in P. 
berghei ANKA has been shown to be essential for the correct replication of zygotes 
into the tetraploid form that precedes meiosis, with knockout parasites incapable 
of developing to ookinete stage (Reininger et al., 2005). Considering the role of 
yeast SPS1 in the maturation of four haploid nuclei within a spore, it is possible 
that NEK4 in Plasmodium spp. shares the orthologous role of this enzyme (Govin 
et al., 2010). As such, an assay of NEK4 phosphorylation activity is warranted, and 
a determination of this enzymes preference for phosphorylation of either H4S1 or 
H3Y41, or both, could be examined (Peck, 2006).  
 
In addition to the possible roles of P. berghei PKB (PBANKA_1460000), NEK4 
(PBANKA_0616700), SET1 (PBANKA_1128500), and SET8 (PBANKA_1001600) in 
regulating gametocyte-specific PTMs that are essential for progression of sexual 
development, two more gametocyte-specific PTMs at the H2A N-terminal tail, 
K5ac and K10ac, are likely the product of PbHAT1 and PbMYST (Figure 4.6). In 
human cell lines, H2AK5 acetylation was shown in vivo to be a result of HAT1 
activity (Tafrova and Tafrov, 2014). In P. berghei, the PbHAT1 amino acid 
sequence had greatest sequence homology to the human HAT1, and, as 
demonstrated in this study (section 3.3.6), a complete KO of this gene resulted in 
a significant decrease in female gametocyte conversion, though 
gametocytogenesis was not inhibited entirely (suggesting that HAT1 function is 
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redundant to some extent). With regard to acetylation of K10 on H2A, studies in 
S. cerevisiae have identified the histone acetyltransferase ESA1 as catalysing 
H2AK5 acetylation as part of the NuA4 HAT complex in this species (Keogh et al., 
2006; Mehta et al., 2010). When searching for amino acid homology, PbMYST was 
the protein with nearest sequence identify (Figure 4.6; blastp results not shown). 
To test these hypotheses, in vitro histone methyltransferase assays (Fingerman, 
Du and Briggs, 2008) could be carried out, or in the case of PbHAT1, histone 
extraction from a pbhat1- line generated in this study (Chapter 3) may be used to 
identify missing or reduced H2AK5Ac presence from mature gametocyte histones.  
 
In summary, a number of leads have been determined in the identification of 
potential epigenetic regulatory enzymes that play a role in gametocytogenesis, 
based upon gametocyte-specific histone PTMs and known eukaryotic mediators of 
these histone PTMs. Though these findings are potentially important in discovering 
an enzyme that modulates commitment to gametocytogenesis, the histone PTMs 
identified in this study alone provide an insight into the conformation of the 
nucleosome in mature P. berghei schizonts and mature P. berghei gametocytes. 
These marks themselves can influence DNA accessibility and monoclonal 
antibodies to these histone PTMs can be used to immunoprecipitate genes or loci 
that are associated with these histone modifications (Collas, 2010). 
 
4.4.2 Sex-specific histone PTMs and their effect on the nucleosome     
 
Genome-wide nucleosomal maps demonstrate that gene ORFs are nucleosome-
dense, and so changes to nucleosome architecture, such as changes resulting from 
histone PTMs, can greatly affect gene transcription (Campos and Reinberg, 2009). 
Each histone alone has a histone fold domain that consists of three alpha helices 
(a1-a3) that are linked together by short loops (L1 and L2) that facilitate 
heterodimerisation of histone dimers (H2A with H2B, and H3 with H4) (Hammond 
et al., 2017). Following oligomerisation of H2A-H2B and H3-H4 dimers to form a 
complete nucleosome, the H3-H4 tetramer occupies the central ‘dyad’ of the 
nucleosome, with two H2A-H2B dimers forming entry and exit points for 
nucleosome-bound DNA. In addition to a1-a3 helices, H2A contains two short 
helices, H2B contains one C-terminal helix, and H3 harbours an N-terminal helix 
(H3aN) (Hammond et al., 2017) (Figure 4.8 C and D). A number of schizont- and 
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gametocyte- specific histone PTMs identified in this study were located at 
positions of DNA-histone and histone-histone contact that could influence 
nucleosome dynamics (Bowman and Poirier, 2015). These histone PTMs are shown 





Figure 4.8: Overview of P. berghei ANKA schizont and gametocyte nucleosomes with stage-
specific histone modifications. Images A and B are cartoon representations of P. berghei ANKA 
schizont and gametocyte nucleosomes respectively. In both A and B, stage-specific modifications 
identified using LC-MS/MS in the present study are indicated in dark blue text. All histone 
modifications on N- and C-terminal tails, and those with a putative role in regulating nucleosome 
dynamics are shown. In this figure, the H3/H4 heterodimer represents all canonical and variant H3 
and H4 combinations. The H2A/H2B heterodimer cartoon also represents all combinations of 
canonical and variant H2A and H2B histones. Histone modifications however are labelled as to 
whether they were present in the canonical or variant histone type. This cartoon representation 
of nucleosomes and their histones was drawn in the style of Figure 2 (B) from Bowman and Poirier, 
2015. Images C and D are cartoon representations of the histone modification changes observed in 
P. berghei schizont and gametocyte H3. In each histone, the N-terminus is indicated with an ‘N’ 
and the C-terminal end of the histone is indicated with a ‘C’. The positions of all histone 
modifications that differed between schizont and gametocyte H3s are indicated in dark green text. 
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The structurally important loop 1 and 2 domains of histones are labelled L1 and L2 respectively. 
The a-helical domains of H3 histones are indicated in yellow and labelled N-terminal a-helix (aN), 
a1, a2, and a3, based on both recombinant and human histone structural data (Luger et al., 1997; 
Iwasaki et al., 2013). Amino acid positions that mark the beginning and end of a-helical domains 
are numbered next to the a-helices in bold text.  
     
Figure 4.8 A and B illustrate the locations of schizont- and gametocyte-specific 
P. berghei histone PTMs that are known to influence nucleosome dynamics in 
eukaryotes (Bowman and Poirier, 2015). Though only 28 histone PTMs were 
identified as schizont-specific in 2 or more biological replicates, with 26 
differential histone PTMs in gametocyte histones, many of these modifications 
appear at nucleosome DNA entry/exit points, particularly, the histone 3 N-
terminal tail and the unique aN helix. The positions are again visualised in Figure 
4.8 C and D, with Figure 4.8 C showing the location of schizont-specific histone 
PTMs and Figure 4.8 D showing the location of gametocyte-specific H3 PTMs.  
 
Using the X. laevis model, mutation of any residues from H3K36 to H3S57 resulted 
in nucleosome sliding; a process in which nucloeosomal DNA accessibility is 
increased and the histone octamer is relocated to adjacent DNA segments (Becker, 
2002; Ferreira et al., 2007). In mature schizonts (Figure 4.8 A and C), the H3 aN 
helix is flanked and marked by 4 histone PTMs: H3K42me1, H3K49ac, H3K53ac, 
and H3K56ac. Of these marks, H3K56 acetylation has been extensively studied, 
and acetylation of this amino acid considerably increases nucleosome unwrapping 
and alters H3/H4 binding to histone chaperones (Bowman and Poirier, 2015). 
H3K56 acetylation leads to unwrapping of DNA from the histone octamer and is a 
marker of DNA replication (Stejskal et al., 2015).  
 
Conversely, in the gametocyte nucleosome (depicted in Figure 4.8 B), the histone 
3 residues associated with chromatin accessibility (H3K36 to H3S57) in other 
eukaryotes are marked by three different histone PTMs: H3K36me1, H3Y41ph, and 
H3T45ph (also depicted in Figure 4.8 D). H3K36 is located in the H3 N-terminal 
tail just ahead of the DNA entry/exit site of the nucleosome, though H3K36 itself 
does not interact directly with DNA. Instead, modification of H3K36, particularly 
trimethylation of this mark, is associated with binding of the Tudor domain-
containing PHD (plant homeodomain) finger protein 1 (PHF1), with results in 
downstream gene silencing (Musselman et al., 2013). The effect of H3K36 mono-
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methylation remains unclear. However, the adjacent H3T45 residue makes direct 
hydrogen bonds with the DNA backbone, with phosphorylation of both this mark 
and H3Y41 expected to result in DNA unwrapping from the histone octamer and 
exclusion of HP1 from cells (Dawson et al., 2009; Bowman and Poirier, 2015). In 
human cell lines, phosphorylation of H3Y41 appears tissue-specific (Dawson et al., 
2012). 
 
To summarise, mature asexual (schizont) stage and mature sexual (gametocyte) 
stage P. berghei ANKA parasites bear distinct histone PTMs (Figure 4.8). The 
extensively studied histone H3, and PTMs at the N-terminal domain and aN helix 
of this histone, suggests differential nucleosome-DNA binding at this point 
between these P. berghei life cycle stages. Though in both cases, histone marks 
on H3 are largely indicative of nucleosome unwrapping, the histone-DNA 
interactions at these stages may result in divergent gene expression profiles, with 
the H3K56ac mark, for example, marking asexual-stage genes for transcription 
(Bowman and Poirier, 2015). In gametocytes, the phosphorylation of H3Y41 and 
H3T45 in particular, may be associated with the expulsion of HP1 from repressed 
genes that are necessary for gametocyte conversion and later sexual maturation 
(Dawson et al., 2009; Brehove et al., 2015). Though shown to similarly promote 
nucleosome unwrapping and DNA accessibility in other eukaryotes (Brehove et al., 
2015), the results of this study suggest that these marks are stage-specific in P. 
berghei. ChIP-sequencing using H3K56ac and H3Y41 antibodies in P. berghei 
asexual stages and gametocytes would determine whether these histone PTMs 
associate with asexual-stage genes or genes upregulated during 
gametocytogenesis.  
 
In addition to further ChIP-sequencing studies, assays to determine the potential 
enzyme activity of P. berghei NEK4 and HAT1, as complete KO lines are already 
available for further examination, are warranted.   
 
4.4.3 Additional experimental methods to improve extraction and 
identification of histone modifications from Plasmodium spp.  
 
As alluded to in section 4.2.3, acid-extracted or high-salt-extracted histones can 
be analysed by immunoblotting or MS for identification (and possible 
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quantification) of histone PTMs. Immunoblotting is a limited method of PTM 
detection because detection is limited by the availability of antibodies, and that, 
even when an antibody is available, cross-reactivity between similar PTMs (such 
as di- or tri-methylation of a specific lysine) can occur (Egelhofer et al., 2011).  
 
At present, MS is the most useful tool for the identification of known or novel 
PTMs on histones. When preparing acid-extracted or high-salt-extracted histones 
for MS, the intact proteins must first be digested by proteolysis into peptides, 
ideally in the 5-20 aa size range, that can be more easily separated by LC, and 
more easily ionised for MS detection (Sidoli et al., 2016). The use of trypsin as the 
digesting enzyme (cleaving proteins at lysine and arginine residues, except where 
either is followed by a proline) is a standard approach in proteomics but can be 
an issue in the analysis of histones, which are lysine-rich and can yield tryptic 
fragments that are too small for LC retention.  
 
To overcome this problem, lysine derivatisation techniques using propionic 
anhydride have been developed in which the e-amino groups of unmodified and 
mono-methylated lysine residues are derivatised to propionyl amides, protecting 
them from trypsin digest (Garcia et al., 2007; Sidoli et al., 2015). Trypsin digest 
then takes place only at the C-termini of arginine residues (Sidoli et al., 2016). A 
second round of derivatisation is then used to modify the amino groups of newly-
generated N-termini, increasing peptide hydrophobicity and facilitating better 
interaction with LC reverse-phase columns (Karch, Sidoli and Garcia, 2016; Sidoli 
et al., 2016). Though not used in the present study, the addition of a lysine 
derivatisation step, and the addition of a greater number of protease inhibitors to 
cell lysis buffers and SDS-PAGE buffer (as described in section 4.3.3) may result 
in a greater number of histone PTMs detected by LC-MS/MS, particularly at the 
lysine-rich N-terminal tails of Plasmodium spp. histones.   
 
Using tandem MS (MS/MS), PTMs on histone amino acids are identified based on 
changes to the peptide mass-to-charge ratio (m/z), with isobaric peptides 
(peptides of identical m/z; for example, peptides containing K18ac or K23ac are 
isobaric) being separated only at MS/MS level, i.e. according to their unique 
fragment ions at a second (or later) round of MS detection (Sidoli et al., 2016). 
Several software options are available for the examination and interpretation of 
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MS/MS spectra from highly modified proteins such as histones (Sidoli, Cheng and 
Jensen, 2012). Quantification of high-resolution MS/MS data obtained from non-
labelled histones (for example, to quantify and compare the extent of post-
translational modifications between asexual and sexual P. berghei ANKA parasites) 
is also possible with the development of the ‘EpiProfile’ program (Yuan et al., 
2015). Such quantification software could also be applied in future to the dataset 
produced in this study, enabling quantification of a number of histone PTMs at 
asexual and sexual stages.  
 
4.4.4 Biological limitations to P. berghei histone extraction 
 
In the present study, a number of issues were taken into consideration when 
interpreting the results of LC-MS/MS spectra from P. berghei ANKA asexual and 
sexual stage parasites. In this study, the AP2-G over-expressor P. berghei ANKA 
line (the P. berghei G1142 line) was used to decrease contamination of either 
mature asexual stage parasites (schizonts) or mature sexual stage parasites 
(gametocytes) with parasites of an undesired life cycle stage (discussed in section 
4.3.1). One could argue that, though asexual or sexual development was assured 
by the absence or administration of rapamycin respectively, the forced manner in 
which gametocytogenesis was either prevented or induced produced histone 
modifications that were not natural to the P. berghei parasite. In a wild-type P. 
berghei line, commitment to gametocytogenesis may be the result of histone 
modifications (and subsequent downstream effects) that are bypassed when AP2-
G is conditionally induced in the G1142 line.  
 
In addition, assuring gametocyte maturity in both WT and G1142 P. berghei ANKA 
lines may have resulted in the loss of early gametocyte histone modifications that 
are only present at the moment of sexual commitment. To ensure that this is not 
the case, future experiments would need to be carried out in a non-inducible P. 
berghei ANKA line, and with a timed infection of a rodent model by synchronous 
merozoites. In the present study, an attempt was made to infect a rat with 
synchronous merozoites for examination of synchronous trophozoite histone 
modifications, with intravenous infection of a Wistar rat carried out in the same 
method as intravenous infection of synchronous, purified P. berghei parasites into 
the lateral tail veins of mice (section 2.1.3). Unfortunately, owing to the 
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thickened skin overlying the vasculature of the adult rat tail, attempts to infect 
rats intravenously with P. berghei failed. Infection of rats with synchronous, 
purified P. berghei parasites for the production of schizonts and gametocytes was 
carried out by intraperitoneal (IP) injection (as described in section 2.1.2).   
 
4.4.5 Limitations to identification and quantification of histone PTMs from LC-
MS/MS data using Mascot and EpiProfile software 
 
In the present study, identification of histone PTMs was carried out using a so-
called ‘bottom-up’ proteomics analysis approach, i.e. histones were extracted 
from P. berghei ANKA cells, digested with a protease (trypsin), and analysed by 
LC-MS/MS (Yuan et al., 2014). In a ‘top-down’ proteomics approach, intact 
proteins, i.e. proteins that have not been lysed by trypsin or any other protease, 
are introduced to the mass spectrometer. The latter approach, though requiring 
more starting material and longer running times, may be more useful in the 
identification of proteoforms compared to a ‘bottom-up’ approach (Catherman, 
Skinner and Kelleher, 2014). In the present study, a ‘bottom-up’ proteomics 
approach was sufficient.   
 
As was recommended for discovery of peptide PTMs using this approach, Mascot 
software version 2.6.2 (Matrix Science) was used to identify stage-specific histone 
modifications in P. berghei parasites (Sidoli et al., 2016). Mascot is a probability-
based protein identification software, written in ANSI C, that calculates the 
probability that the observed match between the experimental dataset and a 
sequence database entry is a chance event, and the match with the lowest 
probability is given the highest score and presented to the user (Perkins et al., 
1999). In the present study, Mascot software was used in combination with a P. 
berghei ANKA amino acid FASTA database (version 35), with a significance 
threshold of p<0.05, and a false discovery rate (FDR) less than 1%. An allowance 
was made for up to five missed cleavages by trypsin digest which enabled 
detection of the lysine-rich N-termini of P. berghei ANKA histones. Without this 
allowance being made, PTMs such as H2AK5ac and H3K9ac were not identified.  
 
Though developed following the commencement of this study, quantification of 
chemically-unlabelled histone PTMs in P. berghei ANKA may be possible by using 
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the EpiProfile software tool, a feat not possible using Mascot software alone (Yuan 
et al., 2015). This software is freely available upon request and was used to 
quantify a selection of PTMs in P. falciparum that were identified by LC-MS/MS in 
a similar manner to the present study (Coetzee et al., 2017). EpiProfile quantifies 
histone PTMs based upon chromatographic elution retention times of known 
histone peptides. Raw MS1 and MS2 files can be imported into EpiProfile and 
quantification of histone peptides carried out. Quantification of P. berghei ANKA 
histone PTMs identified in the present study would be possible using this software 





































5. Identification of genes regulated by histone modifications  
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5.1 Chapter Aim 
 
The aim of this chapter was to determine P. berghei ANKA genes that were 
targeted by four epigenetic modifications (H3K9ac, H3K9me3, H4K8ac, and 
H3K122ac) in both schizonts and gametocytes to examine their stage-specificity 
and possible involvement in the regulation of gametocytogenesis. 
 
5.2 Introduction: Chromatin immunoprecipitation (ChIP) 
 
The identification of differences between mature asexual stage (schizont) and 
sexual stage (gametocyte) P. berghei histone PTMs (Chapter 4) warranted an 
investigation into the possible target genes of these differential marks. To 
facilitate such an examination, chromatin immunoprecipitation (ChIP) was 
employed; a procedure that enables investigators to probe the relationship of a 
protein-of-interest (POI), or a modified POI, to a genomic DNA region (Carey, 
Peterson and Smale, 2009). A ChIP procedure can be carried out on samples in 
which the DNA and protein have not been chemically crosslinked (called native 
ChIP or ‘N-ChIP’) or in samples in which a protein and its target DNA have been 
crosslinked chemically (sometimes referred to as ‘XChIP’). Formaldehyde is the 
most commonly-used protein-DNA crosslinker used in ChIP analyses (Hoffman et 
al., 2015).  
 
In fact, a ChIP procedure is quite straightforward, and it is only with multiple 
options available at each step of the procedure that the complete protocol can 
become complicated. For example, the investigator must choose between native- 
or crosslinked- ChIP; must choose a crosslinking chemical to work with; must 
choose between Tris or glycine for quenching of the crosslinking reaction; must 
choose to fragment cell pellets by douncing, micrococcal nuclease (MNase) 
digestion, sonication, or a combination of these methods (Haring et al., 2007). 
Even more choices are required after these preparation steps; a control sample to 
normalise results against must be chosen, and library preparation before high-
throughput sequencing can be undertaken in multiple different ways, generating 
the separate techniques: standard ChIP-seq, ChIP-exo, or ChIPmentation (to name 
but a few) (Carey, Peterson and Smale, 2009; Schmidl et al., 2015; Perreault and 
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Venters, 2016). Both standard ChIP-seq and ChIPmentation procedures were 
attempted during the present study (experimental procedures detailed in sections 
2.2.11 and 2.2.12 respectively).   
 
Though standard ChIP-seq and ChIPmentation protocols in the present study are 
described for sequencing using Illumina sequencing platforms, a standard ChIP 
procedure, followed by immunoprecipitation and de-crosslinking, would produce 
DNA fragments amenable to other forms of DNA sequencing, with only slight 
changes to library preparation. Sequencing of ChIP DNA by sequencing platforms 
from Pacific Biosciences or Oxford Nanopore Technologies, though not common, 
is possible (Rhoads and Au, 2015; Jain et al., 2018). In the present study, all ChIP-
sequencing and ChIPmentation experiments were carried out as described in 
sections 2.2.11 and 2.2.12 respectively, with bioinformatic analysis carried out 




5.3.1 Optimising ChIPmentation in P. berghei: Cell number, sonication, and 
de-crosslinking 
 
Although novel protocols for ChIP-seq experiments are currently being devised for 
fewer and fewer cell numbers; for example, a protocol for ultra-low-input native 
ChIP-seq from as few as 1000 cells (Brind’Amour et al., 2015), or the 
amalgamation of drop-based microfluidics and chromatin fragment barcoding to 
enable the first single-cell ChIP-seq analysis from as few as 50 embryonic stem 
cells (Rotem et al., 2015); standard ChIP-seq protocols still require abundant 
starting material, often in the range of 1-20 million single cells per 
immunoprecipitation (Gilfillan et al., 2012).  
 
To overcome this limitation, and to study cells from a single stage of the P. berghei 
ANKA life-cycle, the present study was designed to test the reliability of a 
ChIPmentation protocol using the Tn5 transposase from a Nextera DNA library 
preparation kit (Illumina, Inc.) (Schmidl et al., 2015). Though the initial aim of 
this chapter was to examine both asexual- and sexual- stage P. berghei parasites, 
time restrictions allowed only for optimisation of ChIPmentation using P. berghei 
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schizonts. Synchronous P. berghei ANKA schizonts provided the greatest 
abundance of starting genetic material, and multiple antibodies could be tested 
from the same schizont sample at 250,000, 2.5 million, and 25 million cells, with 
later analyses revealing the optimum cell number and antibody concentration for 
a successful ChIPmentation experiment. Standard ChIP-seq analysis was also 
attempted using the same cell numbers as described in section 2.2.11, though 
there was never enough genetic material left after the library preparation 
procedure for high-throughput sequencing to be carried out.   
 
Other alterations to a standard ChIP protocol used when studying P. berghei ANKA 
in the present study included a change to sonication conditions (detailed in 
sections 2.2.11.2 and 2.2.12.2) which were adapted according to consultation 
with Dr Agnieszka Religa at the University of Glasgow. When undertaking ChIP in 
P. berghei schizonts, this sequence of sonication pulses was often repeated to 
obtain chromatin-DNA fragments in the range of 100-1000 bp, with regions of 100-
300 bp excised by gel excision for further immunoprecipitation.  
 
One final note must be made regarding the optimisation of de-crosslinking and 
enzyme denaturation temperatures when undertaking ChIP experiments and ChIP 
DNA library preparation in Plasmodium parasites. As alluded to in Fraschka et al.  
(Fraschka et al., 2018), the extreme AT-richness of Plasmodium genomes requires 
that a lowered temperature be used when de-crosslinking chromatin from DNA in 
a ChIP experiment (45ºC instead of 65ºC). A standard 65ºC de-crosslinking 
temperature (usually carried out from 6 h to overnight), results in denaturation 
of ChIP DNA, particularly in standard ChIP-seq samples or inputs (personal 
experience). It is possible that ligation of Illumina adapters prior to de-crosslinking 
in ChIPmentation experiments somewhat ameliorated the loss of genetic material 
by increasing the GC content of DNA fragments during the ‘tagmentation’ process. 
This may explain why ChIPmentation experiments in this study proved successful, 
while a standard ChIP-seq protocol failed.    
 
At the outset of the present study, all experiments were carried out with overnight 
de-crosslinking at 65ºC, resulting in the loss of many input samples. Upon 
publication of Fraschka et al, 2018 (Fraschka et al., 2018), in which the de-
crosslinking of ChIP DNA from Plasmodium spp. at 45ºC was noted, the cause for 
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loss of ChIP material in the present study had also been narrowed down to this 
point in the experimental procedure. When undertaking a standard ChIP-seq 
experiment, altering enzyme denaturation temperatures when using the NEBNext® 
UltraTM II DNA Library Prep Kit for Illumina® (Catalogue No. #E7645S; New England 
BioLabs Inc.) was also attempted upon consultation with Dr Kathryn Crouch and 
Craig Lapsley at the University of Glasgow. In this case, the replacement of 65ºC 
incubation steps with SPRIselect bead (Beckman Coulter, Inc.) clean-ups had 
considerably reduced the loss of genetic material when studying subtelomeric 
regions in the genome of trypanosomatid parasites. Despite this, using a standard 
ChIP-seq protocol in the present study failed to produce amplifiable DNA libraries.  
 
5.3.2 Comparative analysis of 250K, 2.5M, and 25M schizonts  
 
Following an initial pilot study of H4K8 acetylation with 22.7 million schizont-
stage P. berghei parasites per sample (results not shown), further optimisation of 
the ChIPmentation procedure was carried out to identify an optimum cell number 
for further experiments. Although cultivation of 22.7 million synchronous 
schizonts was possible, the collection of such cell numbers from other P. berghei 
life-cycle stages was not possible without a great number of animals being 
infected and resulting samples pooled. As such, it was decided to attempt the 
same procedure with 250,000, 2.5 million, and 25 million synchronous schizont-
stage parasites. For each number of cells, an input was also taken, and each cell 
amount was investigated with 4 separate antibodies: H4K8ac, H3K9me3, H3K9ac, 
and H3K122ac.  
 
Owing to issues with de-crosslinking temperature and loss of ChIP DNA (discussed 
in section 5.3.1), only one input sample produced a usable library for sequencing 
following tagmentation, de-crosslinking and amplification steps; an input sample 
for 250,000 schizont cells. Consequently, this sample was used as a control for all 
initial UpSetR visualisation of ChIPmentation samples from 250,000, 2.5 million, 
and 25 million cells.  Later ChIPmentation repeats (with 2.5 million cells) would 
also be normalised to input data downloaded from NCBI 
(https://www.ncbi.nlm.nih.gov/sra/SRR5935720) (Fraschka et al., 2018), as this 
input provided greater genome coverage than the input obtained in the present 
study. Peak-calling software options were then tested as described in section 
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5.3.4. The number of peaks called and the number of peaks shared between 
different software packages are shown for all samples as an UpSet plot (separate 
UpSet plots are shown for examination of each histone PTM).  
 
5.3.3 Correlating ChIPmentation results to RNA-seq data 
 
It is important for the present study that ChIPmentation results using each of the 
four antibodies tested (H4K8ac, H3K9ac, H3K9me3, and H3K122ac) were aligned 
alongside transcriptomic data (i.e. RNA-sequencing (RNA-seq) data) to evaluate 
whether the presence of each histone modification correlated to gene expression, 
gene repression, or a mixture of both (for example, if the modification is 
dependent upon co-localisation of a second histone mark; such as the relationship 
between H3K9ac and H3K4me3 (Gates et al., 2017)).  
 
In the present study, because optimisation of the ChIPmentation technique took 
place only with mature asexual (schizont-stage) P. berghei parasites owing to time 
limitations, comparative analysis between the previous developmental stage (16 
h trophozoites) and 22 h schizonts was undertaken to identify transcripts that 
were specific to mature schizonts. Down-regulation of transcription in 22 h 
schizonts indicated that greater expression of a particular gene took place during 
earlier asexual development. Upregulation of transcription in schizonts indicated 
that a gene was expressed to a greater extent in the mature 22 h asexual parasites 
(Otto, Böhme, et al., 2014). Methods used to analyse RNA-seq data are described 
in section 2.2.14.     
 
In Plasmodium spp. parasites so far, H4K8ac has been linked to transcriptional 
activation in euchromatic regions of the genome, and at heterochromatic regions, 
where it marks transcription of the active var gene at the promoter (Gupta et al., 
2017). Trimethylation of H3K9 is associated with silent multicopy variant gene 
families at the nuclear periphery and transcriptional repression (Lopez-Rubio, 
Mancio-Silva and Scherf, 2009; Karmodiya et al., 2015), while acetylation of H3K9 
in Plasmodium is associated with transcriptional activation (Salcedo-Amaya et al., 
2009; Srivastava et al., 2014). The recently characterised H3K122ac modification 
has never before been studied in a Plasmodium parasite, but has been associated 
with transcriptional activation and marking a subset of active enhancers in human 
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cell lines (K562 and MCF-7 lines) and mouse embryonic stem cells (Tropberger et 
al., 2013; Pradeepa et al., 2016).  
 
5.3.4 Optimisation of peak-calling software  
 
In the present study, identification of a ‘peak-caller’ that could adequately 
identify the broad peaks associated with some histone PTMs was carried out using 
P. berghei schizont ChIPmentation data. It is well-noted that a number of PTMs, 
for example H4K20me1 and H3K27me3, associate with large genomic regions 
(Rintisch et al., 2014), and so a number of algorithms have been developed to 
assist in the identification of broad peaks from ChIP-sequencing experiments, with 
or without a priori knowledge of the genomic distribution of a histone PTM to be 
analysed (Wang, Lunyak and King Jordan, 2013; Heinig et al., 2015; Starmer and 
Magnuson, 2016; Khomtchouk, Van Booven and Wahlestedt, 2017).   
 
In this study, three ChIP peak-calling software packages were tested for their 
ability to identify broad peaks associated with histone modifications in P. berghei. 
The peak-calling software packages, MACS2 (Zhang et al., 2008), HOMER (Heinz 
et al., 2010), and Epic (Xu et al., 2014) were tested and the ‘UpSetR’ R package 
was used to display unique and shared peak data as described by Conway et al. 
(Conway, Lex and Gehlenborg, 2017). HOMER ChIP peak annotation software was 
later used to label ChIP peaks relative to their location adjacent to, or within, an 
ORF (http://homer.ucsd.edu/homer/ngs/annotation.html). In the case of 
H3K9me3, ChIP data from this study was also mapped alongside HP1 ChIP data 
which was downloaded from NCBI 
(https://www.ncbi.nlm.nih.gov/sra/SRX3095675[accn]) (Fraschka et al., 2018). 
Results from these analyses are shown in the sections below. 
 
5.3.5 Identifying outlying ChIPmentation samples by multidimensional scaling 
 
As described in section 2.2.15, and often used to examine heterogeneity between 
RNA-seq datasets (bulk or single-cell samples) (Dey, Hsiao and Stephens, 2017), 
multidimensional scaling (MDS) was carried out in this study to map similarity 
between ChIPmentation sample datasets and inputs. Using edgeR, outlying 
ChIPmentation datasets for each of the four histone marks analysed, at 2.5 million 
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schizonts per experiment, were identified and excluded from the study (Robinson, 
Mccarthy and Smyth, 2010). MDS results are shown in Figure 5.1.  
 
Figure 5.1: Multidimensional scaling (MDS) of triplicate ChIPmentation samples to determine 
outliers. The MDS plot shown was generated using edgeR (Robinson, McCarthy and Smyth, 2010). 
The ‘plotMDS’ function was applied to all three replicate datasets from ChIPmentation with four 
separate histone modification antibodies: H4K8ac, H3K9me3, H3K9ac, and H3K122ac. All 12 of 
these samples were derived from 2.5 million P. berghei ANKA schizonts. In the case of inputs; the 
first input (S3_INPUT) was derived from 250,000 mature P. berghei schizonts during the present 
study. As no further inputs were successfully collected during the present study (owing to the 65°C 
de-crosslinking temperature used), a second input was also downloaded for P. berghei schizonts 
from (https://www.ncbi.nlm.nih.gov/sra/SRR5935720) (Fraschka et al., 2018). This input was 
used to normalise triplicate ChIPmentation studies using 2.5 million schizont cells. X- and y- axes 
represent the leading log fold change (logFC) dimension 1 (dim 1) and leading logFC dimension 2 
(dim 2). Samples are colour-coded in addition to labelling.  
 
As can be seen from Figure 5.1, inputs cluster separately within the MDS plot and 
in the case of each histone modification antibody, two samples in each case 
appear to cluster together, with a third sample appearing to be an outlier. In the 
case of H3K122ac, two samples (samples JP5_H3K122Ac and JP10_H3K122Ac) are 
clustered closely. A third replicate, S8_H3K122Ac, appears to be an outlier among 
the triplicate samples and so final H3K122ac results are based on the former two 
clustered samples. In the case of H4K8 acetylation, two samples clearly cluster 
together (samples JP4_H4K8Ac and JP9_H4K8Ac), while the third replicate 
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(S2_H4K8Ac) was a clear outlier and so was again discarded during in-depth 
analysis of H4K8 acetylation in later sections. 
 
Regarding histone 3, lysine 9 modifications; in each case, two samples cluster 
vertically at the x-axis: S5_H3K9Ac and JP3_H3K9Ac, and S5_H3K9me3 and 
JP7_H3K9me3. In both of these cases also, outlying samples (JP6_H3K9Ac and 
JP2_H3K9me3) were discarded in final results sections.  
 
Though outlying samples were removed in the text, a complete list of merged 
peaks for all four antibodies, between all three biological replicates, are provided 
in Supplemental Material ES3 alongside peaks called for each sample separately, 
and peaks called using Epic software for clustered duplicate samples.   
 
5.4 H4K8 acetylation in P. berghei schizonts 
 
5.4.1 H4K8ac: Cell number and genomic distribution   




Figure 5.2: A comparison of shared and unique peaks from H4K8ac ChIP samples using MACS2, 
HOMER, and Epic software. This UpSet plot shows the number of unique peaks called using MACS2, 
HOMER, and Epic software on the left-hand side. Each sample name is shown next to the number 
of unique peaks per category, with cell numbers and software name clearly labelled. The main 
histogram depicts the number of overlapping peaks in each H4K8ac sample. At the base of the 
histogram, overlapping peaks shared between samples are indicated using circles, or circles joined 
with a straight line. From the histogram above, it is very clear that MACS2 software (Zhang et al., 
2008) was identifying a small number of unique peaks, but no overlapping peaks, in the H4K8ac 
replicate samples (no peaks were detected for the 22.7 million cell sample; not shown). In 
contrast, using HOMER (Heinz et al., 2010) and Epic (Xu et al., 2014), a much greater number of 
unique and overlapping peaks were identified. Using both HOMER and Epic, peaks were called for 
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As shown in Figure 5.4, the greatest number of overlapping peaks were identified 
using Epic, the most recently developed peak-calling software for disperse ChIP-
enriched regions, based on the SICER peak-calling algorithm (Xu et al., 2014). Epic 
called 1328 overlapping peaks across the P. berghei ANKA genome from a sample 
of 2.5 million schizonts. Using Epic, a score is generated for each overlapping peak 
and these scores are listed alongside the gene identifiers and peak position in 
Electronic Supplemental Material 2 (ES2).  
 
To further assess the accuracy of the Epic peak-calling software and to compare 
the results from all three different cell numbers (and the 22.7 M cell pilot study), 
alignment of all bigwig (H4K8ac/control) and Epic peak files was undertaken and 




Figure 5.3: H4K8ac peaks across the P. berghei ANKA genome using Epic peak-calling software. 
Using the Integrative Genome Viewer (IGV) (Robinson et al., 2011), H4K8ac-bound (sample/input) 
reads (for 250K, 2.5 million, 22.7 million, and 25 million schizonts) are shown across the entire P. 
berghei ANKA genome (version 34) alongside peaks called using the ‘Epic’ peak-calling software 
(in .bed format; results are normalised to the 250K schizont ChIP input sample) (a). At the base of 
these tracks, the general feature format (.gff) file shows the location of genes as black bars. For 
each sample, aligned ChIP data is displayed in blue. Epic peaks are shown in a separate track 
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underneath ChIP data and are displayed in a dark yellow colour. In (b), aligned reads and peak 
files are again shown as in (a), though in this case, only the developmentally important (during 
gametocytogenesis) chromosome 14 is shown in closer detail (Kooij et al., 2005; Lopez-Rubio, 
Mancio-Silva and Scherf, 2009; Fraschka et al., 2018). Again, colour-coding is carried out as in (a).  
 
As seen in Figure 5.3, both the whole genome view of aligned ChIP data (Figure 
5.3 (a)) and a zoomed-in visualisation of P. berghei ANKA chromosome 14 
(syntenic to P. falciparum chromosome 12; a chromosome that has previously 
been heavily analysed due to its role in gametocytogenesis) (Figure 5.3 (b); (Kooij 
et al., 2005; Lopez-Rubio, Mancio-Silva and Scherf, 2009; Salcedo-Amaya et al., 
2009; Fraschka et al., 2018)) showed quite an even distribution of raw data and 
Epic peaks between all samples except for 250,000 schizont cells. In Figure 5.3 
(a), it is evident that quite a few of the peaks in raw data seen with >2.5 million 
cells were not enriched in this sample. Taking a closer look at chromosome 14 
(Figure 5.3 (b)) also showed that fewer peaks were observed when ChIPmentation 
was carried out with 250,000 cells. With these data, it was decided to repeat the 
ChIPmentation protocol using two more independent P. berghei ANKA samples of 
2.5 million synchronous schizonts. With these data, a comparative analysis of 
H4K8ac-binding across the P. berghei genome could be undertaken with a greater 
degree of certainty. These data were also aligned to an input with greater genome 
coverage (downloaded from NCBI (Fraschka et al., 2018)).   
 
5.4.2 H4K8ac analysis in triplicate (2.5 M schizonts) 
 
Following a comparison of three peak-calling algorithms across samples of either 
250,000, 2.5 million, 22.7 million (a pilot study), or 25 million cells, a final analysis 
of H4K8ac-binding during mature asexual schizont stage in P. berghei was carried 
out using 2.5 M cells in triplicate. All peaks called using Epic peak-calling software 
for all independent replicate experiments are listed in detail in Electronic 
Supplemental Material 3 (ES3). All samples shown were normalised to input data 
obtained as part of a previous P. berghei ANKA schizont ChIP experiment (Fraschka 
et al., 2018). Final results show shared peaks between duplicate biological 
replicates JP4_H4K8Ac and JP9_H4K8Ac, following removal of outlying sample 
S2_H4K8Ac based on MDS analysis (Figure 5.3.5). An overview of read and peak 
distribution for these H4K8ac samples of 2.5 million schizont cells is shown in 
Figure 5.4.  






Figure 5.4: H4K8ac peak distribution across the P. berghei ANKA genome. Using the Integrative 
Genome Viewer (IGV) (Robinson et al., 2011), H4K8ac-bound reads (relative to an input sample 
from Fraschka et al., 2018) from two independent samples of 2.5 million schizonts are shown in 
(a). Raw data are displayed in blue and Epic peaks are displayed in yellow underneath the raw 
data track. Merged peaks between both samples are shown in pink underneath individual results. 
Genes are displayed in general feature format (.gff) in the final track as black bars. (b) is a pie-
chart showing gene ontology (GO) terms for biological processes that were associated with the 
genes to which H4K8ac was bound (with a P-value < 0.025). Image (c) shows the same data as (b), 
though this time, the location of the area of H4K8ac enrichment is shown relative to the nearest 
gene ORF.  
 
Using the Epic algorithm, ChIP-enriched ‘islands’ are delineated and assessed for 
statistical significance by i) partitioning the genome into non-overlapping 
windows, ii) identifying an ‘eligible’ region of enrichment according to a read 
count threshold (which takes into consideration the average number of reads 
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within a window, within the library, and the genome length), iii) determining 
clusters of windows as contiguous ChIP-enriched islands by searching for gaps of a 
pre-determined basepair value, iv) identifying ‘candidate’ islands that are 
unlikely to appear by chance (assigned an initial ‘s(l)’ score), and v) if a control is 
available, candidate islands of ChIP-enrichment are further filtered based on the 
control signal, with values assigned a P-value based on Poisson distribution and a 
false discovery rate (FDR) reported using the P-value adjusted for multiple-testing 
(Xu et al., 2014). In the ES3 material, the ‘s(l)’ score, log2 fold change (log2FC), 
P-value, and FDR are shown in columns O, P, Q, and R respectively for each 
independent experiment.  
 
To annotate peaks, the Epic output (.bed) file was mapped to the reference 
genome using the HOMER (Hypergeometric Optimization of Motif Enrichment) 
script downloaded from http://homer.ucsd.edu/homer/ngs/annotation.html. 
With regard to the genome locations shown in Figure 5.4 (c), the promoter-
transcription start site (promoter-TSS) is defined by default as -1 kb to +100 bp 
around the TSS using the P. berghei ANKA genome (version 34) annotation. The 
transcription termination site (TTS) is defined as -100 bp to +1 kb either side of 
the TTS. The exon and intron locations are defined according to the P. berghei 
ANKA genome annotation (version 34). An ‘intergenic’ region is defined as 
anything up- or down- stream of exons and introns that is not covered by the 
‘promoter-TSS’ or ‘TTS’ parameters.  
 
Figure 5.4 (b) depicts the GO terms for biological processes associated with 
H4K8ac-bound genes. When analysing GO terms using PlasmoDB for merged 
H4K8ac peaks, a P-value cut-off was set at 0.025. Taking the 1396 merged peaks 
between two independent experiments, H4K8ac-bound genes were associated 
with tRNA processing (44%), DNA replication (23%), nucleobase-containing 
compound transport (13%), phenylalanyl-tRNA aminoacylation (10%) and protein 
oligomerisation (10%) (Figure 5.4 (b)), all processes suggesting active DNA 
replication in mature schizonts. When an analysis of H4K8 acetylation was carried 
out in P. falciparum, this mark was associated in schizonts with transcription of 
genes involved in DNA replication, excision-repair, and apicoplast/mitochondrial 
import (Gupta et al., 2017). However, it should also be noted that a recent 
transcriptomic analysis between multiple different P. falciparum strains at 
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schizont stage determined that there were significantly differentially-expressed 
genes between schizonts from laboratory-adapted P. falciparum strains and 
clinical isolates, particularly at genes involved in gametocytogenesis; meaning 
that caution should be taken when comparing P. falciparum H4K8ac results to P. 
berghei ANKA H4K8ac results seen in this experiment (Tarr et al., 2018). 
Differences in H4K8ac distribution may not only occur between human and rodent 
Plasmodium lineages, but also between strains among the same Plasmodium 
species.       
     
In addition, transcriptional activity in P. falciparum was noted as occurring only 
when H4K8ac-occupancy shifted from the 5’-end of the ORF to within the protein-
coding region (Gupta et al., 2017). In Figure 5.4 (c), it can be seen that of the 
merged H4K8ac peaks, H4K8ac-occupancy was mainly located at exons (62% of 
peaks), TTS regions (17%), and promoter-TSS regions (14% of peaks), almost 
exclusively. Taking into account the association of H4K8ac occupancy in these 
regions and altered transcription in P. falciparum, it may be the case that H4K8ac 
merged peaks associated with exons correlate with differential RNA expression in 
P. berghei. To examine this possible relationship, all H4K8ac merged peaks 
located at exons from duplicate schizont samples (1396 merged peaks) were 
searched among differentially-expressed genes (as discussed in section 5.3.3). 




Figure 5.5: H4K8ac-binding at P. berghei schizont exons and association with differential RNA 
expression. The Venn diagram on the left of this image depicts the overlap between H4K8ac-
associated exons (thought to be associated with greater transcriptional regulation in P. falciparum 
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(Gupta et al., 2017)) and differentially-expressed genes between schizont- and trophozoite- stage 
P. berghei ANKA parasites (with a false discovery rate (FDR) less than 0.005). 1396 merged peaks 
across duplicate H4K8ac ChIPmentation experiments were compared to 2161 differentially-
expressed genes with FDR < 0.005. Within these two groups, 389 H4K8ac-associated exons were 
associated with differentially-expressed genes; 188 genes that were up-regulated in schizonts 
compared to trophozoites, and 201 genes that were down-regulated in schizonts compared to 
trophozoites. Up-regulation and down-regulation is indicated by upward and downward facing 
arrows next to the figure respectively. To the right of this Venn diagram, GO terms for up-
regulated and down-regulated genes associated with H4K8ac-binding are shown (P < 0.001). Again, 
arrows indicate up-regulation or down-regulation of RNA transcription, with the tables shown also 
depicting the GO ID for these particular datasets alongside the GO term and fold enrichment for 
each term.     
  
As shown in Figure 5.5, H4K8ac-binding at P. berghei ANKA exons is not solely 
associated with up-regulation of RNA at a particular gene. These data corroborate 
the results of Gupta et al. (Gupta et al., 2017) who, in their study, showed a 
similar pattern of overlap between H4K8ac occupancy and differential expression, 
with H4K8 acetylation being a potential regulator of chromatin-linked 
transcriptional changes associated with both euchromatin and heterochromatin. 
Of the H4K8ac-associated genes in P. falciparum, up-regulated genes were 
associated with chromatin modification, merozoite surface proteins, and genes 
encoding for transport proteins. Of the down-regulated H4K8ac-associated genes, 
genes involved in excision repair and DNA replication were effected to the 
greatest extent (Gupta et al., 2017).   
 
In the present study, H4K8ac-bound exons that correlated with greatest gene up-
regulation in P. berghei ANKA were associated with DNA metabolic processes 
(which includes DNA repair and excision), multi-organism processes (which include 
adhesion of symbionts to a host), interspecies interactions, and symbiosis (Figure 
5.5). Of the down-regulated H4K8ac-associated exons, greatest down-regulation 
was associated with GO terms encompassing gene expression, protein folding, and 
non-coding RNA processes, all of which are consistent with previous results in P. 
falciparum (Gupta et al., 2017; The Gene Ontology Consortium, 2017).  
 
With regard to all H4K8ac-bound regions identified in the present study, the 
highest-scoring shared peaks for H4K8ac-bound genes from duplicate independent 
samples (according to the Epic algorithm) are shown in Table 5.1.  





Table 5.1: Highest-scoring H4K8ac peaks in P. berghei schizonts. This table displays the top 10 
H4K8ac-bound genes according to their Epic peak-calling score. All genes are shared among 
duplicate H4K8ac ChIPmentation experiments and the highest score between replicates is shown 
in the fifth column. The list of genes is numbered from highest to lowest score and the first and 
second columns of the table list gene IDs and current known function (if any) of the gene in P. 
berghei ANKA [as of 09-07-18]. The fourth column shows the location of H4K8ac peaks relative to 
the gene in question. The sixth column indicates differentially-expressed gene regulation in 
schizonts at 22 h compared to 16 h trophozoite expression (Otto, Böhme, et al., 2014). The 
following columns list the log2 fold change (log2FC), P-value, and false discovery rate (FDR) (where 
applicable) of the differential RNA expression.  
 
One striking feature of Table 5.1 is the fact that H4K8 acetylation is associated 
with differential RNA expression in all genes other than PIR protein pseudogenes 
and the reticulocyte binding protein, Pb235 (encoded by PBANKA_0501000.1. All 
of these H4K8ac-bound genes were found in both duplicate independent 
experiments and of the only two gene that have so far been characterised (SOC2 
and a small rRNA), the SOC2 protein is associated with mitotic spindle assembly, 
and therefore cell replication, alongside the small rRNA (Fang et al., 2017). 
However, of the highest scoring peaks according to Epic, the five H4K8ac-bound 
regions that also coincide with differential expression of genes do not meet the 
threshold for statistically significant differential expression, a Log2FC false 
discovery rate < 0.05.  
 
With regard to the PIR genes/pseudogenes, these genes comprise the largest 
multigene family in Plasmodium spp., with a recent study in P. chabaudi AS 
implicating a number of ‘cir’ proteins in rosetting of infected RBCs and merozoite 
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invasion (Yam et al., 2016). The H4K8ac-bound ‘bir’ genes identified in Table 5.1 
did not correlate with differential RNA expression. However, like other multigene 
families implicated in antigenic variation, such as P. falciparum var genes, 
H4K8ac-binding may only indicate that a gene is poised for expression, with a 
unique set of both activating and repressive histone modifications necessary for 
mutually exclusive transcription (Karmodiya et al., 2015). Mapping of repressive 
histone modifications, such as H3K9me3 shown below in section 5.5, may provide 
more evidence as to which ‘bir’ family members are in fact transcribed, and which 
are silenced.   
                          
5.5 H3K9 trimethylation in P. berghei schizonts 
 
Using identical sequencing methods and bioinformatic analysis as those used to 
delineate the role of H4K8ac-binding in mature schizonts (section 5.4), the 
location of H3K9me3-bound regions in the P. berghei ANKA schizont genome were 
examined. Unlike H4K8 acetylation, H3K9me3-binding in Plasmodium spp. was 
previously shown to demarcate large heterochromatic domains in all subtelomeric 
regions and a few internal regions in some chromosomes (Salcedo-Amaya et al., 




Figure 5.6: Distribution of H3K9 trimethylation across the P. berghei ANKA genome at schizont 
stage. Using the IGV browser, H3K9me3-bound (sample/input) reads (for 250K, 2.5 million, and 25 
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million schizonts) are shown across the entire P. berghei ANKA genome (version 34) alongside peaks 
called using the ‘Epic’ peak-calling software (in .bed format; results are normalised to the 250K 
schizont ChIP input sample) (a). At the base of these tracks, the general feature format (.gff) file 
shows the location of genes as black bars. For each sample, aligned ChIP data is displayed in blue. 
Epic peaks are shown in a separate track underneath ChIP data and are displayed in a dark yellow 
colour. In (b), aligned reads and peak files are again shown as in (a), though in this case (as for 
Figure 5.3, only the developmentally important chromosome 14 is shown in closer detail 
(homologous to P. falciparum chromosome 12) (J.-J. Lopez-Rubio, Mancio-Silva and Scherf, 2009; 
Fraschka et al., 2018). Colour-coding is carried out as in (a). 
 
From an initial comparison of P. berghei H3K9me3 ChIPmentation results in Figure 
5.6 (a), it appears that, as in P. falciparum, the H3K9me3 modification 
demarcates heterochromatic regions at chromosome telomeres (Lopez-Rubio, 
Mancio-Silva and Scherf, 2009). The repressive H3K9me3 mark appears enriched 
at the telomeres of all 14 chromosomes, though when focussing in on chromosome 
14 (Figure 5.6 (b), three H3K9me3-enriched loci at the centre of the chromosome 
are not present as in the homologous P. falciparum chromosome 12 (Lopez-Rubio, 
Mancio-Silva and Scherf, 2009). In the P. falciparum 3D7 strain used by Lopez-
Rubio et al., H3K9 trimethylation is present at the AP2-G transcription factor locus 
(PF3D7_1222600), at a subtelomeric locus of rif, stevor, and var group B genes 
(Chr12: 2,184,000 bp – 2,250,000 bp), and at a second upstream locus of var group 
C genes (Chr12: 1,686,000 bp – 1,746,000 bp). In P. berghei ANKA and other non-
Laveranian Plasmodium spp., var genes are absent. However, in P. berghei, the 
AP2-G transcription factor is located on chromosome 14 (PBANKA_1437500) and 
this gene will be analysed in greater detail in repeat experiments of 2.5 million 
cells below.  
 
As with H4K8 acetylation, the three separate ChIP peak-callers, MACS2, HOMER, 
and Epic, were used to determine H3K9me3-enriched regions of the genome. In 
addition to these results, and the alignment profile shown in Figure 5.6, an 
optimum cell number and peak-calling software were chosen to analyse repeat 
experiments. Shared H3K9me3 peaks for 250,000, 2.5 million, and 25 million 
schizonts are shown in Figure 5.7.    
 




Figure 5.7: A comparison of shared and unique peaks from H3K9me3 ChIP samples using 
MACS2, HOMER, and Epic software. The present UpSet plot shows the number of unique peaks 
called using MACS2, HOMER, and Epic software on the left-hand side. Each sample name is shown 
next to the number of unique peaks per category, with cell numbers and software name clearly 
labelled. The main histogram depicts the number of overlapping peaks in each H3K9me3 sample 
(from 25 million, 2.5 million, and 250K P. berghei schizonts). At the base of the histogram, 
overlapping peaks shared between samples are indicated using circles, or circles joined with a 
straight line. Similar to the H4K8ac results (Figure 5.2), MACS2 software (Zhang et al., 2008) 
identified only a small number of unique peaks for both 250K and 2.5 million cells, but with 
overlapping peaks only detected using 250K schizonts. For 25 million schizonts, MACS2 identified 
no unique or overlapping peaks. In contrast, both HOMER (Heinz et al., 2010) and Epic (Xu et al., 
2014) identified peaks in all H3K9me3 ChIPmentation samples. 16 peaks were shared between all 
samples using both peak-callers.  
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Using the ‘Epic’ peak-caller (Xu et al., 2014), 1084 overlapping peaks were 
identified using 25 million schizonts; 736 overlapping peaks were identified from 
2.5 million schizonts; and 10 overlapping peaks were identified from 250,000 
schizont-stage parasites. As can be observed in Figure 5.7 (a), the distribution of 
reads across the entire genome for both 25 million and 2.5 million schizonts were 
also similar, with only the 250K schizont sample falling behind with regards to 
coverage across all 14 P. berghei chromosomes. Because of this, H3K9me3 
ChIPmentation was again repeated three times with 2.5 million schizonts from 
independent P. berghei infections. Sample JP2_H3K9me3 was then discarded from 
final results according to MDS plot results shown in Figure 5.1. Remaining results 
from duplicate H3K9me3 experiments of equal cell number are shown in Figure 




Figure 5.8: H3K9me3 merged peak distribution across the P. berghei ANKA genome at schizont 
stage. In this series of images, (a) shows H3K9me3 peak distribution across the entire genome of 
P. berghei using IGV. H3K9me3-bound reads (relative to an input sample from Fraschka et al., 
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2018) from duplicate samples of 2.5 million schizonts are shown. Raw data are displayed in blue 
and Epic peaks are displayed in yellow underneath the ChIP track. Merged peaks for both replicates 
are shown in pink. Genes are displayed in general feature format (.gff) as black bars. (b) is a pie-
chart representation of gene ontology (GO) terms for biological processes that were associated 
with the genes to which H3K9me3 was bound across both independent experiments (with a P-value 
< 0.025). Image (c) shows the same data as (b), though this time, the location of the area of 
H3K9me3 enrichment is shown relative to the nearest gene ORF.  
 
Unlike H4K8 acetylation, H3K9me3-enrichment occurs often at the promoter of a 
gene, or at the exon (Salcedo-Amaya et al., 2009; Biga et al., 2017). In P. 
falciparum, it has been suggested that clonally variant multicopy gene families 
(such as var genes) remain un-transcribed if the H3K9me3-binding site is located 
to the 3’ end of the ORF (Karmodiya et al., 2015). Of the duplicate H3K9me3 
experiments undertaken during this study, 20% of merged peaks between both 
experiments were located at promoter-TSS regions (-1kb to +100 bp either side of 
the TSS), while 50% of merged peaks were located within exons (Figure 5.8 (c)).  
 
When examining GO terms of biological processes associated with H3K9me3-bound 
loci, this repressive mark is enriched equally for seryl-tRNA aminoacylation, mRNA 
cis splicing via the spliceosome, and cis-assembly of the pre-catalytic spliceosome 
(Figure 5.8 (b)) (The Gene Ontology Consortium, 2017). To examine the 
relationship between H3K9 trimethylation and differential RNA expression in 
schizonts compared to 16 h trophozoites, a comparison of the overlap of merged 
peaks with differentially-expressed genes was undertaken and the results are 
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Figure 5.9: H3K9me3-binding in the P. berghei ANKA schizont genome and association with 
differential RNA expression. The Venn diagram on the left of this image depicts the overlap 
between all H3K9me3 merged peaks and differentially-expressed genes between schizont- and 
trophozoite- stage P. berghei ANKA parasites (with a false discovery rate (FDR) less than 0.005). 
55 merged peaks across two independent H3K9me3 ChIPmentation experiments were compared to 
2161 differentially-expressed genes with FDR < 0.005. Of the 46 overlapping differentially-
expressed genes, 17 were associated with up-regulation of RNA in schizonts and 29 were associated 
with down-regulation of RNA in schizonts. Only 9 H3K9me3 merged peaks did not correlate to any 
change in RNA expression between trophozoites and schizonts. Black arrows indicate increased or 
decreased RNA expression according to the direction of the arrow. Tables to the right of the Venn 
diagram show GO terms associated with up- and down- regulated genes that are bound at any 
location by H3K9 trimethylation. GO identifiers (GO IDs), description of GO term, and fold 
enrichment are listed for these genes.  
 
As shown in Figure 5.9, 55 merged peaks were identified between both replicates 
of 2.5 million schizonts when ChIPmentation was carried out for H3K9 
trimethylation. Though a correlation has been shown in P. falciparum between 
the presence of H3K9me3 at virulence genes and their epigenetic silencing via 
perinuclear repressive centres at the nuclear periphery (Lopez-Rubio, Mancio-
Silva and Scherf, 2009), Figure 5.9 shows that in P. berghei ANKA schizonts, H3K9 
trimethylation was associated with both increased and decreased RNA expression 
in schizonts compared to trophozoites, as was the case with H4K8 acetylation 
(Figure 5.5). However, the subset of up-regulated genes associated with H4K8ac-
binding at the exon, and H3K9me3-binding, were different. Whereas H4K8 
acetylation was associated with up-regulation at genes responsible for DNA 
replication and host-parasite symbiosis (Figure 5.5), H3K9me3-marked genes 
associated with RNA up-regulation (where function was known) were associated 
with movement of a cell or subcellular component, cell gliding, and the electron 
transport chain (P < 0.05). As for H3K9me3 merged peaks associated with down-
regulation of RNA expression in schizonts, only one GO term was enriched with a 
P < 0.01, and that was cis-assembly of the pre-catalytic spliceosome (GO: 
0000354) (Figure 5.9) (The Gene Ontology Consortium, 2017).     
 
As previously mentioned, both H3K9me3- and HP1- binding is associated with 
monoallelic expression of clonally variant multicopy gene families, including those 
that are associated with antigenic variation (Lopez-Rubio, Mancio-Silva and 
Scherf, 2009; Fraschka et al., 2018). To identify H3K9me3-enriched regions, and 
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to determine if any identifiable peaks are associated with HP1 and reduced 
transcription in schizonts, duplicate H3K9me3 experiments with 2.5 million 
schizonts were aligned to both HP1-bound peaks and RNA-seq data obtained from 
previous studies (Otto, Böhme, et al., 2014; Fraschka et al., 2018). All ChIP 
experiments were normalised using the input from Fraschka et al., and Epic was 











Figure 5.10: Comparative analysis of H3K9me3 binding and HP1 binding in P. berghei ANKA 
schizonts. This series of images depicts merged H3K9me3-enriched loci (Epic peaks) from 
duplicate independent experiments of 2.5 million schizonts. Merged peaks are aligned to the P. 
berghei ANKA genome (version 34) alongside Epic peaks called for HP1-enriched regions (Fraschka 
et al., 2018). In each image, H3K9me3 merged peaks are shown in dark yellow, HP1 peaks are 
shown in pink, and the locations of genes are shown in black. In (a), the complete coverage across 
all 14 chromosomes is shown for H3K9me3 merged peaks and HP1 merged peaks in dark yellow and 
pink respectively. Five regions are labelled ‘b’ to ‘f’ in this image and these areas correspond to 
genes at which a H3K9me3 merged peak and HP1 peak are present at the same gene. (b) to (e) 
show the resulting genes and peaks corresponding to the lettering provided in (a). From (b) to (f), 
dashed vertical lines are used to highlight loci at which peaks are located.  
 
From results shown in Figure 5.10 (b) to (f), it can be seen that, though there is 
a clear enrichment of both H3K9me3 merged peaks and HP1 peaks at chromosome 
telomeres, only 5 genes in fact shared H3K9me3 and HP1 enrichment according to 
ChIPmentation and broad peak analysis carried out in the present study (Figure 
5.10 (a)). These genes that shared both merged H3K9me3 peaks and HP1 peaks 
were PBANKA_0300600 (Figure 5.10 (b), the locus containing PBANKA_1245821.1, 
PBANKA_1245841.1, and PBANKA_1245861 (Figure 5.10 (d), PBANKA_1246981.1 
(Figure 5.10 (e), the promoter-TSS of PBANKA_1400600.1 (Figure 5.10 (f)), and 
a cluster of genes on chromosome 6 at which duplicate peaks for located 
immediately adjacent to one another, PBANKA_0622921.1 and PBANKA_0622941 
(both marked by a merged H3K9me3 peak), and PBANKA_0622961.1 which is 
immediately down-stream of these genes and is marked by two HP1 peaks (Figure 
5.10 (c)).  
 
Marked by H3K9me3/HP1-binding at its 3’ end (TTS) (and with HP1-binding 
encompassing the exon also), PBANKA_0300600 is a Plasmodium exported protein 
of unknown function [as of 13-09-18] (Figure 5.10 (b). Interestingly, this protein 
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appears to be completely specific to rodent malaria parasites, with orthologues 
so far being identified in P. yoelii (strains YM, 17X, and 17XNL) only 
(www.PlasmoDB.org, 2018). A protein with a highly-repetitive internal amino acid 
sequence, PBANKA_0300600 was shown to be non-essential in P. berghei sexual 
commitment and ookinete conversion (Kehrer, Frischknecht and Mair, 2016). 
However, PBANKA_0300600 does appear to be a factor of the Plasmodium gamete 
“egressome”, i.e. it is released when the gamete egresses from the host 
erythrocyte within the mosquito vector (Kehrer, Frischknecht and Mair, 2016). 
 
In Figure 5.10 (c), a particular genetic locus is shown at which two peaks each 
for H3K9me3- and HP1- binding are located immediately adjacent to one another, 
suggesting that these genes are located within a heterochromatic region of 
chromosome 6. Marked by H3K9me3 merged peaks, genes PBANKA_0622921.1 and 
PBANKA_0622941 encode for an 18S ribosomal RNA and a 5.8S ribosomal RNA, the 
former of which has been disrupted in P. berghei knockout experiments, resulting 
in a strongly delayed maturation of oocysts in the mosquito midgut, and a 
subsequently reduced number of salivary gland sporozoites [correct as of 13-09-
18] (www.PlasmoDB.org, 2018) (van Spaendonk et al., 2001). The adjacent HP1-
bound PBANKA_0622961.1 encodes for a 28S ribosomal RNA, which, when 
disrupted, results in the same phenotype as the upstream H3K9me3-bound 18S 
rRNA: a strong delay of oocyst maturation, and reduced salivary gland sporozoites 
(though these sporozoites did remain infective in NIH Swiss mice) [correct as of 
13-09-18] (www.PlasmoDB.org, 2018).  
 
As for Figure 5.10 (d), a subtelomeric cluster of three genes on chromosome 12 
are marked by both H3K9 trimethylation and HP1-binding. These genes are 
PBANKA_1245821.1, PBANKA_1245841.1, and PBANKA_1245861, encoding for an 
18S ribosomal RNA, a 5.8S ribosomal RNA, and a 28S ribosomal RNA once more 
[correct as of 13-09-18] (www.PlasmoDB.org, 2018). Unlike with the previous 
cluster of rRNA-encoding genes on chromosome 6 (Figure 5.10 (c)), this cluster 
of rRNA genes have yet to be disrupted, or their proteins characterised [correct 
as of 13-09-18] (www.PlasmoDB.org, 2018).  
 
In Figure 5.10 (e) and Figure 5.10 (f), two single genes are marked at the exon 
and exon/TTS respectively by both H3K9me3- and HP1- binding: 
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PBANKA_1246981.1 and PBANKA_1400600.1, encoding for a PIR protein 
pseudogene and a cytoadherence-linked asexual protein respectively [correct as 
of 13-09-18] (www.PlasmoDB.org, 2018). The former PIR protein pseudogene on 
chromosome 12 remains uncharacterised at present, but the latter 
cytoadherence-linked asexual gene (a member of the ‘clag’ multigene family or 
sometimes ‘rhoph1’ gene family) on chromosome 14 has been deemed as essential 
in erythrocytic stages of P. berghei development, and may be homologous in its 
function to the PF3D7_0302200 clag 3.2 which remains invariably HP1-bound 
between multiple Plasmodium species (Gupta, Thiruvengadam and Desai, 2015; 
Fraschka et al., 2018).  
 
What is evident from Figure 5.10 (a) is that HP1-enrichment is not exclusively 
associated with the presence of H3K9me3-enrichment and vice versa. Also evident 
is the fact that HP1-binding, alone or in combination with H3K9me3, is not solely 
an indicator of transcriptional repression, with up-regulation of RNA expression in 
schizonts compared to trophozoites seen in the cases of PBANKA_1245861 
(encoding for a 28S rRNA) (Figure 5.10 (c)) and PBANKA_1400600.1 (encoding for 
a clag protein) (Figure 5.10 (f)), though only the latter is up-regulated in schizonts 
to a significant extent (log2FC of 2.16; P-value = 4.97 x 10-7) (Supplemental 
Material E4). 
 
Similarly, a number of H3K9me3-enriched loci can be seen in Figure 5.10 (a) that 
are not associated with HP1-binding. Taking into consideration previous findings 
in P. falciparum showing that H3K9me3-enrichment occurs typically at clusters of 
clonally variant gene families involved in parasite antigenic variation (Lopez-
Rubio, Mancio-Silva and Scherf, 2009; Salcedo-Amaya et al., 2009), a study of 
H3K9me3-enriched loci in P. berghei ANKA schizonts was undertaken. Results are 
shown in Figure 5.11. 















Figure 5.11: P. berghei schizont loci enriched for H3K9 trimethylation without HP1-
enrichment. This series of images depicts merged H3K9me3-enriched loci (Epic peaks) from 
duplicate experiments of 2.5 million schizonts. Merged peaks are aligned to the P. berghei ANKA 
genome (version 34) alongside a track in which Epic peaks are called for HP1-enriched regions 
(Fraschka et al., 2018). In each image, H3K9me3 merged peaks are shown in dark yellow, HP1 
peaks are shown in pink, and the locations of genes are shown in black. From images (b) to (n), 
no HP1 peaks are present at these H3K9me3-enriched loci and so no pink peaks are portrayed. 
Image (a) shows the merged H3K9me3 peak results for all 14 chromosomes above a track showing 
HP1 peaks across the P. berghei ANKA genome also. In (a), H3K9me3 merged peaks for which no 
corresponding HP1 peaks are seen are labelled (b) to (n). Zoomed-in views of these peaks are then 
depicted from (b) to (n) below the overview image. Genome coordinates are displayed in the upper 
right-hand corner of each image. All images were taken using the IGV genome browser. As in Figure 
5.10, dashed vertical lines are used to highlight loci at which peaks are located.    
 
As can be seen in Figure 5.11 (a), there are a number of H3K9me3-enriched loci 
in P. berghei ANKA schizonts that are not also enriched for HP1-binding. In Figure 
5.11 (a), 13 of these solely H3K9me3-enriched loci are labelled (b) to (n). In 
Figure 5.11 (b), a clear H3K9me3 peak is located at the intergenic region between 
PBANKA_0308100 and PBANKA_0308000.1, encompassing the promoter-TSS region 
of PBANKA_0308000.1 (encoding for a putative Ras-related protein Rab-5A). 
Expression of this gene is greatest at 22 h schizonts (Otto et al., 2014), and its 
function is haemoglobin uptake at the parasite plasma membrane and transport 
to the food vacuole (Ebine et al., 2016).  
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In Figure 5.11 (c) and Figure 5.11 (d), H3K9 trimethylation is associated with the 
5’ region of PBANKA_0504400, the promoter-TSS region of PBANKA_0504300.1, 
and the exon of PBANKA_0513700.1, encoding for a conserved Plasmodium protein 
of unknown function, a putative flagellar outer arm dynein-associated protein, 
and a second conserved Plasmodium protein of unknown function [correct as of 
13-09-18] (www.PlasmoDB.org, 2018). Regarding the characterised PBANKA_ 
0504300.1 (Figure 5.11 (c)), this protein is heavily associated with the male 
gametocyte (Otto et al., 2014; Yeoh et al., 2017) and is also subject to AP2-G2 
expression (Yuda et al., 2015). Regarding both conserved Plasmodium proteins of 
unknown function, the PBANKA_0504400 gene, marked at the exon and TTS by 
H3K9 trimethylation, appears to be involved in female gametocytogenesis, in 
direct contrast to its neighbour, PBANKA_0504300.1 (Otto et al., 2014; Yeoh et 
al., 2017). This gene is also under control of the AP2-G2 transcriptional regulator 
(Yuda et al., 2015), suggesting that the locus depicted in Figure 5.11 (c) is 
regulated by AP2-G2, and H3K9 trimethylation (both suggestive of transcriptional 
repression), but not with HP1.        
 
Depicted in Figure 5.11 (e) and Figure 5.11 (f) are two genes that are completely 
associated at the ORF with merged H3K9me3 peaks from repeat experiments: 
PBANKA_0615400.1 and PBANKA_0929200. These genes encode for a putative 
serine-tRNA ligase, and a conserved Plasmodium protein of unknown function, 
both of which remain uncharacterised, though the former is known to be 
expressed at intra-erythrocytic parasite stages and is amenable to disruption 
[correct as of 13-09-18] (www.PlasmoDB.org, 2018). From Figure 5.11 (b) to 
Figure 5.11 (f), all but one gene (PBANKA_0615400.1) are associated with up-
regulation in 22 h schizonts compared to 16 h trophozoites, though all are marked 
with H3K9 trimethylation (Supplemental Material ES4) (Otto et al., 2014).   
 
Though H3K9me3-enrichment is associated with repression of transcription 
(Lopez-Rubio, Mancio-Silva and Scherf, 2009; Salcedo-Amaya et al., 2009), H3K9 
di-methylation and trimethylation fail to bind HP1 in the presence of H3S10 
phosphorylation (Hirota et al., 2005). In the present study, it was observed that 
both H3S10 and H3.3S10 were phosphorylated at schizont stage in P. berghei 
(Table 4.3). Therefore, it may not be the level of H3K9 trimethylation that is 
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important for heterochromatin formation alone. It may be that differential 
transcription between P. berghei ANKA stage transitions is facilitated by a 
H3K9me3-H3S10ph ratio, with H3S10ph resulting in heterochromatin dissociation 
(Hirota et al., 2005; Bannister and Kouzarides, 2011). This histone crosstalk may 
also explain why, in P. berghei schizonts, the differential expression occurring at 
genes with H3K9me3 peaks is not uniquely repressive in nature (Figure 5.9).  
 
In Figure 5.11 (g) and Figure 5.11 (h), two more genes are associated with H3K9 
trimethylation at the exon: PBANKA_1008500.1 and PBANKA_1020600, encoding 
for translocon component PTEX150 and putative actin-related protein ARP4a 
[correct as of 13-09-18] (www.PlasmoDB.org, 2018). The translocon component 
PTEX150 is refractory to gene deletion and essential for intra-erythrocytic growth 
in its role as a core component of the PTEX protein export complex (Garten et al., 
2018). The actin-related ARP4a protein is also refractory to deletion in P. berghei, 
and both ARP4 and ARP6 are suggested to be subunits of a chromatin-remodelling 
complex in Apicomplexa (Gordon and Sibley, 2005). Both genes are down-
regulated in 22 h schizonts in comparison with 16 h trophozoites, though only 
ARP4a to a statistically significant degree (log2FC: -1.73; P-value = 3.73 x 10-6) 
(Supplemental Material ES4). 
 
Of the final 6 H3K9me3-bound genes (Figure 5.11 (i) to Figure 5.11 (n)), all 
merged peaks encompass almost the entire ORF of each gene. These genes are: 
PBANKA_1138200 (putative RuvB-like helicase 3), PBANKA_1326300.1 (putative 
cytochrome c1 precursor), PBANKA_1337200.1 (putative protein transport protein 
SFT2), PBANKA_1344300 (a putative chromatin assembly factor 1 subunit), 
PBANKA_1423300.1 (DNA/RNA-binding protein Alba1), and PBANKA_1457700 
(ookinete-expressed protein PSOP26), 3 of which are down-regulated, and 3 of 
which are up-regulated in 22 h schizonts compared to 16 h trophozoites 
(www.PlasmoDB.org, 2018) (Supplemental Material ES4) (Otto et al., 2014).  
 
With regard to their expression and functions, RuvB-like helicase 3 is expressed 
greatly in female gametocytes and appears to be AP2-G2-regulated, in addition to 
being marked by H3K9me3 (Otto et al., 2014; Yuda et al., 2015; Yeoh et al., 2017). 
The putative cytochrome c1 precursor (PBANKA_1326300.1) is refractory to 
disruption and essential for intra-erythrocytic growth, while protein transport 
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protein SFT2 in P. berghei ANKA is non-essential, and expressed in all parasite 
stages except female gametocytes (reduced RNA transcription at this life-cycle 
stage) (Otto et al., 2014; Yuda et al., 2015; Yeoh et al., 2017) 
(www.PlasmoDB.org, 2018). 
 
Of the final three H3K9me3-bound proteins, the chromatin assembly factor 1 
subunit (PBANKA_1344300) is essential for asexual growth, and is expressed 
predominantly in 22 h schizonts and male gametocytes, with a suggested 
interaction with AP2-G2 (Otto et al., 2014; Yuda et al., 2015; Yeoh et al., 2017). 
Alba1 (encoded by PBANKA_1423300.1) is predominantly expressed during asexual 
P. berghei life-cycle stages, while PBANKA_1457700 (the ookinete-expressed 
PSOP26) is dispensable, unregulated by AP2-G2, and associated with gametocytes, 
particularly male gametocytes, along with being characterised as ookinete-
specific and under control by the AP2-O transcriptional regulator (Otto et al., 
2014; Yuda et al., 2015; Zheng et al., 2016; Yeoh et al., 2017). 
    
In summary, of the merged H3K9me3 peaks from duplicate experiments of P. 
berghei mature schizonts without concomitant HP1-binding, 5 were positively 
associated with expression in gametocytes (PBANKA_0504300.1, 
PBANKA_0504400, PBANKA_1138200, PBANKA_1344300, and PBANKA_1457700) 
while one was negatively associated with RNA expression in female gametocytes 
(PBANKA_1337200.1). All 5 H3K9me3-bound genes that are associated with 
positive transcription in gametocyte stages were also associated with regulation 
by either AP2-G2, or AP2-O (in the case of PBANKA_1457700) (Otto et al., 2014; 
Yuda et al., 2015; Zheng et al., 2016; Yeoh et al., 2017). One of the more 
interesting results can be seen in Figure 5.11 (c), in which two adjacent 
H3K9me3-bound genes on chromosome 13 are both AP2-G2-associated, one being 
expressed in male gametocytes (PBANKA_0504300.1), and the other being 
expressed almost solely in female gametocytes (PBANKA_0504400) (Otto et al., 
2014; Yuda et al., 2015). Though both H3K9me3- and AP2-G2- associated, it 
remains to be seen how both adjacent genes can be associated with differential 
transcription between male and female gametocytes.     
 
To complete a study of H3K9me3 merged peaks, a list of the genes to which the 
highest-scoring H3K9me3 Epic peaks are associated are depicted in Table 5.2. All 
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further peaks discovered, and a list of merged peaks common to both duplicate 




Table 5.2: Highest-scoring H3K9me3 peaks in P. berghei schizonts. This table displays the top 
10 H3K9me3-bound genes according to their Epic peak-calling score. Genes are shared among 
duplicate independent H3K9me3 ChIPmentation experiments. The highest score between 
replicates is shown in the fifth column. The list of genes is numbered from highest to lowest score 
and the first and second columns of the table list gene IDs and current known function (if any) of 
the gene in P. berghei ANKA [as of 26-08-18]. The fourth column shows the locations of the 
H3K9me3 peak relative to the gene in question across both independent experiments. The sixth 
column indicates differentially-expressed gene regulation in schizonts at 22 h compared to 16 h 
trophozoite expression (Otto et al., 2014). The following three columns list the log2 fold change 
(log2FC), P-value, and false discovery rate (FDR) (where applicable) of the differential RNA 
expression.  
           
Remarkably, all but one of the H3K9me3-enriched genes shown in Table 5.2 are 
members of the PIR protein multicopy gene family, or the fam-a multicopy gene 
family in P. berghei (Fougère et al., 2016; Yam et al., 2016; Fraschka et al., 2018). 
Regarding PIR and fam-a proteins, genes from both of these subtelomeric 
multigene families have a wide array of functions throughout the parasite 
developmental cycle, nearly all of which remain uncharacterised (Fougère et al., 
2016; Yam et al., 2016). Of the genes shown in Table 5.2, the PIR protein 
pseudogene PBANKA_1100051.1, appears in the top 10 H4K8ac-enriched genes also 
(Table 5.1), though without differential RNA expression between trophozoite and 
schizont stages.  
 
Of the ten H3K9me3-enriched genes shown in Table 5.2, only one gene 
(PBANKA_MIT01900.1; mitochondrial cytochrome b (CYTB) protein), showed 
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significant differential RNA expression in 22 h schizonts compared to 16 h 
trophozoites; a significant up-regulation of transcription (log2FC of 1.33; P-value: 
0.009; FDR: 0.02). This gene is suggested as being responsible for susceptibility 
and resistance of P. falciparum to 8-aminoquinolines and hydroxynapthoquinones 
(Vaidya et al., 1993), with new research determining that P. falciparum resistance 
to the napthoquinone antimalarial, atovaquone, is in fact a result of mitochondrial 
heteroplasmy, and the failure of atovaquone to inhibit the cytochrome bc1 
complex of the electron transport chain (https://doi.org/10.1101/232033). 
Though var genes are indeed regulated epigenetically, it is unknown as to whether 
epigenetic marks such as H3K9 trimethylation play an additional role in 
mitochondrial heteroplasmy, or regulation of mitochondrial genome replication in 
general (Deshmukh, Srivastava and Dhar, 2013).     
 
The results shown in Table 5.2 suggest that, though H3K9 trimethylation has been 
implicated in transcriptional repression in Plasmodium spp. (Lopez-Rubio, Mancio-
Silva and Scherf, 2009; Salcedo-Amaya et al., 2009; Fraschka et al., 2018), it is 
most likely that clonally variant multicopy gene families are regulated by a 
conglomeration of histone modifications and other regulatory processes, such as 
long non-coding RNAs (lncRNAs), antisense RNAs, or exoribonucleases (Liao,Q., 
Shen,J., Liu,J., Sun,X., Zhao,G., Chang,Y., Xu,L., Li,X., Zhao,Y., Zheng,H. Zhao, 
Y. and Wu, 2014; Zhang et al., 2014; Filarsky et al., 2018). However, with a 
number of HP1 and H3K9me3-enriched loci located at, or adjacent to, genes 
involved in sexual development (Figures 5.10 and 5.11), it may be that some of 
the PIR and fam-a genes shown in Table 5.2 could also be involved in the 
transmission stage of P. berghei ANKA. Therefore, these genes are good 
candidates for further functional studies.  
 
5.6 H3K9 acetylation in P. berghei schizonts 
 
To complement the findings of ChIPmentation studies using an anti-H3K9me3 
antibody, identical examinations of 250,000, 2.5 million, and 25 million mature 
synchronous schizonts were carried out to map the binding of an anti-H3K9ac 
antibody. In Plasmodium spp., H3K9ac-binding correlates with transcriptional 
activation at gene promoters and H2A.Z binding (Bártfai et al., 2010). Using the 
MACS2, Epic, and HOMER peak-callers once more, H3K9ac-bound regions were 
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identified and the resulting peak numbers are depicted as an UpSet plot in Figure 
5.12. An overview of H3K9ac peak distribution is also depicted in Figure 5.13.     
 
 
Figure 5.12: A comparison of shared and unique peaks from H3K9ac ChIP samples using MACS2, 
HOMER, and Epic software. The present UpSet plot shows the number of unique peaks called using 
MACS2, HOMER, and Epic software on the left-hand side. Each sample name is shown next to the 
number of unique peaks per category, with cell numbers and software name clearly labelled. The 
main histogram depicts the number of overlapping peaks in each H3K9as sample (from 25 million, 
2.5 million, and 250K P. berghei schizonts). At the base of the histogram, overlapping peaks shared 
between samples are indicated using circles, or circles joined with a straight line. Using the anti-
H3K9ac antibody, MACS2 software (Zhang et al., 2008) identified no unique peaks for any of the 
samples analysed. However, when using Epic and HOMER peak-calling software, 414 overlapping 
peaks were identified across all samples, with HOMER identifying 1043 overlapping peaks from the 
250K schizont sample alone.  
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From a comparison of H3K9ac ChIPmentation results using both HOMER and Epic 
peak-calling software, it is clear that HOMER identified more samples from 250K 
schizonts than any other sample or software used (Figure 5.12). However, for the 
purposes of comparative analysis following visualisation of both H4K8ac and 
H3K9me3 results, Epic was again used for peak-calling of H3K9ac-enriched regions 
of the genome. Epic peaks for 250,000, 2.5 million, and 25 million schizonts are 
shown in Figure 5.12, with results from 2.5 million schizonts in triplicate 
(normalised to the Fraschka et al., 2018 input once more) carried out 
subsequently. Taking into consideration MDS analysis (Figure 5.1), final results 
shown in Figure 5.14 include duplicate samples S5_H3K9Ac and JP3_H3K9Ac, with 




Figure 5.13: Distribution of H3K9 acetylation across the P. berghei ANKA genome at schizont 
stage. Using the IGV browser, H3K9ac-bound (sample/input) reads (for 250K, 2.5 million, and 25 
million schizonts) are shown across the entire P. berghei ANKA genome (version 34) alongside peaks 
called using the ‘Epic’ peak-calling software (in .bed format; results are normalised to the 250K 
schizont ChIP input sample) (a). At the base of these tracks, the general feature format (.gff) file 
shows the location of genes as black bars. For each sample, aligned ChIP data is displayed in blue. 
Epic peaks are shown in a separate track underneath ChIP data and are displayed in a dark yellow 
colour. In (b), aligned reads and peak files are again shown as in (a), though in this case (as for 
Figure 5.3 and Figure 5.6), only the developmentally important chromosome 14 is shown in closer 
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detail (J.-J. Lopez-Rubio, Mancio-Silva and Scherf, 2009; Fraschka et al., 2018). Colour-coding is 
carried out as in (a). 
 
Unlike both H4K8ac and H3K9me3 ChIPmentation experiments, visualisation of 
raw ChIP data and Epic peaks for H3K9 acetylation across the genome (Figure 
5.12) indicated that ChIPmentation of 250,000 schizonts worked quite well for 
examination of antibody enrichment. However, in the case of H3K9ac-enrichment 
with 250,000 and 25 million schizonts, both the genome overview (Figure 5.13 
(a)) and overview of chromosome 14 (Figure 5.13 (b)) show IGV tracks that 
appears to have a considerable amount of background reads that may skew Epic 
peak results. As a result, and to remain consistent with previous experiments, 
H3K9ac-enriched regions were once again examined from 2.5 million schizont-
stage parasites in duplicate. These results were analysed using Epic, with 
annotation carried out using a HOMER annotation script 
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Figure 5.14: H3K9ac peak distribution across the P. berghei ANKA genome. In this series of 
images, (a) shows H3K9ac peak distribution across the entire genome of P. berghei using IGV. 
H3K9ac-bound reads (relative to an input sample from Fraschka et al., 2018) from duplicate 
independent samples of 2.5 million schizonts are shown. Raw data are displayed in blue and Epic 
peaks are displayed in yellow underneath the ChIP track. Genes are displayed in general feature 
format (.gff) as black bars. (b) is a pie-chart showing gene ontology (GO) terms for biological 
processes that were associated with the genes to which H3K9ac was bound (showing results for 22 
merged peaks across both independent experiments). Image (c) shows the same data, but the 
locations of H3K9ac-enrichment relative to the nearest gene are depicted in graph format (as a 
percentage of 100%).  
 
As can be seen in Figure 5.14 (a), merged Epic peak distribution from duplicate 
H3K9ac ChIPmentation experiments is very sparse, suggesting that either few loci 
are marked by H3K9 acetylation, or that this particular histone modification is 
very dynamic in nature, with few conserved peaks between samples, even samples 
of the same P. berghei ANKA life-cycle stage. Taking a look at GO terms for 
biological processes enriched in these samples (P < 0.05) using the 22 merged 
peaks from duplicate experiments (Figure 5.14 (b)), it appears that H3K9 
acetylation peaks are equally associated with protein palmitoylation, DNA duplex 
unwinding, DNA geometric change, and RNA secondary structure unwinding 
(The Gene Ontology Consortium, 2017).  
 
In a previous ChIP-on-chip profiling study, H3K9 acetylation was shown to be 
homogenous across both active and inactive genes, with the mark moving to the 
5’end of active genes in schizonts (Salcedo-Amaya et al., 2009). In the present 
study, and as seen in Figure 5.14 (c), merged peaks are indeed associated with 
5’ promoter-TSS regions predominantly (50%). Of genes that were associated with 
up-regulated RNA expression (shown in Figure 5.15 below), all H3K9ac peaks were 
located upstream of the gene in question, either at the upstream 
intergenic/promoter-TSS region, or at the 5’ end of the ORF (Supplemental 
Material ES3).  
 
In a separate study, acetylation of H3K9 at promoter regions was also found to be 
indicative of gene activation in P. falciparum (Bártfai et al., 2010). In P. berghei, 
if H3K9ac at promoter regions is to be associated with active gene transcription, 
the processes identified in Figure 5.14 (b) should predominantly be activated in 
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schizonts. Previous studies suggest that genes encoding for the processes shown 
in Figure 5.14 (b), namely translation (DNA unwinding; DNA geometric change) 
and other protein-related metabolic processes (protein palmitoylation), are in 
fact associated with peak transcription and mRNA stabilisation at late trophozoite 
stage in vivo in P. falciparum (Bozdech et al., 2003; Painter et al., 2018).  
 
To examine whether H3K9ac enrichment was associated with up-regulation of RNA 
expression between P. berghei ANKA trophozoites and schizonts, merged peaks 
between duplicate H3K9ac experiments were compared with differentially 
expressed genes and the results are shown in Figure 5.15.  
 
 
Figure 5.15: Comparison of H3K9ac merged peaks and differential gene expression in P. 
berghei ANKA schizonts. The Venn diagram on the left of this image depicts the overlap of H3K9ac 
merged peaks and differentially-expressed genes between schizont- and trophozoite- stage P. 
berghei ANKA parasites (with a false discovery rate (FDR) less than 0.005). 22 merged peaks across 
two independent H3K9ac ChIPmentation experiments were compared to 2161 differentially-
expressed genes with FDR < 0.005. Of the 8 overlapping differentially-expressed genes, 5 were 
associated with up-regulation of RNA in schizonts and 3 were associated with down-regulation of 
RNA in schizonts. 14 H3K9ac merged peaks did not correlate to any change in RNA expression 
between trophozoites and schizonts. Black arrows indicate increased or decreased RNA expression. 
Tables to the right of the Venn diagram show the 5 upregulated genes and 3 down-regulated genes 
that are bound at any location by the H3K9 acetylation modification. Gene identifiers (Gene IDs), 
description of gene function, and log2 fold change (log2FC) are all listed for these genes.   
 
In Figure 5.15, increased RNA expression in schizonts when compared to 
trophozoites was associated with H3K9 acetylation at only 5 genes, and down-
regulation of transcription in only 3 genes. The most up-regulated gene 
(PBANKA_0108300.1) was associated with H3K9ac at the promoter-TSS region. This 
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gene encodes for palmitoyltransferase DHHC2, an AP2-G2-associated gene (Yuda 
et al., 2015), expressed predominantly in female gametocytes (Yeoh et al., 2017), 
that is essential for post-fertilisation development of P. berghei ANKA in the 
mosquito midgut and ookinete formation (Santos et al., 2015).  
 
The second H3K9ac-associated, up-regulated gene, PBANKA_0828300, encoding 
for a putative dynein light chain protein, is once again linked to AP2-G2 expression 
(Yuda et al., 2015) and transcribed predominantly in male gametocytes (Otto et 
al., 2014; Yeoh et al., 2017). Of the three remaining up-regulated, H3K9ac-
associated genes, PBANKA_1442100.1 (a conserved Plasmodium protein of 
unknown function), PBANKA_0607400.1 (protein phosphatase PPM11), and 
PBANKA_1116700.1, none are associated with AP2-G2 expression (Yuda et al., 
2015), though each shows a negative correlation to transcription in the male 
gametocyte, and greatest expression in both intraerythrocytic parasite stages and 
female gametocytes in P. berghei ANKA (Otto et al., 2014; Yeoh et al., 2017). 
With these results, and those of H3K9 trimethylation shown in section 5.5, could 
it be possible that changes to the histone H3K9 are a determining factor in AP2-
G2 binding and the regulation of genes involved in parasite sexual development 
and transmission?  
 
Of the H3K9ac-associated, down-regulated genes, one (PBANKA_0316941.1) is an 
uncharacterised PIR protein that is expressed predominantly during ring-stage 
asexual development (Otto et al., 2014), one (PBANKA_1021700.1) is a conserved 
Plasmodium protein of unknown function that is again transcribed predominantly 
during ring-stage development in P. berghei ANKA (Otto et al., 2014), and the only 
characterised gene, PBANKA_0301500.1, encodes for a putative MAK16 protein, 
an essential RNA-binding protein that is almost exclusively expressed in ring-stage 
P. berghei ANKA parasites (Otto et al., 2014).  
 
It should also be noted that all up-regulated and down-regulated genes shown in 
Figure 5.15 are not the same as those differentially expressed and marked by 
H4K8 acetylation (Figure 5.5). This suggests that, though both histone 
modifications are posited as having a role in transcriptional activation, these post-
translational marks are involved in the regulation of different gene families in P. 
berghei (Gates et al., 2017; Gupta et al., 2017). To demonstrate the differential 
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global distribution of these two activating marks across the P. berghei ANKA 
genome, and to further analyse genes enriched for H3K9 acetylation, a comparison 
of H4K8ac and H3K9ac merged peak distribution and the top 10 peaks for H3K9ac 






Figure 5.16: Differential distribution of H4K8 and H3K9 acetylation marks and highest-scoring 
peaks for H3K9ac-enriched genes. Image (a) is a screenshot of merged H4K8ac peaks (1396 
merged peaks) called using Epic software (in dark yellow) adjacent to H3K9ac merged peaks (in 
pink) called using Epic peak-calling software also. Tracks are labelled to the left and chromosomes 
are numbered 1-14 at the top of the image. Genes (in .gff) format are displayed in black 
underneath merged ChIP peak tracks. (b) is a table of the top 10 highest-scoring merged peaks 
identified for H3K9 acetylation across two independent biological replicates. All merged peaks are 
listed in Supplemental Material ES3. Gene IDs, known function [up-to-date as of 27-08-18], highest 
peak score across all peak-calling analyses, peak location, and corresponding RNA expression data 
are provided in (b). Further differential RNA expression data can be found in Supplemental 
Material ES4.  
 
It is clear from Figure 5.16 (a), that many conserved peaks were present across 
duplicate biological samples when studying H4K8 acetylation in 2.5 million P. 
berghei schizonts, compared to H3K9 acetylation in which only 22 merged peaks 
were identified. A small number of peak locations do appear to be shared among 
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these activating histone modifications, i.e. at the distal end of chromosomes 3 
and 9, and the centre of chromosome 13. Despite this, the table shown as Figure 
5.16 (b) reveals that only one of the highest-scoring H3K9ac-enriched genes was 
shared with H4K8ac: PBANKA_1100051.1, a PIR pseudogene that is marked by all 
four histone modifications examined during the present study, and that is 
associated with intraerythrocytic, asexual parasite stages only (Yeoh et al., 2017).  
 
Of all of the highest scoring H3K9ac-enriched genes (Figure 5.16 (a)), 6 are PIR 
pseudogenes/protein of unknown function, 1 is an exported protein of unknown 
function that is significantly up-regulated in 22 h schizonts (PBANKA_1200600.1), 
1 is an 18S ribosomal RNA (PBANKA_0622921.1), one is an apicoplast-located gene, 
a DNA-directed RNA polymerase subunit (rpoC2), and one is an S-antigen 
(PBANKA_0519000.1) that is heavily up-regulated in 22 h schizonts, and appears 
to be dispensable to asexual growth of the parasite [up-to-date as of 14-09-18] 
(www.PlasmoDB.org, 2018).   
 
Though a number of H3K9ac-enriched genes are discussed in Figure 5.15 and 
Figure 5.16, analysis of duplicate independent experiments using Epic software 
discovered 22 common peaks between samples. A complete list of these results 
are provided in the “H3K9ac_S5JP3mergedpeaks” section of Supplemental 
Material ES3.    
 
5.7 H3K122 acetylation in P. berghei schizonts 
 
The final histone modification examined in the present study was H3K122 
acetylation, owing to the fact that an analysis of post-translational histone 
modifications (PTMs) using mass spectrometry showed acetylation of this mark in 
P. berghei gametocytes and methylation of H3K122 only in P. berghei schizonts 
(Chapter 4). The H3K122 acetylation mark was only recently discovered in 
Plasmodium by Coetzee et al. (Coetzee et al., 2017), and as of the time of writing 
[27-08-18], no antibody to H3K122 methylation in any species is available 
commercially. Therefore, to examine the role of H3K122 acetylation in a 
Plasmodium parasite, ChIPmentation with an anti-H3K122ac antibody was 
attempted in schizonts first, to provide a background level of acetylation at 
H3K122 at asexual-stage to which future studies in gametocytes could be 
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compared. Initial alignment of H3K122ac peaks from different numbers of P. 
berghei schizonts are shown below in Figure 5.17, with repeat experiments of 2.5 
million schizonts shown in Figure 5.19. This study represents the first time that 




Figure 5.17: Distribution of H3K122 acetylation across the P. berghei ANKA genome at schizont 
stage. Using the IGV browser, H3K122ac-bound reads and peaks (for 250K, 2.5 million, and 25 
million schizonts) are shown across the entire P. berghei ANKA genome (version 34) (in .bed 
format; results are normalised to the 250K schizont ChIP input sample) (a). At the base of these 
tracks, the general feature format (.gff) file shows the location of genes as black bars. For each 
sample, aligned ChIP data is displayed in blue. Epic peaks are shown in a separate track underneath 
ChIP data and are displayed in a dark yellow colour. In (b), aligned reads and peak files are again 
shown as in (a), though in this case (as for Figure 5.3, Figure 5.6 and Figure 5.13), only 
chromosome 14 is shown in closer detail (J.-J. Lopez-Rubio, Mancio-Silva and Scherf, 2009; 
Fraschka et al., 2018). Colour-coding is carried out as in (a). 
 
As in previous ChIPmentation experiments, similar distribution of H3K122ac-
enriched loci were observed for 2.5 million and 25 million schizont cells (Figure 
5.17), at both the genome level, and when focussing on chromosome 14 alone. 
Following the precedent set in previous studies of H4K8ac, H3K9me3, and H3K9ac 
modifications, 2.5 million P. berghei schizonts were examined twice more to 
determine if the ChIPmentation protocol and peak-calling analysis yielded 
reproducible results. MDS analysis was then carried out (Figure 5.1) and sample 
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‘S8_H3K122Ac’ was discarded in the final analysis. Genome distribution for 
H3K122ac-enriched regions in these experiments are shown in Figure 5.19.      
 
In studies using yeast and human cell lines, the H3K122 acetylation mark has 
become associated with nucleosome disassembly and transcriptional activation 
(Tropberger et al., 2013; Chatterjee et al., 2015). A recent study in human 
embryonic stem cells also suggested that acetylation of H3K122 was not only 
present at active gene promoters, but that H3K122ac marks a subset of active 
enhancers distinct from those marked by H3K27ac (Pradeepa et al., 2016). In the 
present study, as was the case with H4K8ac, H3K9me3, and H3K9ac, an 
examination of H3K122 acetylation was carried out using 250,000, 2.5 million, and 
25 million P. berghei schizonts. All peaks identified using either MACS2, HOMER, 
or ‘Epic’ software are shown in Figure 5.18.    
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Figure 5.18: A comparison of shared and unique peaks from H3K122ac ChIP samples using 
MACS2, HOMER, and Epic software. The present UpSet plot shows the number of unique peaks 
called using MACS2, HOMER, and Epic software on the left-hand side. Each sample name is shown 
next to the number of unique peaks per category, with cell numbers and software name clearly 
labelled. The main histogram depicts the number of overlapping peaks in each H3K122ac sample 
(from 25 million, 2.5 million, and 250K P. berghei schizonts). At the base of the histogram, 
overlapping peaks shared between samples are indicated using circles, or circles joined with a 
straight line. Using the anti-H3K122ac antibody, MACS2 software (Zhang et al., 2008) identified 
overlapping peaks only from a sample of 250K schizonts. Using Epic and HOMER, 1025 shared peaks 
were identified between samples of 2.5 million schizonts and 25 million schizonts.  
 
As with analyses of all ChIPmentation data using three different antibodies 
(H4K8ac, H3K8me3, and H3K9ac), MACS2 software failed to call broad peaks from 
nearly all samples; in this case, peaks were only called from a sample of 250K 
schizonts, with no peaks called from samples of 2.5 million or 25 million P. berghei 
schizonts (Figure 5.18). With the Epic peak-caller showing overlapping peaks from 
all samples, and to align with previous analyses, Epic was once more chosen to 
examine H3K122ac-enriched areas between duplicate 2.5 million schizont samples 
(samples ‘JP5_H3K122Ac’ and ‘JP10_H3K122Ac’ shown in Figure 5.1). Unlike with 
previous findings, results from a ChIPmentation experiment using an anti-
H3K122ac antibody in Plasmodium has never been published and so no 
comparisons can be made between the findings of these experiments to any 
studies carried out in a human malaria parasite or other Plasmodium species. 
Analysis of H3K122ac peak distribution, GO term associations, and location of 









Figure 5.19: H3K122ac peak distribution across the P. berghei ANKA genome. In this series of 
images, (a) shows H3K122ac peak distribution across the entire genome of P. berghei using IGV. 
H3K122ac-bound reads (relative to an input sample from Fraschka et al., 2018) from duplicate 
samples of 2.5 million schizonts are shown. Raw data are displayed in blue and Epic peaks are 
displayed in yellow underneath the ChIP track. Merged H3K122ac peaks are shown in pink. Genes 
are displayed in general feature format (.gff) as black bars. (b) is a pie-chart representation of 
gene ontology (GO) terms for biological processes that were associated with the genes to which 
H3K122ac was bound across both independent experiments. Image (c) shows the same data, but 
the locations of H3K122ac-enrichment relative to the nearest gene are depicted in graph format. 
 
Results in Figure 5.19 (a) show an abundance of H3K122 acetylation across the P. 
berghei ANKA genome at schizont stage. Unlike previous histone modifications 
(particularly H3K9me3), no particular areas of H3K122ac-enrichment can be 
observed at subtelomeric chromosome regions or otherwise. When establishing 
enriched GO terms for biological processes (Figure 5.19 (b), the 2592 H3K122ac 
merged peaks covered an array of biological processes (with a P < 0.005), with 
H3K122 acetylation associated with genes involved in the regulation of 
macromolecule metabolic processes (31%), regulation of primary metabolic 
processes (30%), regulation of cellular metabolic processes (30%), and regulation 
of cellular protein metabolic processes (9%), all biological terms correlating to 
metabolism. These GO terms have previously been associated with transcribed 
genes during late trophozoite growth and schizogony (Bozdech et al., 2003; 
Painter et al., 2018), indicating that H3K122 acetylation may indeed be associated 
with active promoters and enhancers in eukaryotes (Tropberger et al., 2013; 
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Pradeepa et al., 2016). As seen in Figure 5.19 (c)), H3K122ac-enrichment often 
appeared at the gene exon, with 68% of merged peaks located at exons.  
 
To examine a possible relationship between H3K122 acetylation and RNA 
expression, all merged H3K122ac peaks were compared to a list of differentially-
expressed genes in schizonts compared to trophozoites, as was carried out for 
previous histone modifications (Otto et al., 2014). The results of this comparison 
are shown in Figure 5.20.  
 
 
Figure 5.20: A comparison of H3K122 acetylation and RNA expression in P. berghei ANKA 
schizonts. The Venn diagram in this image depicts the overlap of H3K122ac merged peaks and 
differentially-expressed genes between schizont- and trophozoite- stage P. berghei ANKA parasites 
(with a false discovery rate (FDR) less than 0.005). 2592 merged peaks across two independent 
H3K122ac ChIPmentation experiments were compared to 2161 differentially-expressed genes (FDR 
< 0.005). Of 1363 overlapping differentially-expressed genes, 697 were associated with up-
regulation of RNA in schizonts and 666 were associated with down-regulation of RNA in schizonts. 
1229 H3K122ac merged peaks did not correlate to any change in RNA expression between 
trophozoites and schizonts. Black arrows indicate increased or decreased RNA expression. Tables 
to the right of the Venn diagram show the GO terms associated with up- and down- regulated genes 
that are bound at any location by the H3K122 acetylation modification. GO identifiers (GO IDs), 
description of GO term, and fold enrichment of these terms are all listed for these genes.       
 
As demonstrated in Figure 5.20, an association of a gene with H3K122 acetylation 
is, as with previous histone marks assessed during the present study, not uniquely 
associated with increased or decreased RNA expression in P. berghei 22 h schizonts 
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when compared to 16 h trophozoites. In all cases, histone marks are associated 
with genes that are both up- and down- regulated. Of the GO terms shown in 
Figure 5.20 that are associated with upregulation of RNA expression and H3K122 
acetylation, two GO terms (P < 0.001) are shared with up-regulated H4K8ac-
marked exons: GO: 0044419 (interspecies interaction between organisms, and GO: 
0044403 (symbiosis, encompassing mutualism through parasitism) (Figure 5.4 and 
Figure 5.20). These results would suggest that both H4K8 acetylation and H3K122 
acetylation at a gene exon is indicative of transcriptional activation, as was 
previously suggested for these particular histone modifications (Tropberger et al., 
2013; Pradeepa et al., 2016; Gupta et al., 2017). In addition, H3K122 acetylation 
is associated with upregulation at genes responsible for phosphorylation (Figure 
5.20).   
 
With regard to H3K122ac-associated genes that are also down-regulated in 22 h 
schizonts compared to 16 h trophozoites, only one GO term is shared among 
H4K8ac- and H3K122ac- associated genes, GO: 006457, protein folding (Figure 5.4 
and Figure 5.20). Unlike with H4K8ac-associated exons, down-regulated genes 
associated with H3K122 acetylation are (with P < 0.0001), largely associated with 
nitrogen-containing biosynthetic and metabolic processes (Figure 5.20), which 
ties in with previous results that showed that all H3K122ac-bound genes were 
enriched for those involved in metabolic processes (Figure 5.20). If H3K122 
acetylation is associated transcription of enhancers at a separate subset of genes 
than H4K8ac, or even H3K27ac (Pradeepa et al., 2016), the results shown in Figure 
5.19 and Figure 5.20 would suggest that, in P. berghei ANKA, H3K122 acetylation 
is associated with the regulation of genes involved in parasite metabolism, 
whether they are transcriptionally activated, or repressed.      
 
To examine whether H3K122 acetylation displays a similar pattern of binding to 
putative activating acetylation marks H4K8ac and H3K9ac, the top 10 highest-
scoring H3K122ac-enriched genes (according to Epic software) were identified and 










Table 5.3: Highest-scoring H3K122ac peaks in P. berghei ANKA schizonts. This table displays 
the top 10 H3K122ac-bound genes according to their Epic peak-calling score. Genes are shared 
among duplicate independent H3K122ac ChIPmentation experiments. The highest score between 
all replicates is shown in the fifth column. The list of genes is numbered from highest to lowest 
score and the first and second columns of the table list gene IDs and current known function (if 
any) of the gene in P. berghei ANKA [as of 11-07-18]. The fourth column shows the location of the 
H3K122ac peak relative to the gene in question. The sixth column indicates differential gene 
expression in schizonts compared to 16 h trophozoites (Otto et al., 2014). The final three columns 
show the log2 fold change (log2FC), and associated P-value and false discovery rate (FDR) (if 
applicable).  
 
As was the case with all other antibodies used in the present ChIPmentation 
studies, the PBANKA_1100051.1 gene (encoding for a PIR protein pseudogene) was 
found among the top 10 highest Epic peak scores for H3K122ac enrichment (Table 
5.3). Four more genes; another PIR protein pseudogene (PBANKA_0006900.1), the 
conserved rodent malaria protein of unknown function encoded by 
PBANKA_0600071.1, the conserved Plasmodium protein of unknown function, 
PBANKA_0214100.1, and the SOC2 protein, encoded for by PBANKA_1442200.1, 
also appeared to be marked by both a merged H3K122ac peak as well as a merged 
H4K8ac peak. However, these genes were not associated with H3K9 acetylation or 
trimethylation (Table 5.2 and Figure 5.16 (b)). As previously mentioned, the 
SOC2 protein encoded for by PBANKA_1442200.1 is responsible for mitotic spindle 
formation during microgametogenesis and was upregulated in 22 h schizonts, but 
not to a significant degree (Otto et al., 2014; Invergo et al., 2017).  
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Of the remaining H3K122ac-enriched genes, two were members of multigene 
families (one fam-a protein and one fam-b protein), two were conserved proteins 
of unknown function (PBANKA_1341000.1 and PBANKA_0803700.1), and one was 
the pre-mRNA-processing-splicing factor 8 (PRPF8) (PBANKA_1003100.1). Of all 10 
H3K122ac-associated genes shown, only the three conserved Plasmodium proteins 
of unknown function (encoded for by PBANKA_0214100.1 PBANKA_1341000.1, and 
PBANKA_0803700.1) were significantly up-regulated in 22 h schizonts when 
compared to 16 h trophozoites, and one gene, PBANKA_0901000.1 (a fam-a gene) 
was significantly down-regulated (Figure 5.20) (Otto et al., 2014; Deng et al., 
2016; Fougère et al., 2016).   
            
Of the uniquely H3K122ac-enriched genes mentioned, both the Fam-a and Fam-b 
family genes have no associated phenotypic data as of yet (PhenoPlasm; up-to-
date as of 11-07-18) (Sanderson and Rayner, 2017). As for conserved Plasmodium 
protein PBANKA_1341000.1 (a conserved Plasmodium protein of unknown 
function), this gene was refractory to disruption in P. berghei ANKA but amenable 
to piggyBac transposon insertion in P. falciparum (Zhang et al., 2018). The second 
and third H3K122ac-enriched conserved Plasmodium proteins, encoded for by 
PBANKA_0803700.1 and PBANKA_0214100.1, were either refractory to disruption 
in P. berghei ANKA (PBANKA_0803700.1) or no data was available at the present 
time (P. falciparum status also unreported at present) (PhenoPlasm; up-to-date 
as of 11-07-18). The uniquely H3K122ac-enriched gene, encoding for putative 
PRPF8 (PBANKA_1003100.1), was refractory to disruption in both P. berghei ANKA 
and P. falciparum 3D7 (PhenoPlasm; up-to-date as of 11-07-18).  
 
Taking a look at merged peaks for both H4K8 acetylation and H3K122 acetylation 
in the present study (found in ES3); of the 1396 H4K8ac-enriched peaks and the 
2592 H3K122ac-enriched peaks identified, 1013 were shared between these 
samples. Of the 22 H3K9ac merged peaks, 6 are shared with H3K122ac merged 
peaks. Taking all three acetylation marks together, only 2 merged peaks are 
shared between all three samples. These comparisons are displayed in Figure 
5.21. As with all previous experiments, all peaks for independent ChIPmentation 
analyses are listed in Electronic Supplemental Material ES3 alongside complete 
merged peak data.   





Figure 5.21: A comparison of peaks associated with H4K8ac, H3K9ac, and H3K122ac in P. 
berghei ANKA schizonts. The Venn diagram shown above depicts the overlap between H3K9ac 
merged peaks, H4K8ac merged peaks, and H3K122ac merged peaks (n = 2 in each case). To the 
right of the Venn diagram, all genes that were associated with merged peaks from all three 
antibodies and statistically significant differential RNA expression (P-value < 0.005) in 22 h 
schizonts (compared to 16 h trophozoites) are listed (Otto et al., 2014). In each case, gene IDs, 
putative function according to PlasmoDB [up-to-date as of 28-08-18], and log2 fold change (in 
brackets) are shown.  
 
Despite all three acetylation marks (H4K8ac, H3K9ac, and H3K122ac) shown in 
Figure 5.21 being previously associated with active transcription in Plasmodium 
spp. and other eukaryotes ((Lopez-Rubio, Mancio-Silva and Scherf, 2009; Salcedo-
Amaya et al., 2009; Tropberger et al., 2013; Karmodiya et al., 2015; Pradeepa et 
al., 2016; Gupta et al., 2017), a comparison of all genes and differential RNA 
expression associated with all three marks at schizont stage in P. berghei ANKA 
shows that in fact both shared genes were down-regulated in schizonts compared 
to trophozoites to a statistically significant degree (Otto et al., 2014) 
(Supplemental Material ES4). Notably, both genes contained structural DNA/RNA-
binding PHD or zinc finger motifs (Figure 5.21), though only the former, 
PBANKA_0408300.1, has been characterised to any extent in P. berghei, being 
dispensible for asexual growth (though a slow growth phenotype was observed), 
and being expressed predominantly in male gametocytes and ring-stage asexual 
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parasites (Otto et al., 2014; Yeoh et al., 2017). The zinc finger protein encoded 
by PBANKA_1327800.1, is expressed predominantly during the 4 h ring stage of 
asexual parasite growth (Otto et al., 2014; Yeoh et al., 2017).  
 
In addition to identifying shared gene associations between three different histone 
modifications in P. berghei, Figure 5.21 also demonstrates that each antibody in 
question (H4K8ac, H3K9ac, and H3K122ac) was enriched at different genes across 
two independent biological replicates, indicating that in each case, antibodies 
chosen for ChIPmentation in P. berghei were most likely not attributing randomly 
to GC-enriched areas or particular genome sequences. Merged peak data for all 
experiments are present in Supplemental Material ES3, with all differential RNA 




The key findings from this chapter were: 
 
• Considerable optimisation of ChIPmentation in P. berghei ANKA limited this 
chapter to a study of mature asexual parasites (schizonts) only. 
• A ChIP procedure of the AT-rich P. berghei ANKA genome requires a 
decrease of de-crosslinking temperature from 65ºC to 45ºC. 
• The minimum cell number for a ChIPmentation procedure of P. berghei 
schizonts was 2.5 M cells. 
• Peak-calling software packages, ‘Epic’ and ‘HOMER’ consistently detected 
a greater number of shared and unique histone modification peaks when 
compared with MACS2. 
• 1396 shared peaks were identified between two H4K8ac samples in 2.5 M 
P. berghei ANKA schizonts; 62% of which were identified at gene exons, 
with 389 peaks associated with differential RNA expression between 
trophozoite and schizont stages of parasite development. 
• 55 shared peaks were identified between two H3K9me3 samples from 2.5 
M P. berghei ANKA schizonts; 50% of which were associated with gene 
exons, and with only 46 peaks associated with differential gene expression 
between trophozoite and schizont stages of parasite development. 
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• 22 shared peaks were identified between two H3K9ac samples from 2.5 M 
P. berghei ANKA schizonts; 50% of which were associated with gene 
promoter-TSS regions, and with only 8 peaks associated with differential 
gene expression between trophozoite and schizont stages of parasite 
development. 
• 2592 shared peaks were identified between two H3K122ac samples from 
2.5 M P. berghei ANKA schizonts; 68% of which were associated with gene 
exons, and with 1363 peaks associated with differential gene expression 
between trophozoite and schizont stages of parasite development. 
• Two genes with upregulated transcription at schizont stage were marked 
by all three potentially activating histone modifications: zinc finger 
domain-containing proteins, PBANKA_0408300.1 and PBANKA_1327800.1.   
 
5.8.1 The AT-rich Plasmodium spp. genomes: issues in ChIP sequencing 
 
During the present study, ChIP-seq of P. berghei ANKA schizonts using standard 
next-generation sequencing library preparation was attempted using 10 million 
and 5 million cells on multiple occasions. Despite completion of the protocol and 
attempts using two separate library preparation kits, no amplified libraries 
contained enough DNA for a successful sequencing run (results not shown). Upon 
much discussion and analysis of published methods, it became clear that the de-
crosslinking temperature and library preparation kit temperatures (65ºC for 
human and other eukaryotic genomes) were proving detrimental to the ChIP DNA 
obtained from P. berghei samples.  
 
With the publication of Fraschka et al. (Fraschka et al., 2018), the first publication 
to acknowledge a decrease in de-crosslinking temperature to 45ºC during a ChIP 
protocol, attempts to de-crosslink P. berghei ChIP samples at 65ºC were halted. 
In Plasmodium spp., it is necessary to decrease the chromatin-DNA de-crosslinking 
overnight temperature to 45ºC (Fraschka et al., 2018), as opposed to previously 
published protocols which suggested 65ºC for Plasmodium spp. ChIP-seq (Lopez-
Rubio, Siegel and Scherf, 2012; Gómez-Díaz et al., 2014). In some cases, the de-
crosslinking temperature was simply brushed over when describing experimental 
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methods in Plasmodium spp. ChIP-seq (Kaneko et al., 2015; Karmodiya et al., 
2015).  
 
In a similar vein, when undertaking ChIP-seq library preparation using the 
NEBNext® UltraTM II DNA Library Prep Kit for Illumina® (Catalogue No. #E7645S; 
New England BioLabs Inc.), the 30 min 65ºC incubation between end-repair, dA-
tailing, and adapter ligation should be substituted with clean-up using SPRIselect 
beads (Beckman Coulter, Inc.). The initial denaturation step in PCR amplification 
of libraries can also be lowered from 98ºC to 94ºC to minimise damage to AT-rich 
DNA. In addition to ChIP and DNA sequencing work on Plasmodium spp., these 
temperature changes can also be adopted in experiments in which subtelomeric 
or telomeric DNA regions (particularly AT-rich regions) are under investigation 
(consultation with Dr Kathryn Crouch and Craig Lapsley at the University of 
Glasgow, and technicians from New England BioLabs, Inc.). 
 
5.8.2 Advantages and disadvantages of ChIPmentation 
 
As depicted in Figure 2.8, the ChIPmentation approach combines a ChIP 
procedure with library preparation using a hyperactive Tn5 transposase that 
enables simultaneous ChIP DNA fragmentation and adapter tagging (Adey et al., 
2010; Schmidl et al., 2015). In this procedure, adapter tagging is undertaken while 
the ChIP DNA is still bound to the attached chromatin-antibody complex. Because 
de-crosslinking and library amplification can be undertaken directly after this 
step, ChIPmentation bypasses the multiple purification steps required in a 
standard ChIP-seq protocol. Therefore, using ChIPmentation, sequencing of ChIP 
DNA from smaller cell numbers is possible because DNA loss is minimised (Schmidl 
et al., 2015). This procedure was then particularly suitable for studies of P. 
berghei ANKA parasites which, unlike P. falciparum, require the use of 
experimental animals. ChIPmentation may also be suitable for ChIP studies of 
mosquito-stage parasites such as ookinetes, oocysts, and sporozoites; parasite 
stages that are present in relatively low numbers.    
 
Although ChIPmentation in a Plasmodium spp. parasite has not yet been published, 
a protocol for an Assay of Transposase Accessible Chromatin with high-throughput 
sequencing (ATAC-seq) in Plasmodium parasites, which takes advantage of the Tn5 
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transposase from the same Nextera DNA Library Preparation Kit (Illumina, Inc.) 
has been used to determine genome accessibility throughout asexual blood stages 
(Toenhake et al., 2018) and sporozoite-stage parasites in P. falciparum (Ruiz et 
al., 2018). As such, it is only a matter of time before this Tn5 transposase-based 
approach is applied to ChIP studies in the Plasmodium parasite and beyond.  
 
Despite the apparent advantages of ChIPmentation over standard ChIP-seq, the 
use of a single Tn5 transposase for DNA fragmentation and adapter ligation raises 
the possibility that a greater number of sequence-dependent biases may be 
introduced relative to a standard library protocol (Adey et al., 2010). However, 
extensive investigation of Tn5-transposase-mediated fragmentation and adapter 
ligation across several organisms, and using different sequencing platforms, 
revealed only a slightly greater adapter insertion bias in Tn5-transposase-
catalysed reactions that had little impact at the level of genomic coverage (Adey 
et al., 2010; Picelli et al., 2014). The reduction in ChIP DNA loss that usually 
resulted from the multiple PCR amplification and purification steps in standard 
ChIP-seq also offset any biases during the ChIPmentation procedure, as PCR-free 
transposase-based library construction was possible with this method (Adey et al., 
2010).    
 
5.8.3 Epigenetic regulation of stage-specific genes from P. berghei mature 
schizonts 
 
With the focus of the present study being commitment to gametocytogenesis, 
regions around the AP2-G (PBANKA_1437500) and AP2-G2 genes 
(PBANKA_1034300) were examined closely (Sinha et al., 2014; Yuda et al., 2015). 
In Figure 5.22, the complete repertoire of epigenetic modifications identified in 
the present study are shown aligned to these two transcriptional regulators, along 
with other stage-specific developmental genes. These include the oocyst capsule 
protein Cap380 (PBANKA_1218100) (determined to be HP1/H3K9me3-enriched) 
(Figure 5.10) (Fraschka et al., 2018); the PBANKA_1100051.1 PIR protein 
pseudogene, enriched for multiple epigenetic marks in the present study,; the P. 
berghei apical membrane antigen 1 (AMA1) gene (PBANKA_0915000), a protein 
implicated in the parasites invasion of erythrocytes and hepatocytes in P. 
falciparum (Yang et al., 2017); the ring-stage-expressed P. berghei ATP-
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dependent rRNA helicase SPB4 (PBANKA_1024100); and the DNA repair 
endonuclease XPF (PBANKA_1144700; also referred to as ERCC4) which is 
predominantly expressed in 22 h schizonts (Otto, Rayner, et al., 2014).   
 
To complement previous analyses in P. falciparum, the array of epigenetic 
modifications associated with conserved Plasmodium protein PBANKA_0902300 
(Lopez-Rubio, Mancio-Silva and Scherf, 2009), conserved Plasmodium protein 
UIS27 (PBANKA_1435900) (Fraschka et al., 2018), and the HP1 gene itself 
(PBANKA_1436100) (Brancucci et al., 2014; Fraschka et al., 2018) are also shown 
in Figure 5.22. In each case, RNA expression of the gene at 22 h post-invasion 
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Figure 5.22: An overview of four epigenetic modifications at stage-specific genes. Image (a) to 
(j) above are screenshots from the IGV genome browser of RNA-seq BAM file and coverage data 
mapped to P. berghei ANKA genes in GFF format. Any peaks present from duplicate ChIPmentation 
experiments of H3K9me3, H3K9ac, H4K8ac, and H3K122ac, are shown beneath the GFF track in 
IGV. All tracks are clearly labelled and the size of peaks called using Epic software (in dark blue)  
in base-pairs (bp) is indicated under the peak (if present). All merged peaks for all three 2.5 M 
schizont samples, and merged peaks obtained from the two samples based upon MDS clustering 
are listed in Supplemental Material ES3. Further differential RNA expression data can be found in 
Supplemental Material ES4.  
 
As depicted in Figure 5.22 (a), the ap2-g locus in P. berghei ANKA high-producer 
(HP) mature schizonts is marked at the TTS by H3K122 acetylation, and was down-
regulated in 22 h schizonts when compared to 16 h trophozoites (Otto et al., 
2014). If the current theory regarding the function of the H3K122ac mark is to be 
believed, the ap2-g locus would be poised for transcriptional activation in this 
state (Figure 5.22 (a)). At this point in the asexual cycle, the gene encoding for 
the AP2-G2 transcriptional repressor (Figure 5.22 (b)) is also marked by H3K122 
acetylation, with greatest overlap of peaks at the exon and TTS. 
 
In Figure 5.22 (c), the cap380 oocyst capsule protein locus is depicted, showing 
that in mature schizonts, this gene is marked at the promoter-TSS region and the 
exon by the H4K8ac histone modification. Down-regulation of RNA expression in 
this case indicates that this gene (associated with the transmission stage of P. 
berghei ANKA) is subject to decreased transcriptional activation (Srinivasan, 
Fujioka and Jacobs-Lorena, 2008). From analysis of the 10 genes shown in Figure 
5.22, it becomes clear that H3K122 acetylation alone (Figure 5.22 (a), (b), (f), 
(g), (h) and (j)) or in tandem with H4K8 acetylation acetylation (Figure 5.22 (c), 
is not indicative of increased RNA expression in P. berghei schizonts (Lopez-Rubio, 
Mancio-Silva and Scherf, 2009; Salcedo-Amaya et al., 2009; Tropberger et al., 
2013; Karmodiya et al., 2015; Pradeepa et al., 2016). 
 
With regard to the PIR pseudogene associated with multiple histone modifications 
(Figure 5.22 (d)), it is unclear whether the repetitive nature of the PIR family 
gene sequences was attractive to immunoglobulin-binding, or whether these 
genes are in fact heavily associated with epigenetic marks (Yam et al., 2016). 
Both hypotheses are possible. What is clearest from Chapter 5 in its entirety is 
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that single epigenetic modifications alone, without consideration for their 
location, lncRNAs or histone crosstalk, cannot be used alone as indicators of 
transcriptional activation or repression.  
 
5.8.4 Issues with peak calling software 
 
In addition to the considerable difficulty in optimisation of a ChIP protocol for the 
detection of chromatin-bound regions in the AT-rich Plasmodium genome, further 
issues arose in the present study with attempts to optimise bioinformatic analysis 
of the data produced upon sequencing of histone-bound DNA fragments. It is well-
documented that software tools for differential ChIP-seq analysis can considerably 
influence the outcome of ChIP-sequencing results (Steinhauser et al., 2016; Tu 
and Shao, 2017). In the present study, three peak-callers were compared: MACS2 
(Zhang et al., 2008), HOMER (Heinz et al., 2010), and Epic (based on SICER) (Xu 
et al., 2014).  
 
With MACS2 widely used to perform peak-calling of transcription factor-bound 
regions that often have sharp or isolated peaks (Tu and Shao, 2017), HOMER and 
Epic were tested and compared as described in section 5.3.4. HOMER and Epic 
tools are considered useful tools when working with broad peak ChIP data using 
default settings and when no pre-defined peak parameters have previously been 
determined (as was the case with ChIPmentation in P. berghei) (Steinhauser et 
al., 2016). Despite this, a number of issues arose when using the HOMER 
annotation script (http://homer.ucsd.edu/homer/ngs/annotation.html) to define 
regions of the P. berghei ANKA genome. Though HOMER annotates regions based 
upon information from PlasmoDB (version 34 of P. berghei ANKA in this case), 
prediction of promoters within the AT-rich Plasmodium genome is a difficult task, 
requiring specialised software, and with the Plasmodium genome often encoding 
for bi-directional promoters, large upstream promoters, and the ability to form 
antisense RNAs (Brick et al., 2008). With this in mind, HOMER prediction of peaks 
located at ‘intergenic’ or ‘intron’ regions may in fact encompass regions of 
Plasmodium gene promoters, though relatively few histone marks were 
determined to be located at these regions in the present study (sections 5.4 to 
5.8).  
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In addition to Plasmodium-specific genetic parameters that cannot be determined 
by HOMER annotation, a general issue arises in the method by which the 
‘mergePeaks’ option determines overlapping peaks between two or more peak 
files (for examples, two H4K8ac peak samples). When using the ‘mergePeaks’ 
command, HOMER requires a ‘primary peak file’ to which a second file is compared 
(http://homer.ucsd.edu/homer/ngs/mergePeaks.html). When choosing a primary 
peak file, HOMER software then determines ‘overlapping’ peaks as those with 
peak centres at an equal or lesser difference than 100 bp by default. This method 
of comparison may result in the loss of ‘overlapping peaks’ because the ‘primary 
peak file’ has fewer defined peaks than the secondary peak file. This iterative 
process of discovering overlapping peaks will also effect downstream comparisons 
when a ‘mergedPeaks’ file is again used as a primary file to which further peak 
files are compared. To determine that no peaks are missed when examining a 
series of samples, each file must be compared to one another in a pairwise 
fashion, with the resulting ‘overlapping’ files compared to one another or 
visualised on a genome browser. Visualisation of normalised BAM files of ChIP data 
or visual comparison of peak files may also aid in choosing primary peak files.            
 
5.8.5 Future experiments 
 
With optimisation of a ‘wet lab’ ChIPmentation procedure for P. berghei carried 
out in the present study, experiments to determine the changes to these 
epigenetic modifications in different life-cycle stages of the P. berghei ANKA 
parasite will be carried out (such as an analysis of changes after 
gametocytogenesis). The experiments shown above also represent the first time 
a comparative analysis of multiple peak-calling software packages has been 
undertaken in relation to Plasmodium ChIP experiments. In previous publications, 
only MACS2 software has been used to call peaks, though the use of this software 
may limit the scope of epigenetic findings (broader peaks may not be discovered, 
though they may be present) (Salcedo-Amaya et al., 2009; Karmodiya et al., 2015; 
Filarsky et al., 2018; Fraschka et al., 2018). Further discussion of ChIPmentation 
findings in the present study and the implications of these findings to Plasmodium 
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6.1 Epigenetics and control of Plasmodium gametocytogenesis  
 
It has been shown that gametocytogenesis in Plasmodium spp. is controlled by the 
AP2-G and AP2-G2 transcriptional regulators (Kafsack et al., 2014; Sinha et al., 
2014; Yuda et al., 2015), with AP2-G under the control of epigenetic factors HP1 
and HDAC2/IPK1 (Brancucci et al., 2014; Coleman et al., 2014). In recent studies, 
the role of gametocyte development protein 1 (GDV1) as an antagonist of HP1-
binding to pfap2-g has been shown, as well as the effect of 
lysophosphatidylcholine (LysoPC) levels on the initiation of gametocytogenesis in 
P. falciparum (Brancucci et al., 2017; Filarsky et al., 2018). Interestingly, GDV1 
and the effect of LysoPC on gametocytogenesis induction are both lost in P. 
berghei ANKA and other rodent malaria parasites (Brancucci et al., 2017; Filarsky 
et al., 2018). Loss of both the GDV1 protein and the effect of LysoPC together 
perhaps suggests that GDV1 activation is triggered by the absence of LysoPC, or 
that, in abundance, LysoPC is detrimental to GDV1 antisense RNA production in 
human malaria parasites. This remains to be investigated.  
 
However, upon completion of the present thesis, and during its correction, a 
further development occurred in the field of Plasmodium spp. sexual development 
and transmission that is important to elaborate upon. The initial discovery of AP2-
G and its role in gametocytogenesis (Kafsack et al., 2014; Sinha et al., 2014) was 
followed by development of a method to irreversibly express AP2-G, therefore 
irreversibly inducing sexual conversion of all parasites in a P. berghei experiment 
(Kent et al., 2018). This same method of rapamycin induction to induce sexual 
development was used in the present study to ensure populations of either 100% 
asexual parasites or 100% gametocytes prior to histone extraction (section 
1.7.2.3.1). However, in a recent study by Bancells et al. (Bancells et al., 2019), 
re-analysis of single-cell P. falciparum data determined that there are two distinct 
routes by which the Plasmodium parasite underwent sexual development. In some 
parasites, early ap2-g expression at ring-stage resulted in the growth of a sexual-
stage gametocyte within the same developmental cycle. In a second group of cells, 
ap2-g expression at a later stage (trophozoite stage) resulted in sexually-
committed parasites that remained morphologically asexual until after schizont 
development, merozoite egress, and re-invasion into a new erythrocyte. Only 
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upon re-invasion did the following developmental cycle produce gametocytes 
(Bancells et al., 2019) (Figure 6.1).    
 
 
Figure 6.1: Two routes of gametocytogenesis in a P. berghei model. Using P. berghei as a model 
in this diagram, the two routes by which Plasmodium spp. parasites are postulated to undergo 
gametocytogenesis are shown. In ‘Route 1’, the asexual ring-stage parasite (asexual denoted by 
‘o’) undergoes normal asexual growth until the induction of AP2-G by an as yet unknown 
mechanism. At this stage of asexual development, the parasite becomes committed to sexual 
development and expressed AP2-G, though the trophozoite stage parasite develops into a schizont 
containing either sexually-committed merozoites or a mix of asexual and sexual stage merozoites. 
Upon re-invasion into a new erythrocyte, these parasites develop in the second cycle into male or 
female gametocytes, or, in the case of the mixed schizont, further asexual parasites are produced. 
In ‘Route 2’ of gametocytogenesis, the expression of AP2-G during early ring-stage development 
results in conversion of the asexual parasite to a gametocyte within the same developmental cycle, 
and in the same erythrocyte. The mechanism for sex determination in these cases is unknown as 
of yet (Bancells et al., 2019). 
 
As shown in Figure 6.1, a further finding from the Bancells et al. study was that 
Plasmodium schizonts were not limited to asexual or sexually-committed 
merozoites as was previously thought (Smith et al., 2000), but could contain both 
AP2-G-expressing and AP2-G-negative merozoites. In this study however, the sex-
specificity of these mixed schizont stages was not explored, i.e. whether each 
route towards sexual development produced male and female gametocytes, or 
were sex-specific in nature (Bancells et al., 2019). In fact, the mixed schizont 
depicted in Figure 6.1 could also contain a mixture of asexual merozoites and 
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those committed to producing female gametocytes. All three possibilities 
(asexual, male sexually-committed, and female sexually-committed merozoites) 
may also be found within a single schizont cell, though this remains to be 
determined (Bancells et al., 2019).  
 
These recent findings also raise implications for the present study. In Chapter 4, 
the rapamycin-inducible P. berghei ANKA line was used to ensure a complete 
conversion of asexual parasites to gametocytes, with no induction producing 100% 
asexual parasites (Figure 4.3). The resulting asexual or sexually-committed 
nucleosomes demonstrated distinct histone modification profiles as depicted in 
Figure 4.8. However, our method of ap2-g induction using rapamycin (detailed in 
section 2.1.9) could not distinguish whether the isolated gametocytes were 
produced as a result of ‘Route 1’ or ‘Route 2’ gametocytogenesis, as depicted in 
Figure 6.1. The Bancells et al. study also suggests that ap2-g transcription by 
these developmental pathways resulted from epigenetic alterations at the ap2-g 
or gdv1 loci. To identify histone PTMs that may contribute to these pathways, 
histone extraction of P. berghei ANKA PTMs upon rapamycin induction in timed 
ring-stage parasites versus trophozoite-stage parasites could be undertaken. In 
addition, using rapamycin induction of ap2-g in vivo, followed by immediate in 
vitro culture may determine whether both mature asexual and mature sexual 
parasites develop. The availability of the ‘820’ line in P. berghei ANKA would also 
be useful in that the sex of gametocytes produced by induction at either ring-
stage or trophozoite-stage could be determined.    
 
With the discovery of two routes of gametocytogenesis also comes the possibility 
that enzymes that may result in either asexual or sexual-stage histone PTMs, such 
as those suggested in Table 4.6, may play a greater role than previously thought 
in the induction of sexual development. This is because ap2-g has essentially been 
shown to be an important factor in commitment to gametocytogenesis, but the 
method by which ap2-g is regulated remains unknown and is the subject of much 
research (Kafsack et al., 2014; Sinha et al., 2014; Bancells et al., 2019). The 
epigenetic landscape of P. berghei asexual and sexual-stage parasites as carried 
out in the present study provides new leads as to which enzymes may be involved 
in the process of gametocytogenesis. 
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With this study, insights have also been gleaned into the roles of both P. berghei 
HAT1 and HDA1 in asexual development and gametocytogenesis (Chapter 3). 
Further studies of the clonal and tagged parasite lines produced in this study will 
result in the expansion of our current knowledge of the relatively limited 
repertoire of epigenetic regulatory enzymes in Plasmodium spp. and related 
Apicomplexa.  
 
Finally, with continued optimisation of the ChIPmentation procedure, beginning 
with the lessons learned from Chapter 5 of this study, investigation of specific 
histone PTMs at various stages of the Plasmodium life-cycle can be carried out. 
For instance, proteomic analysis of histone PTMs before and after induction of 
gametocytogenesis using the G1142 P. berghei line (section 1.7.2.3.1), followed 
by ChIPmentation of differential PTMs (if present) between gametocytes induced 
at either ring-stage or trophozoite-stage, could shed light on the processes that 
produce the two different routes depicted in Figure 6.1.  
 
Finally, from Chapter 5, it is clear that, using Epic peak-calling software, H4K8ac 
and H3K122ac peaks are abundantly present in the P. berghei mature schizont 
genome, with H4K8 acetylation found at exons predominantly associated with 
tRNA processing and DNA recombination (Figure 5.4), and H3K122 acetylation 
associated with the exons of genes involved in macromolecule and cellular 
metabolic processes (Figure 5.19). Far fewer peaks were called for H3K9 
trimethylation and acetylation marks, with the H3K9me3 modification 
predominantly found at genes involved in spliceosome functions and seryl-tRNA 
aminoacylation (Figure 5.8). H3K9 acetylation marks were then associated with 
DNA geometric changes, RNA unwinding, and protein palmitoylation. However, 
these results form the basis for future ChIPmentation studies in P. berghei 
gametocytes, with results then comparable to the findings of Chapter 5. This 
chapter also highlights the difficulty associated with choosing an appropriate 
peak-calling software for analysis of ChIP-sequencing results. Further optimisation 
of peak-calling software for analysis of broad peaks in the AT-rich Plasmodium 
genome will aid studies of epigenetic marks in future.    
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6.2 H3K79 methylation in the absence of DOT1: the potential for unidentified 
Plasmodium histone methyltransferases 
 
One particularly intriguing finding from an analysis of histone post-translational 
modifications (PTMs) in both asexual-stage (schizont) and sexual-stage 
(gametocyte) P. berghei ANKA parasites, was the presence of mono-methylation 
of histone 3, lysine 79 (H3K79) in both mature schizonts and mature gametocytes 
(section 4.3.4). This histone modification was also found during a quantitative 
study of histone PTMs in P. falciparum (Coetzee et al., 2017).  
 
The reason for the unusual nature of this finding is that Plasmodium parasites of 
both Plasmodium and Laverania subgenera lack genes homologous to the human 
disruptor of telomeric-silencing 1 (DOT1), the enzyme responsible for H3K79 
methylation (Farooq et al., 2016). DOT1 was previously described as the ‘sole’ 
enzyme responsible for methylation of H3K79 in humans, Drosophila 
melanogaster, and Saccharomyces cerevisiae (Van Leeuwen, Gafken and 
Gottschling, 2002; Farooq et al., 2016), though with the findings of the present 
study, alongside those of Coetzee et al. (Coetzee et al., 2017), this statement 
simply cannot be accurate.  
 
In Trypanosoma brucei brucei, two DOT1 homologues, DOT1A and DOT1B, are 
responsible for dimethylation and trimethylation of the parasite H3K76 
(corresponding to H3K79 in other eukaryotes) respectively (Janzen et al., 2006). 
DOT1B in particular, has been suggested as having an essential role in chromatin 
remodelling during developmental differentiation of T. brucei brucei (Dejung et 
al., 2016). Taking both T. brucei brucei (TREU927 strain) DOT1A (Tb927.8.1920) 
and DOT1B (Tb927.1.570) protein and BLASTing these sequences against all 
currently identified Plasmodium spp. protein sequences (EuPathDB version 36 for 
both), DOT1B generated no hits (result not shown). However, three hits were 
generated when comparing DOT1A to known Plasmodium spp. proteins: one 
uncharacterised protein in P. coatneyi Hackeri (a non-human primate malaria) and 
the heat shock 90 protein (HSP90) from both strains of the non-human Laverania 
species, P. reichenowi. Further comparison of these proteins was then carried out 
using  Clustal (Sievers and Higgins, 2014) (Figure 6.2). 
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Figure 6.2: Clustal alignment of T. brucei brucei DOT1 methyltransferases with Plasmodium 
spp. proteins of greatest homology. In this image, two regions of a Clustal alignment are shown. 
Three T. brucei brucei DOT1 methyltransferases (Tb927.8.1920 (DOT1A); Tb927.1.570 (DOT1B), 
and a putative DOT1 protein (Tb927.11.3200)) are aligned to three protein hits generated upon 
BLAST-searching for T. brucei brucei DOT1A. These Plasmodium spp. proteins were a P. coatneyi 
Hackeri uncharacterised protein (encoded by PCOAH_00011280) and the heat shock protein 90 
(HSP90) of P. reichenowi CDC and GO1 strains (encoded by PRCDC_1116600 and PRG01_1115400 
respectively). In both (b) and (d), the protein regions corresponding to S-adenosyl-L-methionine 
(SAM) protein binding motifs are outlined within the Clustal alignment. In (a) and (c), regions of 
the peptides corresponding to DOT1-specific motifs, labelled D1 and D2, are outlined. Greatest 
homology appears between SAM-binding motifs in these particular proteins. 
 
As can be seen in Figure 6.2, the regions within Plasmodium spp. proteins with 
greatest homology to three T. bruci brucei DOT1 methyltransferases are S-
adenosyl-L-methionine (SAM)-binding motifs, and not the DOT1 
methyltransferase-specific motifs (Min et al., 2003; Janzen et al., 2006). These 
results suggest that perhaps these Plasmodium spp. proteins maintain SAM-
dependent properties, but are not capable of histone methyltransferase activity, 
as is the case with many other SAM-binding proteins (Gana et al., 2013). 
 
To conclude, there are no proteins homologous to DOT1 found in any Plasmodium 
spp. so far identified. Therefore, it remains to be seen whether methylation of 
H3K79 in Plasmodium spp. is a result of SET methyltransferase activity, or 
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previously unknown methyltransferase activity of a new class of eukaryotic or 
Plasmodium-specific proteins (SAM-dependent or otherwise). 
 
6.3 Translating epigenetic findings into anti-malarial targets 
 
In the present study, the epigenetic landscape of the rodent malaria parasite, P. 
berghei ANKA, was investigated with the aim of identifying differences between 
the regulation of gene expression in asexual-stage parasites and sexual-stage 
parasites (gametocytes). The discovery of the epigenetic regulatory mechanisms 
underlying commitment to gametocytogenesis in P. berghei may provide insight 
into the biology of malaria transmission.  
 
At present, epigenetic regulation of the clonally variant var genes in the most 
lethal human malaria parasite, P. falciparum, has generated interest in the 
proteins that drive these processes as potential anti-malarial drug targets (Duffy 
et al., 2014; Ay et al., 2015; Duraisingh and Horn, 2016). In recent years, a number 
of studies have been published that have demonstrated the effects of approved 
and novel inhibitors of epigenetic regulators on Plasmodium asexual- and sexual-
stage parasites (Darkin-Rattray et al., 1996; Agbor-Enoh et al., 2009; Wheatley et 
al., 2010; Andrews et al., 2012; Sumanadasa et al., 2012; Hansen et al., 2014; 
Malmquist et al., 2015; Alves Avelar et al., 2017; Chua et al., 2017). These 
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280 ± 90 nM (P. falciparum; In 
vitro) 
390 ± 90 nM (P. vivax; In vitro) 
50 mg/kg/day (P. berghei; In vivo) 
Novel P. falciparum (multiple 
strains), P. vivax (clinical 
isolates), P. berghei   






340 ± 160 nM (P. falciparum; In 
vitro) 
240 ± 70 nM (P. vivax; In vitro) 
50 mg/kg/day (P. berghei; In vivo) 
Novel P. falciparum (multiple 
strains), P. vivax (clinical 
isolates), P. berghei   
Malmquist et al., 2015 
 
Vorinostat (SAHA) Plasmodium histone 
deacetylase 1 (HDAC1) 
250 ± 140 nM (P. falciparum; In 
vitro) 
370 ± 20 nM (P. knowlesi; In vitro)  
50 mg/kg/day (P. berghei; In vivo) 
Approved 
(FDA/EMA) 
P. falciparum 3D7, P. 
knowlesi A1H.1, P. berghei   
Chua et al., 2017 
Belinostat (PXD101) Plasmodium histone 
deacetylase 1 (HDAC1) 
170 ± 4 nM (P. falciparum; In vitro) 
190 ± 20 nM (P. knowlesi; In vitro)  
Approved 
(FDA/EMA) 
P. falciparum 3D7, P. 
knowlesi A1H.1, P. berghei   
Chua et al., 2017 
 
Panobinostat (LBH-589) Plasmodium histone 
deacetylase 1 (HDAC1) 
4 ± 0.2 nM (P. falciparum; In vitro) 
9 ± 1 nM (P. knowlesi; In vitro)  
50 mg/kg/day (P. berghei; In vivo) 
Approved  
(FDA/EMA) 
P. falciparum 3D7, P. 
knowlesi A1H.1, P. berghei   
Chua et al., 2017 
 
Romidepsin (FK228) Plasmodium histone 
deacetylase 1 (HDAC1) 
140 ± 4 nM (P. falciparum; In 
vitro) 
210 ± 20 nM (P. knowlesi; In vitro)  
Approved  
(FDA) 
P. falciparum 3D7, P. 
knowlesi A1H.1, P. berghei   
Chua et al., 2017 
YC-II-88 (WR301801)  Histone deacetylases (non-
specific) 
1.25 nM (P. falciparum 3D7; In 
vitro) 
50 mg/kg/day (P. berghei; In vivo) 
Novel P. falciparum (multiple 
strains), P. berghei   
Agbor-Enoh et al., 2009 
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Pracinostat (SB939) Histone deacetylases (non-
specific; likely 
Plasmodium HDAC1) 
80 ± 30 nM (P. falciparum 3D7; In 
vitro) 
150 ± 30 nM (P. falciparum Dd2; In 
vitro) 
50 mg/kg/day (P. berghei; In vivo) 
Approved 
(FDA/EMA) 
P. falciparum (3D7 + Dd2), 
P. berghei ANKA 
Sumanadasa et al., 2012 
“6h” Histone deacetylases (non-
specific; likely 
Plasmodium HDAC1) 
70 nM (P. falciparum 3D7; In vitro) 
70 nM (P. falciparum Dd2; In vitro) 
Novel P. falciparum (3D7 + Dd2)  Alves Avelar et al., 2017 
Trichostatin A (TSA) Histone deacetylases (non-
specific; likely 
Plasmodium HDAC1) 
8-11 nM (P. falciparum 3D7; In 
vitro) 
Approved (FDA) P. falciparum 3D7  Andrews et al., 2012 
2-ASA-9 Histone deacetylases (non-
specific; likely 
Plasmodium HDAC1) 
15-39 nM (P. falciparum 3D7; In 
vitro) 
Novel P. falciparum 3D7  Andrews et al., 2012 
Apicidin Histone deacetylases (non-
specific) 
91 nM (P. falciparum Dd2; In vitro) 
50 mg/kg/day (P. berghei; In vivo) 
Experimental only P. falciparum Dd2, P. 
berghei KBG 173  
Darkin-Rattray et al., 
1996 
LMK235 Plasmodium histone 
deacetylase 1 (HDAC1) 
90-112 (P. falciparum 3D7; In 
vitro) 
Novel P. falciparum 3D7  Hansen et al., 2014 
Asu-9 Plasmodium histone 
deacetylase 1 (HDAC1) 
15 nM (P. falciparum 3D7; In vitro) Novel P. falciparum 3D7  Wheatley et al., 2010 
Asu-13a Plasmodium histone 
deacetylase 1 (HDAC1) 
14 nM (P. falciparum 3D7; In vitro) Novel P. falciparum 3D7  Wheatley et al., 2010 
 
Table 6.1: Chemical inhibitors of Plasmodium spp. epigenetic regulatory proteins. This table lists all chemical inhibitors of Plasmodium spp. 
histone/lysine methyltransferases (HKMTs) and histone/lysine deacetylases (HDACs) that have been identified to date. From left to right, each row lists the 
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name of the compound (both commercial and chemical names if present); the epigenetic regulator to which they are targeted; the half maximal inhibitory 
concentration (IC50) of each compound (and the Plasmodium species in which this result was achieved); the approval of each drug for medicinal use (showing 
the drug as novel (untested in humans), experimental (established as a laboratory drug but not approved in humans), or approved); the Plasmodium species 
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As can be seen from Table 6.1, quite a few novel and approved chemical inhibitors 
of epigenetic regulators have been identified as having potential anti-malarial 
properties, some in multiple Plasmodium spp., both in vitro and in vivo. What is 
abundantly clear is that the majority of the compounds listed are histone 
deacetylase (HDAC) inhibitors, owing to the fact that these drugs have already 
proven effective in treating human cancers, with drugs listed as ‘approved’ in 
Table 6.1 referring to those HDAC inhibitors that have already been approved for 
the treatment of cancers only (Li and Seto, 2016). 
 
There are two main issues that arise when studying HDACs as potential targets for 
anti-malarial therapy: i) the cytotoxicity of novel and approved HDAC inhibitors 
to host cells, with the potential for intolerable side-effects (Eckschlager et al., 
2017); and ii) the paucity of knowledge regarding the role of HDACs in Plasmodium 
spp. (Kanyal et al., 2018). However, both issues can be overcome with the 
application of basic science; experiments such as those carried out in the present 
study to characterise potential epigenetic regulators such as histone 
acetyltransferase 1 (HAT1) and histone deacetylase 1 (HDA1) will inform future 
studies into the development of Plasmodium-specific inhibitors of epigenetic 
regulators.  
 
6.4 Thesis summary: findings from the present study 
 
Key findings from the present thesis report are listed below: 
 
1. This study represents the first time a Plasmodium histone acetyltransferase 
(HAT1) was shown to play a role in gametocytogenesis. Complete HAT1 KO 
in the P. berghei 820 line resulted in a statistically significant decrease in 
mature female gametocytes (P = 0.048; n = 5). 
 
2. Complete HDA1 knockout in a PbEGAM line resulted in a significant decrease 
in overall gametocytaemia (P = 0.0109; n = 3); a decrease in female 
gametocytes from 2.93% ± 1.09 % to 1.03% ± 0.22% of total parasitaemia (P 
= 0.0415), and a decrease in male gametocytes from 2.07% ± 0.38% to 1.21% 
± 0.32% of total parasitaemia (P = 0.0402). 
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3. P. berghei lines were created in which 4 histone deacetylases were tagged 
with haemagglutinin and a fluorescent marker, enabling future studies to 
be undertaken regarding these epigenetic factors.  
 
4. The differential landscapes of histone modifications in both asexual-stage 
(mature schizont) and sexual-stage (gametocyte) P. berghei parasites were 
determined. 
 
5. A protocol for the use of chromatin immunoprecipitation with high-
throughput sequencing using a Tn5 transposase (ChIPmentation) was 
optimised for use in Plasmodium spp. parasites. 
 
6. Locations within the entire P. berghei ANKA genome at which four histone 
modifications (H4K8ac, H3K9ac, H3K9me3, and H3K122ac) bind were 
determined in mature asexual P. berghei parasites using Epic peak-calling 
software. 
 
7. It was determined that in Plasmodium subgenera, H3K79 methylation, and 
H3K36 di- and tri-methylation, are functions of as-yet unidentified 
histone/lysine methyltransferases, or that a different Plasmodium SET 
protein has evolved to take over the traditional DOT1 and SET2 roles.    
 
6.5 Future work stemming from the present study 
 
With the findings listed above (section 6.4), and the generation of multiple P. 
berghei ANKA parasite lines throughout the course of this study, many more 
experiments are possible that could potentially provide important insights into the 
epigenetic regulation of the Plasmodium life-cycle. A number of these 
experiments are listed below:  
 
1. Transmission of HAT1 knockout P. berghei parasites through mosquitoes to 
determine the role of HAT1 in the generation of gametes, in fertilisation, 




Chapter 6  Discussion 
 317 
 
2. Histone extraction and analysis of histones from HAT1-depleted P. berghei 
schizonts and gametocytes using LC-MS/MS to identify HAT1 acetylation 
targets. 
 
3. Fluorescence microscopy of HDA1 knockout and tagged parasites 
throughout the entire asexual life-cycle in a timed manner to identify 
potential enzyme stage-specificity.  
 
4. Conversion of the AID knockdown plasmids to vectors that could be used for 
conditional degradation of proteins via the knocksideways system, 
preferably using the faster Gibson Assembly system. 
 
5. ChIPmentation of P. berghei gametocytes to identify differential binding of 
the same four epigenetic marks (H4K8ac, H3K9ac, H3K9me3, and 
H3K122ac) to the parasite genome during sexual development.   
 
6. Application of the rapamycin-inducible DiCre system to any of the 
epigenetic regulatory proteins from this study to complement 
knockout/knockdown findings.  
 
7. A bioinformatic analysis of potential methyltransferase motifs in rodent 
Plasmodium genomes to identify novel histone/lysine methyltransferases 
that could take over the methyltransferase function of DOT1 and SET2.  
 
8. Phosphorylation assays with recombinant P. berghei ANKA NEK4 and protein 
kinase B (PKB) with putative histone substrates to identify their function. 
 
9. Histone extraction from parasites of the rapamycin-inducible ap2-g P. 
berghei line before induction of ap2-g expression, after induction of ap2-g 
in ring-stage parasites, and after induction of ap2-g during trophozoite 
growth to identify epigenetic differences between parasites that undergo 
gametocytogenesis in the same developmental cycle versus those that have 
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Table 7.1: Primers used in the present study. The table below lists all PCR primer sequences designed and used in the present study alongside their name/number, 
recommended melting temperature (Tm), restriction site(s) (if present), the gene identifier (ID) of the gene from which the sequence was taken (excluding an 
introduced restriction enzyme recognition site), and a description of how the primer was used. All names given to primers are a number followed by a ‘GU’ prefix, 
standing for ‘Glasgow University’ (from where the primers were designed and ordered). In primer sequences that contain a restriction enzyme recognition site; the 
nucleobases of the restriction site are shown in red and in lower case, and the Tm shows the temperature of the sequence not including the restriction site. In primer 
sequences with nucleobases shown in green text, the adjacent Tm is the temperature of this particular primer sequence (and is also shown in green text). Lower case 
nucleobase letters in black text (reserved for primers designed for Gibson Assembly) indicates that this portion of the sequence overlaps with that of a second primer 
sequence. These overlapping fragments would be required for accurate Gibson assembly of a DNA construct into the knocksideways (KS) pL0078 background DNA 




Sequence (5’®3’) Tm  Restriction 
site 
Gene ID Description 
GU3199 ATTaagcttGTGCCACCACATTTGAATTTTAG 52°C HindIII PBANKA_1436100 HP1 KO upstream region forward primer 
GU3200 TATccgcggTTATGTTATGCTATATTTCACTATTTTGTT 51°C SacII PBANKA_1436100 HP1 KO upstream region reverse primer 
GU3201 ATAggtaccATGTATAGAGAATCCTCTTAGGC 52°C KpnI PBANKA_1436100 HP1 KO downstream region forward primer 
GU3202 AATctcgagATGCATACATATAGCCACTAATTCA 51°C XhoI PBANKA_1436100 HP1 KO downstream region reverse primer 
GU3219 ATAgggcccGTAGTAGCTATTTGTGAATTTCCATT 52°C ApaI PBANKA_0415300 RNAseII KO upstream region forward primer 
GU3220 ATAccgcggCACTTTCGTATACAACAACTTACTT 51°C SacII PBANKA_0415300 RNAseII KO upstream region reverse primer 
GU3221 TTAggtaccTGATTTGCGTCTTTCAGTTCATTC 52°C KpnI PBANKA_0415300 RNAseII KO downstream region forward 
primer 
GU3222 ATTctcgagCTTGTATTGGACTTCGATGTGATT 52°C XhoI PBANKA_0415300 RNAseII KO downstream region reverse 
primer 
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GU3223 ATAgggcccGAAATTTTGGTGTTTCTCCACTTC 52°C ApaI PBANKA_1414600 IPK2 KO upstream region forward primer 
GU3224 ATAccgcggATGGATATACATATATTCCCTTTGAC 52°C SacII PBANKA_1414600 IPK2 KO upstream region reverse primer 
GU3225 TATggtaccCACAGTTTATTATTTCCAGTTGATGT 52°C KpnI PBANKA_1414600 IPK2 KO downstream region forward primer 
GU3226 ATTctcgagTTTTGTACCCCACATGTACATTAC 52°C XhoI PBANKA_1414600 IPK2 KO downstream region reverse primer 
GU3227 ATAgggcccATTGTATGCATGTACGCTTAGCA 52°C ApaI PBANKA_0826500 HDAC1 KO upstream region forward primer 
GU3228 ATTccgcggAGTTGCTTATATACTTGGACCATC 52°C SacII PBANKA_0826500 HDAC1 KO upstream region reverse primer 
GU3229 TATggtaccGGAGTGTAATTTGTGTGTATGAAG 52°C KpnI PBANKA_0826500 HDAC1 KO downstream region forward 
primer 
GU3230 ATActcgagTTTCCCCATTTCATTTATTCCCTC 52°C XhoI PBANKA_0826500 HDAC1 KO downstream region reverse primer 
GU3262 ATTaagcttCATCCCCATATATGCCTGAGT 52°C HindIII PBANKA_1206200 HDAC2/IPK1 KO upstream region forward 
primer 
GU3263 ATAccgcggTGCAAATGTATATACTTTATACATACACA 52°C SacII PBANKA_1206200 HDAC2/IPK1 KO upstream region reverse 
primer 
GU3264 TATggtaccGAAGCTATCCCTCTATGCTAC 52°C KpnI PBANKA_1206200 HDAC2/IPK1 KO downstream region forward 
primer 
GU3265 ATActcgagCGACAGCATATACATAGAATGAC 52°C XhoI PBANKA_1206200 HDAC2/IPK1 KO downstream region reverse 
primer 
GU3280 AATggcgcgccCAAGATGATATGGGGAATACTCT 52°C AscI PBANKA_1436100 HP1 KD forward primer 
GU3281 ATTctcgagAACCGTTCTATATCTAAGTCTTGATA 52°C XhoI PBANKA_1436100 HP1 KD reverse primer 
GU3282 ATTACATCTAAGAATAAAGAAAATGATTgtcgac 
CCGTTCCATATGATGTGG 
48°C SalI PBANKA_0415300 RNAseII KD forward primer 
GU3283 ATTctcgagGACAAAACGTAGGTTCCACATAT 52°C XhoI PBANKA_0415300 RNAseII KD reverse primer for SalI site 
insertion 
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48°C SalI PBANKA_0415300 RNAseII KD reverse primer 
GU3286 CTTATCATCACTTGCAAAAATACgtcgac 
CAAAAATCTGTAATACAAAAGTAGC 
48°C SalI PBANKA_1414600 IPK2 KD forward primer 
GU3287 ATTctcgagTTCACTTATAGAGCAATTCGAAAAATAAT 52°C XhoI PBANKA_1414600 IPK2 KD reverse primer for SalI site insertion 
GU3288 AATggcgcgccACTGAAAAGTCTGAAGTTGATGATAA 52°C AscI PBANKA_1414600 IPK2 KD forward primer for SalI site insertion 
GU3289 GCTACTTTTGTATTACAGATTTTTGgtcgac 
GTATTTTTGCAAGTGATGATAAG 
48°C SalI PBANKA_1414600 IPK2 KD reverse primer 
GU3290 AATggcgcgccCATGATTATGAATATGTTGATTTTTTATCAT 51°C AscI PBANKA_0826500 HDAC1 KD forward primer 
GU3291 ATTctcgagAATAATTCCTTGATCTCTGTCTGAC 53°C XhoI PBANKA_0826500 HDAC1 KD reverse primer 
GU3292 AATggcgcgccTATGCATGGTTATATCTATGCTGTGA 52°C AscI PBANKA_1206200 HDAC2/IPK1 KD forward primer 
GU3293 ATTctcgagAATCGAGGATTTTACTTTTTCAATAGTTT 52°C XhoI PBANKA_1206200 HDAC2/IPK1 KD reverse primer 
GU3294 GTAGTGTTTTCGAAGCCTTgtcgac 
ATGTTGTACATGCAATAAAATAGTA 
48°C SalI PBANKA_1343800 SIR2A KD forward primer 
GU3295 ATTctcgagTTTTCCTCTTTTAATATTTCGATCAAATTAG 52°C XhoI PBANKA_1343800 SIR2A KD reverse primer for SalI site 
insertion 




47°C SalI PBANKA_1343800 SIR2A KD reverse primer 
GU3298 GTATCAAATTATAATCAAAATTTACTCAgtcgac 
AAAGGGAAAATGTTCAACAAACT 
48°C SalI PBANKA_1315100 SIR2B KD forward primer 
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GU3299 ATTctcgagTACACATTCAAATAAGTCGTTGGTG 53°C XhoI PBANKA_1315100 SIR2B KD reverse primer for SalI site 
insertion 




48°C SalI PBANKA_1315100 SIR2B KD reverse primer 
GU3302 CGATAACTAATACTATCTCAAAAAAgtcgac 
ATGCGCACGAAAAGAGAG 
48°C SalI PBANKA_1335400 HDA1 KD forward primer 
GU3303 ATTctcgagATTTTTTAGGTGATTCCATAAATTATTTAAC 51°C XhoI PBANKA_1335400 HDA1 KD reverse primer for SalI site 
insertion 




48°C SalI PBANKA_1335400 HDA1 KD reverse primer 
GU3306 TTATATTAGACGTTGATGTGCATgtcgac 
CAAGGTGATGGAACAGCA 
48°C SalI PBANKA_1106200 HDAP KD forward primer 
GU3307 ATTctcgagTCCATGTTTTCCCTTTGTAGCC 52°C XhoI PBANKA_1106200 HDAP KD reverse primer for SalI site 
insertion 




48°C SalI PBANKA_1106200 HDAP KD reverse primer 
GU3310 TTGTCAATTCTAACATAAAAGAAATTAgtcgac 
CTGTAGAAGATCCAGCAG 
48°C SalI PBANKA_0718400 HAT1 KD forward primer 
Chapter 7  Appendix 
 323 
GU3311 ATTctcgagAAGTGGGTATAATGACCTCAACTT 52°C XhoI PBANKA_0718400 HAT1 KD reverse primer for SalI site 
insertion 




48°C SalI PBANKA_0718400 HAT1 KD reverse primer 
GU3399 GACAACCAAGAAATTACATTTCAAAAG 52°C - PBANKA_1436100 HP1 KO 5’ integration forward primer 
GU3400 AGAATTAAGCTGGGCTGCAG 52°C - - Pbeef1a  promoter reverse primer (to 
confirm KO construct integration) 
GU3401 TTAGCGAAGATTAACACGTTTGC 52°C -  PBANKA_1436100 HP1 KO 3’ integration reverse primer 
GU3402 GTTACTGGTGCCCTCGAC 53°C -  - yfcu sequence forward primer (to confirm 
KO construct integration) 
GU3403 GGTAATACTGGAATGAGATAGTAG 52°C - PBANKA_0415300 RNAseII KO 5’ integration forward primer 
GU3404 AATTATGACACTACAGAAGATTACCAT 52°C - PBANKA_0415300 RNAseII KO 3’ integration reverse primer 
GU3405 CCCATACATAGGACTGGCTTA 52°C - PBANKA_1414600 IPK2 KO 5’ integration forward primer 
GU3406 GAAGTTTTCCCCGAAGAAGG 52°C - PBANKA_1414600 IPK2 KO 3’ integration reverse primer 
GU3407 CTGGCATGTATACACACATATAAG 52°C - PBANKA_0826500 HDAC1 KO 5’ integration forward primer 
GU3408 AGTTTATCCCATGTTTTACCTTTTC 51°C - PBANKA_0826500 HDAC1 KO 3’ integration reverse primer 
GU3409 CCACCTATCTTTCCCTCCATT 52°C - PBANKA_1206200 HDAC2/IPK1 KO 5’ integration forward 
primer 
GU3410 CATGAAAATATATTATTGTTCAATGGAGG 53°C - PBANKA_1206200 HDAC2/IPK1 KO 3’ integration reverse 
primer 
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GU3433 TCGAATTCAGTATTGCACGACTAGATAT 56°C -  - 3’ Pb48/45 reverse primer (to confirm KD 
construct integration) 
GU3434 GCGACACGGAAATGTTGAATACTC 56°C - - Amp sequence forward primer (to confirm 
KD construct integration) 
GU3871 GTGTATGTATAAAGTATATACATTTGCATATAATTTATTG 56.3°C - PBANKA_1206200 HDAC2/IPK1 KD integration forward primer 
(extra internal primer)  
GU3872 CGGACCCTTCAAAAAGTAAATCTGAAG 56.7°C - PBANKA_1206200 HDAC2/IPK1 KD integration forward primer 
(extra internal primer) 
GU3435  CAAATACATGGTGAGTACCTTCCCT 56°C - PBANKA_1343800 SIR2A KD 5’ integration forward primer 
GU3436 GACGAAGTAAATGTATACTTTACAAACCC 56°C - PBANKA_1343800 SIR2A KD 3’ integration reverse primer 
GU3437 CAAAAATGTGCATGATGTACTAGACACAG 57°C - PBANKA_1315100 SIR2B KD 5’ integration forward primer 
GU3438 CCAGCCATTCCATGTGGGCA 56°C - PBANKA_1315100 SIR2B KD 3’ integration reverse primer 
GU3439 GAGTGCATGATGTGTCATATATAAAGATG 56°C - PBANKA_1335400 HDA1 KD 5’ integration forward primer 
GU3440 CGTTCATGAGAATATCAAGTTTATTGTGG 56°C - PBANKA_1335400 HDA1 KD 3’ integration reverse primer 
GU3441 GTTATATGGGGATTGGGGTTATTTGG 56°C - PBANKA_1106200 HDAP KD 5’ integration forward primer 
GU3442 TATCATATGTGAACGATTTGGTCGGG 56°C - PBANKA_1106200 HDAP KD 3’ integration reverse primer 
GU3443 CTTTAAAGGATGTGAAGGAAAAATCGAAC 56°C - PBANKA_0718400 HAT1 KD 5’ integration forward primer 
GU3444 CGAACCTTCTATTAACCCTCAAAATG 55°C - PBANKA_0718400 HAT1 KD 3’ integration reverse primer 
GU3445 GCATTTTACACTATTTTGCCATAAGCAC 56°C - - OsTIR1/9Myc construct sequencing forward 
primer (within HSP70 promoter 3’UTR 
sequence) 
GU3446 CTCCTCAACATCTTGCATTTCTCC 56°C -  - OsTIR1/9Myc construct sequencing reverse 
primer (within OsTIR1 sequence) 
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GU3447 GGATTTGGGGACAGGGAATTTGAC 57°C - - OsTIR1/9Myc construct sequencing forward 
primer (within OsTIR1 sequence) 
GU3448 CCAAAGGGATCGCATTGTCTCG 57°C - - OsTIR1/9Myc construct sequencing reverse 
primer (within OsTIR1 sequence) 
GU3449 GTATTCGAATTCAGTATTGCACGACTAG 57°C - - OsTIR1/9Myc construct sequencing reverse 
primer (within OsTIR1 sequence) 
GU3450 GCAATATATAGCTATATGTAATGGTGAGTG 56°C - - Additional AID::HA construct reverse primer 
(within AID::HA sequence) 
GU4150 CAGGATCAGATGAAGAATTTGAAATAGG 55.5°C - PBANKA_1436100 Extra HP1 KD 5’ integration forward primer 
GU4151 CCTTGTTTGCAGGCTCATTATTCAG 56°C - - Additional AID::HA construct reverse primer 
(within AID::HA sequence) 
GU4152 CCGATTTAGAGCTTGACGGGG 56.3°C - - Additional AID::HA construct forward primer 
(within plasmid background sequence) 
GU4153 GGATGTTATTAGGTGCCTAAGAGG 55.7°C - PBANKA_1436100 Extra HP1 KD 3’ integration reverse primer 
GU4154 GGTCCAAGTATATAAGCAACTCCC 55.7°C - PBANKA_0826500 Extra HDAC1 KD 5’ integration forward 
primer 
GU4155 CGACGTCATGAGTCGTAGATCC 56.7°C - PBANKA_0826500 Extra HDAC1 KD 5’ integration reverse 
primer 
GU4156 GCTCGTATTTTATAAAATGGCGTGTCG 56.7°C - PBANKA_0826500 Extra HDAC1 KD 3’ integration reverse 
primer 
GU4157 CGAAATGTGCTAAGCTCTATGAGG 55.7°C - PBANKA_1206200 Extra HDAC2/IPK1 KD 5’ integration forward 
primer 
GU4158 GGTGCTCCGTCCATTGATACC 56.3°C - - Additional AID::HA construct reverse primer 
(within AID::HA sequence) 
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GU4159 CGACTCACTATAGGGCGAATTGG 57.1°C - - Additional AID::HA construct forward primer 
(within plasmid background sequence) 
GU4160 GGTATATGATGGTGTAGATACGGG 55.7°C - PBANKA_1206200 Extra HDAC2/IPK1 KD 3’ integration reverse 
primer 
GU4161 GGAATGTTTGACGAAAACGAGATGG 56°C - PBANKA_1343800 Extra SIR2A KD 5’ integration forward primer 
GU4162 GGAAACCATCACGTTCTTCCGG 56.7°C - - Additional AID::HA construct reverse primer 
(within AID::HA sequence) 
GU4163 GCTAACCAAAGATCGGACATAGC 55.3°C - PBANKA_1343800 Extra SIR2A KD 3’ integration reverse primer 
GU4164 GCATTAAATGCAAGCGGGGTCG 56.7°C - PBANKA_1335400 Extra HDA1 KD 5’ integration forward primer 
GU4165 GGAGCCACTGTATCTCCACC 55.9°C -  Additional AID::HA construct reverse primer 
(within AID::HA sequence) 
GU4175 GCCACTACCAGGTGAATTTTCCC 57.1°C - PBANKA_1335400 Extra HDA1 KD 3’ integration reverse primer 
GU4167 GGATGAACAAATATGGGACTATCC 54°C - PBANKA_1106200 Extra HDAP KD 5’ integration forward primer 
GU4168 CCCTCTCTTGTTTCCGGTTACC 56.7°C - - Additional AID::HA construct reverse primer 
(within AID::HA sequence) 
GU4169 CATTCGCCATTCAGGCTGCG 55.9°C - - Additional AID::HA construct forward primer 
(within plasmid background sequence) 
GU4170 CTTCGCTTTTTAAATATGGCATAGCC 54.8°C - PBANKA_1106200 Extra HDAP KD 3’ integration reverse primer 
GU4171 CGAAAAGTAGAATGGTTTTATCACTGG 55.2°C - PBANKA_0718400 Extra HAT1 KD 5’ integration forward primer 
GU4172 CCCAGTCACGACGTTGTAAAACG 57.1°C -  Additional AID::HA construct forward primer 
(within plasmid background sequence) 
GU4173 CTGTTTACACACAATATATTTCCATTCC 54.1°C -  PBANKA_0718400 Extra HAT1 KD 3’ integration reverse primer 
GU4062 CATACTAGCCATTTTATGTGTG 57°C - - PlasmoGEM GW1 forward primer 
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GU4063 GACTTTGGTGACAGATACTAC 58°C - - PlasmoGEM GW2 reverse primer 
GU4260 CTAGGCCCAGGCGCAGAGGA 60°C - - PlasmoGEM GT reverse primer 
GU4166 TGGGGGCTCTTCTTCATCATCCTCA 59.3°C - - PlasmoGEM GT forward primer 
GU4315 GCAGCTACCCCTCCTGCATTG 58.3°C - PBANKA_1335400 HDA1 5’ reverse primer for PlasmoGEM KO 
construct integration  




74.6°C - PBANKA_1436100 HP1 KS forward primer (for Gibson Assembly) 
GU4262 GGCGGCCGCTATCTAGACACTAGTGAGAACC 
GTTCTATATCTAAGTCTTGATAAAAGAAAG 
71.4°C - PBANKA_1436100 HP1 KS reverse primer (for Gibson Assembly) 
GU4263 CTTTCTTTTATCAAGACTTAGATATAGAAC 
GGTTCTCACTAGTGTCTAGATAGCGGCCGCC 
71.4°C - PBANKA_1436100 HP1 KS forward primer (for Gibson Assembly) 
GU4264 GGAAACTAAAATTCAAATGTGGTGGCACCATGG 
atgggagtgcaggtggaaaccatctcccc 
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E., Carrió, E., Moes, S., Jenoe, P., Ba ́rtfai, R. and Voss, T. S. (2018) ‘GDV1 
induces sexual commitment of malaria parasites by antagonizing HP1-
dependent gene silencing’, Science, 359(6381): 1259-1263.  
Fingerman, I. M., Du, H. N. and Briggs, S. D. (2008) ‘In vitro histone 
methyltransferase assay’, Cold Spring Harbor Protocols. doi: 
10.1101/pdb.prot4939.  
Flannery, E. L., Chatterjee, A. K. and Winzeler, E. A. (2013) ‘Antimalarial drug 
discovery - approaches and progress towards new medicines.’, Nature 
reviews. Microbiology, 11(12): 849–62.  
Flensburg, C., Kinkel, S. A., Keniry, A., Blewitt, M. E. and Oshlack, A. (2014) ‘A 
comparison of control samples for ChIP-seq of histone modifications.’, 
Frontiers in genetics. Frontiers Media SA, 5, p. 329. doi: 
10.3389/fgene.2014.00329.  
Flueck, C., Bartfai, R., Niederwieser, I., Witmer, K., Alako, B. T. F., Moes, S., 
Bozdech, Z., Jenoe, P., Stunnenberg, H. G. and Voss, T. S. (2010) ‘A major 
role for the Plasmodium falciparum ApiAP2 protein PfSIP2 in chromosome 
end biology’, PLoS Pathogens, 6(2). doi: 10.1371/journal.ppat.1000784.  
Chapter 8  References 
 344 
Fonager, J., Franke-Fayard, B. M., Adams, J. H., Ramesar, J., Klop, O., Khan, S. 
M., Janse, C. J. and Waters, A. P. (2011) ‘Development of the piggyBac 
transposable system for Plasmodium berghei and its application for random 
mutagenesis in malaria parasites’, BMC Genomics, 12(1), p. 155. doi: 
10.1186/1471-2164-12-155.  
Foote, S. J., Galatis, D. and Cowman, A. F. (1990) ‘Amino acids in the 
dihydrofolate reductase-thymidylate synthase gene of Plasmodium 
falciparum involved in cycloguanil resistance differ from those involved in 
pyrimethamine resistance’, Proceedings of the National Academy of 
Sciences of the United States of America, 87(8): 3014–3017.  
Foth, B. J., Zhang, N., Chaal, B. K., Sze, S. K., Preiser, P. R. and Bozdech, Z. 
(2011) ‘Quantitative time-course profiling of parasite and host cell proteins 
in the human malaria parasite Plasmodium falciparum.’, Molecular & 
cellular proteomics, 10(8), p. M110.006411. doi: 
10.1074/mcp.M110.006411.  
Fouge ̀re, A., Jackson, A. P., Paraskevi Bechtsi, D., Braks, J. A. M., Annoura, T., 
Fonager, J., Spaccapelo, R., Ramesar, J., Chevalley-Maurel, S., Klop, O., 
van der Laan, A. M. A., Tanke, H. J., Kocken, C. H. M., Pasini, E. M., Khan, 
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